Both	O
the	O
tails	O
and	O
globular	O
domains	O
of	O
histones	O
can	O
undergo	O
multiple	O
posttranslational	O
modifications	O
,	O
including	O
acetylation	O
,	O
methylation	O
,	O
phosphorylation	O
,	O
ADP	O
ribosylation	O
,	O
ubiquitination	O
and	O
sumoylation	O
,	O
giving	O
rise	O
to	O
the	O
so	O
-	O
called	O
histone	O
code	O
(	O
Strahl	O
&	O
Allis2000	O
;	O
Turner2000	O
;	O
Jenuwein	O
&	O
Allis2001	O
;	O
Bhaumik	O
et	O
al	O
.	O
2007	O
;	O
Kouzarides2007	O
;	O
Suganuma	O
&	O
Workman2011	O
).	O

Therefore	O
,	O
in	O
considering	O
early	O
vitamin	O
D	O
supplementation	O
,	O
the	O
question	O
becomes	O
whether	O
there	O
is	O
physiological	O
benefit	O
to	O
rapid	O
replenishment	O
with	O
vitamin	O
D	O
(	O
e	O
.	O
g	O
.	O

Use	O
of	O
the	O
Report	O
Card	O
grades	O
by	O
state	O
governments	O
has	O
grown	O
since	O
the	O
Report	O
Cards	O
were	O
first	O
launched	O
in	O
2008	O
,	O
and	O
coverage	O
by	O
local	O
media	O
is	O
consistently	O
strong	O
.	O

Also	O
,	O
increasing	O
physical	O
activity	O
during	O
pregnancy	O
has	O
been	O
related	O
to	O
lower	O
GWG	O
in	O
some	O
[	O
41	O
]	O
but	O
not	O
all	O
[	O
42	O
]	O
observational	O
studies	O
.	O

A	O
recent	O
study	O
further	O
revealed	O
that	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
inversely	O
correlated	O
with	O
the	O
risk	O
of	O
transient	O
early	O
wheezing	O
[	O
11	O
].	O

While	O
the	O
use	O
of	O
a	O
more	O
sensitive	O
test	O
would	O
provide	O
more	O
detailed	O
and	O
accurate	O
estimates	O
of	O
early	O
neurodevelopmental	O
achievement	O
,	O
the	O
ASQ	O
has	O
been	O
validated	O
against	O
robust	O
assessment	O
tools	O
[	O
32	O
],	O
and	O
in	O
a	O
paediatric	O
population	O
[	O
33	O
].	O

We	O
initially	O
tested	O
all	O
covariates	O
,	O
and	O
those	O
included	O
in	O
the	O
final	O
models	O
were	O
considered	O
to	O
be	O
important	O
confounding	B
factors	I
for	O
the	O
relation	O
between	O
the	O
main	O
exposure	O
and	O
psychotic	O
-	O
like	O
symptoms	O
.	O

The	O
significant	O
associations	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
with	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
remained	O
,	O
unattenuated	O
,	O
on	O
mutual	O
adjustment	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
post	O
-	O
natal	O
exposure	O
(	O
table	O
4and	O
supplementary	O
table	O
E4	O
,	O
respectively	O
).	O

Polycystic	O
Ovary	O
Syndrome	O
PCOS	O
is	O
the	O
most	O
often	O
diagnosed	O
endocrinological	O
disorder	O
in	O
women	O
in	O
their	O
reproductive	O
period	O
,	O
affecting	O
15	O
%–	O
20	O
%	O
of	O
population	O
,	O
according	O
to	O
the	O
European	O
Society	O
for	O
Human	O
Reproduction	O
and	O
Embryology	O
standards	O
[	O
21	O
].	O

The	O
placebo	O
control	O
group	O
allowed	O
for	O
an	O
absolute	O
evaluation	O
of	O
the	O
effects	O
of	O
micronutrients	O
on	O
haematological	O
parameters	O
.	O

Both	O
the	O
Diabetes	O
Prevention	O
Program86and	O
the	O
Finnish	O
Diabetes	O
Prevention	O
Study87demonstrated	O
this	O
,	O
with	O
an	O
intensive	O
intervention	O
including	O
lifestyle	O
coaches	O
,	O
strict	O
supervised	O
exercise	O
regimes	O
and	O
caloric	O
restriction	O
.	O

Discussion	O
At	O
present	O
,	O
this	O
is	O
one	O
of	O
the	O
largest	O
studies	O
to	O
investigate	O
pregnancy	O
outcomes	O
following	O
maternal	O
use	O
of	O
SGA	O
monotherapy	O
and	O
polytherapy	O
with	O
other	O
psychotropic	O
medications	O
.	O

(	O
2013	O
)*	O
Phthalates	O
:	O
Dibutylphthalate	O
(	O
DBP	O
)	O
RatOral	O
(	O
gavage	O
)	O
(	O
500	O
mg	O
/	O
kg	O
/	O
d	O
)	O
In	O
uteroIn	O
utero	O
to	O
early	O
adulthood	O
F1male	O
offspring	O
↓	O
testicular	O
testosterone	O
and	O
Leydig	O
stem	O
cellsHistone	O
modificationKilcoyne	O
et	O
al	O
.	O

Maternal	O
iron	O
deficiency	O
and	O
anemia	O
early	O
in	O
gestation	O
can	O
result	O
in	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

Subjects	O
/	O
Methods	O
:	O
The	O
study	O
in	O
293	O
women	O
aged	O
from	O
17	O
to	O
45	O
years	O
old	O
was	O
nested	O
within	O
a	O
double	O
-	O
blind	O
,	O
randomised	O
placebo	O
-	O
controlled	O
trial	O
of	O
periconceptional	O
MMN	O
supplementation	O
[	O
ISRCTN	O
13687662	O
],	O
using	O
the	O
United	O
Nations	O
International	O
Multiple	O
Micronutrient	O
Preparation	O
(	O
UNIMMAP	O
),	O
received	O
daily	O
for	O
one	O
year	O
or	O
until	O
conception	O
.	O

Feeding	O
cereal	O
grains	O
is	O
one	O
way	O
to	O
raise	O
net	O
energy	O
supply	O
because	O
energy	O
dense	O
grains	O
can	O
be	O
utilized	O
in	O
the	O
rumen	O
and	O
the	O
small	O
intestine	O
to	O
produce	O
volatile	O
fatty	O
acids	O
and	O
glucose	O
for	O
energy	O
production	O
.	O

No	O
prior	O
studies	O
have	O
specifically	O
examined	O
impacts	O
of	O
maternal	O
intake	O
of	O
sweets	O
or	O
soft	O
drinks	O
in	O
pregnancy	O
on	O
offspring	O
weight	O
parameters	O
.	O

Mean	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
significantly	O
lower	O
among	O
children	O
with	O
S	O
-	O
ECC	O
than	O
caries	O
-	O
free	O
controls	O
(	O
68	O
.	O
9	O
±	O
28	O
.	O
0	O
nmol	O
/	O
L	O
vs	O
.	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
(	O
Table	O
2	O
).	O

Many	O
of	O
the	O
dopaminergic	O
cells	O
in	O
this	O
region	O
also	O
express	O
neuropeptides	O
such	O
as	O
bradykinan	O
,	O
neurotensin	O
and	O
substance	O
P	O
.	O
The	O
protein	O
with	O
the	O
greatest	O
fold	O
change	O
in	O
this	O
study	O
was	O
thimet	O
oligopeptidase	O
(	O
down	O
-	O
regulated	O
1	O
.	O
67	O
),	O
which	O
is	O
involved	O
in	O
the	O
degradation	O
of	O
these	O
small	O
proteins	O
[	O
37	O
].	O

The	O
major	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
glomerular	O
development	O
and	O
renal	O
structure	O
at	O
birth	O
,	O
10	O
days	O
and	O
adulthood	O
in	O
mice	O
born	O
to	O
mothers	O
fed	O
a	O
diet	O
restricted	O
in	O
vitamin	O
D	O
.	O
Although	O
,	O
we	O
examined	O
other	O
variables	O
,	O
such	O
as	O
body	O
mass	O
and	O
24	O
h	O
urine	O
,	O
the	O
present	O
study	O
was	O
not	O
designed	O
to	O
investigate	O
renal	O
functional	O
and	O
metabolic	O
consequences	O
but	O
rather	O
was	O
designed	O
to	O
answer	O
the	O
question	O
of	O
whether	O
there	O
were	O
structural	O
,	O
glomerular	O
alterations	O
or	O
transgenerational	O
effects	O
.	O

The	O
authors	O
of	O
the	O
study	O
suggest	O
a	O
direct	O
effect	O
of	O
vitamin	O
D	O
on	O
AMH	O
production	O
,	O
and	O
thus	O
longer	O
maintenance	O
of	O
ovarian	O
reserve	O
in	O
the	O
patients	O
with	O
its	O
higher	O
concentration	O
[	O
46	O
].	O

All	O
53	O
exposure	O
variables	O
from	O
5	O
chemical	O
classes	O
were	O
included	O
in	O
the	O
final	O
BHLM	O
model	O
for	O
analysis	O
.	O

Current	O
OECD	O
human	O
health	O
related	O
TGs	O
that	O
have	O
the	O
potential	O
for	O
adaptation	O
to	O
include	O
epigenetic	O
endpoints	O
.	O
Type	O
of	O
studyTGsDescriptionGeneral	O
exposure	O
studiesTG	O
451Carcinogenicity	O
studies	O
TG	O
452Chronic	O
toxicity	O
studies	O
TG	O
453Combined	O
chronic	O
toxicity	O
/	O
carcinogenicity	O
studiesPost	O
-	O
mitotic	O
cell	O
studiesTG	O
424Neurotoxicity	O
study	O
in	O
rodentsPrenatal	O
effectsTG	O
414Prenatal	O
development	O
toxicity	O
study	O
TG	O
426Developmental	O
neurotoxicity	O
studyReproductive	O
effectsTGs	O
415	O
,	O
416One	O
-	O
and	O
two	O
-	O
generation	O
reproduction	O
toxicity	O
TG	O
421	O
(	O
Revised	O
)	O
Reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
422	O
(	O
Revised	O
)	O
Combined	O
repeated	O
dose	O
toxicity	O
study	O
with	O
the	O
reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
443Extended	O
one	O
-	O
generation	O
reproductive	O
toxicity	O
studyGenotoxicity	O
testsTG	O
483	O
(	O
Revised	O
2015	O
)	O
Mammalian	O
spermatogonial	O
chromosome	O
aberration	O
testAlternative	O
models	O
integrating	O
multiple	O
mechanisms	O
of	O
toxicityTG	O
236	O
-	O
Zebrafish	O
embryo	O
epigenetic	O
toxicity	O
assay	O
Xenopus	O
Embryo	O
Thyroid	O
Assay	O
(	O
XETA	O
Assay	O
)	O
(	O
in	O
validation	O
)	O
Updated	O
from	O
Greally	O
and	O
Jacobs	O
(	O
2013	O
).	O

We	O
are	O
presenting	O
a	O
case	O
of	O
gestational	O
diabetes	O
insipidus	O
in	O
a	O
patient	O
with	O
HELLP	O
syndrome	O
.	O

In	O
addition	O
,	O
participants	O
with	O
GDM	O
in	O
this	O
study	O
were	O
mostly	O
urban	O
residents	O
with	O
a	O
higher	O
socioeconomic	O
status	O
.	O

The	O
doses	O
for	O
adults	O
and	O
elderly	O
people	O
of	O
proper	O
body	O
weight	O
,	O
and	O
pregnant	O
and	O
lactating	O
women	O
should	O
not	O
exceed	O
4000	O
IU	O
daily	O
,	O
and	O
the	O
supplementation	O
dosage	O
recommended	O
for	O
pregnant	O
women	O
in	O
winter	O
and	O
less	O
sunny	O
countries	O
is	O
1500	O
–	O
4000	O
IU	O
per	O
day	O
(	O
37	O
.	O
5	O
–	O
50	O
.	O
0	O
μg	O
/	O
day	O
)	O
[	O
10	O
,	O
66	O
,	O
70	O
].	O

This	O
may	O
be	O
attributable	O
to	O
the	O
synergistic	O
effects	O
of	O
food	O
[	O
34	O
]	O
and	O
associated	O
with	O
fish	O
being	O
a	O
source	O
of	O
other	O
nutrients	O
which	O
are	O
important	O
for	O
infant	O
development	O
such	O
as	O
iodine	O
and	O
vitamin	O
D	O
.	O
Presently	O
,	O
there	O
have	O
been	O
no	O
randomised	O
control	O
trials	O
examining	O
neurocognitive	O
outcomes	O
associated	O
with	O
prenatal	O
multivitamin	O
use	O
and	O
infant	O
neurodevelopment	O
,	O
and	O
these	O
are	O
unlikely	O
to	O
occur	O
given	O
ethical	O
implications	O
of	O
such	O
[	O
35	O
].	O

Summary	O
Many	O
women	O
experience	O
type	O
I	O
allergies	O
during	O
pregnancy	O
.	O

The	O
cross	O
-	O
sectional	O
design	O
did	O
not	O
allow	O
us	O
to	O
distinguish	O
between	O
cause	O
and	O
effect	O
.	O

Sensitivity	O
analysis	O
As	O
the	O
women	O
were	O
allowed	O
to	O
continue	O
taking	O
vitamin	O
D	O
supplements	O
containing	O
up	O
to	O
400	O
IU	O
/	O
d	O
,	O
in	O
sensitivity	O
analyses	O
,	O
we	O
included	O
only	O
women	O
who	O
were	O
not	O
taking	O
additional	O
vitamin	O
D	O
–	O
containing	O
supplements	O
at	O
34	O
weeks	O
of	O
gestation	O
(	O
n	O
=	O
224	O
,	O
67	O
.	O
7	O
%).	O

Results	O
:	O
Only	O
rs12785878	O
(	O
DHCR7	O
)	O
was	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
[	O
β	O
=	O
3	O
.	O
1	O
nmol	O
/	O
L	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
1	O
.	O
0	O
to	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
<	O
0	O
.	O
004	O
].	O

Other	O
publication	O
has	O
also	O
reported	O
a	O
protective	O
effect	O
of	O
adherence	O
to	O
Mediterranean	O
diet	O
during	O
pregnancy	O
and	O
risk	O
of	O
delivering	O
a	O
fetal	O
growth	O
–	O
restricted	O
infant	O
for	O
weight	O
in	O
Atlantic	O
area	O
[	O
16	O
].	O

In	O
May	O
2014	O
,	O
Nicaragua	O
expanded	O
influenza	O
vaccination	O
to	O
all	O
pregnant	O
women	O
in	O
the	O
country	O
.	O

Vitamin	O
D	O
deficiency	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
in	O
humans	O
has	O
been	O
associated	O
with	O
cardiovascular	O
disease	O
,	O
diabetes	O
and	O
obesity	O
in	O
offspring	O
[	O
23	O
],	O
which	O
could	O
be	O
linked	O
to	O
the	O
potential	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
regulation	O
of	O
adiposity	O
[	O
24	O
],[	O
25	O
].	O

Having	O
done	O
so	O
,	O
however	O
,	O
some	O
of	O
our	O
participants	O
may	O
not	O
have	O
accurately	O
remembered	O
their	O
use	O
of	O
supplements	O
early	O
in	O
pregnancy	O
or	O
before	O
conception	O
.	O

Several	O
of	O
the	O
components	O
of	O
the	O
network	O
converge	O
on	O
MAPK1	O
,	O
a	O
MAP	O
kinase	O
that	O
serves	O
to	O
integrate	O
multiple	O
biochemical	O
signals	O
(	O
previously	O
known	O
as	O
ERK2	O
),	O
that	O
was	O
found	O
to	O
be	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
proteomics	O
study	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0002383	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Network	O
analysis	O
of	O
the	O
proteins	O
assembled	O
by	O
Ingenuity	O
Pathway	O
Analysis	O
.	O

Ethics	O
approval	O
was	O
obtained	O
from	O
the	O
ALSPAC	O
Ethics	O
and	O
Law	O
Committee	O
(	O
IRB	O
00003312	O
)	O
and	O
the	O
Local	O
National	O
Health	O
Service	O
Research	O
Ethics	O
Committees	O
.	O

The	O
Efficacy	O
and	O
Safety	O
of	O
a	O
High	O
Dose	O
of	O
Vitamin	O
D	O
in	O
Mothers	O
with	O
Gestational	O
Diabetes	O
Mellitus	O
:	O
A	O
Randomized	O
Controlled	O
Clinical	O
Trial	O
Abstract	O
Background	O
:	O
During	O
pregnancy	O
and	O
lactation	O
outstanding	O
changes	O
occur	O
in	O
mother	O
’	O
s	O
vitamin	O
D	O
metabolism	O
.	O

The	O
capillaries	O
were	O
not	O
arranged	O
in	O
lobules	O
and	O
rather	O
were	O
dispersed	O
among	O
spicules	O
of	O
mineralized	O
bone	O
.	O

Thus	O
,	O
the	O
impact	O
of	O
early	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
needs	O
confirmation	O
in	O
a	O
larger	O
scale	O
trial	O
.	O

Therefore	O
,	O
strategies	O
that	O
up	O
-	O
regulate	O
both	O
hyperplasia	O
and	O
hypertrophy	O
of	O
fat	O
cells	O
are	O
effective	O
ways	O
to	O
improve	O
IMF	O
deposition	O
.	O

The	O
MiG	O
Study	O
randomized	O
751	O
women	O
with	O
GDM	O
to	O
treatment	O
with	O
insulin	O
or	O
metformin	O
.	O
72The	O
women	O
in	O
the	O
metformin	O
arm	O
were	O
treated	O
with	O
supplemental	O
insulin	O
if	O
the	O
maximal	O
dose	O
of	O
metformin	O
,	O
2500	O
mg	O
daily	O
,	O
failed	O
to	O
meet	O
the	O
glucose	O
targets	O
.	O

Likewise	O
,	O
non	O
-	O
vaccination	O
status	O
was	O
corroborated	O
if	O
no	O
information	O
on	O
vaccination	O
including	O
specific	O
date	O
for	O
vaccination	O
was	O
identified	O
from	O
these	O
sources	O
.	O

They	O
showed	O
that	O
supplementation	O
with	O
an	O
oral	O
dose	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
and	O
500	O
-	O
1000	O
mg	O
daily	O
of	O
calcium	O
led	O
to	O
an	O
increase	O
in	O
the	O
concentration	O
of	O
serum	O
vitamin	O
D	O
from	O
15	O
to	O
81	O
.	O
4	O
nmol	O
/	O
l	O
.	O

At	O
94	O
dpc	O
15	O
AP	O
-	O
samples	O
met	O
the	O
appropriate	O
quality	O
control	O
criteria	O
(	O
94	O
dpc	O
-	O
LP	O
:	O
16	O
;	O
1	O
dpn	O
-	O
AP	O
:	O
15	O
;	O
1	O
dpn	O
-	O
LP	O
:	O
14	O
;	O
28	O
dpn	O
-	O
AP	O
:	O
14	O
;	O
28	O
dpn	O
-	O
LP	O
:	O
15	O
;	O
188	O
dpn	O
-	O
AP	O
:	O
16	O
;	O
188	O
dpn	O
-	O
LP	O
:	O
16	O
samples	O
).	O

Introduction	O
Adolescent	O
and	O
adult	O
women	O
of	O
childbearing	O
age	O
in	O
the	O
United	O
States	O
of	O
America	O
have	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
[	O
1	O
],[	O
2	O
].	O

Researchers	O
were	O
blinded	O
to	O
subject	O
allocation	O
scheme	O
and	O
subjects	O
and	O
field	O
staff	O
knew	O
only	O
the	O
colour	O
-	O
coded	O
allocation	O
groups	O
.	O

Second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O

Though	O
compliance	O
with	O
weekly	O
dosage	O
may	O
be	O
better	O
than	O
daily	O
regimen	O
because	O
of	O
reduced	O
side	O
effects	O
,	O
it	O
is	O
desirable	O
to	O
conduct	O
further	O
field	O
randomized	O
controlled	O
trials	O
in	O
order	O
to	O
establish	O
the	O
efficacy	O
of	O
weekly	O
supplementation	O
compared	O
to	O
daily	O
regimen	O
.	O

The	O
composition	O
of	O
UNIMMAP	O
is	O
shown	O
inTable	O
1	O
(	O
UNICEF	O
/	O
WHO	O
/	O
UNU	O
1999	O
).	O

2001	O
).	O

I	O
agree	O
with	O
Dr	O
Eyles	O
’	O
comment	O
that	O
the	O
vitamin	O
D	O
theory	O
is	O
‘	O
highly	O
parsimonious	O
.’	O
Indeed	O
,	O
it	O
was	O
love	O
of	O
parsimony	O
that	O
led	O
me	O
to	O
first	O
hypothesize	O
that	O
vitamin	O
D	O
is	O
intimately	O
involved	O
in	O
the	O
pathology	O
and	O
epidemiology	O
of	O
both	O
autism	O
and	O
influenza	O
(	O
21	O
).	O

TL	O
,	O
T	O
lymphocytes	O
;	O
SNS	O
,	O
sympathetic	O
nervous	O
system	O
.	O

Thus	O
,	O
the	O
reversibility	O
of	O
environmentally	O
induced	O
changes	O
is	O
also	O
critically	O
important	O
when	O
determining	O
the	O
true	O
potential	O
adversity	O
of	O
an	O
environmental	O
exposure	O
.	O

Health	O
and	O
dietary	O
information	O
were	O
obtained	O
from	O
parental	O
report	O
and	O
confirmed	O
by	O
medical	O
records	O
from	O
the	O
primary	O
care	O
physician	O
or	O
the	O
hospital	O
.	O

PTB	O
rates	O
were	O
20	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
248	O
),	O
12	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
267	O
),	O
13	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
255	O
)	O
and	O
9	O
%	O
in	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
294	O
)	O
(	O
Table	O
2	O
).	O

found	O
that	O
a	O
prolonged	O
labor	O
(	O
greater	O
than	O
18	O
–	O
24	O
hours	O
)	O
resulted	O
in	O
an	O
increased	O
risk	O
for	O
autism	O
[	O
18	O
].	O

The	O
aim	O
was	O
to	O
include	O
22	O
women	O
in	O
each	O
cluster	O
of	O
which	O
11	O
in	O
the	O
first	O
trimester	O
and	O
11	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

The	O
Avy	O
model	O
in	O
particular	O
has	O
been	O
put	O
forward	O
as	O
a	O
potential	O
epigenetic	O
toxicological	O
tool	O
(	O
Dolinoy2008	O
;	O
Rosenfeld2010	O
;	O
Faulk	O
et	O
al	O
.	O
2013	O
).	O

The	O
same	O
study	O
stressed	O
that	O
the	O
level	O
of	O
knowledge	O
about	O
food	O
sources	O
and	O
the	O
role	O
of	O
folic	O
acid	O
during	O
pregnancy	O
was	O
influenced	O
by	O
socio	O
-	O
demographic	O
factors	O
,	O
especially	O
the	O
level	O
of	O
education	O
[	O
38	O
].	O

Thus	O
,	O
49	O
261	O
returned	O
the	O
questionnaires	O
and	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

A	O
significant	O
correlation	O
was	O
observed	O
between	O
the	O
first	O
and	O
second	O
trimesters	O
visfatin	O
level	O
with	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
,	O
such	O
that	O
this	O
relationship	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

(	O
2006	O
)],	O
presence	O
within	O
1	O
kb	O
of	O
at	O
least	O
one	O
of	O
258	O
computationally	O
predicted	O
transcription	O
factor	O
binding	O
site	O
(	O
TFBS	O
)	O
sequences	O
obtained	O
from	O
the	O
tfbsConsSites	O
track	O
of	O
the	O
University	O
of	O
California	O
–	O
Santa	O
Cruz	O
(	O
UCSC	O
)	O
Genomes	O
Browser	O
site	O
(	O
TFBS	O
z	O
-	O
score	O
>	O
2	O
)	O
(	O
Kent	O
et	O
al	O
.	O

However	O
,	O
the	O
urinary	O
uric	O
acid	O
and	O
proteinuria	O
values	O
were	O
not	O
different	O
across	O
the	O
groups	O
.	O

Routine	O
use	O
of	O
iron	O
supplements	O
is	O
common	O
,	O
as	O
it	O
is	O
difficult	O
to	O
ensure	O
adequate	O
intake	O
from	O
food	O
sources	O
,	O
even	O
from	O
those	O
with	O
relatively	O
high	O
iron	O
bioavailability	O
[	O
29	O
,	O
30	O
].	O

However	O
,	O
only	O
among	O
participants	O
vaccinated	O
in	O
the	O
first	O
trimester	O
,	O
the	O
percentage	O
with	O
preterm	O
birth	O
was	O
12	O
%,	O
significantly	O
higher	O
than	O
the	O
unvaccinated	O
group	O
(	O
6	O
%;	O
p	O
-	O
value	O
<	O
0	O
.	O
05	O
;	O
Supplementary	O
material	O
A2	O
).	O

[	O
30	O
],	O
we	O
used	O
the	O
Zymo	O
DNA	O
extraction	O
kit	O
(	O
Zymo	O
Research	O
)	O
to	O
extract	O
microbial	O
DNA	O
from	O
thawed	O
samples	O
and	O
quantified	O
the	O
DNA	O
using	O
OD260	O
/	O
280	O
nanodrop	O
.	O

Sequencing	O
of	O
genomic	O
DNA	O
revealed	O
a	O
T	O
-	O
to	O
-	O
A	O
transversion	O
at	O
nucleotide	O
position	O
1151	O
,	O
causing	O
a	O
mutation	O
from	O
an	O
isoleucine	O
residue	O
to	O
an	O
asparagine	O
residue	O
(	O
I384N	O
)	O
(	O
Figure	O
3A	O
,	O
left	O
panel	O
).	O

Neonatal	O
data	O
collected	O
at	O
birth	O
from	O
the	O
medical	O
file	O
include	O
date	O
and	O
time	O
of	O
birth	O
,	O
gender	O
,	O
Apgar	O
score	O
(	O
at	O
1	O
and	O
5	O
min	O
)	O
[	O
56	O
],	O
vital	O
signs	O
,	O
medical	O
interventions	O
required	O
,	O
foetal	O
distress	O
and	O
presence	O
of	O
meconium	O
stained	O
liquor	O
.	O

Of	O
the	O
256	O
(	O
37	O
%)	O
women	O
who	O
met	O
eligibility	O
criteria	O
,	O
253	O
(	O
99	O
%)	O
consented	O
to	O
take	O
part	O
.	O

Thumbprint	O
or	O
signature	O
consent	O
was	O
obtained	O
from	O
the	O
child	O
'	O
s	O
parents	O
(	O
mother	O
and	O
father	O
if	O
in	O
Kabul	O
or	O
another	O
family	O
member	O
responsible	O
for	O
the	O
child	O
)	O
at	O
home	O
if	O
the	O
child	O
met	O
our	O
study	O
criteria	O
and	O
after	O
either	O
the	O
parent	O
read	O
the	O
Dari	O
consent	O
form	O
or	O
it	O
was	O
explained	O
to	O
him	O
or	O
her	O
by	O
the	O
fieldworker	O
.	O

However	O
,	O
a	O
limitation	O
of	O
50	O
%	O
CIs	O
when	O
used	O
for	O
multiple	O
frequentist	O
hypothesis	O
tests	O
is	O
that	O
they	O
have	O
a	O
higher	O
Type	O
I	O
error	O
rate	O
than	O
using	O
alpha	O
level	O
=	O
0	O
.	O
05	O
.	O

Objectives	O
and	O
hypothesis	O
The	O
trial	O
objectives	O
are	O
to	O
evaluate	O
the	O
effect	O
of	O
early	O
availability	O
and	O
promotion	O
of	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
,	O
low	O
birthweight	O
and	O
preterm	O
delivery	O
.	O

However	O
,	O
they	O
suggested	O
that	O
this	O
applied	O
only	O
in	O
developed	O
countries	O
and	O
when	O
no	O
adjustments	O
for	O
confounders	B
were	O
made	O
[	O
6	O
].	O

Delivering	O
high	O
doses	O
of	O
mHealth	O
interventions	O
has	O
implications	O
in	O
terms	O
of	O
cost	O
,	O
participant	O
burden	O
,	O
and	O
potential	O
“	O
wear	O
out	O
”	O
effects	O
(	O
ie	O
,	O
overexposure	O
).	O

The	O
models	O
will	O
evaluate	O
the	O
impact	O
of	O
the	O
interventions	O
over	O
time	O
by	O
testing	O
for	O
an	O
interaction	O
between	O
time	O
and	O
intervention	O
group	O
.	O

The	O
serum	O
osmolality	O
was	O
356	O
mOsm	O
/	O
kg	O
;	O
urine	O
sodium	O
21	O
mEq	O
/	O
L	O
and	O
urine	O
osmolality	O
was	O
inappropriately	O
low	O
(	O
225	O
mOsm	O
/	O
kg	O
).	O

Since	O
the	O
mid	O
-	O
1990s	O
,	O
the	O
use	O
of	O
SGAs	O
has	O
increased	O
drastically	O
and	O
expanded	O
rapidly	O
to	O
the	O
treatment	O
of	O
depressive	O
and	O
anxiety	O
disorders	O
.	O
10	O
–	O
13Furthermore	O
,	O
deinstitutionalisation	O
,	O
the	O
destigmatisation	O
of	O
mental	O
illness	O
and	O
the	O
improved	O
side	O
effect	O
profile	O
of	O
SGAs	O
,	O
particularly	O
the	O
reduced	O
incidence	O
of	O
hyperprolactinaemia	O
in	O
most	O
SGAs	O
,	O
have	O
all	O
contributed	O
to	O
increased	O
fertility	O
rates	O
among	O
treated	O
women	O
.	O
9The	O
rise	O
in	O
birth	O
rate	O
in	O
women	O
with	O
psychiatric	O
disorders	O
,	O
combined	O
with	O
the	O
increase	O
in	O
off	O
-	O
label	O
usage	O
of	O
these	O
medications	O
,	O
has	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
fetuses	O
exposed	O
to	O
this	O
newer	O
class	O
of	O
antipsychotics	O
.	O

Study	O
location	O
and	O
population	O
Kiang	O
West	O
is	O
a	O
semi	O
-	O
arid	O
area	O
of	O
savannah	O
-	O
scrubland	O
with	O
a	O
rural	O
population	O
of	O
14	O
000	O
people	O
,	O
predominantly	O
of	O
the	O
Mandinka	O
tribe	O
.	O

Vitamin	O
A	O
and	O
E	O
status	O
will	O
be	O
determined	O
using	O
high	O
pressure	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
and	O
ultraviolet	O
light	O
detection	O
[	O
71	O
].	O

First	O
trimester	O
BMI	O
was	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
for	O
both	O
first	O
and	O
third	O
trimester	O
pregnant	O
women	O
.	O

However	O
,	O
according	O
to	O
the	O
recent	O
studies	O
,	O
vitamin	O
D	O
deficiency	O
is	O
also	O
common	O
in	O
these	O
countries10	O
,	O
11	O
.	O

The	O
fact	O
that	O
several	O
risk	O
factors	O
during	O
the	O
prenatal	O
and	O
labor	O
periods	O
are	O
implicated	O
in	O
autism	O
should	O
prompt	O
the	O
medical	O
community	O
to	O
focus	O
on	O
the	O
pregnancy	O
and	O
labor	O
periods	O
as	O
preventive	O
measures	O
to	O
curb	O
the	O
incidence	O
of	O
autism	O
.	O

Interestingly	O
,	O
the	O
height	O
of	O
the	O
child	O
continued	O
at	O
ages	O
5	O
and	O
9	O
to	O
be	O
strongly	O
correlated	O
with	O
that	O
of	O
the	O
PGF	O
,	O
not	O
easily	O
explainable	O
by	O
conventional	O
genetic	O
inheritance	O
,	O
though	O
there	O
may	O
be	O
a	O
Y	O
-	O
related	O
influence	O
at	O
play	O
through	O
the	O
father	O
,	O
who	O
himself	O
is	O
highly	O
correlated	O
with	O
his	O
father	O
.	O

Although	O
there	O
was	O
no	O
difference	O
in	O
the	O
rate	O
of	O
clinical	O
infection	O
diagnosis	O
between	O
the	O
two	O
arms	O
of	O
the	O
parent	O
trial	O
,	O
longitudinal	O
malaria	O
exposure	O
may	O
have	O
been	O
an	O
effect	B
modifier	I
or	O
confounding	B
variable	O
in	O
this	O
study	O
and	O
ought	O
to	O
be	O
assessed	O
formally	O
in	O
future	O
work	O
.	O

Regarding	O
female	O
offspring	O
,	O
two	O
-	O
way	O
ANOVA	O
indicated	O
a	O
main	O
effect	O
of	O
prenatal	O
diet	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
7	O
.	O
517	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
and	O
an	O
almost	O
significant	O
effect	O
of	O
treatment	O
[	O
F	O
(	O
3	O
,	O
31	O
)=	O
3	O
.	O
928	O
,	O
P	O
=	O
0	O
.	O
056	O
]	O
on	O
chocolate	O
intake	O
(	O
Figure3G	O
).	O

Vasopressinase	O
is	O
a	O
cysteine	O
aminopeptidase	O
of	O
molecular	O
weight	O
330	O
kDa	O
,	O
and	O
is	O
produced	O
by	O
the	O
placental	O
trophoblasts	O
during	O
pregnancy	O
as	O
discussed	O
by	O
Gordge	O
et	O
al	O
.	O

Preexisting	O
asthma	O
symptoms	O
may	O
worsen	O
,	O
improve	O
,	O
or	O
remain	O
unchanged	O
during	O
pregnancy	O
.	O

Abstract	O
Background	O
Pet	O
keeping	O
has	O
been	O
linked	O
with	O
decreased	O
risk	O
of	O
allergic	O
sensitization	O
,	O
which	O
has	O
been	O
associated	O
with	O
the	O
Hygiene	O
Hypothesis	O
;	O
and	O
more	O
recently	O
,	O
by	O
ourselves	O
and	O
others	O
,	O
to	O
particular	O
home	O
microbiome	O
patterns	O
.	O

A	O
study	O
team	O
member	O
not	O
involved	O
in	O
day	O
-	O
to	O
-	O
day	O
field	O
operations	O
constructed	O
the	O
assignment	O
table	O
.	O

This	O
finding	O
was	O
possibly	O
confounded	O
by	O
smoking	O
,	O
which	O
was	O
more	O
prevalent	O
in	O
the	O
deficient	O
GDM	O
mothers	O
compared	O
with	O
deficient	O
non	O
-	O
GDM	O
mothers	O
.	O

The	O
pleasant	O
feeling	O
of	O
motherhood	O
can	O
probably	O
play	O
a	O
role	O
in	O
decreasing	O
depression	O
specially	O
in	O
primiparous	O
mothers	O
[	O
77	O
].	O

Aims	O
of	O
the	O
study	O
The	O
aims	O
of	O
the	O
NuPED	O
study	O
are	O
1	O
)	O
to	O
assess	O
dietary	O
intake	O
and	O
nutritional	O
status	O
of	O
urban	O
pregnant	O
women	O
in	O
Johannesburg	O
,	O
South	O
Africa	O
,	O
and	O
2	O
)	O
to	O
determine	O
associations	O
with	O
birth	O
outcomes	O
,	O
measures	O
of	O
maternal	O
health	O
,	O
as	O
well	O
as	O
measures	O
of	O
offspring	O
health	O
and	O
development	O
.	O

To	O
this	O
date	O
there	O
has	O
been	O
some	O
contradicting	O
evidence	O
as	O
to	O
the	O
role	O
of	O
these	O
polymorphisms	O
in	O
fetal	O
outcomes	O
[	O
17	O
–	O
19	O
].	O

Vitamin	O
D	O
deficiency	O
has	O
been	O
linked	O
to	O
rickets	O
in	O
children	O
and	O
osteomalacia	O
in	O
adults	O
[	O
1	O
].	O

It	O
is	O
also	O
relevant	O
to	O
note	O
that	O
Hibbeln	O
et	O
al	O
.	O

The	O
integration	O
of	O
the	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplement	O
and	O
deworming	O
program	O
into	O
the	O
existing	O
health	O
infrastructure	O
in	O
Yen	O
Bai	O
province	O
has	O
been	O
described	O
elsewhere	O
[	O
14	O
].	O

2002	O
),	O
and	O
localization	O
within	O
each	O
of	O
the	O
following	O
classes	O
of	O
repetitive	O
element	O
as	O
defined	O
by	O
the	O
Repeatmasker	O
track	O
of	O
Genomes	O
Browser	O
:	O
Alu	O
,	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
and	O
mammalian	O
wide	O
-	O
interspersed	O
repeat	O
elements	O
(	O
MIRs	O
).	O

Spearman	O
correlations	O
(	O
ρ	O
)	O
were	O
used	O
to	O
assess	O
the	O
association	O
between	O
each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
obtained	O
at	O
various	O
time	O
points	O
:	O
(	O
1	O
)	O
at	O
the	O
corresponding	O
follow	O
-	O
up	O
visit	O
;	O
(	O
2	O
)	O
at	O
delivery	O
;	O
(	O
3	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
(	O
using	O
the	O
area	O
under	O
the	O
curve	O
from	O
visit	O
3	O
to	O
visit	O
7	O
);	O
and	O
(	O
4	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
.	O

This	O
study	O
found	O
that	O
four	O
calcium	O
binding	O
proteins	O
were	O
significantly	O
altered	O
in	O
the	O
nucleus	O
accumbens	O
of	O
the	O
adult	O
DVD	O
-	O
deficient	O
rat	O
(	O
calbindin	O
,	O
calbindin2	O
,	O
hippocalcin	O
and	O
calreticulin	O
).	O

Background	O
Placental	O
pathology	O
is	O
often	O
found	O
in	O
pregnancies	O
complicated	O
by	O
intrauterine	O
growth	O
restriction	O
,	O
preeclampsia	O
or	O
intrauterine	O
fetal	O
death	O
.	O

Generalized	O
UniFrac	O
unifies	O
weighted	O
and	O
unweighted	O
UniFrac	O
to	O
detect	O
differences	O
in	O
moderately	O
abundant	O
lineages	O
instead	O
of	O
those	O
exclusively	O
in	O
highly	O
abundant	O
or	O
rare	O
lineages	O
[	O
43	O
,	O
44	O
].	O

Credit	O
:	O
Boston	O
Consulting	O
Group	O
with	O
the	O
Global	O
Preterm	O
Birth	O
Mortality	O
Reduction	O
Analysis	O
Group	O
.	O

Of	O
these	O
,	O
38	O
(	O
78	O
%)	O
returned	O
at	O
three	O
months	O
for	O
the	O
final	O
study	O
visit	O
.	O

The	O
mean	O
number	O
of	O
glomeruli	O
varied	O
from	O
10897	O
±	O
614	O
for	O
the	O
F1	O
-	O
SC	O
mice	O
to	O
14064	O
±	O
308	O
for	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
(	O
30	O
%	O
difference	O
;	O
P	O
<	O
0	O
.	O
0001	O
,	O
t	O
-	O
test	O
)	O
and	O
from	O
10466	O
±	O
867	O
for	O
the	O
F2	O
-	O
SC	O
mice	O
to	O
12015	O
±	O
785	O
for	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

[	O
17	O
]	O
Rojroongwasonkul	O
et	O
al	O
.	O

Similar	O
magnitudes	O
of	O
decreased	O
risk	O
for	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
were	O
observed	O
among	O
PTB	O
subtypes	O
:	O
spontaneous	O
PTB	O
(	O
58	O
%)	O
and	O
indicated	O
PTB	O
(	O
61	O
%).	O

Our	O
aim	O
was	O
to	O
assess	O
whether	O
oral	O
supplementation	O
of	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
will	O
reduce	O
the	O
incidence	O
and	O
severity	O
of	O
pneumonia	O
in	O
a	O
high	O
-	O
risk	O
infant	O
population	O
.	O

Multiple	O
regression	O
analysis	O
was	O
performed	O
for	O
mean	O
25	O
(	O
OH	O
)	O
D	O
including	O
independent	O
variables	O
significantly	O
associated	O
with	O
vitamin	O
D	O
levels	O
on	O
bivariate	O
analysis	O
or	O
known	O
to	O
influence	O
vitamin	O
D	O
status	O
.	O

Although	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
levels	O
do	O
correlate	O
to	O
maternal	O
levels	O
,	O
factors	O
that	O
affect	O
fetal	O
growth	O
may	O
not	O
be	O
uniform	O
throughout	O
pregnancy	O
and	O
this	O
difference	O
in	O
timing	O
could	O
affect	O
study	O
findings	O
.	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6In	O
addition	O
,	O
maternal	O
characteristics	O
such	O
as	O
obesity	O
or	O
pre	O
-	O
eclampsia	O
could	O
also	O
affect	O
results	O
that	O
may	O
not	O
have	O
been	O
seen	O
if	O
vitamin	O
D	O
samples	O
were	O
obtained	O
during	O
early	O
pregnancy	O
.	O

Stridor	O
was	O
present	O
while	O
crying	O
and	O
the	O
infant	O
had	O
a	O
barking	O
cough	O
and	O
occasional	O
wheeze	O
.	O

Eligibility	O
Criteria	O
Articles	O
published	O
in	O
peer	O
-	O
reviewed	O
journals	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
in	O
this	O
review	O
.	O

One	O
OTU	O
classified	O
to	O
the	O
genus	O
Corynebacterium	O
was	O
negatively	O
associated	O
with	O
maternal	O
dairy	O
intake	O
(	O
p	O
=	O
0	O
.	O
0044	O
),	O
and	O
one	O
each	O
OTU	O
classified	O
to	O
the	O
species	O
Acinetobacter	O
rhizosphaerae	O
(	O
p	O
=	O
0	O
.	O
0040	O
)	O
and	O
to	O
the	O
family	O
Ruminococcaceae	O
(	O
p	O
=	O
0	O
.	O
0061	O
),	O
respectively	O
,	O
were	O
also	O
positively	O
associated	O
with	O
maternal	O
dairy	O
intake	O
,	O
but	O
we	O
did	O
not	O
observe	O
multiple	O
related	O
OTUs	O
with	O
similar	O
associations	O
.	O

This	O
finding	O
is	O
in	O
agreement	O
with	O
previous	O
studies	O
in	O
humans	O
,	O
which	O
demonstrated	O
that	O
offspring	O
exposed	O
to	O
famine	O
or	O
hyperemesis	O
gravidarum	O
in	O
the	O
first	O
part	O
of	O
pregnancy	O
did	O
not	O
show	O
lower	O
birth	O
weight	O
(	O
Roseboom	O
et	O
al	O
.,	O
2006	O
;	O
Grooten	O
et	O
al	O
.,	O
2015	O
).	O

Two	O
-	O
way	O
ANOVA	O
and	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
females	O
;	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
RC	O
males	O
;	O
ns	O
,	O
non	O
-	O
significant	O
.	O

Second	O
,	O
our	O
previous	O
report	O
concluded	O
that	O
relatively	O
low	O
vitamin	O
D	O
levels	O
were	O
common	O
in	O
the	O
PATCH	O
population	O
sample	O
of	O
children	O
and	O
young	O
adults	O
with	O
an	O
inverse	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
age	O
being	O
shown	O
here	O
[	O
51	O
].	O

Background	O
Vitamin	O
D	O
status	O
and	O
season	O
are	O
intrinsically	O
linked	O
;	O
upon	O
exposure	O
to	O
natural	O
ultraviolet	O
solar	O
radiation	O
,	O
endogenous	O
skin	O
production	O
of	O
vitamin	O
D	O
occurs	O
.	O

In	O
order	O
to	O
investigate	O
transcriptional	O
features	O
of	O
developmental	O
nutritional	O
programming	O
we	O
conducted	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

Sensible	O
sun	O
exposure	O
and	O
education	O
of	O
the	O
public	O
about	O
the	O
beneficial	O
effects	O
of	O
some	O
limited	O
sun	O
exposure	O
to	O
satisfy	O
their	O
body	O
'	O
s	O
vitamin	O
D	O
requirements	O
should	O
be	O
implemented	O
.	O

Therefore	O
,	O
programs	O
that	O
target	O
peer	O
norms	O
may	O
be	O
effective	O
in	O
preventing	O
overweight	O
in	O
adolescents	O
.	O

To	O
minimize	O
the	O
effect	O
of	O
stress	O
during	O
HRV	O
assessment	O
,	O
we	O
conducted	O
a	O
pilot	O
project	O
two	O
months	O
prior	O
to	O
begin	O
the	O
current	O
study	O
.	O

By	O
clustering	O
,	O
we	O
hoped	O
to	O
uncover	O
biologically	O
meaningful	O
groups	O
of	O
CpG	O
loci	O
,	O
with	O
similar	O
methylation	O
patterns	O
,	O
which	O
may	O
share	O
biological	O
characteristics	O
such	O
as	O
comparable	O
functionality	O
in	O
certain	O
developmental	O
pathways	O
or	O
location	O
in	O
similar	O
genomic	O
regions	O
.	O

Stress	O
increases	O
circulating	O
concentrations	O
of	O
cortisol	O
,	O
a	O
typical	O
stress	O
marker	O
[	O
99	O
].	O

However	O
,	O
the	O
associations	O
between	O
maternal	O
diet	O
and	O
infant	O
gut	O
microbial	O
communities	O
did	O
not	O
always	O
differ	O
by	O
delivery	O
mode	O
.	O

Snoring	O
that	O
is	O
infrequent	O
or	O
non	O
-	O
habitual	O
has	O
not	O
been	O
shown	O
to	O
be	O
a	O
useful	O
screen	O
for	O
sleep	O
disordered	O
breathing	O
in	O
large	O
epidemiologic	O
studies	O
[	O
41	O
,	O
42	O
].	O

BAT	O
,	O
the	O
principal	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
i	O
.	O
e	O
.,	O
heat	O
production	O
that	O
does	O
not	O
involve	O
skeletal	O
muscle	O
contraction	O
),	O
is	O
present	O
in	O
most	O
mammals	O
and	O
its	O
maturation	O
in	O
the	O
perinatal	O
period	O
varies	O
between	O
species	O
,	O
according	O
to	O
their	O
developmental	O
status	O
at	O
birth	O
(	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
use	O
BHLM	O
to	O
simultaneously	O
examine	O
the	O
association	O
between	O
exposure	O
to	O
5	O
different	O
EDC	O
classes	O
(	O
phthalates	O
and	O
BPA	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
),	O
2	O
organophosphate	O
pesticides	O
(	O
OPPs	O
)	O
and	O
2	O
heavy	O
metals	O
,	O
lead	O
(	O
Pb	O
)	O
and	O
mercury	O
(	O
Hg	O
),	O
with	O
birth	O
weight	O
among	O
women	O
and	O
their	O
children	O
in	O
the	O
Health	O
Outcomes	O
and	O
Measures	O
of	O
Environment	O
(	O
HOME	O
)	O
Study	O
[	O
34	O
].	O

Transcriptional	O
excursions	O
regarding	O
stress	O
and	O
immune	O
response	O
The	O
biological	O
effect	O
of	O
glucocorticoids	O
is	O
modulated	O
by	O
glucocorticoid	O
receptors	O
.	O

Another	O
positive	O
point	O
is	O
that	O
few	O
studies	O
have	O
collected	O
data	O
on	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Pregnant	O
sows	O
were	O
fed	O
either	O
a	O
gestational	O
low	O
protein	O
diet	O
(	O
LP	O
,	O
6	O
%	O
CP	O
)	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
,	O
12	O
%	O
CP	O
).	O

The	O
aims	O
of	O
this	O
review	O
are	O
to	O
describe	O
some	O
of	O
the	O
main	O
factors	O
regulating	O
UCP1	O
activity	O
in	O
brown	O
and	O
brite	O
adipocytes	O
,	O
as	O
well	O
as	O
to	O
discuss	O
the	O
potential	O
role	O
of	O
UCP1	O
activation	O
for	O
the	O
treatment	O
of	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
associated	O
with	O
obesity	O
.	O

ACHOIS	O
has	O
shown	O
that	O
it	O
is	O
acceptable	O
to	O
the	O
majority	O
of	O
women	O
.	O

In	O
total	O
we	O
found	O
13	O
,	O
357	O
probe	O
-	O
sets	O
expressed	O
within	O
94	O
dpc	O
and	O
1	O
dpn	O
(	O
1	O
dpn	O
and	O
28	O
dpn	O
:	O
13	O
,	O
259	O
;	O
28	O
dpn	O
and	O
188	O
dpn	O
:	O
12	O
,	O
637	O
)	O
according	O
to	O
MAS5	O
analysis	O
(	O
Table1	O
).	O

The	O
participants	O
were	O
in	O
the	O
third	O
trimester	O
of	O
their	O
pregnancy	O
.	O

Liver	O
samples	O
were	O
collected	O
immediately	O
,	O
snap	O
-	O
frozen	O
in	O
liquid	O
nitrogen	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Furthermore	O
,	O
alterations	O
of	O
the	O
maternal	O
diet	O
,	O
that	O
is	O
,	O
avoidance	O
of	O
milk	O
and	O
egg	O
consumption	O
during	O
pregnancy	O
did	O
not	O
seem	O
to	O
lower	O
the	O
risk	O
of	O
sensitization	O
in	O
the	O
child	O
[	O
83	O
,	O
84	O
].	O

The	O
20	O
µl	O
reactions	O
were	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
and	O
held	O
at	O
4	O
°	O
C	O
.	O

Almost	O
all	O
mother	O
-	O
child	O
pairs	O
(	O
97	O
%)	O
were	O
vitamin	O
D	O
sufficient	O
[	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
],	O
and	O
about	O
half	O
of	O
the	O
mother	O
-	O
child	O
pairs	O
had	O
optimal	O
vitamin	O
D	O
status	O
[	O
25	O
(	O
OH	O
)	O
D	O
≥	O
80	O
nmol	O
/	O
L	O
].	O

Differences	O
were	O
considered	O
significant	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Food	O
intake	O
was	O
recorded	O
daily	O
until	O
the	O
end	O
of	O
pregnancy	O
.	O

Complex	O
evaluation	O
of	O
vitamin	O
D	O
activity	O
mechanism	O
on	O
fertility	O
requires	O
further	O
studies	O
.	O

Approximately	O
25	O
-	O
30	O
g	O
of	O
calcium	O
are	O
transferred	O
to	O
the	O
fetal	O
skeleton	O
by	O
the	O
end	O
of	O
pregnancy	O
,	O
most	O
of	O
which	O
is	O
transferred	O
during	O
the	O
last	O
trimester	O
.	O

Based	O
on	O
the	O
hypothesis	O
under	O
study	O
we	O
interpreted	O
the	O
RR	O
<	O
1	O
as	O
a	O
negative	O
association	O
(	O
for	O
simplicity	O
we	O
refer	O
to	O
it	O
from	O
now	O
on	O
"	O
decreased	O
risk	O
")	O
and	O
RR	O
>	O
1	O
as	O
a	O
positive	O
association	O
(	O
for	O
simplicity	O
we	O
refer	O
to	O
it	O
from	O
now	O
on	O
as	O
"	O
increased	O
risk	O
").	O

Nonetheless	O
,	O
folic	O
acid	O
supplementation	O
might	O
address	O
other	O
forms	O
of	O
anaemia	O
,	O
and	O
the	O
advice	O
might	O
also	O
increase	O
the	O
likelihood	O
of	O
folic	O
acid	O
use	O
before	O
and	O
during	O
future	O
pregnancies	O
.	O

Gluckman	O
et	O
al	O
.	O

However	O
,	O
at	O
adult	O
stage	O
a	O
diet	O
-	O
dependent	O
up	O
-	O
regulation	O
of	O
'	O
mTOR	O
signaling	O
'	O
in	O
LP	O
offspring	O
suggests	O
a	O
transcriptional	O
priority	O
for	O
cellular	O
growth	O
and	O
proliferation	O
.	O

The	O
membranes	O
were	O
washed	O
thoroughly	O
for	O
30	O
min	O
with	O
TBS	O
-	O
0	O
.	O
1	O
%	O
Tween	O
,	O
before	O
incubation	O
with	O
the	O
secondary	O
HRP	O
-	O
conjugated	O
immunoglobulin	O
(	O
1	O
:	O
2000	O
)	O
for	O
1	O
hr	O
at	O
room	O
temperature	O
and	O
further	O
washing	O
for	O
30	O
min	O
with	O
TBS	O
-	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
.	O

During	O
days	O
30	O
–	O
32	O
,	O
we	O
completed	O
3	O
-	O
hour	O
structured	O
observations	O
of	O
106	O
(	O
85	O
%)	O
control	O
and	O
112	O
(	O
90	O
%)	O
intervention	O
participants	O
(	O
Table	O
2	O
).	O

Both	O
intervention	O
and	O
control	O
treatment	O
arms	O
will	O
receive	O
the	O
usual	O
antenatal	O
and	O
postnatal	O
care	O
services	O
by	O
BRAC	O
.	O

We	O
analyzed	O
various	O
housekeeping	O
genes	O
and	O
selected	O
the	O
most	O
suitable	O
according	O
to	O
their	O
homogeneity	O
.	O

Vitamin	O
D	O
testing	O
and	O
supplementation	O
of	O
pregnant	O
women	O
is	O
a	O
safe	O
,	O
affordable	O
prevention	O
tool	O
that	O
could	O
substantially	O
reduce	O
the	O
occurrence	O
of	O
PTB	O
and	O
the	O
heavy	O
burden	O
of	O
associated	O
morbidity	O
,	O
mortality	O
and	O
economic	O
costs	O
.	O

Nutrition	O
during	O
pregnancy	O
is	O
an	O
important	O
factor	O
associated	O
with	O
both	O
maternal	O
and	O
infant	O
health	O
outcomes	O
[	O
80	O
].	O

Lower	O
vitamin	O
D	O
levels	O
have	O
been	O
found	O
in	O
many	O
autoimmune	O
diseases	O
,	O
such	O
as	O
rheumatoid	O
arthritis	O
,	O
systemic	O
lupus	O
erythematosus	O
,	O
systemic	O
sclerosis	O
,	O
type	O
1	O
diabetes	O
mellitus	O
,	O
multiple	O
sclerosis	O
,	O
inflammatory	O
bowel	O
diseases	O
,	O
autoimmune	O
thyroid	O
diseases	O
[	O
6	O
,	O
7	O
].	O

Assignment	O
of	O
treatments	O
An	O
investigator	O
remote	O
from	O
the	O
field	O
area	O
will	O
assign	O
the	O
interventions	O
to	O
eligible	O
clusters	O
using	O
a	O
fixed	O
randomisation	O
scheme	O
with	O
a	O
uniform	O
allocation	O
ratio	O
of	O
treatments	O
,	O
stratified	O
by	O
subdistrict	O
or	O
Upazila	O
.	O

There	O
were	O
no	O
differences	O
in	O
neonatal	O
outcomes	O
.	O

Blood	O
Pressure	O
(	O
Figure	O
3	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g003	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Systolic	O
blood	O
pressure	O
evolution	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

SGA	O
was	O
defined	O
as	O
weight	O
and	O
/	O
or	O
length	O
at	O
birth	O
<	O
2	O
SD	O
of	O
the	O
population	O
mean	O
and	O
LBW	O
as	O
<	O
2500	O
g	O
.	O
Preterm	O
delivery	O
was	O
defined	O
as	O
delivery	O
<	O
37	O
+	O
0	O
gestational	O
weeks	O
and	O
pregnancy	O
loss	O
as	O
spontaneous	O
abortion	O
or	O
intrauterine	O
fetal	O
death	O
.	O

Table2shows	O
the	O
interventions	O
included	O
in	O
the	O
LiST	O
analysis	O
that	O
prevent	O
preterm	O
births	O
and	O
improve	O
survival	O
of	O
premature	O
babies	O
.	O

Results	O
The	O
incidence	O
rate	O
of	O
Vitamin	O
D	O
deficiency	O
(<	O
50	O
nmol	O
/	O
L	O
)	O
was	O
20	O
.	O
4	O
%.	O

Four	O
identically	O
trained	O
study	O
nurses	O
obtain	O
newborn	O
anthropometry	O
(	O
weight	O
,	O
midarm	O
circumference	O
(	O
MAC	O
),	O
crown	O
-	O
heel	O
length	O
(	O
CHL	O
),	O
head	O
circumference	O
(	O
HC	O
)	O
and	O
thoracic	O
circumference	O
(	O
TC	O
))	O
within	O
12	O
h	O
of	O
birth	O
[	O
57	O
].	O

We	O
selected	O
a	O
95	O
%	O
confidence	O
level	O
and	O
an	O
assumed	O
prevalence	O
of	O
supplement	O
use	O
of	O
50	O
%,	O
informed	O
by	O
other	O
studies	O
[	O
15	O
-	O
19	O
,	O
22	O
],	O
due	B
to	I
the	O
lack	O
of	O
prior	O
data	O
in	O
our	O
region	O
.	O

Therefore	O
,	O
the	O
transcriptional	O
up	O
-	O
regulation	O
of	O
'	O
VEGF	O
signaling	O
'	O
reflects	O
the	O
effort	O
on	O
cell	O
maintenance	O
and	O
angiogenic	O
growth	O
in	O
LP	O
offspring	O
at	O
stage	O
188	O
dpn	O
.	O

One	O
possibility	O
that	O
emerges	O
from	O
our	O
data	O
is	O
that	O
male	O
offspring	O
can	O
increase	O
their	O
body	O
weight	O
by	O
either	O
a	O
reduction	O
of	O
energy	O
expenditure	O
or	O
higher	O
metabolism	O
efficiency	O
.	O

Implement	O
•	O
Define	O
norms	O
and	O
guidelines	O
to	O
support	O
efforts	O
to	O
improve	O
women	O
'	O
s	O
and	O
children	O
'	O
s	O
health	O
,	O
and	O
encourage	O
their	O
adoption	O
through	O
provision	O
of	O
technical	O
assistance	O
and	O
programmatic	O
support	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
preterm	O
births	O
.	O

Improved	O
human	O
exposure	O
data	O
could	O
be	O
collected	O
and	O
used	O
to	O
facilitate	O
the	O
use	O
of	O
more	O
relevant	O
doses	O
,	O
routes	O
of	O
administration	O
,	O
metabolites	O
and	O
mixtures	O
.	O

Background	O
Vitamin	O
D	O
deficiency	O
,	O
defined	O
as	O
a	O
circulating	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
concentration	O
below	O
50	O
nmol	O
/	O
L	O
,	O
has	O
been	O
common	O
among	O
Finnish	O
pregnant	O
women	O
[	O
1	O
].	O

It	O
is	O
an	O
unrecognized	O
epidemic	O
common	O
among	O
children	O
,	O
adults	O
and	O
pregnant	O
women	O
throughout	O
the	O
world	O
,	O
across	O
ethnicity	O
and	O
season	O
.	O

A	O
multi	O
-	O
disciplinary	O
approach	O
is	O
needed	O
to	O
identify	O
women	O
at	O
risk	O
and	O
discover	O
new	O
strategies	O
for	O
prevention	O
including	O
potential	O
biomarkers	O
,	O
such	O
as	O
genomic	O
,	O
microbial	O
,	O
immunologic	O
,	O
and	O
hormonal	O
factors	O
.	O

Conclusions	O
Women	O
who	O
attend	O
their	O
first	O
antenatal	O
visit	O
during	O
the	O
months	O
of	O
extended	O
winter	O
were	O
more	O
likely	O
to	O
have	O
raised	O
insulin	O
resistance	O
in	O
early	O
and	O
late	O
pregnancy	O
,	O
and	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
status	O
.	O

The	O
decrease	O
in	O
OTUs	O
classified	O
to	O
the	O
species	O
Clostridium	O
neonatale	O
with	O
increased	O
maternal	O
fish	O
and	O
seafood	O
intake	O
in	O
infants	O
born	O
by	O
Cesarean	O
section	O
is	O
a	O
possibly	O
beneficial	O
change	O
to	O
infant	O
intestinal	O
microbial	O
communities	O
.	O

Supplementary	O
materialERJ	O
-	O
00073	O
-	O
2017_Supplement	O
Disclosures10	O
.	O
1183	O
/	O
13993003	O
.	O
00073	O
-	O
2017	O
.	O
Supp2	O
A	O
.	O
BédardERJ	O
-	O
00073	O
-	O
2017_Bedard	O
A	O
.	O
J	O
.	O

Therefore	O
,	O
vitamin	O
D	O
status	O
may	O
be	O
important	O
in	O
populations	O
where	O
dietary	O
calcium	O
intake	O
is	O
low	O
which	O
is	O
unlikely	O
in	O
the	O
population	O
of	O
women	O
studied	O
here	O
.	O

The	O
mean	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
case	O
and	O
control	O
groups	O
were	O
48	O
and	O
62	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
and	O
the	O
difference	O
was	O
significant	O
(	O
P	O
=	O
0	O
.	O
036	O
).	O

One	O
third	O
of	O
respondents	O
were	O
single	O
(	O
n	O
=	O
113	O
).	O

The	O
pathophysiological	O
mechanisms	O
underlying	O
these	O
consistently	O
observed	O
associations	O
of	O
short	O
sleep	O
duration	O
,	O
sleep	O
-	O
related	O
breathing	O
disorders	O
,	O
including	O
snoring	O
,	O
with	O
altered	O
glucose	O
metabolism	O
and	O
diabetes	O
are	O
likely	O
to	O
be	O
multifactorial	O
[	O
2	O
,	O
43	O
,	O
44	O
].	O

In	O
the	O
present	O
study	O
we	O
employed	O
an	O
established	O
model	O
of	O
nutritional	O
programming	O
to	O
evaluate	O
the	O
relative	O
influences	O
of	O
prenatal	O
and	O
postnatal	O
nutrition	O
on	O
growth	O
and	O
ovarian	O
function	O
in	O
female	O
offspring	O
.	O

Maternal	O
insulin	O
resistance	O
was	O
calculated	O
using	O
the	O
Homeostasis	O
Model	O
Assessment	O
(	O
HOMA	O
-	O
IR	O
)	O
equation	O
:	O
[	O
fasting	O
serum	O
insulin	O
(	O
μU	O
/	O
ml	O
)	O
×	O
fasting	O
plasma	O
glucose	O
(	O
mmol	O
/	O
l	O
)/	O
22	O
.	O
5	O
].	O

2010	O
).	O

But	O
neither	O
body	O
weight	O
at	O
weaning	O
nor	O
body	O
weight	O
at	O
188	O
dpn	O
differed	O
significantly	O
among	O
offspring	O
of	O
the	O
LP	O
and	O
the	O
AP	O
group	O
,	O
whereas	O
visceral	O
and	O
subcutaneous	O
fat	O
content	O
remained	O
higher	O
in	O
LP	O
than	O
in	O
AP	O
during	O
postnatal	O
life	O
[	O
15	O
-	O
17	O
].	O

Dietary	O
therapy	O
It	O
is	O
generally	O
accepted	O
that	O
dietary	O
therapy	O
is	O
the	O
cornerstone	O
of	O
treatment	O
of	O
GDM	O
.	O

However	O
,	O
it	O
is	O
possible	O
that	O
alternate	O
SNPs	O
/	O
genes	O
that	O
are	O
not	O
clinically	O
important	O
to	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
nonpregnant	O
adults	O
would	O
be	O
significant	O
in	O
pregnant	O
women	O
and	O
could	O
be	O
identified	O
by	O
GWAS	O
.	O

Women	O
who	O
terminated	O
the	O
pregnancy	O
(	O
N	O
=	O
31	O
),	O
were	O
lost	O
to	O
follow	O
-	O
up	O
(	O
N	O
=	O
13	O
)	O
or	O
carried	O
more	O
than	O
one	O
foetus	O
(	O
N	O
=	O
26	O
)	O
were	O
excluded	O
from	O
the	O
present	O
analyses	O
.	O

Biomarkers	O
with	O
<	O
90	O
%	O
detection	O
level	O
or	O
that	O
were	O
only	O
examined	O
in	O
a	O
subset	O
of	O
the	O
participants	O
were	O
excluded	O
from	O
analysis	O
to	O
preserve	O
sample	O
size	O
(	O
Table2	O
).	O

In	O
the	O
nucleus	O
accumbens	O
,	O
dopamine	O
influences	O
the	O
integration	O
of	O
inputs	O
from	O
the	O
ventral	O
hippocampus	O
,	O
the	O
amygdala	O
,	O
and	O
the	O
prefrontal	O
cortex	O
.	O

The	O
handwashing	O
intervention	O
tested	O
in	O
Pakistan	O
consisted	O
of	O
provision	O
of	O
a	O
bar	O
of	O
soap	O
and	O
“	O
encouragement	O
”	O
by	O
birth	O
attendants	O
for	O
mothers	O
and	O
other	O
family	O
members	O
to	O
wash	O
hands	O
“	O
before	O
handling	O
the	O
newborn	O
infant	O
.”	O
There	O
was	O
no	O
assessment	O
of	O
handwashing	O
behavior	O
measures	O
and	O
thus	O
,	O
it	O
is	O
not	O
clear	O
whether	O
the	O
intervention	O
did	O
not	O
affect	O
handwashing	O
behavior	O
or	O
whether	O
improved	O
handwashing	O
behavior	O
did	O
not	O
reduce	O
neonatal	O
mortality	O
.	O

The	O
SNPs	O
included	O
in	O
this	O
analysis	O
were	O
chosen	O
based	O
on	O
findings	O
in	O
the	O
previous	O
GWAS	O
,	O
which	O
included	O
only	O
individuals	O
of	O
European	O
ancestry	O
(	O
8	O
).	O

Despite	O
these	O
limitations	B
,	O
this	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
a	O
gene	O
-	O
maternal	O
environment	O
synergism	O
in	O
relation	O
to	O
infant	O
birth	O
weight	O
,	O
using	O
a	O
very	O
brief	O
assessment	O
of	O
maternal	O
attitudes	O
to	O
pregnancy	O
.	O

These	O
extremely	O
low	O
values	O
are	O
not	O
commonly	O
reported	O
in	O
the	O
United	O
States	O
,	O
although	O
we	O
speculate	O
that	O
an	O
increasing	O
number	O
of	O
cases	O
may	O
be	O
reported	O
in	O
the	O
future	O
due	O
to	O
increased	O
awareness	O
of	O
vitamin	O
D	O
deficiency	O
.	O

Pearson	O
'	O
s	O
product	O
moment	O
correlations	O
were	O
conducted	O
to	O
examine	O
unadjusted	O
associations	O
between	O
WFA	O
z	O
-	O
scores	O
and	O
maternal	O
variables	O
.	O

Endocrine	O
disrupting	O
chemicals	O
can	O
bind	O
to	O
nuclear	O
receptors	O
,	O
and	O
either	O
directly	O
induce	O
activity	O
altering	O
modifications	O
to	O
the	O
epigenetic	O
machinery	O
(	O
such	O
as	O
histone	O
methyl	O
transferases	O
);	O
or	O
act	O
as	O
transcription	O
factors	O
,	O
binding	O
to	O
hormone	O
-	O
responsive	O
promotor	O
elements	O
and	O
promoting	O
expression	O
of	O
ncRNAs	O
and	O
/	O
or	O
epigenetic	O
machinery	O
(	O
Kabir	O
et	O
al	O
.	O
2015	O
;	O
Trevino	O
et	O
al	O
.	O
2015	O
).	O

Therefore	O
,	O
health	O
professionals	O
should	O
be	O
aware	O
of	O
the	O
potential	O
nutritional	O
deficiencies	O
in	O
children	O
suffering	O
from	O
extensive	O
dental	O
caries	O
.	O

South	O
Africa	O
has	O
large	O
economic	O
disparities	O
and	O
20	O
%	O
of	O
the	O
population	O
are	O
living	O
in	O
extreme	O
poverty	O
,	O
indicating	O
they	O
cannot	O
afford	O
the	O
minimum	O
required	O
food	O
intake	O
[	O
17	O
].	O

However	O
,	O
unlike	O
the	O
HAPO	O
trial	O
,	O
we	O
found	O
increased	O
fasting	O
plasma	O
glucose	O
in	O
late	O
pregnancy	O
among	O
those	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

;	O
P	O
=	O
.	O
002	O
).	O

Both	O
during	O
suppressive	O
or	O
substitutive	O
therapy	O
,	O
L	O
-	O
T4	O
requirement	O
increases	O
very	O
early	O
during	O
pregnancy	O
,	O
reaching	O
a	O
plateau	O
after	O
16thto	O
20thweeks	O
of	O
gestation	O
,	O
with	O
a	O
required	O
L	O
-	O
T4	O
dosage	O
approximately	O
30	O
to	O
50	O
%	O
higher	O
than	O
that	O
administered	O
before	O
pregnancy	O
.	O

More	O
information	O
is	O
urgently	O
needed	O
from	O
both	O
providers	O
and	O
patients	O
on	O
the	O
reasons	O
for	O
these	O
shifts	O
in	O
clinical	O
practice	O
and	O
how	O
to	O
promote	O
more	O
conservative	O
obstetric	O
management	O
.	O

We	O
also	O
assumed	O
one	O
fecal	O
contact	O
event	O
to	O
be	O
detected	O
per	O
3	O
-	O
hour	O
structured	O
observation	O
.	O

In	O
addition	O
to	O
the	O
uncertainty	O
concerning	B
the	O
optimal	O
vitamin	O
D	O
intakes	O
preventing	O
vitamin	O
D	O
deficiency	O
,	O
there	O
exists	O
also	O
a	O
lack	O
of	O
recommendations	O
to	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

Among	O
the	O
71	O
infants	O
who	O
underwent	O
infant	O
lung	O
function	O
testing	O
,	O
bacterial	O
cultures	O
from	O
nasopharyngeal	O
specimens	O
were	O
taken	O
from	O
66	O
infants	O
,	O
with	O
a	O
positive	O
culture	O
rate	O
of	O
68	O
.	O
2	O
%	O
(	O
45	O
/	O
66	O
).	O

The	O
interaction	O
between	O
low	O
birth	O
weight	O
and	O
reduction	O
in	O
parasympathetic	O
regulation	O
observed	O
in	O
the	O
present	O
study	O
occurs	O
independently	O
of	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Association	O
of	O
LINE	O
-	O
1	O
(	O
A	O
)	O
and	O
AluYb8	O
(	O
B	O
)	O
methylation	O
with	O
mean	O
RPMM	O
class	O
methylation	O
.	O

Maternal	O
mean	O
1	O
-	O
hour	O
plasma	O
glucose	O
concentrations	O
,	O
adjusted	O
for	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
were	O
highest	O
for	O
women	O
who	O
reported	O
habitual	O
sleep	O
duration	O
≤	O
4	O
hours	O
per	O
night	O
during	O
early	O
pregnancy	O
and	O
lowest	O
for	O
those	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
on	O
average	O
.	O

Among	O
the	O
essential	O
regulators	O
of	O
kidney	O
development	O
are	O
components	O
of	O
the	O
renin	O
-	O
angiotensin	O
system	O
(	O
RAS	O
),	O
podocin	O
(	O
a	O
critical	O
component	O
of	O
the	O
glomerular	O
slit	O
diaphragm	O
)	O
and	O
the	O
Wilms	O
'	O
tumor	O
suppressor	O
gene	O
WT1	O
[	O
12	O
].	O

Although	O
not	O
statistically	O
significant	O
,	O
it	O
is	O
clinically	O
relevant	O
to	O
report	O
that	O
approximately	O
twice	O
as	O
many	O
neonates	O
exposed	O
to	O
polytherapy	O
were	O
LGA	O
(	O
13	O
.	O
6	O
%	O
vs	O
6	O
.	O
5	O
%).	O

Papillary	O
thyroid	O
cancer	O
is	O
the	O
most	O
common	O
histological	O
type	O
detected	O
in	O
pregnant	O
women	O
,	O
and	O
in	O
most	O
series	O
90	O
%	O
to	O
95	O
%	O
of	O
thyroid	O
carcinoma	O
diagnosed	O
are	O
Stage	O
I	O
disease	O
,	O
with	O
the	O
majority	O
found	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
during	O
the	O
first	O
antenatal	O
visit	O
.	O

Considering	O
cut	O
-	O
off	O
point	O
of	O
≥	O
9	O
,	O
data	O
analysis	O
showed	O
that	O
a	O
lot	O
of	O
participants	O
(	O
more	O
than	O
50	O
%)	O
were	O
susceptible	O
to	O
prenatal	O
depression	O
at	O
26	O
–	O
28	O
weeks	O
.	O

Black	O
infants	O
with	O
vitamin	O
D	O
deficiency	O
had	O
2	O
.	O
4	O
greater	O
adjusted	O
odds	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
0	O
,	O
5	O
.	O
8	O
)	O
of	O
SGA	O
.	O

Results	O
Those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
had	O
lower	O
25OHD	O
compared	O
to	O
extended	O
summer	O
(	O
32	O
.	O
9	O
nmol	O
/	O
L	O
vs	O
.	O
44	O
.	O
1	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

We	O
would	O
like	O
to	O
propose	O
a	O
potential	O
model	O
where	O
,	O
during	O
preterm	O
birth	O
,	O
GR	O
α	O
is	O
the	O
predominant	O
receptor	O
since	O
there	O
is	O
a	O
decrease	O
in	O
negative	O
regulators	O
such	O
as	O
GR	O
β	O
,	O
GR	O
γ	O
,	O
and	O
the	O
“	O
pseudo	O
-	O
GRE	O
”	O
GAS5	O
.	O

This	O
hypothesis	O
suggests	O
that	O
structural	O
and	O
functional	O
adaptations	O
are	O
associated	O
with	O
glomerular	O
hypertension	O
,	O
hyperfiltration	O
,	O
and	O
hypertrophy	O
partially	O
compensated	O
for	O
nephron	O
losses	O
[	O
34	O
].	O

However	O
,	O
in	O
contrary	O
to	O
these	O
reports	O
,	O
a	O
survey	O
in	O
Canadian	O
children	O
showed	O
that	O
both	O
low	O
and	O
high	O
vitamin	O
D	O
levels	O
were	O
related	O
to	O
increased	O
risk	O
of	O
wheeze	O
and	O
reduced	O
performance	O
of	O
lung	O
function	O
[	O
35	O
].	O

The	O
mixed	O
model	O
includes	O
group	O
,	O
age	O
and	O
group	O
Χ	O
age	O
of	O
the	O
family	O
member	O
as	O
fixed	O
effects	O
and	O
a	O
random	O
family	O
effect	O
with	O
an	O
unstructured	O
correlation	O
matrix	O
.	O

The	O
rapid	O
acting	O
analogs	O
lispro	O
and	O
aspart	O
are	O
considered	O
safe	O
,	O
but	O
the	O
safety	O
of	O
the	O
long	O
-	O
acting	O
analogs	O
are	O
yet	O
to	O
be	O
determined	O
.	O

Data	O
management	O
and	O
analysis	O
Sample	O
size	O
calculation	O
The	O
number	O
of	O
participants	O
to	O
sample	O
has	O
been	O
calculated	O
using	O
the	O
G	O
*	O
Power	O
3	O
.	O
1	O
.	O
9	O
.	O
2	O
statistical	O
programme	O
[	O
78	O
].	O

Moreover	O
,	O
the	O
ratio	O
of	O
LF	O
/	O
HF	O
was	O
also	O
calculated	O
.	O

We	O
present	O
that	O
the	O
hepatic	O
expression	O
profiles	O
showed	O
considerable	O
modulation	O
during	O
prenatal	O
and	O
postnatal	O
stages	O
,	O
i	O
.	O
e	O
.	O

We	O
also	O
stratified	O
based	O
on	O
fetal	O
sex	O
to	O
evaluate	O
possible	O
effect	O
measure	O
modifications	O
according	O
to	O
whether	O
the	O
mother	O
was	O
carry	O
a	O
male	O
or	O
female	O
fetus	O
.	O

Among	O
those	O
children	O
born	O
from	O
I	O
-	O
131	O
treated	O
women	O
,	O
the	O
authors	O
found	O
only	O
one	O
case	O
of	O
ventricular	O
septal	O
defect	O
and	O
patent	O
ductus	O
arteriosus223940	O
.	O

Estimated	O
BMI	O
correlations	O
,	O
employing	O
the	O
mixed	O
models	O
,	O
and	O
adjusting	O
for	O
age	O
,	O
are	O
shown	O
at	O
each	O
time	O
point	O
for	O
the	O
children	O
and	O
across	O
generations	O
are	O
then	O
displayed	O
intable	O
4	O
.	O

2	O
.	O
2	O
.	O

2006	O
;	O
Wynne	O
-	O
Davies	O
1975	O
)	O
and	O
twin	O
studies	O
(	O
Kesling	O
and	O
Reinker	O
1997	O
)	O
have	O
shown	O
that	O
the	O
cause	O
of	O
spinal	O
deformities	O
,	O
including	O
scoliosis	O
and	O
kyphosis	O
,	O
can	O
have	O
a	O
genetic	O
component	O
.	O

Other	O
studies	O
,	O
however	O
,	O
have	O
found	O
no	O
evidence	O
to	O
support	O
this	O
hypothesis	O
[	O
23	O
],[	O
24	O
],[	O
25	O
],[	O
26	O
],[	O
27	O
],[	O
28	O
],[	O
29	O
],[	O
30	O
].	O

In	O
subjects	O
with	O
type	O
2	O
diabetes	O
,	O
the	O
ADOPT	O
Study	O
has	O
demonstrated	O
that	O
metformin	O
is	O
superior	O
to	O
glyburide	O
in	O
this	O
regard	O
.	O
76As	O
there	O
is	O
transplacental	O
passage	O
of	O
metformin	O
,	O
77	O
,	O
78its	O
effect	O
on	O
fetal	O
insulin	O
resistance	O
might	O
even	O
provide	O
further	O
benefit	O
in	O
light	O
of	O
data	O
of	O
insulin	O
resistance	O
and	O
insulin	O
secretory	O
defects	O
in	O
offspring	O
of	O
diabetic	O
pregnancies	O
.	O
19However	O
,	O
any	O
pharmacological	O
agent	O
which	O
crosses	O
the	O
placenta	O
must	O
be	O
viewed	O
with	O
caution	O
as	O
there	O
always	O
remains	O
the	O
possibility	O
of	O
unexpected	O
long	O
-	O
term	O
effects	O
.	O

Here	O
,	O
the	O
perception	O
of	O
the	O
past	O
users	O
is	O
the	O
only	O
driving	O
tool	O
to	O
refer	O
.	O

RPMM	O
was	O
selected	O
for	O
this	O
analysis	O
because	O
we	O
have	O
demonstrated	O
that	O
RPMM	O
provides	O
more	O
consistent	O
clustering	O
and	O
more	O
robustness	O
in	O
the	O
selection	O
of	O
the	O
number	O
of	O
classes	O
because	O
of	O
its	O
hierarchical	O
presentation	O
of	O
classes	O
,	O
compared	O
with	O
metric	O
hierarchical	O
clustering	O
,	O
for	O
this	O
data	O
set	O
[	O
see	O
Supplemental	O
Material	O
,	O
Supplementary	O
Text	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

It	O
cannot	O
,	O
however	O
,	O
correct	O
for	O
potential	O
bias	O
and	O
confounding	O
of	O
the	O
studies	O
included	O
;	O
we	O
addressed	O
this	O
issue	B
in	O
our	O
review	O
(	O
Martin	O
et	O
al	O
.	O

We	O
adjusted	O
p	O
values	O
for	O
multiple	O
comparisons	O
using	O
the	O
Benjamini	O
and	O
Hochberg	O
method	O
to	O
control	O
the	O
false	O
discovery	O
rate	O
[	O
49	O
].	O

We	O
,	O
therefore	O
,	O
wanted	O
to	O
examine	O
both	O
the	O
potential	O
public	O
health	O
concerns	O
and	O
the	O
resulting	O
regulatory	O
implications	O
of	O
such	O
toxicity	O
.	O

Statistical	O
analysis	O
The	O
analysis	O
was	O
conducted	O
using	O
intention	O
to	O
treat	O
principles	O
,	O
according	O
to	O
the	O
treatment	O
group	O
the	O
woman	O
was	O
randomised	O
to	O
in	O
pregnancy	O
(	O
Lifestyle	O
Advice	O
or	O
Standard	O
Care	O
).	O

When	O
appropriate	O
,	O
data	O
from	O
body	O
weight	O
,	O
caloric	O
intake	O
and	O
compulsive	O
feeding	O
test	O
over	O
time	O
were	O
analyzed	O
by	O
Student	O
'	O
s	O
t	O
-	O
test	O
or	O
three	O
-	O
way	O
repeated	O
measures	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
)	O
with	O
time	O
,	O
diet	O
and	O
sex	O
as	O
factors	O
.	O

A	O
challenge	O
in	O
previous	O
studies	O
on	O
vitamin	O
D	O
status	O
and	O
GDM	O
has	O
been	O
the	O
lack	B
of	I
relevant	O
adjustments	O
,	O
for	O
example	O
adjustments	O
for	O
BMI	O
and	O
smoking	O
status	O
[	O
6	O
].	O

These	O
experiences	O
,	O
combined	O
with	O
repeated	O
exposure	O
to	O
nutritious	O
foods	O
and	O
flavor	O
variety	O
(	O
31	O
-	O
34	O
),	O
should	O
make	O
children	O
more	O
likely	O
to	O
choose	O
a	O
healthy	O
diet	O
.	O

Differences	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
Hispanic	O
and	O
Caucasian	O
infants	O
may	O
be	O
related	O
to	O
lifestyle	O
including	O
sunshine	O
exposure	O
.	O

The	O
increased	O
proportion	O
of	O
preterm	O
deliveries	O
observed	O
in	O
the	O
exposed	O
group	O
may	O
be	O
influenced	O
by	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
,	O
as	O
was	O
reported	O
in	O
a	O
recent	O
paper	O
by	O
Khatibi	O
et	O
al	O
.	O

Previous	O
studies	O
reported	O
that	O
unplanned	O
pregnancy	O
is	O
a	O
risk	O
factor	O
for	O
perinatal	O
depression	O
.	O

Objectives	O
To	O
determine	O
if	O
the	O
reported	O
inverse	O
relationship	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
could	O
be	O
replicated	O
at	O
MUSC	O
,	O
an	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
.	O

Regression	O
techniques	O
were	O
employed	O
to	O
determine	O
whether	O
the	O
association	O
between	O
caries	O
and	O
vitamin	O
D	O
status	O
remained	O
after	O
controlling	O
for	O
confounders	B
.	O

Thus	O
,	O
there	O
are	O
reasons	O
to	O
believe	O
that	O
the	O
dimension	O
of	O
positive	O
symptoms	O
is	O
an	O
independent	O
dimension	O
.	O

Another	O
study	O
investigating	O
the	O
effect	O
of	O
a	O
paternal	O
folate	O
-	O
deficient	O
diet	O
in	O
mice	O
found	O
a	O
relationship	O
with	O
decreased	O
placental	O
weight	O
,	O
placental	O
folate	O
and	O
an	O
increased	O
expression	O
of	O
the	O
folate	O
transporter	O
folate	O
receptor	O
[	O
7	O
].	O

The	O
potential	O
for	O
contamination	O
by	O
heavy	O
metals	O
,	O
as	O
well	O
as	O
risk	O
of	O
listeriosis	O
requires	O
careful	O
consideration	O
of	O
the	O
shaping	O
of	O
dietary	O
messages	O
related	O
to	O
fish	O
intake	O
during	O
pregnancy	O
.	O

She	O
assessed	O
the	O
presence	O
of	O
fully	O
stocked	O
handwashing	O
stations	O
anywhere	O
in	O
the	O
home	O
and	O
specifically	O
in	O
the	O
room	O
where	O
the	O
newborn	O
spent	O
most	O
of	O
his	O
/	O
her	O
time	O
.	O

Alarmingly	O
,	O
in	O
the	O
birth	O
cohort	O
study	O
from	O
the	O
Isle	O
of	O
Wight	O
,	O
about	O
43	O
%	O
of	O
children	O
had	O
been	O
exposed	O
to	O
environmental	O
tobacco	O
smoke	O
during	O
their	O
first	O
year	O
of	O
life	O
[	O
38	O
].	O

These	O
findings	O
suggest	O
that	O
improvements	O
in	O
vitamin	O
D	O
status	O
may	O
decrease	O
the	O
disparity	O
in	O
PTB	O
rates	O
between	O
race	O
/	O
ethnic	O
groups	O
.	O

[	O
20	O
]	O
measured	O
supplement	O
usage	O
during	O
pregnancy	O
.	O

However	O
,	O
the	O
exposed	O
group	O
did	O
have	O
a	O
significantly	O
increased	O
rate	O
of	O
LGA	O
neonates	O
.	O

Also	O
,	O
approximately	O
40	O
%	O
of	O
normal	O
weight	O
women	O
gain	O
more	O
than	O
recommended	O
[	O
6	O
],	O
increasing	O
the	O
risk	O
of	O
obesity	O
in	O
their	O
offspring	O
.	O

Given	O
that	O
all	O
these	O
factors	O
significantly	O
influenced	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
the	O
linear	O
regression	O
model	O
,	O
it	O
was	O
unsurprising	O
that	O
vitamin	O
D	O
status	O
of	O
the	O
women	O
was	O
significantly	O
different	O
between	O
the	O
two	O
recruitment	O
sites	O
.	O

Vitamin	O
D	O
deficiency	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
<	O
20	O
ng	O
/	O
mL	O
)	O
was	O
observed	O
in	O
134	O
women	O
(	O
87	O
.	O
6	O
%).	O

The	O
same	O
researcher	O
blinded	O
to	O
the	O
clinical	O
data	O
conducted	O
the	O
assessment	O
of	O
all	O
children	O
.	O

The	O
integral	O
absorbance	O
values	O
were	O
measured	O
.	O

The	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
is	O
the	O
same	O
as	O
for	O
nonpregnant	O
patients	O
.	O

Ninety	O
-	O
nine	O
percent	O
(	O
99	O
%)	O
of	O
the	O
respondents	O
affirmed	O
that	O
ANC	O
was	O
important	O
not	O
only	O
for	O
the	O
mother	O
but	O
for	O
the	O
foetus	O
as	O
well	O
.	O

A	O
recent	O
study	O
illustrates	O
that	O
the	O
neuropathology	O
of	O
some	O
individuals	O
who	O
are	O
diagnosed	O
as	O
having	O
ASD	O
may	O
actually	O
also	O
have	O
focal	O
cortical	O
dysplasias	O
,	O
which	O
could	O
explain	O
the	O
high	O
incidence	O
of	O
sensory	O
irregularities	O
and	O
seizures	O
in	O
ASD	O
diagnosed	O
patients	O
[	O
59	O
].	O

Results	O
The	O
present	O
study	O
was	O
conducted	O
on	O
100	O
children	O
(	O
63	O
boys	O
and	O
37	O
girls	O
)	O
with	O
a	O
mean	O
age	O
of	O
8	O
.	O
85	O
years	O
(	O
Range	O
:	O
6	O
–	O
14	O
;	O
SD	O
=	O
1	O
.	O
82	O
years	O
).	O

A	O
wide	O
range	O
of	O
services	O
encompassing	O
supplementary	O
nutrition	O
;	O
immunization	O
services	O
;	O
health	O
check	O
-	O
ups	O
for	O
children	O
less	O
than	O
six	O
years	O
of	O
age	O
;	O
antenatal	O
care	O
of	O
expectant	O
mothers	O
and	O
postnatal	O
care	O
of	O
nursing	O
mothers	O
;	O
referral	O
services	O
to	O
the	O
beneficiaries	O
who	O
are	O
in	O
the	O
need	O
of	O
prompt	O
medical	O
attention	O
;	O
non	O
-	O
formal	O
pre	O
-	O
school	O
education	O
for	O
children	O
in	O
the	O
3	O
-	O
6	O
years	O
age	O
group	O
;	O
and	O
nutrition	O
&	O
health	O
education	O
especially	O
for	O
the	O
women	O
in	O
the	O
15	O
-	O
45	O
years	O
age	O
group	O
are	O
provided	O
to	O
the	O
beneficiaries	O
(	O
4	O
,	O
5	O
).	O

[	O
29	O
]	O
Vitamin	O
D	O
appears	O
to	O
have	O
a	O
protective	O
effect	O
against	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

Informed	O
consent	O
was	O
obtained	O
from	O
all	O
participants	O
.	O

Very	O
few	O
women	O
(	O
6	O
%)	O
enrolled	O
for	O
ANC	O
during	O
their	O
first	O
trimester	O
of	O
pregnancy	O
,	O
the	O
median	O
gestational	O
age	O
was	O
28	O
weeks	O
(	O
range	O
15	O
to	O
41	O
weeks	O
).	O

All	O
patients	O
should	O
undergo	O
neck	O
ultrasound	O
and	O
serum	O
assay	O
for	O
HTG	O
,	O
HTG	O
antibodies	O
,	O
fT4	O
and	O
TSH	O
.	O

Specific	O
pharmacological	O
agents	O
for	O
treatment	O
of	O
asthma	O
or	O
allergic	O
diseases	O
must	O
be	O
cautiously	O
selected	O
.	O

While	O
such	O
complex	O
networks	O
exist	O
to	O
maintain	O
cellular	O
homeostasis	O
,	O
they	O
are	O
open	O
to	O
environmental	O
perturbation	O
(	O
Figure	O
1	O
).	O

Baseline	O
characteristics	O
between	O
the	O
low	O
and	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
compared	O
using	O
a	O
two	O
-	O
sided	O
t	O
-	O
test	O
for	O
equal	O
means	O
for	O
continuous	O
,	O
normally	O
distributed	O
variables	O
and	O
and	O
χ2	O
-	O
test	O
for	O
categorical	O
variables	O
.	O

Moreover	O
,	O
control	O
women	O
who	O
reported	O
a	O
history	O
of	O
psychiatric	O
disorders	O
or	O
who	O
were	O
exposed	O
in	O
their	O
current	O
pregnancy	O
to	O
a	O
known	O
teratogen	O
were	O
excluded	O
.	O

It	O
found	O
an	O
increase	O
in	O
stillbirth	O
and	O
perinatal	O
mortality	O
,	O
as	O
well	O
as	O
pre	O
-	O
eclampsia	O
amongst	O
those	O
treated	O
with	O
metformin	O
,	O
compared	O
to	O
women	O
treated	O
with	O
insulin	O
or	O
sulphonylureas	O
.	O

Of	O
the	O
original	O
cohort	O
of	O
mothers	O
participating	O
in	O
this	O
vitamin	O
D	O
supplementation	O
trial	O
,	O
55	O
%	O
of	O
the	O
children	O
were	O
available	O
for	O
follow	O
-	O
up	O
,	O
and	O
of	O
those	O
,	O
68	O
%	O
of	O
those	O
who	O
came	O
for	O
follow	O
-	O
up	O
(	O
38	O
%	O
of	O
the	O
original	O
cohort	O
)	O
were	O
able	O
to	O
have	O
a	O
blood	O
sample	O
obtained	O
at	O
the	O
time	O
of	O
the	O
visit	O
.	O

The	O
lack	O
of	O
vitamin	O
A	O
supplementation	O
also	O
increased	O
marbling	O
compared	O
with	O
vitamin	O
A	O
supplementation	O
in	O
a	O
study	O
of	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

Handwashing	O
with	O
soap	O
was	O
significantly	O
higher	O
before	O
breastfeeding	O
and	O
after	O
fecal	O
contact	O
among	O
intervention	O
mothers	O
than	O
among	O
controls	O
;	O
however	O
,	O
washing	O
with	O
soap	O
after	O
fecal	O
contact	O
was	O
less	O
common	O
than	O
the	O
prevalence	O
of	O
this	O
behavior	O
observed	O
among	O
mothers	O
of	O
young	O
children	O
in	O
Bangladesh	O
and	O
elsewhere	O
,	O
underscoring	O
the	O
substantial	O
barriers	O
to	O
handwashing	O
faced	O
by	O
mothers	O
of	O
neonates	O
[	O
21	O
].	O

However	O
,	O
recent	O
studies	O
suggest	O
that	O
allergen	O
exposure	O
may	O
be	O
necessary	O
to	O
induce	O
tolerance	O
,	O
and	O
moreover	O
,	O
a	O
balanced	O
diet	O
prevents	O
malnutrition	O
of	O
both	O
mother	O
and	O
child	O
[	O
82	O
].	O

Repetitive	O
element	O
DNA	O
methylation	O
was	O
determined	O
by	O
bisulfite	O
pyrosequencing	O
of	O
the	O
LINE	O
-	O
1	O
and	O
the	O
AluYb8	O
repetitive	O
elements	O
as	O
previously	O
described	O
(	O
Bollati	O
et	O
al	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
is	O
accepted	O
as	O
the	O
best	O
marker	O
of	O
vitamin	O
D	O
status	O
although	O
it	O
may	O
serve	O
primarily	O
as	O
a	O
marker	O
of	O
exposure	O
rather	O
than	O
clinical	O
outcomes	O
[	O
2	O
].	O
There	O
are	O
few	O
data	O
that	O
correlate	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
with	O
functional	O
outcomes	O
in	O
newborns	O
and	O
small	O
infants	O
.	O

Risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
,	O
in	O
addition	O
to	O
geographic	O
and	O
seasonal	O
variation	O
,	O
are	O
well	O
established	O
.	O

The	O
24	O
h	O
urine	O
output	O
and	O
water	O
intake	O
were	O
adjusted	O
for	O
BM	O
(	O
mL	O
/	O
g	O
BM	O
)	O
and	O
analyzed	O
for	O
urea	O
,	O
creatinine	O
,	O
uric	O
acid	O
and	O
proteinuria	O
using	O
the	O
colorimetric	O
method	O
(	O
Bioclin	O
System	O
II	O
,	O
Quibasa	O
,	O
Belo	O
Horizonte	O
,	O
MG	O
,	O
Brazil	O
).	O

Specifically	O
,	O
each	O
of	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
are	O
simultaneously	O
evaluated	O
for	O
their	O
association	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
extent	O
and	O
the	O
genomic	O
locations	O
or	O
TFBS	O
that	O
are	O
overrepresented	O
within	O
1	O
kb	O
of	O
the	O
loci	O
[	O
for	O
the	O
GSEA	O
results	O
,	O
see	O
Supplemental	O
Material	O
,	O
Figure	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

Thus	O
,	O
a	O
combination	O
of	O
several	O
strategies	O
may	O
be	O
needed	O
to	O
manipulate	O
IMF	O
deposition	O
,	O
depending	O
on	O
the	O
consumer	O
’	O
s	O
beef	O
preference	O
.	O

Thus	O
,	O
central	O
or	O
visceral	O
obesity	O
,	O
in	O
which	O
fat	O
accumulates	O
in	O
the	O
trunk	O
and	O
in	O
the	O
abdominal	O
cavity	O
(	O
in	O
the	O
mesentery	O
and	O
around	O
the	O
viscera	O
),	O
is	O
associated	O
with	O
a	O
much	O
higher	O
risk	O
for	O
several	O
diseases	O
than	O
excess	O
subcutaneous	O
fat	O
accumulation	O
.	O

It	O
is	O
probably	O
regulated	O
by	O
glucose	O
and	O
insulin	O
(	O
6	O
),	O
and	O
increases	O
with	O
gradual	O
degradation	O
of	O
B	O
-	O
cell	O
and	O
progress	O
of	O
insulin	O
-	O
resistance	O
and	O
maternal	O
weight	O
(	O
7	O
).	O

Empowering	O
families	O
and	O
schools	O
and	O
giving	O
them	O
resources	O
to	O
engage	O
in	O
obesity	O
prevention	O
efforts	O
and	O
to	O
provide	O
environments	O
that	O
support	O
healthy	O
behaviors	O
are	O
critical	O
issues	O
that	O
governments	O
and	O
social	O
institutions	O
need	O
to	O
address	O
.	O

Some	O
of	O
the	O
best	O
mHealth	O
evidence	O
comes	O
from	O
smoking	O
cessation	O
studies	O
[	O
9	O
,	O
10	O
].	O

The	O
first	O
step	O
in	O
treatment	O
of	O
urticaria	O
and	O
angioedema	O
in	O
pregnancy	O
is	O
identification	O
and	O
avoidance	O
of	O
causative	O
factors	O
.	O

While	O
association	O
between	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
and	O
autism	O
spectrum	O
disorders	O
is	O
not	O
strong	O
,	O
exposure	O
to	O
terbutaline	O
during	O
the	O
third	O
trimester	O
has	O
shown	O
to	O
increase	O
incidence	O
.	O

$	O
5	O
.	O
18	O
per	O
woman	O
of	O
reproductive	O
age	O
,	O
as	O
compared	O
to	O
the	O
cost	O
of	O
supplementation	O
per	O
woman	O
of	O
reproductive	O
age	O
of	O
USD0	O
.	O
76	O
.	O

This	O
questionnaire	O
is	O
comprised	O
of	O
ten	O
multiple	O
choice	O
questions	O
,	O
the	O
minimum	O
score	O
is	O
0	O
and	O
the	O
maximum	O
is	O
30	O
.	O

Infant	O
Anthropometrics	O
Trained	O
research	O
staff	O
abstracted	O
infant	O
and	O
child	O
weight	O
and	O
length	O
from	O
obstetric	O
and	O
pediatric	O
records	O
.	O

Atopic	O
Eczema	O
(	O
Dermatitis	O
)	O
Gestational	O
itchy	O
dermatoses	O
are	O
relatively	O
common	O
,	O
with	O
eczema	O
being	O
diagnosed	O
in	O
30	O
%	O
to	O
50	O
%	O
of	O
all	O
cases	O
[	O
41	O
].	O

Mechanisms	O
and	O
model	O
systems	O
The	O
nature	O
of	O
the	O
research	O
means	O
that	O
studies	O
in	O
humans	O
are	O
mainly	O
restricted	O
to	O
epidemiological	O
cohorts	O
.	O

In	O
this	O
paper	O
,	O
we	O
describe	O
the	O
protocol	O
of	O
a	O
community	O
-	O
based	O
cluster	O
randomised	O
controlled	O
trial	O
that	O
aims	O
to	O
evaluate	O
the	O
impact	O
of	O
maternal	O
antenatal	O
IFA	O
supplements	O
on	O
perinatal	O
outcomes	O
.	O

These	O
studies	O
can	O
be	O
ranked	O
into	O
categories	O
that	O
demonstrate	O
(	O
1	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
global	O
epigenetic	O
change	O
(	O
s	O
);	O
(	O
2	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
including	O
further	O
subcategories	O
,	O
such	O
as	O
dose	O
-	O
and	O
/	O
or	O
time	O
-	O
dependent	O
changes	O
,	O
single	O
changes	O
within	O
relevant	O
biological	O
pathways	O
,	O
multiple	O
changes	O
within	O
the	O
same	O
biological	O
pathway	O
,	O
correlation	O
of	O
changes	O
with	O
gene	O
expression	O
at	O
mRNA	O
and	O
/	O
or	O
protein	O
level	O
,	O
use	O
of	O
additional	O
mechanistically	O
relevant	O
controls	O
,	O
robust	O
statistical	O
analysis	O
);	O
(	O
3	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	O
,	O
and	O
/	O
or	O
mechanistically	O
linked	O
in	O
a	O
relevant	O
in	O
vitro	O
system	O
;	O
or	O
(	O
4	O
)	O
the	O
same	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
in	O
both	O
rodent	O
model	O
(	O
s	O
)	O
and	O
human	O
cohort	O
(	O
s	O
).	O

The	O
GM	O
of	O
phthalate	O
and	O
BPA	O
concentrations	O
ranged	O
from	O
2	O
.	O
4	O
ng	O
/	O
ml	O
(	O
MCPP	O
)	O
to	O
41	O
.	O
3	O
ng	O
/	O
ml	O
(	O
MECPP	O
).	O

Participants	O
’	O
dietary	O
intake	O
and	O
nutrient	O
status	O
(	O
focus	O
on	O
micronutrients	O
and	O
fatty	O
acids	O
)	O
are	O
assessed	O
at	O
<	O
18	O
,	O
22	O
and	O
36	O
weeks	O
’	O
gestation	O
.	O

Between	O
fetal	O
and	O
perinatal	O
stages	O
(	O
period	O
I	O
),	O
there	O
were	O
1	O
,	O
034	O
(	O
503	O
1	O
dpn	O
≻	O
94	O
dpc	O
)	O
probe	O
-	O
sets	O
showing	O
levels	O
and	O
directions	O
of	O
regulation	O
in	O
the	O
AP	O
group	O
that	O
were	O
different	O
from	O
the	O
LP	O
group	O
.	O

In	O
human	O
body	O
,	O
the	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
where	O
7	O
-	O
dehydrocholesterol	O
is	O
converted	O
to	O
vitamin	O
D3in	O
response	O
to	O
UV	O
exposure	O
.	O

The	O
LINE	O
-	O
1	O
subclass	O
is	O
the	O
most	O
common	O
LINE	O
,	O
representing	O
about	O
20	O
%	O
of	O
the	O
total	O
human	O
genome	O
,	O
whereas	O
the	O
most	O
abundant	O
type	O
of	O
SINE	O
is	O
the	O
Alu	O
element	O
,	O
as	O
exemplified	O
by	O
AluYb8	O
;	O
together	O
LINE	O
and	O
Alu	O
sequences	O
make	O
up	O
nearly	O
one	O
-	O
third	O
of	O
the	O
genome	O
(	O
Choi	O
et	O
al	O
.	O

The	O
third	O
member	O
of	O
the	O
DNMT3	O
family	O
,	O
DNMT3L	O
,	O
does	O
not	O
possess	O
any	O
DNMT	O
activity	O
,	O
but	O
can	O
help	O
to	O
recruit	O
,	O
and	O
stimulate	O
the	O
activity	O
of	O
,	O
DNMT3A	O
and	O
3B	O
.	O

tablet	O
with	O
Internet	O
enabled	O
SIM	O
card	O
for	O
data	O
collection	O
and	O
transmission	O
of	O
data	O
from	O
the	O
community	O
to	O
central	O
database	O
server	O
.	O

PubMed	O
Central	O
:	O

Participants	O
Women	O
who	O
participated	O
in	O
the	O
LIMIT	O
randomised	O
trial	O
,	O
gave	O
birth	O
to	O
a	O
live	O
infant	O
,	O
and	O
who	O
provided	O
consent	O
to	O
the	O
ongoing	O
follow	O
-	O
up	O
of	O
their	O
child	O
,	O
were	O
eligible	O
for	O
inclusion	O
.	O

Risk	O
for	O
glioma	O
also	O
is	O
nearly	O
equal	O
for	O
left	O
-	O
handed	O
and	O
ambidextrous	O
individuals	O
but	O
higher	O
for	O
right	O
-	O
handers	O
.	O

Considering	O
that	O
exposure	O
to	O
SGA	O
monotherapy	O
was	O
not	O
associated	O
with	O
birth	O
defects	O
in	O
our	O
cohort	O
and	O
that	O
the	O
majority	O
of	O
pregnant	O
women	O
with	O
psychiatric	O
disorders	O
are	O
on	O
psychotropic	O
drug	O
polytherapy	O
,	O
research	O
on	O
the	O
reproductive	O
safety	O
of	O
these	O
medications	O
should	O
reflect	O
this	O
reality	O
.	O

Another	O
possibility	O
is	O
that	O
air	O
pollution	O
from	O
Eastern	O
Europe	O
,	O
India	O
and	O
China	O
,	O
which	O
has	O
been	O
increasing	O
in	O
the	O
last	O
20	O
years	O
,	O
has	O
engendered	O
the	O
current	O
crop	O
of	O
autism	O
.	O

The	O
Block	O
Children	O
’	O
s	O
Food	O
Frequency	O
questionnaire	O
was	O
administered	O
at	O
each	O
yearly	O
visit	O
[	O
24	O
].	O

a	O
Principal	O
coordinate	O
plot	O
of	O
generalized	O
UniFrac	O
distances	O
(	O
PERMANOVA	O
p	O
=	O
0	O
.	O
028	O
for	O
maternal	O
fruit	O
intake	O
as	O
a	O
continuous	O
variable	O
),	O
colored	O
by	O
maternal	O
fruit	O
intake	O
tertiles	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Primer	O
used	O
to	O
verify	O
microarray	O
experiments	O
in	O
liver	O
tissue	O
by	O
qRT	O
-	O
PCRGene	O
nameProbe	O
-	O
set	O
IDSequence	O
5	O
'	O
-	O
3	O
'	O
T	O
(°	O
C	O
)	O
Size	O
(	O
bp	O
)	O
CCND2Ssc	O
.	O
15749	O
.	O
1	O
.	O
S1_atFor	O
AGGAGCAGATTGAGGTCGTG86185Rev	O
CAACCAGAGAGAAGGAAGGAGANCAPGSsc	O
.	O
28512	O
.	O
1	O
.	O
S1_atFor	O
CTTGTAGATTTGACGAGACCA60156Rev	O
GGCTTTAGTATAGACCCGAACMGMTSsc	O
.	O
19639	O
.	O
1	O
.	O
A1_atFor	O
GCAACTACTCGGGAGGAATG88171Rev	O
CTGCGAACGCTCAGTCTTGGADD45BSsc	O
.	O
14764	O
.	O
1	O
.	O
A1_atFor	O
GGACTTAGACTTTGGGACTTG60140Rev	O
GTAAGCCTCCCATCTCTCTTSDHBSsc	O
.	O
8939	O
.	O
1	O
.	O
S1_atFor	O
GCAGGACCCGTTCTCTCTGT60170Rev	O
GGTTACAGTCACGTTAGGTTGGPPARGC1ASsc	O
.	O
16864	O
.	O
1	O
.	O
S1_atFor	O
GTAAATCTGCGGGATGATGG60208Rev	O
TGGTGGAAGCAGGATCAAAGPRKAA1Ssc	O
.	O
8107	O
.	O
1	O
.	O
A1_atFor	O
TTGTTAATTTCATAAACTTTGCTTC60193Rev	O
GTGCAGCCTTGACATACTCPRKAA2Ssc	O
.	O
16257	O
.	O
1	O
.	O
S1_atFor	O
TCTGTAATTCTGTTTTGCCTACGA60168Rev	O
AGCAAGAAGGTGATGCCAAGRPL10	O
*	O
Ssc	O
.	O
9130	O
.	O
1	O
.	O
A1_atFor	O
CTGTGTTCGTCTTTTCTTCC60199Rev	O
TCATCCACTTTTGCCTTCT	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
;	O
RPL10	O
-	O
Ribosomal	O
protein	O
10	O
;	O
*	O
house	O
keeping	O
gene	O
.	O

Cocaine	O
has	O
been	O
associated	O
with	O
an	O
increase	O
in	O
the	O
onset	O
of	O
neurodevelopmental	O
abnormalities	O
,	O
but	O
the	O
direct	O
influence	O
on	O
autism	O
development	O
is	O
still	O
lacking	O
.	O

Although	O
poor	O
lung	O
function	O
performance	O
and	O
an	O
increased	O
risk	O
of	O
respiratory	O
tract	O
infection	O
were	O
related	O
to	O
relatively	O
low	O
cord	O
serum	O
vitamin	O
D	O
levels	O
,	O
further	O
extrapolating	O
the	O
effects	O
of	O
vitamin	O
D	O
on	O
the	O
respiratory	O
function	O
of	O
the	O
general	O
infant	O
population	O
might	O
still	O
be	O
difficult	O
.	O

[	O
19	O
]	O
described	O
a	O
syndrome	O
of	O
supravalvular	O
aortic	O
stenosis	O
,	O
peripheral	O
pulmonic	O
stenosis	O
,	O
and	O
body	O
features	O
indistinguishable	O
from	O
those	O
in	O
survivors	O
of	O
the	O
syndrome	O
of	O
idiopathic	O
hypercalcemia	O
of	O
infancy	O
.	O

These	O
groups	O
were	O
chosen	O
to	O
study	O
whether	O
vitamin	O
D	O
insufficiency	O
(	O
30	O
–	O
50	O
nmol	O
/	O
L	O
),	O
sufficiency	O
(≥	O
50	O
nmol	O
/	O
L	O
)	O
or	O
high	O
status	O
(≥	O
75	O
or	O
≥	O
100	O
nmol	O
/	O
L	O
)	O
was	O
associated	O
with	O
the	O
outcomes	O
studied	O
,	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

Volunteering	O
women	O
reporting	O
for	O
ANC	O
planned	O
visits	O
at	O
the	O
study	O
sites	O
were	O
sensitized	O
on	O
the	O
purpose	O
and	O
the	O
procedure	O
of	O
the	O
study	O
.	O

Distribution	O
and	O
storage	O
USD3	O
,	O
597	O
:	O
source	O
Yen	O
Bai	O
People	O
'	O
s	O
Committee	O
financial	O
recordsPromotional	O
material	O
development	O
and	O
production	O
:	O
amortized	O
over	O
5	O
years	O
.	O

The	O
present	O
study	O
involved	O
a	O
substantially	O
larger	O
sample	O
,	O
and	O
reinforces	O
the	O
observed	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
levels	O
and	O
S	O
-	O
ECC	O
.	O

Limited	O
information	O
is	O
available	O
on	O
the	O
effects	O
of	O
the	O
dietary	O
energy	O
-	O
to	O
-	O
protein	O
ratio	O
on	O
IMF	O
content	O
in	O
cattle	O
.	O

Cognitive	O
behavioral	O
strategies	O
are	O
often	O
used	O
to	O
help	O
children	O
make	O
better	O
decisions	O
,	O
solve	O
problems	O
,	O
and	O
monitor	O
their	O
own	O
progress	O
.	O

Further	O
study	O
is	O
needed	O
to	O
clarify	O
the	O
effects	O
of	O
dietary	O
vitamin	O
D	O
on	O
MS	O
and	O
QG	O
in	O
beef	O
cattle	O
.	O

These	O
data	O
were	O
processed	O
in	O
a	O
specific	O
previous	O
routine	O
designed	O
in	O
MatLab	O
(	O
Math	O
Works	O
,	O
6	O
.	O
0	O
version	O
,	O
USA	O
)	O
for	O
the	O
automatic	O
selection	O
of	O
5	O
minutes	O
RR	O
with	O
the	O
smallest	O
variance	O
[	O
29	O
].	O

When	O
he	O
analyzed	O
her	O
milk	O
,	O
he	O
found	O
it	O
contained	O
exorbitant	O
levels	O
of	O
DDT	O
.	O
12	O
Two	O
years	O
later	O
,	O
researchers	O
examined	O
milk	O
samples	O
from	O
32	O
black	O
women	O
at	O
a	O
Washington	O
,	O
DC	O
,	O
hospital	O
.	O
13None	O
of	O
the	O
women	O
worked	O
with	O
pesticides	O
or	O
reported	O
an	O
acute	O
exposure	O
to	O
DDT	O
,	O
yet	O
their	O
milk	O
contained	O
trace	O
amounts	O
of	O
the	O
chemical	O
.	O

Diet	O
The	O
“	O
developmental	O
plasticity	O
hypothesis	O
”	O
refers	O
to	O
the	O
critical	O
developmental	O
period	O
in	O
utero	O
when	O
the	O
fetus	O
is	O
plastic	O
and	O
adaptively	O
imprints	O
to	O
its	O
environment	O
.	O

Conclusions	O
Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
were	O
associated	O
with	O
substantial	O
reduction	O
in	O
PTB	O
risk	O
in	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
.	O

The	O
main	O
aim	O
was	O
to	O
study	O
factors	O
identified	O
in	O
a	O
previous	O
study	O
as	O
potentially	O
causally	O
related	O
to	O
cancer	O
of	O
the	O
oesophagus	O
.	O

Early	O
childhood	O
and	O
adolescence	O
are	O
also	O
periods	O
of	O
significant	O
growth	O
and	O
development	O
,	O
so	O
it	O
is	O
easy	O
to	O
envisage	O
how	O
environmentally	O
induced	O
epigenetic	O
changes	O
during	O
these	O
stages	O
could	O
have	O
detrimental	O
effects	O
on	O
future	O
health	O
and	O
fertility	O
.	O

In	O
particular	O
,	O
mHealth	O
programs	O
have	O
proven	O
effective	O
in	O
drug	O
adherence	O
,	O
as	O
patient	O
reminder	O
systems	O
,	O
and	O
in	O
some	O
areas	O
of	O
areas	O
of	O
chronic	O
disease	O
management	O
,	O
prevention	O
,	O
and	O
control	O
[	O
5	O
,	O
6	O
].	O

In	O
conclusion	O
,	O
our	O
study	O
revealed	O
that	O
children	O
born	O
with	O
low	O
weight	O
presents	O
detriment	O
of	O
the	O
cardiac	O
vagal	O
autonomic	O
modulation	O
.	O

At	O
stage	O
94	O
dpc	O
1	O
,	O
001	O
probe	O
-	O
sets	O
differed	O
significantly	O
between	O
LP	O
and	O
AP	O
fetuses	O
(	O
541	O
LP	O
≻	O
AP	O
).	O

Non	O
-	O
pregnant	O
women	O
were	O
given	O
supervised	O
doses	O
of	O
albendazole	O
(	O
400	O
mg	O
)	O
every	O
four	O
months	O
in	O
the	O
first	O
year	O
of	O
the	O
program	O
and	O
every	O
six	O
months	O
thereafter	O
.	O

Furthermore	O
,	O
in	O
Thailand	O
dairy	O
products	O
are	O
not	O
fortified	O
with	O
vitamin	O
D	O
and	O
very	O
few	O
vitamin	O
D	O
-	O
rich	O
foods	O
are	O
part	O
of	O
the	O
Thai	O
diet	O
.	O

Our	O
findings	O
are	O
consistent	O
with	O
some	O
studies	O
in	O
nonpregnant	O
adults	O
and	O
children	O
showing	O
a	O
connection	O
between	O
higher	O
intake	O
of	O
sweets	O
and	O
soft	O
drinks	O
and	O
increased	O
weight	O
status	O
[	O
32	O
],	O
but	O
conflicting	O
results	O
have	O
been	O
reported	O
in	O
association	O
with	O
GWG	O
[	O
33	O
].	O

The	O
execution	O
of	O
the	O
study	O
is	O
coordinated	O
by	O
the	O
Centre	O
of	O
Excellence	O
for	O
Nutrition	O
of	O
the	O
North	O
-	O
West	O
University	O
.	O

Conclusions	O
Women	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
the	O
months	O
of	O
extended	O
winter	O
were	O
more	O
likely	O
to	O
have	O
raised	O
insulin	O
resistance	O
in	O
early	O
pregnancy	O
,	O
which	O
had	O
a	O
lasting	O
association	O
to	O
28	O
weeks	O
,	O
and	O
was	O
independent	O
of	O
25OHD	O
.	O

In	O
what	O
follows	O
,	O
population	O
correlations	O
are	O
denoted	O
by	O
r	O
and	O
estimates	O
by	O
.	O

Issued	O
by	O
the	O
March	O
of	O
Dimes	O
every	O
year	O
since	O
2008	O
,	O
the	O
Report	O
Cards	O
assign	O
a	O
letter	O
grade	O
to	O
the	O
United	O
States	O
and	O
to	O
each	O
of	O
50	O
state	O
governments	O
.	O

Researchers	O
can	O
determine	O
which	O
women	O
are	O
taking	O
their	O
vitamins	O
by	O
who	O
refills	O
their	O
prescription	O
.	O

Obviously	O
,	O
at	O
least	O
a	O
part	O
of	O
the	O
innate	O
immune	O
system	O
is	O
impaired	O
when	O
LP	O
offspring	O
is	O
faced	O
with	O
a	O
pre	O
-	O
biotical	O
stress	O
like	O
weaning	O
.	O

In	O
addition	O
,	O
six	O
mitochondrial	O
proteins	O
were	O
down	O
-	O
regulated	O
in	O
DVD	O
-	O
deficient	O
rats	O
(	O
NDUAA	O
,	O
UQCR1	O
,	O
ODPB	O
,	O
IDH3A	O
,	O
HKK1	O
,	O
VDAC2	O
).	O

That	O
is	O
,	O
analyses	O
were	O
conducted	O
assuming	O
that	O
missing	O
values	O
had	O
,	O
firstly	O
,	O
a	O
substantially	O
greater	O
incidence	O
,	O
and	O
secondly	O
,	O
a	O
substantially	O
reduced	O
incidence	O
of	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
as	O
compared	O
with	O
the	O
observed	O
data	O
.	O

These	O
findings	O
show	O
that	O
higher	O
vitamin	O
D	O
status	O
is	O
significantly	O
associated	O
with	O
lower	O
PTB	O
risk	O
for	O
both	O
PTB	O
subtypes	O
and	O
that	O
vitamin	O
D	O
plays	O
an	O
important	O
role	O
in	O
the	O
underlying	O
causes	O
of	O
indicated	O
PTB	O
including	O
maternal	O
hypertension	O
,	O
pre	O
-	O
existing	O
diabetes	O
,	O
and	O
non	O
-	O
reassuring	O
fetal	O
status	O
.	O

Means	O
are	O
adjusted	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

Increasing	O
awareness	O
amongst	O
health	O
providers	O
regarding	O
folic	O
acid	O
allergy	O
may	O
improve	O
the	O
identification	O
and	O
counselling	O
of	O
patients	O
with	O
this	O
allergy	O
.	O

Interestingly	O
,	O
chronic	O
central	O
IL	O
-	O
6	O
stimulation	O
desensitized	O
IL	O
-	O
6	O
signal	O
transduction	O
characterized	O
by	O
reversal	O
of	O
elevated	O
pSTAT3	O
levels	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Upon	O
the	O
glucose	O
gavage	O
,	O
blood	O
glucose	O
concentrations	O
were	O
determined	O
15	O
and	O
60	O
min	O
later	O
and	O
the	O
incremental	O
area	O
under	O
the	O
curve	O
(	O
iAUC	O
)	O
was	O
calculated	O
.	O

Finally	O
,	O
I	O
explain	O
my	O
reasons	O
why	O
this	O
theory	O
deserves	O
immediate	O
attempts	O
to	O
disprove	O
it	O
.	O

Similarly	O
,	O
the	O
activation	O
of	O
TEs	O
would	O
be	O
deleterious	O
for	O
the	O
embryonic	O
genome	O
and	O
so	O
the	O
continued	O
silencing	O
of	O
such	O
loci	O
through	O
early	O
embryogenesis	O
is	O
essential	O
for	O
genome	O
stability	O
and	O
subsequent	O
normal	O
development	O
.	O

More	O
frequent	O
use	O
of	O
supplements	O
during	O
pregnancy	O
was	O
found	O
to	O
be	O
associated	O
with	O
a	O
higher	O
socio	O
-	O
economic	O
status	O
,	O
higher	O
level	O
of	O
education	O
and	O
use	O
of	O
prenatal	O
medical	O
services	O
in	O
studies	O
conducted	O
in	O
Finland	O
[	O
15	O
],	O
the	O
United	O
Kingdom	O
[	O
16	O
],	O
the	O
United	O
States	O
of	O
America	O
[	O
17	O
],	O
Denmark	O
[	O
18	O
]	O
and	O
Tanzania	O
[	O
19	O
].	O

Low	O
levels	O
of	O
physical	O
activity	O
and	O
sedentary	O
lifestyle	O
are	O
known	O
contributing	O
factors	O
to	O
obesity	O
and	O
weight	O
gain	O
in	O
the	O
general	O
population	O
[	O
40	O
].	O

5	O
.	O

Across	O
the	O
five	O
visits	O
made	O
in	O
the	O
neonatal	O
period	O
,	O
intervention	O
households	O
were	O
between	O
5	O
.	O
7	O
and	O
15	O
.	O
2	O
times	O
as	O
likely	O
as	O
control	O
households	O
to	O
have	O
soap	O
and	O
water	O
present	O
at	O
the	O
handwashing	O
station	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
.	O

Because	O
the	O
risk	O
of	O
developing	O
GDM	O
gradually	O
increases	O
in	O
overweight	O
and	O
obese	O
women	O
,	O
the	O
total	O
sample	O
was	O
divided	O
into	O
three	O
pre	O
-	O
pregnancy	O
BMI	O
groups	O
for	O
comparison	O
:	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
BMI	O
≥	O
25	O
kg	O
/	O
m2and	O
<	O
30	O
kg	O
/	O
m2and	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
.	O

PubMed	O
Central	O
:	O

Compromised	O
calcium	O
buffering	O
in	O
the	O
nucleus	O
accumbens	O
could	O
disrupt	B
adaptive	O
and	O
goal	O
-	O
directed	O
behaviors	O
.	O

Although	O
an	O
assessment	O
was	O
conducted	O
at	O
6	O
months	O
post	O
-	O
partum	O
involving	O
66	O
%	O
of	O
participants	O
[	O
18	O
],	O
there	O
have	O
been	O
no	O
early	O
infant	O
outcomes	O
reported	O
to	O
date	O
.	O

Measured	O
the	O
odds	O
of	O
improved	O
development	O
scores	O
due	O
to	O
fish	O
intake	O
.	O

However	O
there	O
is	O
so	O
far	O
no	O
conclusive	O
evidence	O
about	O
the	O
causality	O
of	O
these	O
relationships	O
,	O
as	O
no	O
randomised	O
controlled	O
trials	O
of	O
vitamin	O
D	O
supplementation	O
with	O
an	O
appropriate	O
assessment	O
of	O
a	O
variety	O
of	O
health	O
outcomes	O
have	O
been	O
carried	O
out	O
to	O
date	O
[	O
21	O
].	O

Both	O
these	O
prospective	O
studies	O
had	O
relatively	B
few	I
cases	O
of	O
pregnancy	O
loss	O
and	O
may	O
therefore	O
have	O
been	O
insufficiently	B
powered	O
to	O
study	O
this	O
association	O
.	O

Acryomns	O
used	O
:	O
ANC	O
=	O
Antenatal	O
care	O
;	O
CPAP	O
=	O
Continuous	O
positive	O
airway	O
pressure	O
;	O
HIV	O
=	O
Human	O
Immunodeficiency	O
Virus	O
;	O
IMCI	O
=	O
Integrated	O
Management	O
of	O
Childhood	O
Illnesses	O
;	O
IPTp	O
=	O
Intermittent	O
presumptive	O
treatment	O
during	O
pregnancy	O
for	O
malaria	O
;	O
pPROM	O
=	O
prelabour	O
premature	O
rupture	O
of	O
membranes	O
;	O
STI	O
=	O
Sexually	O
Transmitted	O
Illness	O
.	O

Conclusions	O
In	O
summary	O
,	O
20	O
.	O
4	O
%	O
pregnant	O
women	O
with	O
GDM	O
in	O
their	O
middle	O
and	O
late	O
pregnancy	O
are	O
deficient	O
in	O
Vitamin	O
D	O
,	O
though	O
their	O
Vitamin	O
D	O
levels	O
were	O
higher	O
than	O
the	O
general	O
population	O
.	O

Therefore	O
,	O
nutritionally	O
-	O
induced	O
accelerated	O
reproductive	O
maturation	O
following	O
high	O
fat	O
exposure	O
may	O
not	O
be	O
limited	O
to	O
one	O
distinct	O
critical	O
developmental	O
window	O
.	O

Participants	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
at	O
their	O
first	O
antenatal	O
visit	O
were	O
likely	O
to	O
have	O
increased	O
fasting	O
glucose	O
at	O
28	O
weeks	O
’	O
gestation	O
,	O
regardless	O
of	O
season	O
.	O

A	O
BRAC	O
PO	O
area	O
approximately	O
comprises	O
of	O
40	O
to	O
50	O
villages	O
with	O
an	O
average	O
population	O
of	O
13	O
,	O
000	O
people	O
.	O

Maternal	O
mortality	O
ratio	O
(	O
MMR	O
)	O
has	O
dropped	O
by	O
47	O
%	O
worldwide	O
during	O
the	O
past	O
20years	O
.	O

),	O
overweight	O
or	O
obesity	O
,	O
excessive	O
gestational	O
weight	O
gain	O
,	O
excessive	O
central	O
body	O
fat	O
deposition	O
,	O
family	O
history	O
of	O
diabetes	O
,	O
short	O
stature	O
(<	O
1	O
.	O
50	O
m	O
),	O
excessive	O
fetal	O
growth	O
,	O
polyhydramnios	O
,	O
hypertension	O
or	O
preeclampsia	O
in	O
the	O
current	O
pregnancy	O
,	O
history	O
of	O
recurrent	O
miscarriage	O
,	O
offspring	O
malformation	O
,	O
fetal	O
or	O
neonatal	O
death	O
,	O
macrosomia	O
,	O
GDM	O
during	O
prior	O
pregnancies	O
and	O
polycystic	O
ovary	O
syndrome	O
.	O

This	O
association	O
indicates	O
that	O
overweight	O
mothers	O
are	O
more	O
likely	O
to	O
have	O
overweight	O
children	O
,	O
and	O
these	O
odds	O
increase	O
with	O
the	O
age	O
of	O
the	O
child	O
.	O

in	O
their	O
study	O
used	O
a	O
dosage	O
of	O
14	O
,	O
000	O
IU	O
vitamin	O
D	O
supplement	O
per	O
week	O
,	O
equal	O
to	O
2000	O
IU	O
per	O
day	O
,	O
started	O
at	O
27	O
–	O
30	O
weeks	O
of	O
gestation	O
.	O

It	O
is	O
worth	O
noting	O
that	O
some	O
genomic	O
regions	O
escape	O
this	O
first	O
global	O
‘	O
reset	O
’,	O
including	O
imprinted	O
control	O
regions	O
(	O
ICRs	O
)	O
and	O
the	O
most	O
active	O
TEs	O
.	O

Methods	O
A	O
cohort	O
of	O
1	O
,	O
290	O
women	O
was	O
interviewed	O
during	O
early	O
pregnancy	O
.	O

Geographical	O
accessibility	O
was	O
the	O
main	O
reason	O
for	O
choosing	O
an	O
ANC	O
site	O
,	O
followed	O
by	O
perceived	O
quality	O
of	O
care	O
provided	O
.	O

Conclusion	O
Black	O
obese	O
mothers	O
on	O
Medicaid	O
without	O
prenatal	O
vitamin	O
use	O
were	O
at	O
the	O
highest	O
risk	O
of	O
delivering	O
neonates	O
with	O
vitamin	O
D	O
deficiency	O
.	O

2009	O
;	O
Zamudio	O
and	O
Bourc	O
’	O
his	O
2010	O
).	O

Caption	O
(	O
FIG	O
)	O
Introduced	O
in	O
the	O
1940s	O
,	O
DDT	O
was	O
widely	O
used	O
until	O
it	O
was	O
banned	O
for	O
most	O
uses	O
in	O
the	O
1970s	O
.	O

Angus	O
crossbred	O
cattle	O
exposed	O
to	O
greater	O
heat	O
stress	O
tend	O
to	O
have	O
a	O
greater	O
MS	O
[	O
82	O
].	O

It	O
would	O
be	O
of	O
interest	O
to	O
repeat	O
these	O
experiments	O
in	O
primary	O
cell	O
lines	O
of	O
syncytialised	O
trophoblasts	O
.	O

Concerning	O
hyperphagia	O
,	O
several	O
studies	O
have	O
reported	O
this	O
feeding	O
alteration	O
after	O
the	O
exposure	O
to	O
undernutrition	O
in	O
critical	O
windows	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
),	O
so	O
it	O
has	O
been	O
proposed	O
as	O
an	O
important	O
contributor	O
of	O
the	O
excessive	O
body	O
weight	O
.	O

Its	O
indirect	O
effects	O
are	O
attributed	O
to	O
vitamin	O
D	O
’	O
s	O
effects	O
on	O
improvement	O
of	O
muscle	O
activities	O
.	O

For	O
example	O
,	O
their	O
skin	O
surface	O
area	O
is	O
comparatively	O
larger	O
and	O
more	O
permeable	O
to	O
lipophilic	O
compounds	O
,	O
which	O
serves	O
to	O
maximize	O
the	O
absorption	O
of	O
compounds	O
such	O
as	O
pesticides	O
into	O
the	O
bloodstream	O
[	O
35	O
–	O
37	O
].	O

Maternal	O
diet	O
effect	O
p	O
<	O
0	O
.	O
001	O
,	O
postnatal	O
diet	O
effect	O
p	O
<	O
0	O
.	O
001	O
in	O
control	O
offspring	O
-	O
in	O
maternal	O
high	O
fat	O
offspring	O
postnatal	O
diet	O
had	O
no	O
effect	O
.	O

A	O
recent	O
trial	O
in	O
northern	O
China	O
identified	O
an	O
annual	O
cost	O
of	O
USD40	O
.	O
00	O
to	O
improve	O
antenatal	O
,	O
delivery	O
and	O
postnatal	O
care	O
of	O
which	O
22	O
%	O
(	O
USD8	O
.	O
80	O
)	O
was	O
to	O
supply	O
and	O
distribute	O
daily	O
supplements	O
to	O
pregnant	O
women	O
[	O
24	O
].	O

Genetic	O
analysis	O
J	O
/	O
QTL	O
software	O
(	O
http	O
://	O
churchill	O
.	O
jax	O
.	O
org	O
/	O
software	O
/	O
jqtl	O
.	O
shtml	O
)	O
was	O
used	O
to	O
calculate	O
LOD	O
scores	O
for	O
the	O
whole	O
-	O
genome	O
SNP	O
analysis	O
.	O

Introduction	O
The	O
belief	O
that	O
the	O
sequence	O
of	O
our	O
DNA	O
(	O
our	O
genome	O
)	O
is	O
the	O
sole	O
determinant	O
of	O
our	O
life	O
-	O
long	O
development	O
and	O
health	O
has	O
long	O
been	O
regarded	O
as	O
too	O
simplistic	O
.	O

The	O
validity	O
of	O
PUFA	O
estimated	O
by	O
means	O
of	O
the	O
FFQ	O
was	O
r	O
=	O
0	O
.	O
5	O
in	O
comparison	O
to	O
adipose	O
tissue	O
composition	O
[	O
26	O
].	O

Then	O
,	O
the	O
hypothalamus	O
was	O
dissected	O
out	O
from	O
the	O
base	O
of	O
the	O
brain	O
according	O
the	O
rat	O
brain	O
atlas	O
of	O
Paxinos	O
and	O
Watson	O
(	O
2007	O
).	O

DEP	O
,	O
one	O
OPP	O
,	O
was	O
associated	O
with	O
a	O
16	O
g	O
birth	O
weight	O
increase	O
using	O
LASSO	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
)	O
and	O
DMP	O
,	O
the	O
other	O
OPP	O
,	O
was	O
associated	O
with	O
a	O
48	O
g	O
decrease	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
).	O

In	O
the	O
same	O
study	O
,	O
patients	O
with	O
the	O
highest	O
concentrations	O
of	O
VD2had	O
the	O
lowest	O
glucose	O
concentration	O
in	O
follicular	O
fluid	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
[	O
61	O
].	O

Fructose	O
also	O
causes	O
generation	O
of	O
uric	O
acid	O
[	O
38	O
],	O
and	O
experimental	O
evidence	O
in	O
mice	O
suggests	O
that	O
uric	O
acid	O
may	O
be	O
an	O
essential	O
initiator	O
and	O
amplifier	O
of	O
T	O
-	O
helper	O
cell	O
type	O
2	O
(	O
Th2	O
)	O
immunity	O
and	O
allergic	O
inflammation	O
,	O
through	O
activation	O
of	O
inflammatory	O
dendritic	O
cells	O
[	O
39	O
].	O

Propensity	O
Score	O
Models	O
adjusted	O
for	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
Fe	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
).	O

Spearman	O
Rank	O
correlation	O
test	O
showed	O
a	O
negative	O
significant	O
relationship	O
between	O
second	O
trimester	O
visfatin	O
level	O
and	O
birth	O
height	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

PubMed	O
Central	O
:	O

Obviously	O
,	O
the	O
increased	O
mRNA	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
regulators	O
within	O
developmental	O
period	O
I	O
in	O
LP	O
offspring	O
accounts	O
for	O
compensatory	O
regulations	O
regarding	O
the	O
lowered	O
fetal	O
weight	O
due	O
to	O
the	O
gestational	O
diet	O
.	O

The	O
patient	O
denied	O
any	O
significant	O
past	O
medical	O
history	O
other	O
than	O
mild	O
hypertension	O
that	O
developed	O
during	O
the	O
third	O
trimester	O
of	O
her	O
pregnancy	O
.	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
class	O
methylation	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Between	O
groups	O
comparisons	O
of	O
depression	O
scores	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrationsVariablesmean	O
±	O
sdDepression	O
score	O
,	O
N	O
(%)	O
Vitamin	O
D	O
groupControl	O
group	O
P	O
-	O
valueVitamin	O
D	O
groupControl	O
group	O
<	O
99	O
–	O
13	O
>	O
13	O
<	O
99	O
–	O
13	O
>	O
13	O
P	O
-	O
value	O
*	O
Depression	O
score	O
at	O
baseline8	O
.	O
44	O
±	O
3	O
.	O
898	O
.	O
64	O
±	O
3	O
.	O
810	O
.	O
74737	O
(	O
49	O
.	O
3	O
)	O
38	O
(	O
50	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
33	O
(	O
42	O
.	O
3	O
)	O
45	O
(	O
57	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
383Depression	O
score	O
at	O
38	O
–	O
40w	O
gestation6	O
.	O
17	O
±	O
3	O
.	O
477	O
.	O
77	O
±	O
3	O
.	O
920	O
.	O
0149	O
(	O
72	O
.	O
1	O
)	O
18	O
(	O
26	O
.	O
5	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
37	O
(	O
50	O
.	O
7	O
)	O
30	O
(	O
41	O
.	O
1	O
)	O
6	O
(	O
8	O
.	O
2	O
)	O
0	O
.	O
024Depression	O
score	O
at	O
post	O
partum	O
(	O
4w	O
)	O
4	O
.	O
59	O
±	O
3	O
.	O
297	O
.	O
36	O
±	O
4	O
.	O
27	O
<	O
0	O
.	O
00158	O
(	O
90	O
.	O
6	O
)	O
6	O
(	O
9	O
.	O
4	O
)	O
0	O
(	O
0	O
)	O
43	O
(	O
59	O
.	O
7	O
)	O
23	O
(	O
31	O
.	O
9	O
)	O
6	O
(	O
8	O
.	O
3	O
)<	O
0	O
.	O
001Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
19	O
±	O
3	O
.	O
767	O
.	O
18	O
±	O
3	O
.	O
99	O
<	O
0	O
.	O
00157	O
(	O
89	O
.	O
1	O
)	O
7	O
(	O
10	O
.	O
9	O
)	O
0	O
(	O
0	O
)	O
46	O
(	O
63	O
.	O
9	O
)	O
22	O
(	O
30	O
.	O
6	O
)	O
4	O
(	O
5	O
.	O
6	O
)	O
0	O
.	O
001Categorized	O
25	O
(	O
OH	O
)	O
D	O
,	O
N	O
(%)<	O
2020	O
–	O
29	O
≥	O
30	O
<	O
2020	O
–	O
29	O
≥	O
30	O
P	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
12	O
.	O
84	O
±	O
7	O
.	O
9111	O
.	O
89	O
±	O
6	O
.	O
400	O
.	O
63a65	O
(	O
86	O
.	O
7	O
)	O
7	O
(	O
9	O
.	O
3	O
)	O
3	O
(	O
4	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
8	O
(	O
10	O
.	O
3	O
)	O
1	O
(	O
1	O
.	O
3	O
)	O
0	O
.	O
6125	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
17	O
.	O
46	O
±	O
10	O
.	O
0912	O
.	O
07	O
±	O
5	O
.	O
980	O
.	O
001a41	O
(	O
66	O
.	O
1	O
)	O
15	O
(	O
24	O
.	O
2	O
)	O
6	O
(	O
9	O
.	O
7	O
)	O
58	O
(	O
85	O
.	O
3	O
)	O
10	O
(	O
14	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
006	O
*	O
Fisher	O
’	O
s	O
Exact	O
Test	O
aMann	O
-	O
Whitney	O
U	O
test	O
The	O
mean	O
depression	O
score	O
of	O
184	O
participants	O
was	O
9	O
.	O
20	O
±	O
4	O
.	O
44	O
at	O
baseline	O
.	O

None	O
of	O
the	O
remaining	O
GR	O
polymorphism	O
subgroups	O
demonstrated	O
any	O
differential	O
correlations	O
between	O
maternal	O
attitudes	O
and	O
fetal	O
weight	O
(	O
data	O
not	O
shown	O
).	O

The	O
increase	O
in	O
body	O
weight	O
of	O
RC	O
male	O
offspring	O
is	O
directly	O
associated	O
with	O
an	O
increase	O
in	O
abdominal	O
fat	O
and	O
,	O
particularly	O
,	O
a	O
higher	O
percentage	O
of	O
perirenal	O
adiposity	O
relative	O
to	O
body	O
weight	O
.	O

Inform	O
•	O
Strengthen	O
global	O
networks	O
to	O
disseminate	O
new	O
research	O
findings	O
and	O
best	O
practice	O
related	O
to	O
preterm	O
birth	O
through	O
leveraging	O
the	O
momentum	O
from	O
Born	O
Too	O
Soon	O
and	O
commitments	O
of	O
these	O
institutions	O
.	O

There	O
are	O
also	O
high	O
preterm	O
birth	O
rates	O
in	O
many	O
high	O
-	O
income	O
countries	O
,	O
including	O
the	O
United	O
States	O
.	O

Two	O
clinical	O
trials	O
support	O
a	O
potential	O
role	O
of	O
vitamin	O
D	O
in	O
the	O
prevention	O
of	O
preeclampsia	O
,	O
although	O
neither	O
of	O
these	O
treated	O
with	O
vitamin	O
D	O
supplements	O
alone	O
.	O

An	O
increasing	O
body	O
of	O
evidence	O
suggests	O
that	O
low	O
birth	O
weight	O
is	O
correlated	O
with	O
alterations	O
in	O
autonomic	O
responses	O
[	O
15	O
–	O
20	O
].	O

There	O
were	O
no	O
differences	O
in	O
anthropometric	O
indices	O
(	O
BMI	O
,	O
weight	O
,	O
and	O
MUAC	O
)	O
between	O
the	O
two	O
groups	O
(	O
Table	O
3	O
).	O

By	O
contrast	O
,	O
in	O
normal	O
weight	O
mothers	O
,	O
lower	O
fat	O
intake	O
(	O
and	O
higher	O
carbohydrate	O
intake	O
)	O
early	O
in	O
pregnancy	O
was	O
a	O
significant	O
predictor	O
of	O
higher	O
offspring	O
weight	O
at	O
6	O
months	O
.	O

Vitamin	O
D3	O
also	O
comes	O
from	O
endogenous	O
sources	O
where	O
it	O
can	O
be	O
synthesized	O
by	O
skin	O
when	O
exposed	O
to	O
ultraviolet	O
irradiation	O
.	O

At	O
6	O
months	O
,	O
the	O
strongest	O
predictors	O
of	O
higher	O
WFA	O
z	O
-	O
scores	O
were	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
t	O
=	O
3	O
.	O
2	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
also	O
greater	O
increases	O
in	O
percentage	O
of	O
calories	O
from	O
protein	O
during	O
pregnancy	O
beta	O
=	O
0	O
.	O
20	O
;	O
Table	O
3	O
).	O

Examination	O
for	O
concentration	O
of	O
VD2and	O
glucose	O
of	O
follicular	O
fluid	O
in	O
101	O
patients	O
treated	O
with	O
IVF	O
-	O
ICSI	O
method	O
reported	O
poorer	O
quality	O
of	O
embryos	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
a	O
lower	O
rate	O
of	O
clinical	O
pregnancies	O
(	O
14	O
.	O
5	O
%)	O
in	O
patients	O
with	O
VD	O
levels	O
exceeding	O
75	O
nmol	O
/	O
L	O
.	O

Labor	O
Induction	O
and	O
Augmentation	O
Since	O
the	O
early	O
1990s	O
,	O
a	O
number	O
of	O
studies	O
have	O
suggested	O
the	O
link	O
between	O
ASD	O
and	O
labor	O
induction	O
,	O
such	O
as	O
the	O
use	O
of	O
oxytocin	O
[	O
67	O
].	O

Our	O
main	O
analyses	O
focused	O
on	O
vaginally	O
delivered	O
infants	O
(	O
n	O
=	O
97	O
).	O

A	O
female	O
must	O
reprogram	O
the	O
paternally	O
imprinted	O
genes	O
on	O
the	O
chromosomes	O
inherited	O
from	O
her	O
father	O
into	O
maternally	O
imprinted	O
genes	O
and	O
vice	O
versa	O
.	O

Despite	O
the	O
similar	O
latitudes	O
of	O
Adelaide	O
and	O
Auckland	O
(	O
Adelaide	O
:	O
34	O
.	O
93	O
°	O
S	O
and	O
Auckland	O
36	O
.	O
85	O
°	O
S	O
),	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
.	O

We	O
evaluated	O
the	O
determinants	O
for	O
the	O
intake	O
of	O
multivitamins	O
as	O
previous	O
studies	O
,	O
as	O
well	O
as	O
the	O
common	O
practice	O
in	O
Romania	O
suggested	O
a	O
high	O
incidence	O
of	O
use	O
[	O
14	O
,	O
35	O
],	O
despite	O
the	O
lack	O
of	O
recommendation	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Maternal	O
25OHD	O
and	O
markers	O
of	O
glucose	O
metabolism	O
in	O
early	O
and	O
late	O
pregnancy	O
among	O
the	O
total	O
group	O
and	O
categorised	O
by	O
season	O
of	O
first	O
antenatal	O
visitSeason	O
at	O
first	O
antenatal	O
visitTotal	O
Group	O
(	O
n	O
=	O
334	O
)	O
Winter	O
(	O
n	O
=	O
166	O
)	O
Summer	O
(	O
n	O
=	O
168	O
)	O
Pd25OHD	O
early	O
<	O
30	O
nmol	O
/	O
La90	O
(	O
26	O
.	O
9	O
)	O
64	O
(	O
38	O
.	O
6	O
)	O
26	O
(	O
15	O
.	O
5	O
)<	O
0	O
.	O
00125OHD	O
early	O
<	O
50	O
nmol	O
/	O
La205	O
(	O
61	O
.	O
4	O
)	O
121	O
(	O
72	O
.	O
9	O
)	O
84	O
(	O
50	O
.	O
0	O
)	O
0	O
.	O
00225OHD	O
28	O
weeks	O
<	O
30	O
nmol	O
/	O
La111	O
(	O
33	O
.	O
2	O
)	O
56	O
(	O
33	O
.	O
7	O
)	O
55	O
(	O
32	O
.	O
7	O
)	O
0	O
.	O
66225OHD	O
28	O
weeks	O
<	O
50	O
nmol	O
/	O
La211	O
(	O
63	O
.	O
2	O
)	O
103	O
(	O
62	O
.	O
0	O
)	O
107	O
(	O
63	O
.	O
7	O
)	O
0	O
.	O
999HOMA	O
-	O
IR	O
earlyb2	O
.	O
1	O
(	O
2	O
.	O
6	O
)	O
2	O
.	O
4	O
(	O
2	O
.	O
8	O
)	O
1	O
.	O
7	O
(	O
2	O
.	O
0	O
)	O
0	O
.	O
004HOMA	O
-	O
IR	O
28	O
weeksb2	O
.	O
8	O
(	O
3	O
.	O
15	O
)	O
2	O
.	O
9	O
(	O
3	O
.	O
4	O
)	O
2	O
.	O
6	O
(	O
2	O
.	O
6	O
)	O
0	O
.	O
064Insulin	O
early	O
(	O
μU	O
/	O
mL	O
)	O
b11	O
.	O
3	O
(	O
12	O
.	O
3	O
)	O
12	O
.	O
8	O
(	O
13	O
.	O
1	O
)	O
9	O
.	O
3	O
(	O
11	O
.	O
1	O
)	O
0	O
.	O
002Insulin	O
28	O
weeks	O
(	O
μU	O
/	O
mL	O
)	O
b14	O
.	O
4	O
(	O
15	O
.	O
6	O
)	O
14	O
.	O
6	O
(	O
16	O
.	O
8	O
)	O
14	O
.	O
1	O
(	O
11	O
.	O
8	O
)	O
0	O
.	O
108Fasting	O
glucose	O
early	O
(	O
mmol	O
/	O
L	O
)	O
c4	O
.	O
48	O
(	O
0	O
.	O
35	O
)	O
4	O
.	O
47	O
(	O
0	O
.	O
33	O
)	O
4	O
.	O
49	O
(	O
0	O
.	O
37	O
)	O
0	O
.	O
566Fasting	O
glucose	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
c4	O
.	O
46	O
(	O
0	O
.	O
46	O
)	O
4	O
.	O
49	O
(	O
0	O
.	O
45	O
)	O
4	O
.	O
42	O
(	O
0	O
.	O
46	O
)	O
0	O
.	O
1571	O
-	O
h	O
GCT	O
28	O
weeks	O
(	O
mmol	O
/	O
L	O
)	O
c6	O
.	O
48	O
(	O
1	O
.	O
44	O
)	O
6	O
.	O
47	O
(	O
1	O
.	O
39	O
)	O
6	O
.	O
50	O
(	O
1	O
.	O
48	O
)	O
0	O
.	O
864	O
Data	O
presented	O
asan	O
(%),	O
bmedian	O
(	O
interquartile	O
range	O
),	O
cmean	O
(	O
SD	O
)	O
dComparison	O
between	O
winter	O
and	O
summer	O
Unadjusted	O
analysis	O
–	O
25OHD	O
,	O
season	O
and	O
markers	O
of	O
glucose	O
metabolism	O
On	O
unadjusted	O
,	O
simple	O
linear	O
regression	O
,	O
early	O
-	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
was	O
not	O
associated	O
with	O
any	O
marker	O
of	O
glucose	O
metabolism	O
in	O
early	O
or	O
late	O
pregnancy	O
(	O
Table3	O
[	O
a	O
]).	O

Of	O
the	O
total	O
(	O
n	O
=	O
128	O
)	O
of	O
participants	O
who	O
self	O
-	O
reported	O
not	O
receiving	O
influenza	O
vaccination	O
,	O
only	O
2	O
(	O
2	O
%),	O
had	O
evidence	O
of	O
influenza	O
vaccination	O
.	O

Methods	O
Study	O
population	O
and	O
setting	O
This	O
preliminary	O
(	O
pilot	O
)	O
study	O
is	O
based	O
on	O
data	O
collected	O
from	O
a	O
cohort	O
of	O
women	O
attending	O
prenatal	O
care	O
clinics	O
affiliated	O
with	O
Swedish	O
Medical	O
Center	O
in	O
Seattle	O
,	O
Washington	O
.	O

found	O
a	O
59	O
%	O
lower	O
risk	O
of	O
PTB	O
for	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
with	O
concentrations	O
≤	O
20	O
ng	O
/	O
mL	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
[	O
12	O
].	O

SIRTs	O
are	O
a	O
class	O
of	O
proteins	O
that	O
have	O
a	O
role	O
in	O
cellular	O
processes	O
associated	O
with	O
body	O
metabolism	O
such	O
as	O
cell	O
differentiation	O
,	O
aging	O
,	O
transcription	O
,	O
apoptosis	O
,	O
inflammation	O
,	O
and	O
stress	O
resistance	O
,	O
as	O
well	O
as	O
energy	O
efficiency	O
and	O
alertness	O
during	O
low	O
-	O
calorie	O
situations	O
.	O

3	O
.	O
5	O
.	O

An	O
increase	O
of	O
'	O
mTOR	O
signaling	O
'	O
within	O
developmental	O
period	O
II	O
was	O
observed	O
in	O
AP	O
offspring	O
,	O
but	O
not	O
in	O
the	O
LP	O
group	O
.	O

These	O
studies	O
are	O
highly	O
therapeutically	O
relevant	O
,	O
as	O
BAT	O
activation	O
in	O
overweight	O
or	O
obese	O
subjects	O
will	O
activate	O
thermogenesis	O
and	O
dissipate	O
heat	O
,	O
while	O
at	O
the	O
same	O
time	O
improving	O
glucose	O
metabolism	O
and	O
insulin	O
resistance	O
.	O

adjusted	O
for	O
paternal	O
IQ	O
but	O
not	O
the	O
home	O
environment	O
[	O
22	O
,	O
23	O
].	O

Insulin	O
therapy	O
for	O
gestational	O
diabetes	O
When	O
treatment	O
targets	O
are	O
not	O
achieved	O
by	O
dietary	O
means	O
,	O
then	O
insulin	O
is	O
required	O
.	O

Depending	O
on	O
the	O
offspring	O
'	O
s	O
nutritional	O
history	O
during	O
the	O
prenatal	O
and	O
lactational	O
periods	O
,	O
subsequent	O
nutrition	O
and	O
body	O
weight	O
gain	O
did	O
not	O
further	O
influence	O
offspring	O
reproductive	O
tempo	O
,	O
which	O
was	O
dominated	O
by	O
the	O
effect	O
of	O
prenatal	O
nutrition	O
.	O

However	O
,	O
only	O
four	O
out	O
of	O
nineteen	O
participants	O
with	O
supplement	O
use	O
who	O
was	O
also	O
positive	O
for	O
Vitamin	O
D2	O
received	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
.	O

These	O
suboptimal	O
levels	O
were	O
also	O
seen	O
in	O
recent	O
reports	O
by	O
Liao	O
et	O
al	O
[	O
31	O
].	O

Both	O
histone	O
modifications	O
and	O
DNA	O
methylation	O
changes	O
can	O
inhibit	O
or	O
promote	O
transcription	O
of	O
mRNAs	O
and	O
ncRNAs	O
.	O

This	O
is	O
achieved	O
through	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Baseline	O
and	O
final	O
values	O
for	O
25	O
(	O
OH	O
)	O
D	O
in	O
38	O
subjects	O
based	O
on	O
initial	O
values	O
above	O
or	O
below	O
20	O
ng	O
/	O
mL	O
.	O

No	O
interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
hypothalamus	O
,	O
but	O
it	O
was	O
found	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
and	O
Dagl	O
β	O
in	O
PAT	O
(	O
TableS2	O
).	O

Discussion	O
The	O
text4baby	O
program	O
is	O
significant	O
in	O
that	O
it	O
represents	O
one	O
of	O
the	O
largest	O
worldwide	O
mHealth	O
programs	O
to	O
date	O
,	O
with	O
more	O
than	O
800	O
,	O
000	O
enrollees	O
from	O
inception	O
in	O
February	O
2010	O
through	O
November	O
2014	O
[	O
40	O
].	O

Other	O
proteins	O
associated	O
with	O
DVD	O
deficiency	O
related	O
to	O
mitochondrial	O
function	O
,	O
and	O
the	O
dynamin	O
-	O
like	O
proteins	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
recent	O
reports	O
of	O
increased	O
polytherapy	O
involving	O
antipsychotics	O
and	O
antidepressants	O
in	O
the	O
USA	O
,	O
20as	O
well	O
as	O
in	O
other	O
cohorts	O
of	O
pregnant	O
women	O
.	O
14161921	O
We	O
found	O
that	O
women	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
differed	O
significantly	O
with	O
respect	O
to	O
a	O
number	O
of	O
characteristics	O
and	O
behaviours	O
that	O
are	O
known	O
to	O
be	O
associated	O
with	O
increased	O
risks	O
for	O
adverse	O
pregnancy	O
outcomes	O
.	O

Debate	O
also	O
exists	O
in	O
relation	O
to	O
seasonality	O
of	O
physical	O
activity	O
levels	O
[	O
30	O
,	O
44	O
].	O

Statistical	O
significance	O
was	O
accepted	O
at	O
the	O
p	O
<	O
0	O
.	O
05	O
level	O
.	O

The	O
RT2	O
reactions	O
including	O
the	O
entire	O
RT1	O
reactions	O
,	O
mixed	O
with	O
5	O
µl	O
moloney	O
murine	O
leukemia	O
virus	O
reverse	O
transcriptase	O
(	O
M	O
-	O
MLV	O
)	O
5	O
×	O
buffer	O
(	O
250	O
mM	O
,	O
pH	O
=	O
8	O
.	O
3	O
)	O
Tris	O
–	O
HCl	O
,	O
15	O
mM	O
MgCl2	O
,	O
50	O
mM	O
dithiothreitol	O
and	O
375	O
mM	O
KCl	O
,	O
1	O
.	O
25	O
µl	O
of	O
10	O
mM	O
-	O
deoxyribonucleotide	O
tripho	O
-	O
sphate	O
,	O
1	O
µl	O
M	O
-	O
MLV	O
RNase	O
(	O
200	O
U	O
/	O
µl	O
)	O
and	O
0	O
.	O
5	O
µl	O
RNase	O
inhibitor	O
(	O
40	O
U	O
/	O
µl	O
).	O

The	O
total	O
intake	O
of	O
all	O
fish	O
and	O
seafood	O
was	O
grouped	O
into	O
six	O
categories	O
(	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
once	O
per	O
week	O
,	O
twice	O
per	O
week	O
,	O
3	O
-	O
4	O
times	O
per	O
week	O
and	O
5	O
times	O
per	O
week	O
or	O
more	O
).	O

Smoking	O
during	O
pregnancy	O
was	O
rare	O
at	O
4	O
.	O
8	O
%,	O
and	O
the	O
population	O
was	O
slightly	O
overweight	O
with	O
an	O
average	O
pre	O
-	O
pregnancy	O
BMI	O
of	O
25	O
.	O
6	O
.	O

in	O
taxonomy	O
labels	O
indicate	O
that	O
the	O
level	O
of	O
taxonomy	O
is	O
family	O
,	O
genus	O
,	O
or	O
species	O
,	O
respectively	O
Infant	O
gut	O
microbiome	O
clusters	O
We	O
identified	O
three	O
distinct	O
clusters	O
of	O
the	O
infant	O
gut	O
microbiome	O
in	O
vaginally	O
delivered	O
infants	O
(	O
n	O
=	O
97	O
),	O
with	O
cluster	O
1	O
characterized	O
by	O
a	O
high	O
abundance	O
of	O
the	O
genus	O
Bifidobacterium	O
,	O
cluster	O
2	O
by	O
the	O
genera	O
Streptococcus	O
and	O
Clostridium	O
,	O
and	O
cluster	O
3	O
by	O
the	O
genus	O
Bacteroides	O
(	O
Additional	O
file	O
1	O
:	O
Figure	O
S1	O
,	O
Table	O
S1	O
).	O

The	O
SS	O
will	O
notify	O
the	O
Field	O
Implementers	O
of	O
any	O
births	O
in	O
their	O
area	O
,	O
and	O
both	O
will	O
visit	O
the	O
mother	O
and	O
her	O
infant	O
within	O
24	O
h	O
,	O
although	O
measurements	O
will	O
be	O
accepted	O
up	O
to	O
72	O
h	O
after	O
birth	O
.	O

Results	O
3	O
.	O
1	O
.	O

All	O
five	O
assessments	O
were	O
successfully	O
completed	O
in	O
104	O
intervention	O
households	O
and	O
97	O
control	O
households	O
.	O

For	O
instance	O
,	O
the	O
Mediterranean	O
diet	O
during	O
pregnancy	O
has	O
been	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
both	O
persistent	O
and	O
atopic	O
wheeze	O
and	O
atopy	O
in	O
children	O
at	O
6	O
.	O
5	O
years	O
old	O
[	O
1	O
,	O
2	O
].	O

1	O
).	O

Similarly	O
,	O
indoor	O
-	O
outdoor	O
pets	O
are	O
efficient	O
carriers	O
of	O
agents	O
into	O
the	O
home	O
,	O
and	O
also	O
pose	O
an	O
exposure	O
source	O
for	O
pesticides	O
from	O
anti	O
flea	O
/	O
tick	O
collars	O
,	O
sprays	O
,	O
and	O
shampoos	O
.	O

The	O
rationale	O
to	O
deliver	O
a	O
bunch	O
of	O
services	O
is	O
to	O
mutually	O
enhance	O
the	O
impact	O
of	O
a	O
specific	O
service	O
with	O
the	O
aid	O
of	O
other	O
services	O
in	O
the	O
long	O
-	O
run	O
(	O
2	O
).	O

At	O
least	O
two	O
physicians	O
will	O
independently	O
review	O
the	O
data	O
,	O
and	O
they	O
will	O
base	O
their	O
decision	O
on	O
an	O
agreement	O
.	O

Thirteen	O
of	O
14	O
cases	O
had	O
no	O
documented	O
recurrence	O
.	O

All	O
whole	O
body	O
DEXA	O
scans	O
were	O
done	O
by	O
the	O
same	O
technologist	O
on	O
a	O
Hologic	O
Discovery	O
A	O
densitometer	O
(	O
Bedford	O
,	O
MA	O
,	O
USA	O
).	O

First	O
,	O
the	O
majority	O
of	O
populations	O
in	O
the	O
studies	O
of	O
Bodnar	O
et	O
al	O
.	O
8and	O
Burris	O
et	O
al	O
.	O
14were	O
white	O
,	O
whereas	O
the	O
majority	O
of	O
our	O
study	O
population	O
was	O
black	O
.	O

Materials	O
and	O
methods	O
For	O
this	O
study	O
,	O
following	O
IRB	O
approval	O
(	O
HR	O
#	O
Pro00020570	O
),	O
de	O
-	O
identified	O
medical	O
record	O
data	O
were	O
obtained	O
for	O
all	O
pregnant	O
women	O
aged	O
18	O
–	O
45	O
years	O
who	O
received	O
a	O
25	O
(	O
OH	O
)	O
D	O
test	O
and	O
delivered	O
at	O
MUSC	O
between	O
September	O
2015	O
and	O
December	O
2016	O
.	O

The	O
primary	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
perinatal	O
vitamin	O
D	O
levels	O
on	O
the	O
performance	O
of	O
respiratory	O
function	O
in	O
infancy	O
.	O

It	O
should	O
be	O
mentioned	O
that	O
refined	O
grains	O
are	O
major	O
source	O
of	O
carbohydrate	O
intake	O
in	O
Iranian	O
diet	O
,	O
which	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
higher	O
risk	O
of	O
some	O
chronic	O
disorders	O
.	O

Our	O
age	O
limits	O
were	O
15	O
to	O
55	O
years	O
and	O
those	O
patients	O
with	O
estimated	O
expanded	O
disability	O
status	O
scale	O
less	O
than	O
5	O
were	O
introduced	O
to	O
the	O
study	O
.	O

The	O
comparison	O
of	O
maternal	O
characteristics	O
of	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
is	O
summarised	O
in	O
Table1	O
.	O

The	O
remaining	O
dietary	O
intake	O
of	O
different	O
food	O
items	O
and	O
specific	O
nutrients	O
were	O
similar	O
among	O
the	O
three	O
groups	O
of	O
women	O
with	O
different	O
levels	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
(	O
Table1	O
).	O

Results	O
were	O
expressed	O
as	O
fold	O
-	O
change	O
by	O
the	O
2	O
−	O
ΔΔCTmethod15and	O
analyzed	O
using	O
ABI	O
DataAssist	O
software	O
version	O
3	O
.	O
0	O
(	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
).	O

Conclusions	O
In	O
summary	O
,	O
we	O
have	O
demonstrated	O
that	O
in	O
the	O
rat	O
,	O
pre	O
-	O
and	O
postnatal	O
nutritional	O
histories	O
together	O
influence	O
both	O
ovarian	O
function	O
and	O
the	O
tempo	O
of	O
reproductive	O
maturation	O
in	O
female	O
offspring	O
.	O

Recruitment	O
and	O
consent	O
of	O
women	O
In	O
the	O
intervention	O
clusters	O
,	O
SSs	O
will	O
make	O
systematic	O
door	O
-	O
to	O
-	O
door	O
visits	O
to	O
identify	O
new	O
pregnancies	O
through	O
menstrual	O
cycle	O
tracking	O
of	O
all	O
women	O
of	O
reproductive	O
age	O
.	O

Since	O
PTB	O
is	O
the	O
leading	O
cause	O
of	O
neonatal	O
death	O
and	O
multiple	O
short	O
and	O
long	O
term	O
health	O
problems	O
[	O
3	O
],	O
it	O
is	O
critical	O
to	O
identify	O
modifiable	O
maternal	O
risk	O
factors	O
that	O
could	O
significantly	O
reduce	O
PTB	O
risk	O
at	O
the	O
population	O
level	O
.	O

Economic	O
situation	O
was	O
assessed	O
by	O
ownership	O
of	O
radio	O
and	O
/	O
or	O
bicycle	O
and	O
information	O
on	O
perceived	O
economic	O
status	O
.	O

IUFD	O
was	O
defined	O
as	O
pregnancy	O
loss	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

In	O
the	O
study	O
,	O
the	O
majority	O
of	O
infants	O
with	O
transient	O
early	O
wheezing	O
had	O
diminished	O
airway	O
function	O
in	O
early	O
life	O
.	O

The	O
results	O
of	O
the	O
LiST	O
analysis	O
found	O
that	O
84	O
%	O
of	O
premature	O
babies	O
(	O
more	O
than	O
921	O
,	O
000	O
lives	O
)	O
could	O
be	O
saved	O
in	O
2025	O
if	O
these	O
interventions	O
were	O
made	O
universally	O
available	O
(	O
95	O
%).	O

In	O
this	O
regard	O
,	O
developmental	O
plasticity	O
would	O
confer	O
a	O
phenotype	O
that	O
is	O
better	O
suited	O
for	O
the	O
environment	O
and	O
thereby	O
increase	O
the	O
organism	O
'	O
s	O
chances	O
of	O
reproducing	O
successfully	O
.	O

GWG	O
was	O
adjusted	O
for	O
consecutive	O
gestational	O
week	O
.	O

Poor	O
maternal	O
vitamin	O
D	O
status	O
has	O
been	O
related	O
to	O
fetal	O
growth	O
restriction	O
[	O
15	O
]	O
but	O
it	O
is	O
unknown	O
whether	O
maternal	O
vitamin	O
D	O
status	O
associates	O
with	O
birth	O
size	O
in	O
infants	O
with	O
normal	O
birth	O
weight	O
.	O

Altogether	O
,	O
these	O
observations	O
suggest	O
that	O
FGF21	O
may	O
be	O
a	O
key	O
factor	O
linking	O
UCP1	O
expression	O
to	O
improved	O
glucose	O
metabolism	O
.	O

Our	O
study	O
supports	O
these	O
findings	O
,	O
as	O
caries	O
-	O
free	O
children	O
were	O
twice	O
as	O
likely	O
to	O
have	O
optimal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(≥	O
75	O
nmol	O
/	O
L	O
)	O
and	O
those	O
with	O
S	O
-	O
ECC	O
were	O
at	O
nearly	O
three	O
times	O
the	O
odds	O
of	O
having	O
deficient	O
levels	O
(<	O
35	O
nmol	O
/	O
L	O
).	O

Comparison	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
based	O
on	O
month	O
of	O
sampling	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
(	O
black	O
line	O
&	O
left	O
axis	O
)	O
and	O
average	O
hours	O
of	O
sunlight	O
per	O
day	O
in	O
Adelaide	O
(	O
grey	O
line	O
&	O
right	O
axis	O
).	O

[	O
17	O
]	O
demonstrated	O
that	O
83	O
.	O
3	O
%	O
of	O
pregnant	O
Thai	O
women	O
,	O
especially	O
in	O
the	O
1st	O
trimester	O
of	O
pregnancy	O
,	O
had	O
vitamin	O
D	O
insufficiency	O
but	O
without	O
association	O
with	O
adverse	O
pregnancy	O
outcomes	O
such	O
as	O
spontaneous	O
abortion	O
,	O
gestational	O
diabetes	O
,	O
cesarean	O
section	O
rate	O
and	O
preterm	O
labor	O
.	O

They	O
are	O
listed	O
in	O
the	O
table	O
footnotes	O
.	O

Also	O
note	O
that	O
,	O
as	O
in	O
that	O
analysis	O
,	O
5we	O
found	O
no	O
difference	O
in	O
BMI	O
heritability	O
estimates	O
between	O
men	O
and	O
women	O
.	O

Camargo	O
et	O
al	O
.	O

The	O
mobile	O
phase	O
flow	O
rate	O
was	O
600	O
µL	O
/	O
min	O
through	O
a	O
Luna	O
3	O
µ	O
C18	O
(	O
2	O
)	O
100A	O
250	O
×	O
4	O
.	O
6	O
mm	O
column	O
held	O
at	O
40	O
°	O
C	O
(	O
Phenomenex	O
,	O
Auckland	O
,	O
New	O
Zealand	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
.	O

To	O
this	O
end	O
,	O
one	O
of	O
the	O
very	O
useful	O
tools	O
is	O
the	O
use	O
of	O
rodent	O
strains	O
with	O
different	O
sensitivities	O
to	O
diet	O
-	O
induced	O
obesity	O
and	O
insulin	O
resistance	O
.	O

Side	O
Effects	O
of	O
Iron	O
Supplements	O
Gastrointestinal	O
distress	O
is	O
commonly	O
observed	O
in	O
women	O
consuming	O
high	O
levels	O
of	O
supplemental	O
iron	O
on	O
an	O
empty	O
stomach	O
[	O
7	O
].	O

In	O
the	O
second	O
experiment	O
(	O
EXP2	O
)	O
offspring	O
selected	O
for	O
the	O
postnatal	O
time	O
points	O
was	O
born	O
to	O
primiparous	O
sows	O
after	O
prostaglandin	O
induction	O
of	O
parturition	O
as	O
described	O
[	O
15	O
]	O
and	O
farrowed	O
after	O
mean	O
pregnancy	O
duration	O
of	O
115	O
days	O
.	O

The	O
goals	O
and	O
principles	O
of	O
management	O
for	O
acute	O
and	O
chronic	O
asthma	O
,	O
rhinitis	O
,	O
and	O
dermatologic	O
disorders	O
are	O
the	O
same	O
during	O
pregnancy	O
as	O
those	O
for	O
asthma	O
in	O
the	O
general	O
population	O
.	O

It	O
should	O
be	O
added	O
that	O
the	O
understanding	O
of	O
the	O
role	O
of	O
IL	O
-	O
6	O
is	O
more	O
complex	O
,	O
as	O
this	O
cytokine	O
is	O
known	O
to	O
be	O
secreted	O
by	O
skeletal	O
muscle	O
in	O
response	O
to	O
exercise	O
,	O
exerting	O
insulin	O
sensitizing	O
effects	O
(	O
Kelly	O
et	O
al	O
.,	O
2004	O
;	O
Petersen	O
and	O
Pedersen	O
,	O
2005	O
).	O

The	O
importance	O
of	O
an	O
exacerbation	O
of	O
eczema	O
and	O
dermatitis	O
during	O
pregnancy	O
should	O
not	O
be	O
underestimated	O
as	O
readout	O
of	O
the	O
atopic	O
state	O
,	O
being	O
of	O
interest	O
for	O
the	O
genetic	O
predisposition	O
of	O
the	O
newborn	O
[	O
42	O
].	O

Overall	O
,	O
the	O
Ministry	O
of	O
Women	O
and	O
Child	O
Development	O
has	O
been	O
given	O
the	O
responsibility	O
to	O
coordinate	O
monitoring	O
at	O
different	O
levels	O
(	O
5	O
).	O

It	O
will	O
also	O
provide	O
valuable	O
evidence	O
about	O
the	O
role	O
of	O
groundwater	O
iron	O
level	O
in	O
modifying	O
the	O
responses	O
of	O
antenatal	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
since	O
there	O
is	O
already	O
some	O
evidence	O
which	O
suggests	O
a	O
positive	O
,	O
dose	O
-	O
response	O
association	O
between	O
natural	O
iron	O
in	O
groundwater	O
and	O
the	O
iron	O
status	O
of	O
women	O
[	O
6	O
].	O

The	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
[	O
25	O
(	O
OH	O
)	O
D	O
<	O
50	O
nmol	O
/	O
L	O
]	O
during	O
pregnancy	O
was	O
similar	O
between	O
mothers	O
with	O
or	O
without	O
GDM	O
[	O
4	O
.	O
9	O
%	O
(	O
4	O
/	O
81	O
)	O
vs	O
3	O
.	O
3	O
%	O
(	O
21	O
/	O
642	O
),	O
P	O
=	O
0	O
.	O
51	O
].	O

Stress	O
was	O
assessed	O
using	O
the	O
short	O
form	O
of	O
the	O
Perceived	O
Stress	O
Scale	O
[	O
29	O
].	O

The	O
homogenates	O
were	O
centrifuged	O
at	O
7380	O
rpm	O
/	O
5000	O
g	O
for	O
20	O
min	O
at	O
4	O
°	O
C	O
,	O
and	O
the	O
supernatants	O
were	O
collected	O
.	O

Relationships	O
between	O
repetitive	O
element	O
and	O
gene	O
associated	O
methylation	O
.	O

These	O
offspring	O
also	O
had	O
higher	O
rates	O
of	O
physiological	O
changes	O
,	O
including	O
atypical	O
sperm	O
formation	O
.	O
38And	O
a	O
mouse	O
study	O
produced	O
evidence	O
that	O
uranium	O
in	O
drinking	O
water	O
caused	O
estrogenic	O
activity	O
even	O
at	O
levels	O
below	O
the	O
EPA	O
safe	O
drinking	O
water	O
level	O
of	O
30	O
µg	O
/	O
L	O
.	O
39	O
To	O
look	O
more	O
closely	O
at	O
the	O
effects	O
of	O
uranium	O
exposure	O
on	O
human	O
reproduction	O
and	O
development	O
,	O
Lewis	O
has	O
recently	O
begun	O
recruiting	O
up	O
to	O
1	O
,	O
500	O
pregnant	O
women	O
to	O
participate	O
in	O
the	O
Navajo	O
Birth	O
Cohort	O
Study	O
.	O
40Besides	O
tracking	O
birth	O
outcomes	O
and	O
infant	O
development	O
,	O
pharmacologist	O
Laurie	O
Hudson	O
of	O
the	O
University	O
of	O
New	O
Mexico	O
is	O
looking	O
at	O
molecular	O
changes	O
that	O
may	O
be	O
induced	O
by	O
exposure	O
to	O
uranium	O
waste	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
.	O

Demographic	O
details	O
,	O
pregnancy	O
history	O
and	O
maternal	O
medical	O
history	O
were	O
found	O
through	O
direct	O
interviews	O
with	O
mothers	O
in	O
their	O
first	O
pregnancy	O
visit	O
,	O
based	O
on	O
the	O
ministry	O
of	O
health	O
’	O
s	O
routine	O
prenatal	O
care	O
questionnaire	O
.	O

All	O
analyses	O
were	O
performed	O
using	O
IBM	O
SPSS	O
software	O
v	O
.	O
20	O
(	O
Armonk	O
,	O
NY	O
,	O
USA	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Demographic	O
data	O
,	O
family	O
and	O
environmental	O
data	O
,	O
outcomes	O
,	O
and	O
infant	O
lung	O
function	O
in	O
groups	O
with	O
different	O
25	O
(	O
OH	O
)	O
D	O
status	O
of	O
cord	O
serum	O
.	O
Low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
36	O
)	O
High	O
cord	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
35	O
)	O
Demographic	O
data	O
Gestational	O
age	O
(	O
weeks	O
)	O
38	O
.	O
6	O
±	O
1	O
.	O
138	O
.	O
4	O
±	O
1	O
.	O
7Male	O
(%)	O
36	O
*	O
59Nature	O
delivery	O
(%)	O
6763Birth	O
BW	O
(	O
kg	O
)	O
3	O
.	O
1	O
±	O
0	O
.	O
43	O
.	O
0	O
±	O
0	O
.	O
3Birth	O
BL	O
(	O
cm	O
)	O
50	O
.	O
4	O
±	O
2	O
.	O
449	O
.	O
8	O
±	O
1	O
.	O
9BW	O
(	O
kg	O
)	O
8	O
.	O
3	O
±	O
1	O
.	O
08	O
.	O
3	O
±	O
1	O
.	O
0BL	O
(	O
cm	O
)	O
68	O
.	O
8	O
±	O
3	O
.	O
668	O
.	O
2	O
±	O
2	O
.	O
2	O
%	O
of	O
fall	O
/	O
winter	O
birth47	O
.	O
146	O
.	O
8	O
Family	O
and	O
environmental	O
data	O
Asthma	O
,	O
mother2	O
.	O
85	O
.	O
7Asthma	O
,	O
father2	O
.	O
82	O
.	O
8AR	O
mother22	O
.	O
237	O
.	O
1AR	O
,	O
father30	O
.	O
622	O
.	O
9AD	O
,	O
mother16	O
.	O
78	O
.	O
6AD	O
,	O
father05	O
.	O
7Daycare	O
attendance	O
(%)	O
13	O
.	O
911	O
.	O
4Maternal	O
smoke	O
in	O
pregnancy	O
(%)	O
2	O
.	O
85	O
.	O
7Postnatal	O
smoke	O
Exposure	O
(%)	O
44	O
.	O
442	O
.	O
9	O
Outcomes	O
NP	O
colonization	O
rate	O
(%)	O
69	O
.	O
762	O
.	O
0Ever	O
RTI	O
till	O
6	O
months	O
(%)	O
40	O
.	O
0	O
**	O
11	O
.	O
1Eczema	O
at	O
6	O
months	O
(%)	O
1914Ever	O
wheeze	O
at	O
6	O
months	O
(%)	O
1118	O
Infant	O
lung	O
function	O
%	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
21423Z	O
score	O
of	O
Rrs	O
-	O
0	O
.	O
18	O
±	O
-	O
0	O
.	O
37	O
**	O
0	O
.	O
10	O
±	O
0	O
.	O
29Z	O
score	O
of	O
Crs	O
-	O
0	O
.	O
19	O
±	O
0	O
.	O
86	O
-	O
0	O
.	O
20	O
±	O
1	O
.	O
20Z	O
score	O
of	O
VmaxFRC0	O
.	O
02	O
±	O
1	O
.	O
0	O
-	O
0	O
.	O
17	O
±	O
1	O
.	O
0	O
BW	O
,	O
body	O
weight	O
;	O
BL	O
,	O
body	O
length	O
;	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
AD	O
,	O
atopic	O
dermatitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
;	O
RTI	O
,	O
respiratory	O
tract	O
infection	O
,	O
Tpef	O
/	O
Te	O
,	O
ratio	O
of	O
time	O
to	O
peak	O
expiratory	O
flow	O
to	O
total	O
expiratory	O
time	O
;	O
Rrs	O
,	O
resistance	O
of	O
respiratory	O
system	O
;	O
Crs	O
,	O
compliance	O
of	O
respiratory	O
system	O
;	O
VmaxFRC	O
,	O
maximal	O
expiratory	O
flow	O
at	O
functional	O
residual	O
capacity	O
.	O

In	O
addition	O
,	O
clinically	O
she	O
became	O
more	O
alert	O
.	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	O
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	O
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
[	O
1	O
-	O
6	O
].	O

However	O
,	O
those	O
who	O
did	O
receive	O
advice	O
were	O
more	O
likely	O
to	O
have	O
personal	O
weight	O
gain	O
targets	O
in	O
line	O
with	O
current	O
clinical	O
recommendations	O
.	O

[	O
43	O
]	O
demonstrated	O
that	O
not	O
accounting	O
for	O
biases	B
in	O
observational	O
data	O
can	O
mislead	O
the	O
results	O
.	O

Improve	O
adherence	O
and	O
monitor	O
compliance	O
To	O
improve	O
adherence	O
,	O
a	O
local	O
pharmaceutical	O
company	O
(	O
Eskayef	O
Bangladesh	O
Limited	O
)	O
will	O
produce	O
IFA	O
supplements	O
in	O
an	O
attractive	O
capsule	O
shell	O
and	O
special	O
blister	O
package	O
.	O

Diet	O
significantly	O
affected	O
the	O
GD	O
at	O
6	O
months	O
of	O
age	O
(	O
P	O
=	O
0	O
.	O
0008	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

All	O
statistical	O
analyses	O
were	O
performed	O
using	O
the	O
R	O
statistical	O
package	O
(	O
version	O
2	O
.	O
10	O
;	O
http	O
://	O
www	O
.	O
r	O
-	O
project	O
.	O
org	O
),	O
and	O
the	O
R	O
function	O
was	O
made	O
available	O
on	O
the	O
GSEA	O
website	O
,	O
using	O
permutation	O
tests	O
as	O
described	O
bySubramanian	O
et	O
al	O
.	O

Women	O
were	O
not	O
enrolled	O
in	O
any	O
other	O
study	O
;	O
in	O
some	O
of	O
the	O
villages	O
,	O
a	O
study	O
on	O
antenatal	O
nutrition	O
that	O
enrolled	O
women	O
early	O
in	O
pregnancy	O
was	O
being	O
implemented	O
concurrently	O
.	O
Eligible	O
women	O
were	O
requested	O
to	O
provide	O
signed	O
informed	O
consent	O
.	O

Data	O
Collection	O
Procedures	O
Investigators	O
held	O
an	O
introductory	O
meeting	O
and	O
training	O
session	O
on	O
the	O
study	O
protocol	O
with	O
clinical	O
staff	O
at	O
Madigan	O
in	O
November	O
2011	O
.	O

Furthermore	O
,	O
many	O
healthcare	O
facilities	O
in	O
Johannesburg	O
serve	O
a	O
predominantly	O
migrant	O
population	O
[	O
81	O
]	O
posing	O
a	O
challenge	O
for	O
longitudinal	O
data	O
collection	O
.	O

)#	O
tp	O
valueHigh	O
cord	O
25	O
(	O
OH	O
)	O
D0	O
.	O
252	O
(	O
0	O
.	O
088	O
)	O
2	O
.	O
736	O
0	O
.	O
005	O
AR	O
,	O
father	O
-	O
0	O
.	O
232	O
(	O
0	O
.	O
103	O
)-	O
2	O
.	O
416	O
0	O
.	O
018	O
Maternal	O
smoke	O
in	O
pregnancy	O
-	O
0	O
.	O
396	O
(	O
0	O
.	O
196	O
)-	O
2	O
.	O
024	O
0	O
.	O
032	O
NP	O
colonization	O
-	O
0	O
.	O
121	O
(	O
0	O
.	O
90	O
)-	O
1	O
.	O
3530	O
.	O
182Male	O
-	O
0	O
.	O
109	O
(	O
0	O
.	O
087	O
)-	O
1	O
.	O
2550	O
.	O
215Asthma	O
,	O
mother	O
-	O
0	O
.	O
144	O
(	O
0	O
.	O
152	O
)-	O
0	O
.	O
9460	O
.	O
348	O
(	O
Constant	O
)	O
0	O
.	O
110	O
(	O
0	O
.	O
102	O
)	O
1	O
.	O
0820	O
.	O
284	O
R2	O
=	O
0	O
.	O

A	O
mutation	O
in	O
this	O
domain	O
would	O
prevent	O
clearance	O
of	O
the	O
NPs	O
and	O
result	O
in	O
their	O
accumulation	O
.	O

Since	B
mothers	O
with	O
depression	O
level	O
of	O
>	O
13	O
were	O
excluded	O
from	O
this	O
study	O
,	O
the	O
results	O
can	O
not	O
extend	O
to	O
mothers	O
with	O
high	O
levels	O
of	O
depression	O
.	O

The	O
mitochondria	O
of	O
BAT	O
are	O
characterized	O
by	O
the	O
presence	O
of	O
uncoupling	O
protein	O
-	O
1	O
(	O
UCP1	O
)	O
in	O
the	O
inner	O
mitochondrial	O
membrane	O
.	O

Promotional	O
and	O
training	O
costs	O
are	O
amortized	O
over	O
5	O
years	O
as	O
a	O
realistic	O
assumption	O
of	O
the	O
lifespan	O
of	O
printed	O
materials	O
and	O
accounting	O
for	O
staff	O
turnover	O
in	O
the	O
health	O
care	O
system	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0023723	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Basis	O
for	O
costs	O
and	O
source	O
of	O
data	O
.	O
Project	O
costsIron	O
-	O
folic	O
acidsupplementsPromotionTrainingMonitoring	O
USD4	O
.	O
55	O
/′	O
000	O
tablets	O
:	O
52	O
tablets	O
/	O
year	O
,	O
target	O
population	O
250	O
,	O
000	O
;	O
costs	O
,	O
insurance	O
,	O
freight	O
included	O
.	O

Patients	O
were	O
also	O
provided	O
the	O
option	O
to	O
disenroll	O
from	O
text4baby	O
by	O
texting	O
“	O
STOP	O
”	O
from	O
their	O
mobile	O
phones	O
if	O
they	O
no	O
longer	O
wanted	O
to	O
participate	O
in	O
the	O
program	O
.	O

Studies	O
in	O
migrants	O
implicate	O
postnatal	O
environmental	O
exposures	O
,	O
but	O
do	O
not	O
exclude	O
prenatal	O
effects	O
.	O
1529Blood	O
concentrations	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
fluctuate	O
with	O
season	O
,	O
but	O
the	O
etiological	O
relevance	O
of	O
these	O
fluctuations	O
to	O
MS	O
risk	O
is	O
unknown	O
.	O

The	O
IMF	O
of	O
Angus	O
steers	O
grown	O
in	O
South	O
Dakota	O
(	O
USA	O
)	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
from	O
189	O
to	O
368	O
kg	O
(	O
live	O
weight	O
from	O
340	O
to	O
591	O
kg	O
)	O
[	O
73	O
].	O

The	O
composition	O
of	O
the	O
various	O
multivitamin	O
compounds	O
taken	O
also	O
varied	O
:	O
the	O
daily	O
dose	O
of	O
vitamin	O
C	O
ranged	O
from	O
0	O
to	O
600	O
mg	O
,	O
vitamin	O
E	O
ranged	O
from	O
0	O
to	O
70	O
mg	O
,	O
vitamin	O
A	O
ranged	O
from	O
0	O
to	O
30	O
,	O
000	O
IU	O
,	O
and	O
folate	O
ranged	O
from	O
0	O
to	O
2000	O
micrograms	O
.	O

At	O
14	O
weeks	O
gestation	O
,	O
on	O
average	O
,	O
participants	O
reported	O
sociodemographic	O
,	O
behavioral	O
,	O
and	O
health	O
characteristics	O
in	O
a	O
structured	O
interview	O
.	O

Generalized	O
linear	O
models	O
were	O
fitted	O
to	O
derive	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CIs	O
)	O
of	O
GDM	O
associated	O
with	O
sleep	O
duration	O
and	O
snoring	O
,	O
respectively	O
.	O

Except	O
for	O
a	O
small	O
percentage	O
of	O
cases	O
,	O
the	O
tumors	O
continue	O
to	O
show	O
high	O
morbidity	O
and	O
mortality	O
.	O

The	O
2009	O
survey	O
identified	O
that	O
it	O
took	O
women	O
an	O
average	O
of	O
17	O
minutes	O
to	O
access	O
the	O
distribution	O
point	O
for	O
weekly	O
supplements	O
.	O

As	O
a	O
result	O
,	O
adjusted	O
clinical	O
pregnancy	O
rates	O
were	O
lower	O
among	O
VD	O
-	O
deficient	O
recipients	O
than	O
among	O
VD	O
-	O
replete	O
recipients	O
(	O
37	O
%	O
vs	O
.	O

“	O
There	O
are	O
inherent	O
difficulties	O
with	O
studying	O
breastfeeding	O
prospectively	O
in	O
a	O
rigorous	O
manner	O
,”	O
explains	O
Tonse	O
Raju	O
,	O
chief	O
of	O
the	O
Pregnancy	O
and	O
Perinatology	O
Branch	O
at	O
the	O
Eunice	O
Kennedy	O
Shriver	O
National	O
Institute	O
of	O
Child	O
Health	O
and	O
Human	O
Development	O
.	O

Other	O
hypotheses	O
postulate	O
mechanisms	O
such	O
as	O
poor	O
placental	O
blood	O
supply	O
because	O
of	O
nicotine	O
-	O
induced	O
vasoconstriction	O
,	O
poor	O
maternal	O
nutrition	O
,	O
and	O
fetal	O
exposure	O
to	O
carbon	O
monoxide	O
.	O

Neonates	O
born	O
prematurely	O
(	O
gestational	O
age	O
<	O
37	O
weeks	O
),	O
those	O
with	O
major	O
birth	O
defects	O
or	O
congenital	O
structural	O
anomalies	O
of	O
the	O
upper	O
airway	O
,	O
those	O
who	O
were	O
hemodynamically	O
unstable	O
,	O
and	O
those	O
with	O
a	O
history	O
of	O
severe	O
lower	O
airway	O
infection	O
with	O
intensive	O
care	O
admission	O
,	O
were	O
excluded	O
from	O
the	O
study	O
.	O

In	O
a	O
few	O
countries	O
,	O
case	O
management	O
of	O
neonatal	O
sepsis	O
is	O
being	O
scaled	O
up	O
using	O
community	O
-	O
based	O
health	O
workers	O
[	O
18	O
].	O

On	O
the	O
other	O
hand	O
,	O
numerous	O
other	O
studies	O
report	O
a	O
lack	O
of	O
association	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
[	O
23	O
],[	O
24	O
],[	O
25	O
],[	O
26	O
],[	O
27	O
],[	O
28	O
],[	O
29	O
],[	O
30	O
].	O

This	O
study	O
was	O
approved	O
by	O
the	O
research	O
council	O
(	O
research	O
project	O
number	O
:	O
193053	O
)	O
and	O
ethics	O
committee	O
(	O
research	O
ethics	O
number	O
:	O
IR	O
.	O
MUI	O
.	O
REC193053	O
).	O

Folate	O
Concentration	O
Analysis	O
Plasma	O
and	O
brain	O
folate	O
concentrations	O
were	O
determined	O
by	O
the	O
microbiological	O
microtiter	O
plate	O
assay	O
using	O
Lactobacillus	O
casei	O
.	O
16	O
,	O
17	O
Hypothalamic	O
Global	O
DNA	O
Methylation	O
Analysis	O
DNA	O
was	O
isolated	O
using	O
the	O
protocol	O
outlined	O
by	O
the	O
DNeasy	O
Blood	O
and	O
Tissue	O
Kit	O
(	O
Qiagen	O
Tech	O
.,	O
Mississauga	O
,	O
ON	O
,	O
Canada	O
).	O

C	O
–	O
postnatal	O
chow	O
diet	O
;	O
HF	O
–	O
postnatal	O
high	O
fat	O
diet	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Approaches	O
to	O
prevent	O
preterm	O
birth	O
and	O
reduce	O
deaths	O
among	O
premature	O
babies	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Red	O
cell	O
parameters	O
and	O
free	O
erythrocyte	O
protoporphyrin	O
concentration	O
were	O
measured	O
at	O
baseline	O
and	O
after	O
12	O
-	O
months	O
in	O
those	O
women	O
who	O
did	O
not	O
conceive	O
.	O

The	O
key	O
factor	O
which	O
results	O
in	O
the	O
development	O
of	O
gestational	O
diabetes	O
appears	O
to	O
be	O
a	O
failure	O
to	O
compensate	O
with	O
increased	O
insulin	O
secretion	O
.	O
3As	O
the	O
increase	O
in	O
insulin	O
resistance	O
is	O
greatest	O
in	O
the	O
third	O
trimester	O
,	O
GDM	O
usually	O
develops	O
going	O
into	O
this	O
period	O
.	O

The	O
present	O
study	O
was	O
approved	O
by	O
the	O
Ethics	O
Committee	O
of	O
Shiraz	O
University	O
of	O
Medical	O
Sciences	O
with	O
the	O
ethics	O
code	O
93	O
–	O
7212	O
.	O

However	O
,	O
substitution	O
of	O
equivalent	O
amount	O
of	O
energy	O
from	O
grazed	O
pasture	O
with	O
high	O
-	O
energy	O
grain	O
-	O
based	O
feed	O
has	O
not	O
increased	O
IMF	O
contents	O
.	O

The	O
median	O
concentration	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D3	O
in	O
the	O
IG	O
was	O
to	O
62	O
.	O
10	O
nmol	O
/	O
l	O
after	O
the	O
intervention	O
,	O
showing	O
an	O
increase	O
of	O
around	O
158	O
%,	O
compared	O
to	O
before	O
intervention	O
(	O
24	O
.	O
25	O
nmol	O
/	O
l	O
)	O
whereas	O
the	O
CG	O
showed	O
a	O
decrease	O
of	O
around	O
4	O
.	O
5	O
%.	O

Their	O
median	O
increase	O
in	O
cathelicidin	O
from	O
the	O
first	O
visit	O
to	O
the	O
second	O
visit	O
was	O
24	O
.	O
0	O
ng	O
/	O
mL	O
(	O
ranging	O
from	O
-	O
1	O
.	O
9	O
ng	O
/	O
mL	O
to	O
+	O
223	O
.	O
4	O
ng	O
/	O
mL	O
,	O
p	O
≤	O
0	O
.	O
0001	O
)	O
(	O
Fig	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIG	O
2	O
Change	O
of	O
Cathelicidin	O
Concentration	O
over	O
Time	O
.	O

The	O
focus	O
was	O
on	O
those	O
canonical	O
pathways	O
which	O
came	O
up	O
at	O
least	O
once	O
within	O
the	O
top	O
ten	O
regulated	O
pathways	O
within	O
one	O
single	O
analysis	O
.	O

The	O
authors	O
mentioned	O
that	O
slight	O
heat	O
stress	O
might	O
induce	O
IMF	O
deposition	O
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpc	O
vs	O
.	O
1	O
dpn	O
AP	O
AMPK	O
signalingup6	O
.	O
96	O
*	O
E	O
-	O
38AKT2	O
,	O
INSR	O
,	O
PIK3C2A	O
,	O
PIK3R1	O
,	O
PPM1B	O
,	O
PRKAA1	O
,	O
PRKACB	O
,	O
RAC1	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown3	O
.	O
25	O
*	O
E	O
-	O
47CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
KIF11	O
,	O
PLK4	O
,	O
PTTG1	O
AP	O
Pyrimidine	O
metabolismdown2	O
.	O
52	O
*	O
E	O
-	O
310CAD	O
,	O
DCTD	O
,	O
DKC1	O
,	O
POLQ	O
,	O
POLR3E	O
,	O
POLR3K	O
,	O
RFC5	O
,	O
RRM1	O
,	O
TYMS	O
,	O
UCK2	O
AP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown2	O
.	O
04	O
*	O
E	O
-	O
46CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CHEK2	O
,	O
UBC	O
,	O
YWHAE	O
LP	O
Purine	O
metabolismup9	O
.	O
20	O
*	O
E	O
-	O
312DDX39	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
RUVBL1	O
,	O
RUVBL2	O
LP	O
Pyrimidine	O
metabolismup6	O
.	O
15	O
*	O
E	O
-	O
714CTPS	O
,	O
PNPT1	O
,	O
POLA2	O
,	O
POLE2	O
,	O
POLR1B	O
,	O
POLR1C	O
,	O
POLR2I	O
,	O
PUS1	O
,	O
RFC3	O
,	O
RRM2	O
,	O
RRM2B	O
,	O
TXNRD1	O
,	O
TYMS	O
,	O
UCK2	O
LP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinaseup7	O
.	O
55	O
*	O
E	O
-	O
57ANAPC4	O
,	O
CDC27	O
,	O
CDK1	O
,	O
ESPL1	O
,	O
FZR1	O
,	O
PPP2R1B	O
,	O
PTTG1	O
LP	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationup3	O
.	O
09	O
*	O
E	O
-	O
23CDK1	O
,	O
CHEK1	O
,	O
YWHAZ	O
LP	O
Wnt	O
signalingdown4	O
.	O
02	O
*	O
E	O
-	O
29AKT3	O
,	O
FZD5	O
,	O
MMP7	O
,	O
NLK	O
,	O
SOX4	O
,	O
TCF3	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5A1	O
dpn	O
vs	O
.	O
28	O
dpn	O
AP	O
AMPK	O
signalingup4	O
.	O
26	O
*	O
E	O
-	O
38AK1	O
,	O
CPT1A	O
,	O
EIF4EBP1	O
,	O
HMGCR	O
,	O
MAPK14	O
,	O
NOS3	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
mTOR	O
signalingup1	O
.	O
89	O
*	O
E	O
-	O
27EIF3F	O
,	O
EIF3G	O
,	O
EIF4EBP1	O
,	O
FNBP1	O
,	O
GNB1L	O
,	O
PRKAA2	O
,	O
PRKAB2	O
AP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationdown6	O
.	O
40	O
*	O
E	O
-	O
36ACAD8	O
,	O
ACADL	O
,	O
ACADSB	O
,	O
BCAT1	O
,	O
DBT	O
,	O
MCCC2	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup7	O
.	O
12	O
*	O
E	O
-	O
811ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
GCDH	O
,	O
HMGCL	O
,	O
HMGCS1	O
,	O
MCCC2	O
,	O
MCEE	O
LP	O
Fatty	O
acid	O
metabolismup3	O
.	O
23	O
*	O
E	O
-	O
38ACADSB	O
,	O
ACAT1	O
,	O
ACAT2	O
,	O
ALDH1A1	O
,	O
AUH	O
,	O
CYP51A1	O
,	O
GCDH	O
,	O
PECI	O
LP	O
Synthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
76	O
*	O
E	O
-	O
65ACAT1	O
,	O
ACAT2	O
,	O
BDH2	O
,	O
HMGCL	O
,	O
HMGCS1	O
LP	O
Biosynthesis	O
of	O
steroidsup3	O
.	O
27	O
*	O
E	O
-	O
45CYP24A1	O
,	O
FDPS	O
,	O
HMGCR	O
,	O
IDI1	O
,	O
SC5DL	O
LP	O
Glucocorticoid	O
receptor	O
signalingup3	O
.	O
57	O
*	O
E	O
-	O
312CDKN1C	O
,	O
CXCL3	O
,	O
IL10	O
,	O
MAP3K1	O
,	O
NCOA2	O
,	O
NFKBIB	O
,	O
NR3C1	O
,	O
POLR2B	O
,	O
PRKACB	O
,	O
RRAS2	O
,	O
SLPI	O
,	O
SMARCA4	O
LP	O
G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
22	O
*	O
E	O
-	O
24CCNE1	O
,	O
CDC25A	O
,	O
CDKN1A	O
,	O
E2F328	O
dpn	O
vs	O
.	O
188	O
dpn	O
AP	O
AMPK	O
signalingup1	O
.	O
50	O
*	O
E	O
-	O
310INSR	O
,	O
MAPK12	O
,	O
PPAT	O
,	O
PPM1A	O
,	O
PPP2CA	O
,	O
PPP2R3A	O
,	O
PRKAA2	O
,	O
SMARCA2	O
,	O
SRC	O
,	O
STK11	O
AP	O
Fatty	O
acid	O
metabolismup1	O
.	O
28	O
*	O
E	O
-	O
28ACADSB	O
,	O
ALDH1A1	O
,	O
CYP1B1	O
,	O
CYP2D6	O
,	O
CYP3A4	O
,	O
CYP4A11	O
,	O
CYP4B1	O
,	O
PECI	O
AP	O
Mitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown8	O
.	O
33	O
*	O
E	O
-	O
37ANAPC5	O
,	O
CDK1	O
,	O
PLK1	O
,	O
PLK2	O
,	O
PPP2R1B	O
,	O
SLK	O
,	O
WEE1	O
AP	O
VEGF	O
signalingdown7	O
.	O
3	O
*	O
E	O
-	O
39AKT3	O
,	O
BCL2	O
,	O
KDR	O
,	O
NOS3	O
,	O
PRKCB	O
,	O
RAC2	O
,	O
RRAS	O
,	O
VCL	O
,	O
VEGFC	O
LP	O
Val	O
,	O
Leu	O
,	O
Ile	O
degradationup1	O
.	O
07	O
*	O
E	O
-	O
27ACAA1	O
,	O
ACAT1	O
,	O
ALDH1B1	O
,	O
AUH	O
,	O
ECH1	O
,	O
IVD	O
,	O
IWS1	O
LP	O
Fatty	O
acid	O
elongation	O
in	O
mitochondriaup2	O
.	O
05	O
*	O
E	O
-	O
23ACAA1	O
,	O
AUH	O
,	O
ECH1	O
LP	O
mTOR	O
signalingup2	O
.	O
65	O
*	O
E	O
-	O
210AKT3	O
,	O
DDIT4	O
,	O
EIF4B	O
,	O
EIF4G3	O
,	O
PPP2R1B	O
,	O
PRKAB2	O
,	O
PRKAG1	O
,	O
PRKAG2	O
,	O
TSC1	O
,	O
VEGFA	O
LP	O
Actin	O
cytoskeleton	O
signalingdown7	O
.	O
99	O
*	O
E	O
-	O
524ACTB	O
,	O
ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CD14	O
,	O
CFL1	O
,	O
F2R	O
,	O
FGD1	O
,	O
LBP	O
,	O
MAP2K1	O
,	O
MYH9	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
TMSB4X	O
,	O
TMSL3	O
,	O
WASF1	O
LP	O
RhoA	O
signalingdow5	O
.	O
05	O
*	O
E	O
-	O
3n12ACTB	O
,	O
ACTR2	O
,	O
ARHGAP1	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
PIKFYVE	O
,	O
PPP1R12A	O
,	O
RDX	O
,	O
ROCK1	O
,	O
ROCK2	O
,	O
WASF1	O
LP	O
Rac	O
signalingdown4	O
.	O
34	O
*	O
E	O
-	O
312ACTR2	O
,	O
ARPC4	O
,	O
ARPC1A	O
,	O
CFL1	O
,	O
MAP2K1	O
,	O
NCKAP1	O
,	O
PAK2	O
,	O
PIK3C3	O
,	O
PIK3C2A	O
,	O
PIK3R4	O
,	O
PIKFYVE	O
,	O
WASF1	O
LP	O
Complement	O
systemdown2	O
.	O
17	O
*	O
E	O
-	O
25C2	O
,	O
C7	O
,	O
C9	O
,	O
CFB	O
,	O
MBL2	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

Although	O
most	O
drugs	O
do	O
not	O
harm	O
the	O
fetus	O
,	O
this	O
knowledge	O
is	O
incomplete	O
.	O

The	O
main	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
association	O
between	O
the	O
dietary	O
intake	O
of	O
different	O
fish	O
species	O
,	O
the	O
dietary	O
intake	O
of	O
PUFAs	O
(	O
omega	O
-	O
3	O
and	O
omega	O
-	O
6	O
)	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
population	O
-	O
based	O
study	O
among	O
Swedish	O
women	O
.	O

The	O
behavior	O
change	O
communication	O
strategy	O
was	O
based	O
on	O
a	O
theoretical	O
model	O
constructed	O
a	O
priori	O
that	O
included	O
concepts	O
of	O
the	O
Health	O
Belief	O
Model	O
and	O
the	O
heuristic	O
model	O
for	O
teachable	O
moments	O
,	O
described	O
by	O
McBride	O
and	O
colleagues	O
[	O
13	O
,	O
15	O
,	O
18	O
].	O

However	O
,	O
due	B
to	I
heavy	O
clinical	O
demand	O
,	O
only	O
31	O
.	O
5	O
%	O
of	O
the	O
162	O
women	O
seen	O
after	O
the	O
change	O
in	O
practice	O
received	O
best	O
-	O
practice	O
individual	O
dietitian	O
review	O
at	O
their	O
first	O
visit	O
.	O

Forty	O
-	O
four	O
per	O
cent	O
,	O
16	O
.	O
5	O
%	O
and	O
11	O
.	O
3	O
%	O
of	O
women	O
in	O
the	O
exposed	O
group	O
reported	O
the	O
use	O
of	O
two	O
,	O
three	O
and	O
four	O
or	O
more	O
psychotropic	O
medications	O
,	O
respectively	O
.	O

At	O
present	O
,	O
there	O
remains	O
a	O
lack	O
of	O
consensus	O
regarding	O
recommendations	O
for	O
UVB	O
exposure	O
for	O
the	O
production	O
of	O
vitamin	O
D	O
for	O
pregnant	O
women	O
[	O
46	O
].	O

Once	O
again	O
some	O
of	O
the	O
most	O
active	O
TEs	O
also	O
escape	O
this	O
second	O
phase	O
of	O
epigenetic	O
re	O
-	O
programing	O
,	O
thereby	O
maintaining	O
genome	O
stability	O
.	O

In	O
brief	O
,	O
800	O
secundigravida	O
women	O
,	O
who	O
had	O
previously	O
delivered	O
a	O
macrosomic	O
infant	O
(>	O
4000	O
g	O
),	O
were	O
randomised	O
to	O
receive	O
either	O
low	O
glycaemic	O
index	O
dietary	O
advice	O
or	O
usual	O
care	O
(	O
no	O
dietary	O
advice	O
)	O
[	O
34	O
].	O

Furthermore	O
,	O
the	O
study	O
field	O
-	O
supervisors	O
mapped	O
the	O
region	O
independently	O
to	O
verify	O
the	O
accuracy	O
of	O
the	O
maps	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
and	O
during	O
recruitment	O
they	O
visited	O
every	O
house	O
in	O
the	O
mapped	O
region	O
to	O
identify	O
families	O
with	O
young	O
children	O
.	O

They	O
had	O
free	O
access	O
to	O
standard	O
diets	O
formulated	O
for	O
post	O
-	O
weaning	O
(	O
d	O
29	O
to	O
d	O
76	O
),	O
growing	O
(	O
d	O
77	O
to	O
d	O
105	O
)	O
and	O
finishing	O
periods	O
[	O
64	O
].	O

Comparing	O
to	O
the	O
control	O
group	O
,	O
depression	O
level	O
decreased	O
in	O
both	O
intervention	O
groups	O
[	O
67	O
].	O

In	O
retrospect	O
,	O
a	O
comprehensive	O
food	O
frequency	O
assessment	O
would	O
have	O
been	O
a	O
useful	O
addition	O
to	O
the	O
study	O
.	O

However	O
,	O
the	O
24	O
h	O
urine	O
output	O
,	O
adjusted	O
for	O
BM	O
,	O
was	O
significant	O
lower	O
(−	O
60	O
%;	O
P	O
=	O
0	O
.	O
004	O
)	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
the	O
F1	O
-	O
SC	O
mice	O
,	O
even	O
without	O
differences	O
in	O
water	O
intake	O
between	O
these	O
groups	O
.	O

This	O
may	O
reflect	O
the	O
lower	O
power	O
of	O
this	O
study	O
,	O
although	O
our	O
findings	O
are	O
similar	O
to	O
other	O
small	O
studies	O
(	O
10	O
,	O
11	O
).	O

Although	O
SSRIs	O
are	O
not	O
contraindicated	O
for	O
use	O
during	O
pregnancy	O
,	O
the	O
effects	O
should	O
be	O
examined	O
more	O
carefully	O
[	O
66	O
].	O

The	O
existing	O
literature	O
on	O
pregnancy	O
outcomes	O
following	O
exposure	O
to	O
FGAs	O
has	O
not	O
shown	O
a	O
significantly	O
increased	O
risk	O
for	O
malformations	O
above	O
the	O
baseline	O
incidence	O
.	O

We	O
only	O
found	O
a	O
difference	O
between	O
RC	O
and	O
CC	O
female	O
offspring	O
at	O
PND	O
20	O
.	O

There	O
are	O
eight	O
data	O
collection	O
time	O
points	O
(	O
here	O
forth	O
referred	O
to	O
as	O
phases	O
).	O

A	O
similar	O
pattern	O
was	O
demonstrated	O
in	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
.	O

We	O
also	O
found	O
a	O
sex	O
effect	O
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Cnr2	O
,	O
and	O
Faah	O
in	O
liver	O
and	O
PAT	O
,	O
Mgll	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
in	O
liver	O
,	O
and	O
Dagl	O
α	O
and	O
Dagl	O
β	O
in	O
PAT	O
.	O

The	O
LOESS	O
curve	O
showed	O
gestational	O
age	O
rising	O
with	O
increasing	O
25	O
(	O
OH	O
)	O
D	O
.	O
Women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
62	O
%	O
lower	O
risk	O
of	O
PTB	O
compared	O
to	O
those	O
<	O
20	O
ng	O
/	O
mL	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

In	O
obese	O
mothers	O
,	O
lower	O
protein	O
intake	O
early	O
in	O
pregnancy	O
and	O
increased	O
protein	O
intakes	O
over	O
the	O
course	O
of	O
the	O
pregnancy	O
were	O
independently	O
related	O
to	O
higher	O
offspring	O
weight	O
at	O
6	O
months	O
.	O

Strengths	O
of	O
this	O
analysis	O
include	O
assessing	O
the	O
relationship	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
risk	O
in	O
the	O
general	O
obstetrical	O
population	O
using	O
medical	O
record	O
data	O
at	O
an	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
.	O

Both	O
mother	O
and	O
infant	O
presented	O
with	O
hypernatremia	O
and	O
dehydration	O
.	O

Surgical	O
removal	O
of	O
AAOC	O
is	O
the	O
treatment	O
of	O
choice	O
.	O

In	O
life	O
history	O
terms	O
,	O
the	O
trade	O
-	O
off	O
for	O
those	O
born	O
to	O
dams	O
undernourished	O
during	O
pregnancy	O
may	O
be	O
an	O
earlier	O
maturation	O
but	O
a	O
faster	O
decline	O
in	O
ovarian	O
function	O
with	O
aging	O
,	O
associated	O
with	O
significantly	O
reduced	O
adult	O
progesterone	O
levels	O
.	O

We	O
therefore	O
adjusted	O
additionally	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
(	O
self	O
-	O
reported	O
),	O
gestational	O
age	O
at	O
delivery	O
,	O
birthweight	O
,	O
maternal	O
weight	O
gain	O
during	O
pregnancy	O
(	O
all	O
abstracted	O
from	O
obstetric	O
records	O
)	O
and	O
child	O
'	O
s	O
BMI	O
at	O
age	O
7	O
years	O
(	O
based	O
on	O
measured	O
height	O
and	O
weight	O
at	O
clinic	O
)	O
(	O
see	O
supplementary	O
figure	O
E1	O
showing	O
a	O
directed	O
acyclic	O
graph	O
).	O

Cortisol	O
is	O
also	O
an	O
important	O
regulator	O
of	O
energy	O
metabolism	O
,	O
including	O
the	O
regulation	O
of	O
lipolysis	O
and	O
lipogenesis	O
,	O
and	O
increases	O
plasma	O
NEFA	O
concentrations	O
[	O
100	O
].	O

Castration	O
Castration	O
of	O
bulls	O
generally	O
increases	O
IMF	O
content	O
in	O
several	O
cattle	O
breeds	O
,	O
although	O
it	O
reduces	O
growth	O
rate	O
[	O
40	O
].	O

The	O
Korean	O
Feeding	O
Standard	O
for	O
Hanwoo	O
[	O
160	O
]	O
describes	O
how	O
to	O
feed	O
Korean	O
cattle	O
at	O
each	O
stage	O
(	O
growth	O
,	O
early	O
fattening	O
,	O
and	O
late	O
fattening	O
stages	O
).	O

Consolidated	O
Standards	O
of	O
Reporting	O
Trials	O
diagram	O
.	O

We	O
identified	O
households	O
with	O
young	O
children	O
with	O
detailed	O
maps	O
and	O
advice	O
from	O
staff	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
a	O
non	O
-	O
governmental	O
organisation	O
working	O
in	O
the	O
region	O
.	O

Among	O
the	O
factors	O
evaluated	O
in	O
our	O
study	O
,	O
area	O
of	O
residence	O
,	O
level	O
of	O
education	O
and	O
marital	O
status	O
were	O
associated	O
with	O
the	O
intake	O
of	O
folic	O
acid	O
during	O
pregnancy	O
,	O
independently	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

detected	O
no	O
difference	O
in	O
outcome	O
,	O
disease	O
-	O
free	O
survival	O
and	O
morbidity	O
when	O
compared	O
to	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women2	O
.	O

This	O
study	O
finds	O
that	O
85	O
.	O
7	O
%	O
of	O
pregnant	O
women	O
received	O
supplements	O
containing	O
Vitamin	O
D	O
.	O
Their	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
levels	O
were	O
higher	O
than	O
those	O
without	O
supplement	O
use	O
.	O

Measurement	O
of	O
metabolites	O
,	O
hepatic	O
enzymes	O
,	O
and	O
leptin	O
in	O
plasma	O
The	O
following	O
plasma	O
metabolites	O
and	O
enzymes	O
were	O
measured	O
:	O
basal	O
glucose	O
,	O
triglycerides	O
,	O
total	O
cholesterol	O
,	O
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
),	O
urea	O
,	O
bilirubin	O
,	O
alkaline	O
phosphatase	O
(	O
ALKP	O
),	O
and	O
the	O
hepatic	O
enzymes	O
alanine	O
aminotransferase	O
(	O
ALT	O
),	O
aspartate	O
aminotransferase	O
(	O
AST	O
),	O
and	O
gamma	O
-	O
glutamyl	O
transpeptidase	O
(	O
γGT	O
).	O

Du	O
et	O
al	O
[	O
17	O
]	O
suggested	O
that	O
a	O
shift	O
in	O
development	O
of	O
mesenchymal	O
stem	O
cells	O
from	O
myogenesis	O
to	O
adipogenesis	O
may	O
increase	O
IMF	O
deposition	O
later	O
in	O
life	O
.	O

Women	O
were	O
diagnosed	O
with	O
GDM	O
if	O
two	O
or	O
more	O
of	O
the	O
100	O
gram	O
OGTT	O
glucose	O
levels	O
exceeded	O
the	O
ADA	O
criteria	O
[	O
28	O
]	O
as	O
follows	O
:	O
fasting	O
≥	O
95	O
mg	O
/	O
dl	O
;	O
1	O
-	O
hour	O
≥	O
180	O
mg	O
/	O
dl	O
;	O
2	O
-	O
hour	O
≥	O
155	O
mg	O
/	O
dl	O
;	O
3	O
-	O
hour	O
≥	O
140	O
mg	O
/	O
dl	O
.	O

Each	O
mouse	O
was	O
decapitated	O
,	O
and	O
the	O
kidneys	O
were	O
rapidly	O
removed	O
and	O
weighed	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Integrated	O
service	O
delivery	O
packages	O
for	O
maternal	O
,	O
newborn	O
and	O
child	O
health	O
.	O

This	O
suggests	O
that	O
cathelicidin	O
may	O
have	O
a	O
protective	O
benefit	O
in	O
preventing	O
disease	O
,	O
which	O
is	O
consistent	O
with	O
its	O
antimicrobial	O
properties	O
.	O

Women	O
who	O
agreed	O
to	O
participate	O
in	O
the	O
study	O
could	O
have	O
been	O
different	O
from	O
women	O
who	O
did	O
not	O
participate	O
in	O
the	O
study	O
,	O
and	O
we	O
did	O
not	O
collect	O
characteristics	O
on	O
women	O
who	O
refused	O
to	O
participate	O
in	O
the	O
study	O
to	O
ascertain	O
this	O
bias	B
.	O

The	O
σβposterior	O
mean	O
was	O
10	O
g	O
,	O
which	O
indicated	O
heterogeneity	O
in	O
the	O
phthalate	O
and	O
BPA	O
effects	O
around	O
this	O
estimate	O
,	O
and	O
that	O
roughly	O
two	O
thirds	O
of	O
the	O
beta	O
coefficients	O
were	O
within	O
10	O
g	O
(	O
one	O
standard	O
deviation	O
)	O
of	O
μβ	O
.	O

Both	O
diet	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
generation	O
(	O
P	O
=	O
0	O
.	O
003	O
)	O
affected	O
the	O
GD	O
,	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

In	O
addition	O
,	O
a	O
significant	O
effect	O
of	O
sex	O
on	O
the	O
plasma	O
levels	O
of	O
total	O
cholesterol	O
,	O
HDL	O
,	O
ALKP	O
,	O
and	O
AST	O
/	O
ALT	O
ratio	O
was	O
also	O
observed	O
.	O

Descriptive	O
research	O
Improved	O
and	O
consistently	O
applied	O
epidemiologic	O
definitions	O
and	O
methods	O
,	O
with	O
clearly	O
defined	O
preterm	O
phenotypes	O
,	O
are	O
the	O
foundation	O
for	O
improved	O
understanding	O
of	O
the	O
burden	O
of	O
preterm	O
birth	O
[	O
31	O
,	O
32	O
]	O
and	O
addressing	O
the	O
multiple	O
and	O
often	O
interrelated	O
causes	O
of	O
preterm	O
birth	O
.	O

observed	O
significantly	O
higher	O
HbA1cin	O
the	O
UK	O
among	O
female	O
patients	O
with	O
type	O
2	O
diabetes	O
in	O
the	O
months	O
February	O
,	O
March	O
and	O
June	O
,	O
and	O
suggested	O
that	O
poorer	O
diet	O
and	O
reduced	O
physical	O
activity	O
associated	O
with	O
Christmas	O
and	O
Easter	O
celebrations	O
may	O
be	O
involved	O
[	O
20	O
].	O

New	O
findings	O
from	O
the	O
NIEHS	O
-	O
funded	O
Northern	O
California	O
Childhood	O
Leukemia	O
Study	O
(	O
NCCLS	O
)	O
show	O
that	O
the	O
disease	O
may	O
originate	O
even	O
earlier	O
—	O
in	O
the	O
foods	O
a	O
woman	O
eats	O
before	O
she	O
even	O
becomes	O
pregnant	O
.	O

In	O
our	O
analysis	O
,	O
MEOHP	O
was	O
associated	O
with	O
a	O
13	O
g	O
birth	O
weight	O
increase	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
).	O

Thus	O
,	O
recommendations	O
for	O
vitamin	O
D	O
supplementation	O
to	O
improve	O
glucose	O
homeostasis	O
in	O
pregnancy	O
cannot	O
be	O
made	O
based	O
on	O
our	O
results	O
.	O

The	O
threshold	O
for	O
defining	O
vitamin	O
D	O
deficiency	O
and	O
the	O
diagnostic	O
criteria	O
for	O
GDM	O
vary	O
between	O
studies	O
,	O
which	O
might	O
affect	O
the	O
results	O
and	O
complicate	O
the	O
comparison	O
of	O
studies	O
.	O

Within	O
this	O
same	O
group	O
,	O
cathelicidin	O
concentration	O
was	O
negatively	O
associated	O
with	O
the	O
number	O
of	O
documented	O
infections	O
a	O
child	O
experienced	O
in	O
the	O
last	O
year	O
(	O
ρ	O
=	O
-	O
0	O
.	O
205	O
,	O
p	O
=	O
0	O
.	O
047	O
).	O

From	O
three	O
to	O
six	O
months	O
,	O
all	O
animals	O
had	O
systolic	O
blood	O
pressure	O
(	O
BP	O
)	O
measured	O
weekly	O
with	O
a	O
non	O
-	O
invasive	O
tail	O
-	O
cuff	O
plethysmography	O
(	O
Letica	O
LE	O
5100	O
,	O
Panlab	O
,	O
Barcelona	O
,	O
Spain	O
).	O

The	O
answer	O
,	O
as	O
it	O
turned	O
out	O
,	O
wasn	O
’	O
t	O
uranium	O
itself	O
but	O
its	O
decay	O
products	O
,	O
including	O
radium	O
,	O
10thorium	O
,	O
11and	O
radon	O
.	O
12	O
Radon	O
is	O
a	O
gas	O
,	O
but	O
with	O
a	O
half	O
-	O
life	O
of	O
four	O
days	O
,	O
it	O
rapidly	O
decays	O
into	O
solid	O
products	O
,	O
explains	O
Doug	O
Brugge	O
,	O
a	O
professor	O
of	O
public	O
health	O
at	O
Tufts	O
University	O
.	O
13	O
“	O
Being	O
solids	O
,	O
these	O
are	O
going	O
to	O
want	O
to	O
stick	O
to	O
things	O
like	O
your	O
lungs	O
,”	O
Brugge	O
says	O
.	O

There	O
was	O
no	O
evidence	O
of	O
rickets	O
both	O
clinically	O
and	O
radiologically	O
.	O

It	O
is	O
also	O
possible	O
that	O
associations	O
between	O
maternal	O
exposures	O
and	O
infant	O
microbiota	O
at	O
6	O
weeks	O
of	O
life	O
are	O
influenced	O
by	O
factors	O
not	O
investigated	O
in	O
this	O
study	O
.	O

In	O
general	O
,	O
screening	O
for	O
GDM	O
depends	O
on	O
a	O
presence	O
of	O
risk	O
factors	O
according	O
to	O
national	O
recommendations	O
[	O
19	O
]	O
and	O
based	O
on	O
these	O
,	O
OGTT	O
was	O
performed	O
on	O
490	O
(	O
54	O
.	O
5	O
%)	O
of	O
the	O
participating	O
mothers	O
.	O

We	O
plan	O
to	O
explore	O
these	O
issues	O
in	O
future	O
experiments	O
.	O

Statistical	O
significance	O
was	O
declared	O
at	O
α	O
=	O
0	O
.	O
05	O
.	O

The	O
RNA	O
-	O
Seq	O
transcriptome	O
and	O
KEGG	O
pathway	O
analyses	O
of	O
differentially	O
expressed	O
genes	O
showed	O
that	O
pathways	O
for	O
PPAR	O
signaling	O
,	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
,	O
biosynthesis	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
FA	O
),	O
and	O
Wnt	O
signaling	O
changed	O
in	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
,	O
whereas	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
diet	O
group	O
showed	O
changes	O
in	O
insulin	O
signaling	O
and	O
mTOR	O
signaling	O
pathways	O
.	O

Early	O
recognition	O
by	O
the	O
emergency	O
physician	O
in	O
addition	O
to	O
successful	O
coordination	O
of	O
care	O
between	O
the	O
emergency	O
physician	O
,	O
obstetrician	O
,	O
and	O
cardiothoracic	O
/	O
vascular	O
surgeon	O
is	O
necessary	O
for	O
a	O
successful	O
outcome	O
.	O

The	O
pathophysiology	O
is	O
not	O
well	O
understood	O
but	O
has	O
been	O
hypothesized	O
to	O
result	O
from	O
excessive	O
stimulation	O
of	O
V1	O
receptors	O
by	O
vasopressinase	O
-	O
altered	O
AVP	O
leading	O
to	O
platelet	O
aggregation	O
,	O
vasospasm	O
,	O
endothelial	O
constriction	O
,	O
and	O
brain	O
stimulation	O
as	O
discussed	O
by	O
Krege	O
and	O
Katz	O
[	O
6	O
].	O

Skm1	O
mice	O
in	O
the	O
lateral	O
position	O
showing	O
kyphosis	O
(	O
C	O
)	O
and	O
in	O
the	O
supine	O
position	O
showing	O
elongated	O
body	O
(	O
D	O
).	O

In	O
total	O
,	O
18	O
of	O
the	O
40	O
studies	O
shown	O
inTable	O
2validated	O
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	O
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
;	O
thereby	O
demonstrating	O
a	O
definitive	O
causal	O
link	O
between	O
exposure	O
(	O
largely	O
high	O
dose	O
)	O
to	O
BPA	O
,	O
formaldehyde	O
,	O
cadmium	O
,	O
methylmercury	O
,	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetra	O
-	O
chloro	O
-	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
),	O
urethane	O
,	O
vinyl	O
carbamate	O
,	O
alcohol	O
,	O
caffeine	O
,	O
overnutrition	O
,	O
cigarette	O
smoke	O
,	O
nicotine	O
or	O
4	O
-(	O
methyl	O
-	O
nitrosamino	O
)-	O
1	O
-(	O
3	O
-	O
pyridyl	O
)-	O
1	O
-	O
butanone	O
(	O
NNK	O
),	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

No	O
umbilical	O
cord	O
care	O
events	O
were	O
observed	O
,	O
given	O
that	O
observations	O
were	O
conducted	O
after	O
the	O
typical	O
time	O
of	O
cord	O
separation	O
.	O

In	O
addition	O
,	O
in	O
women	O
randomized	O
to	O
cholecalciferol	O
,	O
we	O
assessed	O
the	O
relationship	O
between	O
the	O
SNPs	O
and	O
the	O
change	O
in	O
vitamin	O
D	O
using	O
the	O
residuals	O
of	O
25	O
(	O
OH	O
)	O
D	O
at	O
34	O
weeks	O
of	O
gestation	O
regressed	O
on	O
25	O
(	O
OH	O
)	O
D	O
at	O
14	O
weeks	O
of	O
gestation	O
as	O
the	O
outcome	O
.	O

evaluated	O
fertility	O
and	O
the	O
long	O
-	O
term	O
effects	O
of	O
I	O
-	O
131	O
therapy	O
in	O
815	O
women	O
.	O

Expression	O
of	O
psychotic	O
symptoms	O
in	O
populations	O
is	O
continuous	O
and	O
characterized	O
by	O
differing	O
levels	O
of	O
severity	O
and	O
persistence	O
[	O
7	O
].	O

Male	O
adult	O
offspring	O
(	O
n	O
=	O
8	O
)	O
were	O
compared	O
to	O
control	O
male	O
(	O
n	O
=	O
8	O
).	O

Screening	O
for	O
diabetes	O
,	O
at	O
regular	O
intervals	O
,	O
is	O
recommended	O
by	O
a	O
number	O
of	O
diabetes	O
societies	O
.	O
4	O
,	O
85This	O
is	O
important	O
for	O
the	O
early	O
diagnosis	O
of	O
diabetes	O
,	O
to	O
facilitate	O
the	O
prevention	O
of	O
complications	B
.	O

Concerning	O
the	O
potential	O
explanations	O
of	O
the	O
differential	O
phenotypic	O
features	O
between	O
males	O
and	O
females	O
,	O
the	O
leptin	O
sensibility	O
can	O
play	O
an	O
important	O
role	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Estimated	O
lives	O
saved	O
of	O
premature	O
babies	O
in	O
settings	O
with	O
universal	O
coverage	O
of	O
interventionsIntervention	O
reaching	O
95	O
%	O
coverageAlso	O
saves	O
mothers	O
or	O
other	O
babiesBy	O
2015By	O
2025	O
%	O
Deaths	O
avertedLives	O
saved	O
%	O
Deaths	O
avertedLives	O
savedFamily	O
planning	O
*	O
M	O
,	O
SB	O
,	O
N24228	O
,	O
00032345	O
,	O
000Antenatal	O
corticosteroidsN40373	O
,	O
00041444	O
,	O
000Antibiotics	O
for	O
pPRoMN985	O
,	O
0009101	O
,	O
000Immediate	O
assessment	O
and	O
simple	O
care	O
of	O
all	O
babiesN544	O
,	O
000553	O
,	O
000Neonatal	O
resuscitationN765	O
,	O
000777	O
,	O
000Thermal	O
careN15142	O
,	O
00016171	O
,	O
000Kangaroo	O
mother	O
careN48452	O
,	O
00048531	O
,	O
000Interventions	O
implemented	O
togetherM	O
,	O
SB	O
,	O
N81757	O
,	O
00084921	O
,	O
000	O
Note	O
:	O
interventions	O
marked	O
with	O
M	O
will	O
also	O
save	O
maternal	O
lives	O
,	O
SB	O
would	O
avert	O
stillbirth	O
,	O
and	O
N	O
will	O
save	O
newborns	O
dying	O
from	O
causes	O
other	O
than	O
preterm	O
birth	O
.	O

Mining	O
in	O
the	O
area	O
had	O
mostly	O
ceased	O
by	O
the	O
mid	O
-	O
1960s	O
.	O

We	O
will	O
compare	O
neonatal	O
mortality	O
rates	O
&	O
their	O
95	O
%	O
confidence	O
intervals	O
adjusted	O
for	O
clustering	O
between	O
treatment	O
groups	O
in	O
each	O
groundwater	O
iron	O
-	O
level	O
group	O
.	O

However	O
,	O
the	O
risk	O
of	O
repeated	O
pneumonia	O
in	O
the	O
subsequent	O
3	O
months	O
was	O
13	O
%	O
(	O
relative	O
risk	O
[	O
RR	O
]	O
0	O
·	O
78	O
,	O
95	O
%	O
CI	O
0	O
·	O
64	O
–	O
0	O
·	O
94	O
;	O
p	O
=	O
0	O
·	O
01	O
)	O
lower	O
in	O
the	O
vitamin	O
D3compared	O
with	O
the	O
placebo	O
group	O
.	O
3Other	O
more	O
recent	O
studies	O
assessing	O
different	O
outcomes	O
in	O
children	O
or	O
adults	O
have	O
conflicting	O
findings	O
on	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
.	O
There	O
is	O
growing	O
evidence	O
of	O
the	O
vitamin	O
D	O
parancrine	O
system	O
enhancing	O
innate	O
immunity	O
:	O
4the	O
activation	O
of	O
Toll	O
-	O
like	O
receptors	O
on	O
monocytes	O
and	O
macrophages	O
by	O
microbial	O
pathogens	O
results	O
in	O
increased	O
expression	O
of	O
CYP27B1	O
and	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
genes	O
within	O
these	O
cells	O
.	O

In	O
hypothyroid	O
or	O
thyroidectomized	O
pregnant	O
women	O
,	O
such	O
physiological	O
changes	O
obviously	O
cannot	O
occur	O
.	O

Of	O
these	O
293	O
subjects	O
were	O
identified	O
and	O
recruited	O
(	O
Figure	O
1	O
).	O

During	O
the	O
observation	O
period	O
,	O
a	O
data	O
collector	O
positioned	O
herself	O
in	O
the	O
home	O
/	O
compound	O
in	O
order	O
to	O
assess	O
handwashing	O
behaviors	O
at	O
times	O
of	O
possible	O
pathogen	O
transmission	O
to	O
the	O
neonate	O
.	O

Since	O
the	O
exogenous	O
desmopressin	O
is	O
deaminated	O
at	O
the	O
N	O
-	O
terminus	O
,	O
it	O
can	O
escape	O
the	O
degrading	O
effect	O
of	O
the	O
vasopressinase	O
and	O
is	O
considered	O
the	O
treatment	O
of	O
choice	O
in	O
patients	O
with	O
gestational	O
diabetes	O
insipidus	O
as	O
demonstrated	O
by	O
Schrier	O
[	O
4	O
].	O

No	O
genes	O
were	O
found	O
consistently	O
differentially	O
expressed	O
between	O
the	O
groups	O
along	O
all	O
examined	O
stages	O
.	O

Animals	O
were	O
handled	O
and	O
allowed	O
to	O
acclimate	O
for	O
at	O
least	O
4	O
weeks	O
before	O
the	O
diet	O
assignation	O
.	O

Furthermore	O
,	O
metformin	O
can	O
promote	O
the	O
development	O
of	O
lactic	O
acidosis	O
,	O
which	O
surely	O
must	O
be	O
a	O
concern	B
in	O
situations	O
of	O
fetal	O
distress	O
.	O

Discussion	O
The	O
study	O
aimed	O
at	O
exploring	O
the	O
perceptions	O
of	O
pregnant	O
women	O
attending	O
antenatal	O
clinic	O
in	O
the	O
public	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
regarding	O
antenatal	O
care	O
in	O
terms	O
of	O
their	O
knowledge	O
and	O
satisfaction	O
with	O
service	O
delivery	O
.	O

Ethics	O
statement	O
The	O
Institutional	O
Review	O
Board	O
at	O
the	O
Nicaraguan	O
Ministry	O
of	O
Health	O
reviewed	O
and	O
approved	O
the	O
protocol	O
.	O

1	O
Exclusion	O
criteria	O
and	O
data	O
cleaning	O
algorithm	O
.	O

The	O
perinatal	O
mortality	O
rate	O
was	O
2	O
.	O
6	O
%	O
in	O
these	O
women	O
with	O
‘	O
mild	O
GDM	O
’	O
in	O
the	O
1970s	O
,	O
compared	O
to	O
0	O
.	O
7	O
%,	O
in	O
the	O
1980s	O
after	O
routine	O
treatment	O
had	O
been	O
introduced	O
for	O
this	O
group	O
.	O

Only	O
4	O
%	O
of	O
women	O
treated	O
with	O
glyburide	O
achieved	O
inadequate	B
control	O
and	O
required	O
a	O
switch	O
to	O
insulin	O
.	O

This	O
compares	O
to	O
estimates	O
by	O
the	O
National	O
Institute	O
of	O
Nutrition	O
that	O
only	O
20	O
%	O
of	O
pregnant	O
women	O
are	O
covered	O
by	O
the	O
national	O
antenatal	O
program	O
of	O
daily	O
iron	O
supplementation	O
for	O
which	O
there	O
is	O
no	O
costing	O
.[	O
18	O
].	O

Vitamin	O
D	O
status	O
of	O
children	O
with	O
severe	O
early	O
childhood	O
caries	O
:	O
a	O
case	O
–	O
control	O
study	O
Abstract	O
Background	O
Severe	O
Early	O
Childhood	O
Caries	O
(	O
S	O
-	O
ECC	O
)	O
affects	O
the	O
health	O
and	O
well	O
-	O
being	O
of	O
young	O
children	O
.	O

Lastly	O
,	O
the	O
environmental	O
impact	O
of	O
perinatal	O
air	O
pollutants	O
has	O
also	O
been	O
observed	O
[	O
20	O
,	O
21	O
].	O

BMP	O
-	O
7	O
can	O
also	O
affect	O
energy	O
homeostasis	O
by	O
acting	O
on	O
mature	O
brown	O
adipocytes	O
,	O
resulting	O
in	O
the	O
induction	O
of	O
UCP1	O
,	O
thereby	O
enhancing	O
thermogenesis	O
.	O

This	O
study	O
aimed	O
to	O
examine	O
the	O
association	O
of	O
gestational	O
exposure	O
to	O
five	O
chemical	O
classes	O
of	O
potential	O
EDCs	O
:	O
phthalates	O
and	O
bisphenol	O
A	O
,	O
perfluoroalkyl	O
substances	O
(	O
PFAS	O
),	O
polychlorinated	O
biphenyls	O
(	O
PCBs	O
),	O
polybrominated	O
diphenyl	O
ethers	O
(	O
PBDEs	O
),	O
and	O
organochlorine	O
pesticides	O
(	O
OCPs	O
)	O
with	O
infant	O
birth	O
weight	O
.	O

Finally	O
,	O
regression	O
analysis	O
revealed	O
that	O
birth	O
weight	O
was	O
the	O
only	O
significant	O
predictor	O
of	O
HF	O
,	O
and	O
explained	O
16	O
%	O
of	O
the	O
variance	O
in	O
HF	O
(	O
R2	O
=	O
0	O
.	O
16	O
)	O
(	O
Table	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0167328	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Scatter	O
plots	O
showing	O
the	O
correlation	O
between	O
birth	O
weight	O
with	O
systolic	O
(	O
A	O
)	O
and	O
diastolic	O
(	O
B	O
)	O
blood	O
pressure	O
levels	O
.	O

At	O
the	O
opposite	O
,	O
systemic	O
administration	O
of	O
FGF21	O
in	O
obese	O
mice	O
resulted	O
in	O
reduced	O
adiposity	O
,	O
improved	O
glycemic	O
control	O
,	O
as	O
well	O
as	O
increased	O
energy	O
expenditure	O
,	O
as	O
mentioned	O
by	O
the	O
authors	O
(	O
Coskun	O
et	O
al	O
.,	O
2008	O
).	O

There	O
was	O
no	O
difference	O
in	O
the	O
expression	O
of	O
WT1	O
at	O
birth	O
in	O
either	O
the	O
F1	O
or	O
F2	O
generations	O
between	O
the	O
SC	O
and	O
VitD	O
-	O
mice	O
(	O
P	O
>	O
0	O
.	O
05	O
,	O
two	O
-	O
way	O
ANOVA	O
).	O

We	O
did	O
not	O
have	O
measures	O
of	O
total	O
texts	O
or	O
potentially	O
competing	O
messages	O
received	O
by	O
participants	O
in	O
this	O
study	O
,	O
and	O
those	O
are	O
important	O
topics	O
for	O
future	O
research	O
.	O

PubMed	O
Central	O
:	O

Larger	O
studies	O
are	O
needed	O
to	O
determine	O
whether	O
maternal	O
dietary	O
patterns	O
lead	O
to	O
significant	O
modifications	O
in	O
neonatal	O
anthropometric	O
measurements	O
.	O

No	O
differences	O
were	O
seen	O
in	O
the	O
nasopharyngeal	O
bacteria	O
colonization	O
rate	O
between	O
the	O
low	O
and	O
high	O
25	O
(	O
OH	O
)	O
D	O
groups	O
of	O
the	O
maternal	O
or	O
cord	O
serum	O
.	O

Introduction	O
Infection	O
with	O
influenza	O
during	O
pregnancy	O
and	O
its	O
association	O
with	O
adverse	O
birth	O
outcomes	O
has	O
been	O
documented	O
since	O
the	O
early	O
1900s	O
[	O
1	O
],[	O
2	O
].	O

With	O
evidence	O
of	O
the	O
program	O
'	O
s	O
positive	O
impact	O
on	O
women	O
'	O
s	O
iron	O
status	O
the	O
weekly	O
supplement	O
program	O
with	O
twice	O
-	O
yearly	O
de	O
-	O
worming	O
was	O
scaled	O
up	O
to	O
province	O
level	O
(	O
with	O
an	O
estimated	O
target	O
group	O
of	O
250	O
,	O
000	O
women	O
of	O
reproductive	O
age	O
)	O
commencing	O
March	O
2008	O
.	O

Conclusions	O
:	O
The	O
single	O
300	O
,	O
000	O
IM	O
dose	O
of	O
vitamin	O
D	O
is	O
regarded	O
as	O
an	O
effective	O
and	O
safe	O
to	O
promptly	O
improve	O
vitamin	O
D	O
status	O
in	O
GDM	O
.	O

While	O
statistically	O
significant	O
,	O
the	O
clinical	O
significance	O
of	O
such	O
a	O
small	O
difference	O
is	O
questionable	O
,	O
the	O
findings	O
also	O
consistent	O
with	O
a	O
chance	O
occurrence	O
,	O
particularly	O
as	O
this	O
was	O
a	O
secondary	O
outcome	O
,	O
and	O
no	O
other	O
statistically	O
significant	O
differences	O
were	O
identified	O
between	O
the	O
treatment	O
groups	O
in	O
infant	O
BMI	O
,	O
abdominal	O
circumference	O
,	O
or	O
the	O
remainder	O
of	O
infant	O
anthropometric	O
measures	O
obtained	O
.	O

Interestingly	O
,	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
decreased	O
with	O
more	O
frequent	O
use	O
of	O
sunscreen	O
lotion	O
and	O
increased	O
for	O
women	O
who	O
reported	O
preference	O
for	O
shadow	O
(	O
Table	O
5	O
).	O

Predictors	O
with	O
p	O
level	O
≤	O
0	O
.	O
1	O
were	O
further	O
includes	O
in	O
multivariate	O
logistic	O
or	O
linear	O
regression	O
analysis	O
.	O

Such	O
findings	O
will	O
be	O
used	O
to	O
implement	O
informative	O
interventional	O
programs	O
to	O
control	O
impaired	O
fetal	O
growth	O
and	O
develop	O
practical	O
policies	O
to	O
improve	O
the	O
diet	O
quality	O
among	O
pregnant	O
women	O
.	O

This	O
study	O
points	O
towards	O
a	O
potential	O
gene	O
-	O
environment	O
interaction	O
that	O
could	O
be	O
of	O
predictive	O
value	O
for	O
fetal	O
weight	O
.	O

Women	O
in	O
the	O
highest	O
compared	O
with	O
the	O
lowest	O
quartile	O
of	O
vitamin	O
D	O
consumption	O
experienced	O
a	O
37	O
%	O
(	O
95	O
%	O
CI	O
,	O
22	O
-	O
50	O
%)	O
lower	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Body	O
mass	O
index	O
(	O
BMI	O
)	O
was	O
computed	O
using	O
the	O
formula	O
weight	O
(	O
kg	O
)/	O
height	O
(	O
m2	O
).	O

Review	O
of	O
published	O
literature	O
regarding	O
this	O
relationship	O
revealed	O
several	O
relevant	O
studies	O
to	O
ours	O
.	O

Understanding	O
the	O
role	O
EDCs	O
may	O
play	O
in	O
affecting	O
birth	O
weight	O
will	O
inform	O
efforts	O
to	O
prevent	O
low	O
birth	O
weight	O
and	O
the	O
development	O
of	O
chronic	O
diseases	O
.	O

Concerning	O
the	O
number	O
of	O
ANC	O
visits	O
,	O
the	O
health	O
centres	O
follow	O
the	O
Western	O
model	O
of	O
clinic	O
visits	O
with	O
an	O
average	O
of	O
10	O
to	O
12	O
visits	O
.	O

In	O
particular	O
,	O
a	O
7	O
.	O
5	O
-	O
fold	O
OR	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
3	O
–	O
44	O
.	O
9	O
)	O
for	O
low	O
grade	O
astrocytoma	O
has	O
been	O
observed	O
for	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

However	O
,	O
randomised	O
controlled	O
trials	O
are	O
required	O
in	O
specific	O
risk	O
groups	O
of	O
vitamin	O
D	O
deficiency	O
to	O
clarify	O
if	O
vitamin	O
D	O
supplementation	O
affects	O
the	O
risk	O
of	O
GDM	O
.	O

Maternal	O
and	O
neonatal	O
characteristics	O
of	O
our	O
study	O
population	O
,	O
stratified	O
by	O
race	O
,	O
are	O
shown	O
inTable	O
1	O
.	O

Peer	O
-	O
reviewed	O
journal	O
articles	O
published	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
.	O

Based	O
on	O
the	O
behavioural	O
findings	O
in	O
DVD	O
-	O
deficient	O
rats	O
,	O
there	O
is	O
a	O
case	O
to	O
explore	O
proteomic	O
dysregulation	O
in	O
rats	O
after	O
exposure	O
to	O
drugs	O
known	O
to	O
disrupt	O
dopaminergic	O
and	O
glutaminergic	O
pathways	O
.	O

)•	O
Create	O
and	O
implement	O
effective	O
community	O
-	O
based	O
approaches	O
(	O
e	O
.	O
g	O
.,	O
community	O
health	O
workers	O
home	O
visit	O
packages	O
,	O
women	O
'	O
s	O
'	O
groups	O
)	O
Typical	O
timeline	O
to	O
impactNear	O
-	O
term	O
to	O
Long	O
-	O
term	O
(	O
2	O
to	O
15	O
years	O
)	O
Long	O
-	O
term	O
(	O
5	O
to	O
15	O
years	O
)	O
Medium	O
-	O
term	O
(	O
5	O
to	O
10	O
years	O
)	O
Near	O
-	O
term	O
(	O
2	O
to	O
5	O
years	O
)	O
Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

All	O
tests	O
were	O
two	O
-	O
tailed	O
.	O

The	O
endocannabinoid	O
system	O
(	O
ECS	O
)	O
is	O
also	O
implicated	O
in	O
metabolic	O
and	O
behavioral	O
mechanisms	O
involved	O
in	O
fetal	O
programming	O
such	O
as	O
leptin	O
signaling	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
)	O
or	O
dopaminergic	O
system	O
(	O
Melis	O
et	O
al	O
.,	O
2004	O
).	O

Although	O
previous	O
small	O
surveys	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
among	O
pregnant	O
women	O
is	O
common	O
in	O
Europe	O
[	O
29	O
],[	O
30	O
],	O
there	O
are	O
no	O
reliable	O
country	O
-	O
wide	O
estimates	O
of	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
European	O
countries	O
.	O

For	O
example	O
,	O
the	O
increased	O
prevalence	O
of	O
the	O
use	O
of	O
anticonvulsant	O
medications	O
during	O
pregnancy	O
is	O
correlated	O
with	O
an	O
increased	O
risk	O
of	O
autism	O
.	O

The	O
women	O
in	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
significantly	O
younger	O
,	O
had	O
a	O
higher	O
prevalence	O
of	O
overweight	O
and	O
obesity	O
and	O
were	O
less	O
educated	O
than	O
women	O
with	O
less	O
or	O
no	O
experience	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

We	O
defined	O
severe	O
pneumonia	O
as	O
cough	O
plus	O
chest	O
in	O
-	O
drawing	O
and	O
very	O
severe	O
diseases	O
as	O
cough	O
plus	O
any	O
danger	O
signs	O
.	O

Higher	O
glucose	O
levels	O
,	O
either	O
in	O
the	O
glucose	O
tolerance	O
test	O
upon	O
which	O
GDM	O
was	O
diagnosed	O
,	O
or	O
on	O
self	O
-	O
monitoring	O
,	O
and	O
early	O
dietary	O
failure	O
have	O
been	O
found	O
to	O
be	O
associated	O
with	O
glyburide	O
failure	O
.	O
60	O
,	O
58These	O
findings	O
lead	O
to	O
the	O
logical	O
conclusion	O
that	O
subjects	O
with	O
more	O
severe	O
GDM	O
are	O
more	O
likely	O
to	O
require	O
insulin	O
.	O

Also	O
,	O
some	O
maternal	O
dietary	O
patterns	O
characterized	O
by	O
high	O
intakes	O
of	O
vegetable	O
,	O
fruit	O
,	O
white	O
rice	O
[	O
25	O
],	O
Vitamin	O
C	O
,	O
milk	O
,	O
and	O
fat	O
[	O
26	O
]	O
are	O
associated	O
with	O
larger	O
birth	O
size	O
of	O
infant	O
.	O

Program	O
dosage	O
and	O
optimization	O
research	O
should	O
be	O
included	O
to	O
address	O
other	O
features	O
of	O
the	O
mobile	O
phone	O
,	O
such	O
as	O
ubiquity	O
,	O
constant	O
use	O
,	O
and	O
potential	O
to	O
act	O
as	O
a	O
point	O
of	O
decision	O
prompt	O
.	O

Vitamin	O
D	O
should	O
be	O
considered	O
in	O
studies	O
of	O
pets	O
and	O
atopic	O
conditions	O
.	O

Based	O
on	O
the	O
1990	O
IOM	O
guidelines	O
[	O
17	O
],	O
we	O
classified	O
GWG	O
as	O
“	O
excessive	O
”	O
in	O
normal	O
weight	O
women	O
whose	O
gains	O
were	O
more	O
than	O
35	O
pounds	O
(	O
15	O
.	O
9	O
kg	O
)	O
and	O
overweight	O
(	O
BMI	O
>	O
26	O
to	O
29	O
)	O
women	O
whose	O
gains	O
were	O
above	O
25	O
pounds	O
(	O
11	O
.	O
4	O
kg	O
).	O

While	O
vitamin	O
A	O
restriction	O
improves	O
marbling	O
,	O
but	O
vitamin	O
D	O
restriction	O
did	O
not	O
significantly	O
affect	O
marbling	O
in	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

Discussion	O
In	O
our	O
study	O
,	O
less	O
than	O
half	O
the	O
participants	O
used	O
folic	O
acid	O
or	O
iron	O
during	O
their	O
pregnancy	O
,	O
while	O
approximately	O
two	O
thirds	O
took	O
multivitamin	O
supplements	O
.	O

For	O
each	O
subject	O
,	O
16	O
corresponding	O
aggregate	O
methylation	O
values	O
were	O
obtained	O
by	O
averaging	O
together	O
average	O
methylation	O
β	O
-	O
values	O
from	O
all	O
CpGs	O
within	O
each	O
class	O
.	O

A	O
brief	O
wash	O
in	O
1x	O
PBS	O
solution	O
was	O
performed	O
after	O
this	O
.	O

Pyrosequencing	O
of	O
these	O
repeat	O
elements	O
was	O
successful	O
in	O
380	O
samples	O
;	O
we	O
noted	O
no	O
significant	O
differences	O
in	O
the	O
demographics	O
or	O
clinical	O
characteristics	O
of	O
these	O
samples	O
compared	O
with	O
the	O
larger	O
population	O
.	O

In	O
addition	O
,	O
residual	O
confounding	B
due	B
to	I
genetic	O
backgrounds	O
could	O
not	O
be	O
excluded	O
,	O
although	O
we	O
controlled	O
some	O
important	O
potential	O
confounding	B
factors	I
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
levels	O
in	O
intervention	O
and	O
control	O
groups25	O
-	O
OH	O
VitD2	O
(	O
nmol	O
/	O
L	O
)	O
25	O
-	O
OH	O
VitD2	O
detection	O
rate25	O
-	O
OH	O
VitD3	O
(	O
nmol	O
/	O
L	O
)	O
Total25	O
-	O
OH	O
VitD	O
(	O
nmol	O
/	O
L	O
)	O
Deficiency	O
rate	O
(%)	O
Intervention	O
(	O
n	O
=	O
84	O
)	O
11	O
.	O
61	O
±	O
6	O
.	O
7122	O
.	O
6	O
%	O
71	O
.	O
77	O
±	O
26	O
.	O
7874	O
.	O
35	O
±	O
26	O
.	O
13	O
*	O
17	O
.	O
9	O
%	O
Control	O
(	O
n	O
=	O
14	O
)	O
00060	O
.	O
45	O
±	O
23	O
.	O
6335	O
.	O
7	O
%	O
Note	O
:	O
*	O
Compared	O
with	O
control	O
group	O
,	O
p	O
<	O
0	O
.	O
05	O
Seasonal	O
changes	O
of	O
25	O
-	O
OH	O
Vitamin	O
D	O
in	O
pregnant	O
women	O
with	O
GDM	O
Blood	O
samples	O
were	O
taken	O
between	O
October	O
2013	O
and	O
July	O
2015	O
,	O
twenty	O
-	O
one	O
cases	O
were	O
collected	O
in	O
winter	O
,	O
forty	O
-	O
three	O
cases	O
in	O
Spring	O
,	O
twenty	O
two	O
cases	O
in	O
Summer	O
,	O
and	O
twelve	O
cases	O
in	O
Autumn	O
.	O

Sampling	O
and	O
laboratory	O
analyses	O
have	O
been	O
described	O
previously	O
[	O
3	O
].	O

Overall	O
,	O
severe	O
temperature	O
stress	O
may	O
have	O
significant	O
negative	O
effects	O
on	O
animal	O
production	O
,	O
including	O
growth	O
performance	O
and	O
product	O
quality	O
,	O
although	O
mild	O
temperature	O
stress	O
may	O
differentially	O
affect	O
production	O
.	O

Concurrently	O
,	O
we	O
also	O
examined	O
maternal	O
variables	O
known	O
to	O
potentially	O
affect	O
vitamin	O
D	O
levels	O
and	O
SGA	O
in	O
an	O
effort	O
to	O
better	O
understand	O
the	O
role	O
of	O
these	O
risk	O
factors	O
in	O
vitamin	O
D	O
levels	O
and	O
risk	O
of	O
SGA	O
.	O

Eligible	O
studies	O
were	O
those	O
with	O
healthy	O
pregnant	O
women	O
,	O
full	O
term	O
births	O
and	O
offspring	O
with	O
no	O
anomalies	O
or	O
diseases	O
.	O

The	O
strengths	O
of	O
this	O
study	O
include	O
the	O
large	O
sample	O
size	O
,	O
population	O
-	O
based	O
ascertainment	O
of	O
placenta	O
samples	O
,	O
quantitative	O
assessment	O
of	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
,	O
and	O
the	O
use	O
of	O
a	O
well	O
-	O
established	O
,	O
high	O
-	O
density	O
methylation	O
array	O
for	O
methylation	O
profiling	O
.	O

Controlling	O
for	O
mediators	O
may	O
attenuate	O
the	O
total	O
effect	O
of	O
EDCs	O
on	O
birth	O
weight	O
.	O

In	O
the	O
fetal	O
stage	O
,	O
the	O
main	O
process	O
is	O
increasing	O
the	O
number	O
of	O
adipocytes	O
(	O
hyperplasia	O
)	O
derived	O
from	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
[	O
21	O
].	O

While	O
a	O
link	O
between	O
smoking	O
and	O
autism	O
could	O
not	O
be	O
established	O
,	O
air	O
pollution	O
may	O
have	O
a	O
role	O
.	O

Using	O
a	O
nail	O
splitter	O
,	O
the	O
nail	O
plate	O
was	O
vertically	O
cut	O
and	O
reflected	O
proximally	O
to	O
completely	O
visualize	O
the	O
lesion	O
.	O

Ninety	O
-	O
three	O
per	O
cent	O
of	O
the	O
exposed	O
neonates	O
that	O
presented	O
with	O
PNA	O
symptoms	O
were	O
born	O
to	O
mothers	O
receiving	O
psychotropic	O
polytherapy	O
,	O
and	O
53	O
%	O
of	O
these	O
neonates	O
were	O
prenatally	O
exposed	O
to	O
a	O
selective	O
serotonin	O
reuptake	O
inhibitor	O
(	O
SSRI	O
).	O

It	O
is	O
important	O
to	O
note	O
the	O
number	O
methodological	O
limitations	O
in	O
research	O
on	O
diet	O
and	O
infant	O
neurodevelopment	O
that	O
are	O
present	O
in	O
these	O
studies	O
.	O

The	O
course	O
is	O
variable	O
[	O
43	O
].	O

Considering	O
this	O
and	O
the	O
physiological	O
changes	O
to	O
the	O
vitamin	O
D	O
pathway	O
in	O
pregnancy	O
,	O
it	O
is	O
therefore	O
possible	O
that	O
the	O
genetic	O
variants	O
associated	O
with	O
baseline	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
and	O
the	O
response	O
to	O
supplementation	O
also	O
differ	O
between	O
the	O
pregnant	O
and	O
nonpregnant	O
state	O
.	O

However	O
,	O
there	O
was	O
a	O
protective	O
association	O
of	O
having	O
high	O
vitamin	O
D	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
and	O
GDM	O
once	O
standardised	O
based	O
on	O
month	O
serum	O
was	O
sampled	O
.	O

After	O
electrophoresis	O
,	O
the	O
proteins	O
were	O
electroblotted	O
on	O
to	O
PVDF	O
transfer	O
membranes	O
(	O
Hybond	O
-	O
P	O
;	O
Amersham	O
Biosciences	O
).	O

DISCUSSION	O
To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
African	O
trial	O
to	O
evaluate	O
the	O
effect	O
of	O
multiple	O
micronutrient	O
supplementation	O
on	O
red	O
cell	O
parameters	O
and	O
iron	O
status	O
among	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
.	O

In	O
a	O
pooled	O
analysis	O
of	O
data	O
from	O
Canada	O
,	O
UK	O
,	O
Denmark	O
,	O
and	O
Sweden	O
including	O
more	O
than	O
40	O
,	O
000	O
individuals	O
with	O
MS	O
,	O
significantly	O
fewer	O
(	O
8	O
.	O
5	O
%)	O
people	O
with	O
MS	O
were	O
born	O
in	O
November	O
and	O
significantly	O
more	O
(	O
9	O
.	O
1	O
%)	O
were	O
born	O
in	O
May	O
.	O
39This	O
finding	O
suggests	O
that	O
prenatal	O
exposures	O
or	O
exposures	O
in	O
the	O
first	O
months	O
of	O
life	O
could	O
be	O
important	O
in	O
MS	O
etiology	O
,	O
but	O
the	O
link	O
to	O
vitamin	O
D	O
is	O
unclear	O
.	O

Children	O
of	O
school	O
age	O
are	O
highly	O
susceptible	O
to	O
environmental	O
stimuli	O
such	O
as	O
marketing	O
and	O
food	O
availability	O
.	O

Additionally	O
,	O
our	O
findings	O
are	O
observational	O
in	O
nature	O
thus	O
we	O
cannot	O
determine	O
causality	O
.	O

Methods	O
To	O
investigate	O
potential	O
relationships	O
between	O
household	O
pet	O
exposure	O
and	O
cord	O
blood	O
vitamin	O
D	O
concentrations	O
,	O
we	O
analyzed	O
information	O
from	O
a	O
large	O
,	O
geographically	O
-	O
based	O
,	O
general	O
risk	O
birth	O
cohort	O
.	O

We	O
encouraged	O
families	O
to	O
bring	O
their	O
children	O
to	O
the	O
study	O
hospital	O
for	O
any	O
illness	O
for	O
which	O
quality	O
treatment	O
was	O
offered	O
free	O
of	O
charge	O
.	O

masanumasik	O
patya	O
which	O
will	O
lead	O
to	O
healthly	O
&	O
safe	O
motherhood	O
along	O
with	O
its	O
outcome	O
.	O

Blacks	O
had	O
a	O
significantly	O
greater	O
proportion	O
of	O
SGA	O
when	O
compared	O
with	O
whites	O
(	O
P	O
=	O
0	O
.	O
01	O
;	O
Table	O
1	O
).	O

[	O
43	O
].	O

Propensity	O
Score	O
Models	O
adjusted	O
for	O
age	O
,	O
race	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
people	O
in	O
the	O
household	O
,	O
reporting	O
receiving	O
at	O
least	O
one	O
tetanus	O
vaccine	O
,	O
number	O
of	O
antenatal	O
visits	O
,	O
Fe	O
and	O
vitamin	O
B12	O
consumption	O
during	O
pregnancy	O
,	O
albendazol	O
consumption	O
during	O
pregnancy	O
,	O
calcium	O
consumption	O
during	O
pregnancy	O
,	O
aspirin	O
consumption	O
during	O
pregnancy	O
,	O
alcohol	O
consumption	O
before	O
pregnancy	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
number	O
of	O
parturitions	O
,	O
and	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
).	O

Trial	O
Registration	O
:	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

If	O
the	O
measurements	O
cannot	O
be	O
taken	O
by	O
the	O
study	O
nurses	O
,	O
hospital	O
records	O
are	O
used	O
to	O
obtain	O
anthropometrical	O
data	O
(	O
using	O
the	O
same	O
calibrated	O
infant	O
scale	O
).	O

Before	O
doing	O
so	O
,	O
the	O
expression	O
of	O
GAS5	O
and	O
GRs	O
was	O
examined	O
in	O
BeWo	O
and	O
JEG	O
-	O
3	O
cells	O
without	O
administering	O
cortisol	O
.	O

For	O
regulatory	O
purposes	O
,	O
there	O
are	O
major	O
limitations	O
to	O
simply	O
extending	O
lifetime	O
rodent	O
studies	O
beyond	O
the	O
standard	O
2	O
years	O
to	O
examine	O
later	O
-	O
onset	O
epigenetic	O
adverse	O
outcomes	O
,	O
including	O
financial	O
,	O
ethical	O
and	O
scientific	O
considerations	O
.	O

Infant	O
'	O
s	O
Diet	O
Regarding	O
the	O
nutrition	O
of	O
the	O
baby	O
,	O
reduced	O
breast	O
-	O
feeding	O
and	O
early	O
introduction	O
of	O
solid	O
food	O
have	O
been	O
discussed	O
as	O
confounders	B
to	O
allergy	O
development	O
.	O

Introduction	O
The	O
past	O
century	O
has	O
seen	O
a	O
dramatic	O
decline	O
in	O
the	O
age	O
of	O
menarche	O
:	O
in	O
Europe	O
the	O
age	O
of	O
menarche	O
has	O
fallen	O
from	O
17	O
to	O
∼	O
12	O
.	O
5	O
years	O
of	O
age	O
[	O
1	O
]–[	O
5	O
],	O
although	O
the	O
rate	O
of	O
decline	O
is	O
slowing	O
[	O
6	O
],[	O
7	O
].	O

Results	O
Altered	O
maternal	O
nutrition	O
modifies	O
offspring	O
growth	O
Birth	O
weights	O
of	O
offspring	O
born	O
to	O
rat	O
dams	O
that	O
were	O
undernourished	O
during	O
pregnancy	O
were	O
significantly	O
reduced	O
compared	O
to	O
those	O
of	O
control	O
pregnancies	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Figure	O
1A	O
).	O

Both	O
hyperplasia	O
and	O
hypertrophy	O
are	O
involved	O
in	O
IMF	O
deposition	O
(	O
Figure	O
1	O
).	O

Gross	O
anatomical	O
abnormalities	O
were	O
greater	O
in	O
mice	O
fathered	O
by	O
FD	O
mice	O
(	O
27	O
%	O
vs	O
.	O
3	O
%)	O
which	O
included	O
craniofacial	O
,	O
hydrocephalus	O
,	O
limb	O
,	O
and	O
muscle	O
/	O
skeletal	O
defects	O
.	O

The	O
cohort	O
of	O
the	O
mother	O
-	O
child	O
dyads	O
will	O
be	O
followed	O
up	O
from	O
recruitment	O
until	O
42	O
days	O
after	O
birth	O
.	O

Discussion	O
Season	O
of	O
birth	O
in	O
its	O
own	O
right	O
cannot	O
be	O
deemed	O
a	O
cause	O
for	O
glioma	O
.	O

Case	O
Report	O
A	O
previously	O
healthy	O
47	O
-	O
year	O
-	O
old	O
woman	O
in	O
her	O
33rd	O
week	O
of	O
twin	O
gestation	O
presented	O
with	O
progressive	O
lethargy	O
,	O
confusion	O
,	O
polydipsia	O
,	O
and	O
polyuria	O
for	O
approximately	O
one	O
month	O
.	O

Open	O
-	O
reference	O
OTU	O
picking	O
identified	O
a	O
total	O
of	O
4260	O
OTUs	O
in	O
our	O
population	O
of	O
6	O
-	O
week	O
infant	O
stool	O
samples	O
,	O
with	O
2850	O
OTUs	O
corresponding	O
to	O
Greengenes	O
IDs	O
and	O
1410	O
de	O
novo	O
OTUs	O
.	O

Review	O
of	O
Literature	O
Several	O
recent	O
studies	O
have	O
explored	O
season	O
of	O
birth	O
as	O
a	O
risk	O
factor	O
for	O
adult	O
glioma	O
,	O
but	O
results	O
have	O
been	O
mixed	O
(	O
Table	O
1	O
).	O

Data	O
on	O
initial	O
costs	O
for	O
training	O
and	O
educational	O
materials	O
were	O
obtained	O
from	O
the	O
records	O
of	O
the	O
National	O
Institute	O
of	O
Malariology	O
,	O
Parasitology	O
and	O
Entomology	O
and	O
the	O
Yen	O
Bai	O
Malaria	O
Control	O
Program	O
.	O

A	O
factor	O
loading	O
criteria	O
of	O
0	O
.	O
4	O
was	O
used	O
to	O
determine	O
whether	O
to	O
retain	O
individual	O
items	O
in	O
a	O
single	O
principal	O
factor	O
.	O

The	O
central	O
team	O
will	O
comprise	O
of	O
three	O
research	O
fellows	O
,	O
one	O
medical	O
officer	O
and	O
one	O
research	O
investigator	O
and	O
one	O
BRAC	O
national	O
manager	O
.	O

The	O
authors	O
did	O
not	O
say	O
if	O
the	O
improvement	O
occurred	O
in	O
the	O
autism	O
group	O
.	O

To	O
check	O
the	O
linearity	O
assumption	O
for	O
the	O
regression	O
models	O
,	O
we	O
plotted	O
residuals	O
by	O
birth	O
weight	O
percentile	O
for	O
all	O
models	O
and	O
found	O
no	O
evidence	O
for	O
systematic	O
nonlinearity	O
.	O

Severe	O
intrauterine	O
growth	O
retardation	O
occurred	O
in	O
the	O
infant	O
of	O
a	O
mother	O
who	O
applied	O
40	O
mg	O
/	O
d	O
of	O
topical	O
triamcinolone	O
cream	O
from	O
week	O
12	O
to	O
29	O
of	O
gestation	O
to	O
treat	O
her	O
atopic	O
dermatitis	O
[	O
44	O
].	O

In	O
the	O
literature	O
,	O
recent	O
studies	O
across	O
a	O
wide	O
range	O
of	O
populations	O
have	O
demonstrated	O
a	O
positive	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
[	O
8	O
–	O
11	O
,	O
15	O
,	O
16	O
,	O
18	O
,	O
19	O
].	O

Data	O
include	O
date	O
and	O
country	O
of	O
birth	O
,	O
marital	O
status	O
,	O
educational	O
level	O
,	O
home	O
language	O
,	O
employment	O
status	O
,	O
household	O
income	O
,	O
number	O
of	O
members	O
in	O
the	O
household	O
,	O
and	O
beneficiaries	O
of	O
social	O
grants	O
.	O

Conclusion	O
In	O
conclusion	O
,	O
lower	O
early	O
pregnancy	O
25OHD	O
was	O
associated	O
with	O
pregnancy	O
loss	O
.	O

Interestingly	O
,	O
some	O
of	O
these	O
molecules	O
can	O
be	O
secreted	O
by	O
BAT	O
itself	O
,	O
indicating	O
the	O
occurrence	O
of	O
autocrine	O
effects	O
.	O

Cranial	O
ultrasound	O
was	O
done	O
following	O
the	O
seizures	O
and	O
was	O
reported	O
as	O
normal	O
.	O

†	O
t	O
-	O
test	O
,	O
*	O
chi	O
-	O
square	O
,	O
aFisher	O
’	O
s	O
Exact	O
Test	O
.	O

Though	O
the	O
causes	O
are	O
not	O
known	O
,	O
socioenvironmental	O
influences	O
contribute	O
to	O
developmental	O
shifts	O
in	O
intake	O
regulation	O
by	O
overriding	O
biologically	O
based	O
cues	O
of	O
hunger	O
and	O
satiety	O
.	O

Some	O
studies	O
describe	O
a	O
positive	O
association	O
between	O
the	O
use	O
of	O
multivitamins	O
during	O
pregnancy	O
and	O
certain	O
socio	O
-	O
demographic	O
characteristics	O
,	O
such	O
as	O
age	O
[	O
15	O
,	O
16	O
,	O
18	O
,	O
20	O
],	O
education	O
[	O
15	O
,	O
17	O
,	O
18	O
,	O
36	O
,	O
39	O
]	O
and	O
marital	O
status	O
[	O
17	O
];	O
but	O
others	O
have	O
reported	O
an	O
inverse	O
relation	O
between	O
education	O
and	O
the	O
use	O
of	O
multivitamins	O
[	O
27	O
].	O

Lower	O
expression	O
of	O
the	O
anorexigenic	O
genes	O
in	O
the	O
offspring	O
of	O
dams	O
fed	O
the	O
multivamins	O
during	O
pregnancy	O
is	O
consistent	O
with	O
the	O
observed	O
increased	O
food	O
intake	O
.	O

The	O
small	O
proportion	O
of	O
neonates	O
who	O
were	O
SGA	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
>	O
75	O
nmol	O
l	O
−	O
1precluded	O
evaluation	O
at	O
higher	O
cutpoints	O
.	O

Seasonal	O
variation	O
in	O
vitamin	O
D	O
followed	O
a	O
similar	O
pattern	O
to	O
hours	O
of	O
sunlight	O
although	O
was	O
slightly	O
shifted	O
.	O

FA	O
for	O
TG	O
synthesis	O
is	O
derived	O
from	O
de	O
novo	O
synthesis	O
or	O
diet	O
-	O
originating	O
FAs	O
.	O

Cross	O
-	O
linking	O
is	O
more	O
likely	O
if	O
the	O
allergen	O
occurs	O
in	O
dimerized	O
or	O
multimerized	O
form	O
[	O
3	O
].	O

The	O
Born	O
Too	O
Soon	O
series	O
in	O
Reproductive	O
Health	O
was	O
funded	O
by	O
March	O
of	O
Dimes	O
and	O
Save	O
the	O
Children	O
.	O

Participants	O
also	O
completed	O
a	O
questionnaire	O
about	O
use	O
of	O
dietary	O
supplements	O
.	O

Treatment	O
of	O
atopic	O
dermatitis	O
during	O
pregnancy	O
should	O
emphasize	O
avoidance	O
of	O
triggering	O
factors	O
and	O
reliance	O
on	O
topical	O
treatment	O
in	O
an	O
attempt	O
to	O
reduce	O
dryness	O
and	O
pruritus	O
,	O
modulate	O
inflammation	O
,	O
and	O
treat	O
secondary	O
infections	O
.	O

While	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
greater	O
reduction	O
in	O
depression	O
scores	O
than	O
the	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

F	O
.,	O
G	O
.,	O
and	O
S	O
.	O

For	O
all	O
animals	O
of	O
the	O
experiment	O
no	O
significant	O
differences	O
in	O
body	O
weight	O
were	O
observed	O
at	O
28	O
and	O
188	O
dpn	O
[	O
15	O
,	O
16	O
].	O

Phase	O
3	O
data	O
are	O
collected	O
at	O
36	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
).	O

A	O
nested	O
case	O
control	O
study	O
done	O
by	O
Lyall	O
et	O
al	O
.	O

Thus	O
,	O
there	O
is	O
a	O
lack	O
of	O
published	O
information	O
regarding	O
the	O
efficacy	O
of	O
perinatal	O
handwashing	O
promotion	O
interventions	O
on	O
maternal	O
handwashing	O
behavior	O
in	O
the	O
neonatal	O
period	O
and	O
on	O
neonatal	O
mortality	O
.	O

The	O
main	O
objectives	O
in	O
clinical	O
monitoring	O
of	O
pregnant	O
thyroid	O
cancer	O
patients	O
are	O
:	O
1	O
)	O
to	O
reach	O
an	O
adequate	O
balance	O
of	O
maternal	O
calcium	O
and	O
thyroid	O
hormones	O
that	O
is	O
absolutely	O
required	O
by	O
the	O
foetal	O
central	O
nervous	O
system	O
for	O
normal	O
maturation	O
;	O
2	O
)	O
to	O
maintain	O
optimal	O
levels	O
of	O
maternal	O
thyroxin	O
to	O
avoid	O
possible	O
recurrence	O
or	O
spread	O
of	O
disease	O
;	O
and	O
3	O
)	O
to	O
perform	O
safe	O
follow	O
-	O
up	O
visits	O
for	O
the	O
mother	O
and	O
to	O
plan	O
further	O
therapy	O
when	O
needed	O
.	O

BAT	O
transplantation	O
also	O
increased	O
insulin	O
-	O
stimulated	O
glucose	O
uptake	O
in	O
BAT	O
,	O
WAT	O
,	O
and	O
heart	O
,	O
but	O
not	O
in	O
skeletal	O
muscle	O
(	O
Stanford	O
et	O
al	O
.,	O
2013	O
).	O

Briefly	O
,	O
each	O
animal	O
was	O
laid	O
in	O
a	O
supine	O
position	O
and	O
samples	O
were	O
obtained	O
by	O
inserting	O
the	O
tip	O
of	O
a	O
100	O
ul	O
pipette	O
tip	O
approximately	O
2	O
–	O
4	O
mm	O
into	O
the	O
vagina	O
,	O
releasing	O
sterile	O
water	O
(∼	O
50	O
ul	O
)	O
and	O
immediately	O
drawing	O
back	O
to	O
collect	O
the	O
sample	O
.	O

In	O
this	O
study	O
using	O
C57BL	O
/	O
6	O
male	O
mice	O
,	O
stress	O
induced	O
GAS5	O
RNA	O
levels	O
in	O
the	O
hippocampus	O
and	O
this	O
increase	O
was	O
accompanied	O
by	O
a	O
rise	O
of	O
corticosterone	O
levels	O
[	O
22	O
].	O

Recent	O
research	O
has	O
suggested	O
that	O
effects	O
of	O
methyl	O
-	O
mercury	O
on	O
infant	O
brain	O
development	O
may	O
be	O
mediated	O
by	O
LC	O
n	O
-	O
3PUFA	O
[	O
36	O
].	O

Second	O
-	O
generation	O
antihistamines	O
such	O
as	O
loratadine	O
or	O
cetirizine	O
[	O
21	O
,	O
29	O
]	O
can	O
also	O
be	O
used	O
(	O
after	O
the	O
first	O
trimester	O
--	O
as	O
a	O
general	O
precaution	O
).	O

Statistical	O
analysis	O
was	O
performed	O
by	O
using	O
SPSS	O
20	O
.	O
0	O
for	O
windows	O
(	O
SPSS	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
and	O
GraphPad	O
Prism	O
version	O
6	O
.	O
0	O
(	O
GraphPad	O
Software	O
Inc	O
.,	O
San	O
Diego	O
,	O
CA	O
,	O
USA	O
).	O

Lindberg	O
et	O
al	O
[	O
37	O
],	O
in	O
their	O
cross	O
sectional	O
study	O
of	O
6	O
,	O
799	O
Swedish	O
women	O
,	O
for	O
instance	O
,	O
reported	O
that	O
self	O
-	O
reported	O
snoring	O
and	O
excessive	O
daytime	O
sleepiness	O
was	O
an	O
independent	O
risk	O
factor	O
for	O
type	O
2	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
82	O
;	O
95	O
%	O
CI	O
0	O
.	O
97	O
-	O
3	O
.	O
43	O
).	O

However	O
,	O
one	O
study	O
,	O
a	O
randomised	O
controlled	O
trial	O
,	O
was	O
underpowered	B
to	O
realistically	O
address	O
the	O
effectiveness	O
and	O
safety	O
of	O
metformin	O
in	O
GDM	O
.	O
73In	O
another	O
study	O
,	O
a	O
retrospective	O
case	O
control	O
study	O
,	O
subjects	O
treated	O
with	O
insulin	O
had	O
a	O
greater	O
degree	O
of	O
initial	O
glucose	O
intolerance	O
,	O
so	O
the	O
comparison	O
was	O
of	O
limited	O
validity	O
.	O
74A	O
third	O
study	O
comprised	O
a	O
retrospective	O
cohort	O
which	O
included	O
a	O
mixture	O
of	O
both	O
GDM	O
and	O
women	O
with	O
Type	O
2	O
diabetes	O
seen	O
from	O
1966	O
–	O
1991	O
.	O

Environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
an	O
issue	B
that	O
has	O
been	O
highlighted	O
as	O
a	O
current	O
research	O
focus	O
within	O
Public	O
Health	O
England	O
’	O
s	O
(	O
PHE	O
'	O
s	O
)	O
Center	O
for	O
Radiation	O
,	O
Chemical	O
and	O
Environmental	O
Hazards	O
(	O
CRCE	O
),	O
the	O
wider	O
PHE	O
organization	O
as	O
part	O
of	O
the	O
early	O
life	O
priority	O
‘	O
ensuring	O
every	O
child	O
has	O
the	O
best	O
start	O
in	O
life	O
’,	O
and	O
the	O
international	O
research	O
and	O
governmental	O
communities	O
.	O

No	O
monetary	O
value	O
was	O
assigned	O
to	O
the	O
women	O
'	O
s	O
time	O
since	O
the	O
time	O
required	O
per	O
person	O
was	O
very	O
modest	O
and	O
respondents	O
stated	O
that	O
this	O
did	O
not	O
involve	O
loss	O
of	O
work	O
time	O
or	O
incur	O
a	O
financial	O
cost	O
.	O

At	O
follow	O
-	O
up	O
,	O
44	O
%	O
(	O
47	O
/	O
106	O
)	O
in	O
the	O
control	O
arm	O
and	O
70	O
%	O
in	O
the	O
intervention	O
arm	O
(	O
77	O
/	O
110	O
)	O
reported	O
doing	O
so	O
.	O

Conclusion	O
The	O
study	O
shows	O
that	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
regular	O
de	O
-	O
worming	O
is	O
a	O
low	O
-	O
cost	O
and	O
cost	O
-	O
effective	O
intervention	O
and	O
would	O
be	O
appropriate	O
for	O
population	O
-	O
based	O
introduction	O
in	O
settings	O
with	O
a	O
high	O
prevalence	O
of	O
anaemia	O
and	O
iron	O
deficiency	O
and	O
low	O
malaria	O
infection	O
rates	O
.	O

Many	O
of	O
the	O
findings	O
regarding	O
the	O
relationship	O
between	O
vitamin	O
D	O
deficiency	O
and	O
GDM	O
are	O
based	O
on	O
case	O
-	O
control	O
studies	O
,	O
which	O
may	O
include	O
a	O
potential	O
selection	O
bias	B
.	O

This	O
is	O
therefore	O
a	O
novel	O
analysis	O
and	O
a	O
considerable	O
expansion	O
on	O
the	O
previous	O
one	O
.	O

Clinical	O
outcomes	O
are	O
currently	O
being	O
examined	O
.	O

In	O
contrast	O
,	O
the	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
did	O
not	O
show	O
changes	O
in	O
body	O
weight	O
and	O
adiposity	O
,	O
but	O
exhibited	O
higher	O
levels	O
of	O
LDL	O
and	O
glucose	O
in	O
plasma	O
,	O
and	O
a	O
reduction	O
in	O
chocolate	O
preference	O
at	O
adolescence	O
and	O
total	O
caloric	O
intake	O
at	O
adulthood	O
.	O

Iron	O
deficiency	O
anaemia	O
accounts	O
for	O
75	O
–	O
95	O
%	O
of	O
cases	O
of	O
anaemia	O
in	O
pregnancy	O
[	O
9	O
].	O

A	O
recent	O
study	O
published	O
in	O
The	O
Lancet	O
examined	O
preterm	O
birth	O
prevention	O
potential	O
in	O
39	O
high	O
-	O
income	O
countries	O
and	O
estimated	O
that	O
if	O
five	O
interventions	O
reached	O
high	O
coverage	O
there	O
would	O
only	O
be	O
a	O
5	O
%	O
relative	O
reduction	O
of	O
preterm	O
birth	O
rate	O
from	O
9	O
·	O
59	O
%	O
to	O
9	O
·	O
07	O
%	O
of	O
livebirths	O
by	O
2015	O
,	O
averting	O
an	O
estimated	O
58	O
,	O
000	O
preterm	O
births	O
and	O
saving	O
US	O
$	O
3	O
billion	O
annually	O
[	O
11	O
].	O

Adipogenesis	O
normally	O
begins	O
around	O
mid	O
-	O
gestation	O
in	O
ruminant	O
animals	O
[	O
20	O
].	O

These	O
data	O
suggest	O
that	O
dosage	O
of	O
texts	O
received	O
regarding	O
risks	O
of	O
alcohol	O
use	O
,	O
which	O
included	O
messages	O
regarding	O
risks	O
due	O
to	O
alcohol	O
while	O
breastfeeding	O
,	O
had	O
a	O
cumulative	O
effective	O
.	O

These	O
genes	O
display	O
diet	O
-	O
dependent	O
longitudinal	O
transcriptomic	O
regulation	O
(	O
Figure1	O
).	O

One	O
southern	O
U	O
.	O
S	O
.	O
state	O
,	O
with	O
the	O
second	O
highest	O
preterm	O
birth	O
rate	O
in	O
the	O
country	O
,	O
has	O
received	O
an	O
"	O
F	O
"	O
on	O
its	O
Report	O
Card	O
every	O
year	O
since	O
2008	O
.	O

Offspring	O
biometry	O
Body	O
mass	O
(	O
Figures	O
1and2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Body	O
mass	O
evolution	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
at	O
earlier	O
stages	O
of	O
development	O
.	O

Vitamin	O
D	O
status	O
and	O
GDM	O
In	O
our	O
cohort	O
GDM	O
was	O
present	O
in	O
81	O
of	O
the	O
723	O
women	O
(	O
11	O
%).	O

It	O
was	O
found	O
that	O
maternal	O
prenatal	O
weight	O
gain	O
,	O
but	O
not	O
prepregnancy	O
body	O
mass	O
index	O
,	O
is	O
directly	O
related	O
to	O
an	O
increased	O
risk	O
of	O
ASD	O
.	O

Although	O
DNMT2	O
has	O
demonstrated	O
some	O
weak	O
DNMT	O
activity	O
,	O
it	O
is	O
predominantly	O
associated	O
with	O
RNA	O
,	O
particularly	O
tRNA	O
,	O
methylation	O
,	O
potentially	O
contributing	O
to	O
the	O
regulation	O
of	O
RNA	O
stability	O
and	O
translation	O
(	O
Motorin	O
et	O
al	O
.	O
2010	O
).	O

The	O
effect	O
is	O
characterised	O
by	O
a	O
programming	O
of	O
the	O
genome	O
that	O
leads	O
to	O
different	O
responsiveness	O
and	O
adaptability	O
of	O
the	O
gene	O
expression	O
machinery	O
to	O
chronic	O
and	O
acute	O
environmental	O
stimuli	O
,	O
i	O
.	O
e	O
.	O

These	O
four	O
miRNAs	O
are	O
miR	O
-	O
124a	O
,	O
miR	O
-	O
142	O
-	O
3p	O
,	O
miR	O
-	O
30	O
and	O
miR	O
-	O
204	O
,	O
the	O
miRNAs	O
binding	O
sites	O
on	O
the	O
3	O
′	O
UTR	O
of	O
GR	O
were	O
shown	O
inFig	O
.	O

However	O
,	O
these	O
studies	O
have	O
been	O
limited	O
by	O
the	O
relatively	O
low	O
rates	O
of	O
assessment	O
[	O
18	O
–	O
20	O
].	O

Investigators	O
estimated	O
the	O
odds	O
of	O
change	O
over	O
time	O
in	O
response	O
to	O
each	O
of	O
the	O
behavioral	O
outcome	O
variables	O
as	O
a	O
function	O
of	O
text4baby	O
text	O
message	O
exposure	O
through	O
use	O
of	O
an	O
interaction	O
term	O
including	O
program	O
exposure	O
and	O
progression	O
to	O
follow	O
-	O
up	O
measurement	O
.	O

In	O
our	O
study	O
,	O
while	O
puberty	O
was	O
accelerated	O
in	O
maternal	O
high	O
fat	O
exposed	O
offspring	O
,	O
ovarian	O
function	O
was	O
maintained	O
or	O
enhanced	O
into	O
adult	O
life	O
.	O

We	O
were	O
also	O
able	O
to	O
perform	O
sensitivity	O
analysis	O
for	O
self	O
-	O
reported	O
vaccination	O
.	O

Newborn	O
and	O
infant	O
children	O
have	O
greater	O
contact	O
with	O
these	O
contaminants	O
since	O
they	O
lie	O
,	O
crawl	O
and	O
play	O
near	O
the	O
ground	O
and	O
frequently	O
place	O
their	O
hands	O
,	O
objects	O
or	O
food	O
in	O
their	O
mouths	O
[	O
29	O
,	O
33	O
,	O
34	O
].	O

The	O
recommended	O
dose	O
of	O
400	O
IU	O
(	O
10	O
micrograms	O
)	O
daily	O
for	O
infants	O
was	O
established	O
based	O
on	O
typical	O
amounts	O
in	O
a	O
teaspoon	O
of	O
cod	O
liver	O
oil	O
[	O
1	O
].	O

We	O
compared	O
baseline	O
characteristics	O
and	O
the	O
distribution	O
of	O
our	O
prestated	O
confounders	O
for	O
intervention	O
and	O
placebo	O
groups	O
.	O

As	O
with	O
the	O
trials	O
in	O
the	O
older	O
children	O
,	O
giving	O
higher	O
doses	O
of	O
vitamin	O
D	O
,	O
25	O
,	O
34we	O
too	O
did	O
not	O
record	O
any	O
adverse	O
effects	O
associated	O
with	O
vitamin	O
D	O
supplementation	O
.	O

The	O
TSH	O
concentration	O
generally	O
lies	O
within	O
the	O
normal	O
range	O
after	O
the	O
16th	O
to	O
18th	O
week11171920	O
.	O

Genotyping	O
/	O
mapping	O
DNA	O
was	O
isolated	O
from	O
tail	O
biopsy	O
specimens	O
using	O
overnight	O
digestion	O
in	O
a	O
lysis	O
buffer	O
containing	O
proteinase	O
K	O
(	O
10	O
nM	O
Tris	O
,	O
2	O
mM	O
EDTA	O
,	O
0	O
.	O
5	O
%	O
SDS	O
,	O
0	O
.	O
4	O
M	O
NaCl	O
,	O
and	O
0	O
.	O
2	O
mg	O
/	O
ml	O
proteinase	O
K	O
),	O
followed	O
by	O
a	O
phenol	O
/	O
chloroform	O
extraction	O
.	O

[	O
12	O
]	O
Chailurkit	O
et	O
al	O
.	O

Materials	O
and	O
Methods	O
Program	O
implementation	O
,	O
compliance	O
and	O
impact	O
assessment	O
In	O
May	O
2006	O
the	O
National	O
Institute	O
of	O
Malariology	O
,	O
Parasitology	O
and	O
Entomology	O
(	O
NIMPE	O
)	O
and	O
partners	O
introduced	O
a	O
pilot	O
program	O
consisting	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
periodic	O
de	O
-	O
worming	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
Yen	O
Bai	O
province	O
.	O

The	O
mechanism	O
of	O
action	O
may	O
involve	O
epigenetic	O
processes	O
or	O
DNA	O
changes	O
with	O
the	O
capacity	O
to	O
modulate	O
or	O
influence	O
oncogenic	O
outcomes	O
in	O
the	O
distant	O
future	O
.	O

In	O
a	O
similar	O
study	O
done	O
by	O
Simpson	O
et	O
al	O
.	O

Surprisingly	O
,	O
high	O
maternal	O
seafood	O
consumption	O
,	O
of	O
the	O
type	O
known	O
to	O
be	O
contaminated	O
with	O
mercury	O
,	O
has	O
been	O
associated	O
with	O
fewer	O
–	O
not	O
more	O
–	O
autistic	O
markers	O
in	O
the	O
offspring	O
(	O
17	O
).	O

Our	O
findings	O
represent	O
the	O
largest	O
,	O
most	O
extensive	O
,	O
and	O
most	O
complete	O
follow	O
-	O
up	O
of	O
infants	O
to	O
6	O
months	O
of	O
age	O
who	O
were	O
born	O
to	O
overweight	O
and	O
obese	O
women	O
following	O
the	O
conduct	O
of	O
the	O
largest	O
randomised	O
trial	O
to	O
date	O
evaluating	O
the	O
provision	O
of	O
a	O
comprehensive	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
.	O

Seasons	O
were	O
defined	O
according	O
to	O
the	O
UK	O
Meteorological	O
Office	O
recommendations	O
(	O
www	O
.	O
metoffice	O
.	O
gov	O
.	O
uk	O
)	O
with	O
winter	O
(	O
December	O
to	O
February	O
),	O
spring	O
(	O
March	O
to	O
May	O
),	O
summer	O
(	O
June	O
to	O
August	O
),	O
and	O
autumn	O
(	O
September	O
to	O
November	O
).	O

Results	O
Figure	O
1outlines	O
the	O
flow	O
of	O
participants	O
.	O

Infant	O
anthropometric	O
measurements	O
Infant	O
growth	O
is	O
assessed	O
at	O
each	O
postnatal	O
visit	O
.	O

Final	O
live	O
-	O
birth	O
rates	O
were	O
31	O
%	O
among	O
vitamin	O
D	O
-	O
deficient	O
recipients	O
,	O
compared	O
with	O
59	O
%	O
among	O
vitamin	O
D	O
-	O
replete	O
recipients	O
.	O

Fifteen	O
(	O
62	O
.	O
5	O
%)	O
of	O
the	O
subjects	O
in	O
the	O
IG	O
were	O
suffering	O
from	O
a	O
moderate	O
vitamin	O
D	O
deficiency	O
,	O
which	O
decreased	O
to	O
zero	O
after	O
the	O
intervention	O
(	O
table	O
3	O
).	O

The	O
responses	O
in	O
the	O
questionnaires	O
were	O
transcribed	O
into	O
EPIInfo	O
version	O
3	O
.	O
5	O
.	O
1	O
database	O
(	O
CDC	O
/	O
WHO	O
,	O
Atlanta	O
,	O
USA	O
).	O

Prospective	O
studies	O
are	O
needed	O
to	O
minimize	O
these	O
biases	B
.	O

Liver	O
tissue	O
was	O
immediately	O
collected	O
from	O
lobus	O
sinister	O
hepaticus	O
,	O
frozen	O
in	O
liquid	O
nitrogen	O
,	O
and	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
use	O
for	O
RNA	O
isolation	O
.	O

Although	O
the	O
role	O
of	O
hypothalamic	O
regulation	O
in	O
determining	O
the	O
phenotype	O
is	O
uncertain	O
,	O
our	O
gene	O
expression	O
data	O
are	O
novel	O
because	O
we	O
show	O
that	O
feeding	O
neurocircuitry	O
undergoes	O
modification	O
both	O
in	O
utero	O
and	O
into	O
maturity	O
.	O

Harvey	O
et	O
al	O
.	O

However	O
,	O
due	O
to	O
recent	O
changes	O
in	O
national	O
health	O
policies	O
,	O
intake	O
of	O
vitamin	O
D	O
has	O
increased	O
resulting	O
in	O
decreasing	O
rates	O
of	O
vitamin	O
D	O
deficiency	O
[	O
2	O
–	O
5	O
].	O

Conclusions	O
Developmental	O
vitamin	O
D	O
deficiency	O
was	O
associated	O
with	O
subtle	O
changes	O
in	O
protein	O
expression	O
in	O
the	O
nucleus	O
accumbens	O
.	O

A	O
minimum	O
sample	O
of	O
120	O
children	O
in	O
each	O
group	O
was	O
expected	O
to	O
provide	O
80	O
%	O
power	O
to	O
detect	O
a	O
one	O
-	O
tailed	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
levels	O
between	O
the	O
groups	O
at	O
α	O
=	O
0	O
.	O
05	O
.	O

Social	O
networks	O
seem	O
to	O
play	O
a	O
role	O
in	O
the	O
spread	O
of	O
obesity	O
in	O
both	O
adults	O
and	O
adolescents	O
.	O

Adaptive	O
versus	O
adverse	O
epigenetic	O
change	O
Epigenetic	O
change	O
offers	O
a	O
much	O
more	O
versatile	O
,	O
reversible	O
and	O
rapid	O
way	O
for	O
adapting	O
to	O
changes	O
in	O
our	O
environment	O
compared	O
with	O
genetic	O
mutation	O
.	O

Children	O
were	O
assessed	O
using	O
the	O
dmft	O
index	O
(	O
a	O
cumulative	O
score	O
of	O
decayed	O
,	O
missing	O
,	O
filled	O
primary	O
teeth	O
).	O

Vitamin	O
D	O
stimulates	O
anti	O
-	O
Müllerian	O
hormone	O
(	O
AMH	O
)	O
production	O
as	O
well	O
,	O
which	O
is	O
highly	O
correlated	O
with	O
ovarian	O
reserve	O
preservation	O
.	O

Impact	O
of	O
maternal	O
caloric	O
restriction	O
on	O
the	O
expression	O
of	O
the	O
endogenous	O
cannabinoid	O
system	O
in	O
organs	O
related	O
to	O
energy	O
expenditure	O
and	O
metabolism	O
The	O
sex	O
-	O
dependent	O
effects	O
of	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
and	O
metabolic	O
profile	O
in	O
offspring	O
can	O
be	O
a	O
result	O
of	O
a	O
differential	O
re	O
-	O
programming	O
in	O
energy	O
metabolism	O
.	O

We	O
then	O
controlled	O
for	O
potential	O
confounders	O
that	O
changed	O
multivariable	O
RRs	O
by	O
more	O
than	O
10	O
%	O
relative	O
to	O
the	O
unadjusted	O
RR	O
[	O
31	O
].	O

Further	O
study	O
is	O
warranted	O
to	O
understand	O
what	O
mechanisms	O
affect	O
the	O
adipogenic	O
potential	O
by	O
nutritional	O
modulation	O
during	O
the	O
fetal	O
period	O
at	O
specific	O
gestation	O
stages	O
,	O
thereafter	O
affecting	O
marbling	O
and	O
IMF	O
deposition	O
at	O
the	O
progeny	O
slaughter	O
stage	O
.	O

The	O
median	O
was	O
used	O
as	O
the	O
measure	O
of	O
central	O
tendency	O
.	O

Regression	O
analysis	O
confirmed	O
no	O
association	O
between	O
oral	O
glucose	O
tolerance	O
test	O
results	O
and	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
>	O
0	O
.	O
53	O
).	O

*	O
Note	O
that	O
Control	O
offspring	O
inFigure	O
3andFigure	O
4are	O
the	O
same	O
animals	O
.	O

Error	O
bars	O
are	O
standard	O
errors	O
.	O

Indeed	O
,	O
for	O
the	O
risk	O
of	O
GDM	O
an	O
opposite	O
effect	O
of	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
observed	O
depending	O
on	O
fetal	O
sex	O
.	O

It	O
is	O
important	O
to	O
identify	O
the	O
mechanisms	O
responsible	O
for	O
initial	O
muscle	O
and	O
fat	O
cell	O
growth	O
during	O
the	O
developmental	O
stage	O
of	O
cattle	O
to	O
better	O
understand	O
IMF	O
deposition	O
in	O
later	O
life	O
.	O

In	O
a	O
large	O
retrospective	O
study	O
on	O
595	O
pregnancy	O
-	O
associated	O
thyroid	O
cancers	O
,	O
Yasmeen	O
et	O
al	O
.	O

Innovate	O
•	O
Work	O
in	O
partnership	O
to	O
provide	O
universal	O
access	O
to	O
the	O
essential	O
package	O
of	O
interventions	O
,	O
including	O
both	O
prevention	O
and	O
care	O
,	O
and	O
involving	O
task	O
shifting	O
where	O
appropriate	O
.	O

In	O
their	O
study	O
,	O
YG	O
was	O
reduced	O
,	O
and	O
HCW	O
tended	O
to	O
be	O
reduced	O
in	O
offspring	O
of	O
dams	O
nutritionally	O
restricted	O
.	O

Although	O
we	O
accept	O
that	O
rodents	O
and	O
humans	O
may	O
differ	O
in	O
their	O
adaptive	O
responses	O
to	O
early	O
life	O
cues	O
,	O
there	O
are	O
many	O
reports	O
outlining	O
associations	O
between	O
a	O
suboptimal	O
early	O
life	O
environment	O
and	O
altered	O
phenotype	O
in	O
both	O
species	O
[	O
60	O
],[	O
61	O
].	O

Little	O
is	O
known	O
about	O
the	O
actual	O
mechanisms	O
by	O
which	O
maternal	O
diet	O
affects	O
children	O
’	O
s	O
health	O
;	O
we	O
hypothesize	O
that	O
maternal	O
diet	O
impacts	O
the	O
development	O
of	O
the	O
gut	O
microbiome	O
in	O
infancy	O
and	O
subsequently	O
influences	O
child	O
health	O
outcomes	O
.	O

A	O
p	O
value	O
≤	O
0	O
.	O
05	O
was	O
significant	O
.	O

More	O
than	O
half	O
of	O
the	O
surveyed	O
women	O
(	O
57	O
%)	O
reported	O
having	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
);	O
conditions	O
were	O
more	O
common	O
among	O
vaccinated	O
(	O
60	O
%)	O
than	O
unvaccinated	O
women	O
(	O
53	O
%)	O
(	O
p	O
-	O
value	O
<	O
0	O
.	O
01	O
).	O

National	O
Osteoporosis	O
Foundation	O
'	O
s	O
(	O
NOF	O
)	O
recommends	O
400	O
-	O
800IU	O
vitamin	O
D	O
for	O
pregnant	O
women	O
.	O

Vitamin	O
C	O
Vitamin	O
C	O
can	O
be	O
synthesized	O
from	O
glucose	O
in	O
the	O
liver	O
of	O
many	O
mammalian	O
species	O
other	O
than	O
guinea	O
pigs	O
,	O
humans	O
,	O
and	O
other	O
primates	O
[	O
146	O
].	O

Similarly	O
,	O
maternal	O
prenatal	O
behaviors	O
may	O
differentially	O
impact	O
birth	O
and	O
6	O
months	O
offspring	O
weights	O
(	O
e	O
.	O
g	O
.,	O
protein	O
impacting	O
6	O
month	O
but	O
not	O
birth	O
weight	O
in	O
the	O
current	O
study	O
).	O

Tested	O
at	O
42	O
months	O
,	O
7	O
and	O
8	O
years	O
.	O
Two	O
FFQs	O
during	O
pregnancy	O
(	O
at	O
15	O
weeks	O
and	O
32	O
weeks	O
)	O
were	O
used	O
to	O
estimate	O
fish	O
intake	O
in	O
early	O
and	O
late	O
pregnancy	O
.	O
Cognitive	O
&	O
behavioural	O
outcomes	O
in	O
offspring	O
at	O
9	O
years	O
using	O
the	O
Wechsler	O
Abbreviated	O
Scale	O
of	O
Intelligence	O
.	O

Guidelines	O
from	O
Australia	O
[	O
2	O
],	O
Europe	O
[	O
3	O
]	O
and	O
the	O
USA	O
[	O
4	O
]	O
encourage	O
the	O
consumption	O
of	O
fish	O
during	O
pregnancy	O
.	O

We	O
demultiplexed	O
and	O
divided	O
datasets	O
using	O
Illumina	O
MiSeq	O
Reporter	O
and	O
a	O
custom	O
Python	O
script	O
.	O

Our	O
data	O
,	O
from	O
this	O
small	O
dataset	O
,	O
can	O
only	O
be	O
used	O
to	O
partially	O
answer	O
this	O
question	O
specifically	O
related	O
to	O
bone	O
health	O
.	O

We	O
studied	O
kidney	O
stereology	O
at	O
birth	O
,	O
10	O
days	O
and	O
6	O
months	O
of	O
age	O
in	O
each	O
generation	O
(	O
n	O
=	O
6	O
for	O
each	O
group	O
).	O

The	O
nail	O
plate	O
was	O
subsequently	O
reflected	O
back	O
into	O
place	O
.	O

Future	O
interventions	O
can	O
tailor	O
text	O
message	O
and	O
other	O
mHealth	O
message	O
content	O
(	O
eg	O
,	O
through	O
social	O
media	O
or	O
apps	O
)	O
both	O
to	O
a	O
specific	O
target	O
audience	O
and	O
to	O
an	O
optimal	O
time	O
for	O
delivery	O
.	O

No	O
Australian	O
GDM	O
Nutrition	O
Practice	O
Guidelines	O
exist	O
and	O
systematic	O
delivery	O
of	O
dietetic	O
care	O
to	O
women	O
with	O
GDM	O
does	O
not	O
occur	O
in	O
Australia	O
.	O

Other	O
potential	O
mechanism	O
that	O
would	O
explain	O
the	O
impairment	O
of	O
the	O
vagal	O
modulation	O
observed	O
in	O
children	O
with	O
low	O
birth	O
weight	O
could	O
be	O
mediated	O
by	O
renin	O
-	O
angiotensin	O
system	O
(	O
RAS	O
).	O

They	O
were	O
followed	O
up	O
at	O
3	O
time	O
points	O
thereafter	O
through	O
delivery	O
of	O
their	O
baby	O
.	O

Statistical	O
analysis	O
of	O
the	O
maternal	O
Tht111	O
I	O
polymorphism	O
has	O
shown	O
an	O
inverse	O
correlation	O
between	O
negative	O
maternal	O
attitude	O
and	O
infant	O
birth	O
weight	O
(	O
r	O
=	O
−	O
0	O
.	O
41	O
,	O
P	O
=	O
0	O
.	O
030	O
),	O
only	O
in	O
Tht111	O
I	O
CC	O
polymorphism	O
subgroup	O
.	O

One	O
possible	O
interpretation	O
for	O
these	O
data	O
is	O
that	O
a	O
vagal	O
withdrawal	O
,	O
rather	O
than	O
a	O
sympathetic	O
overactivity	O
,	O
could	O
precede	O
the	O
development	O
of	O
hypertension	O
and	O
other	O
cardiometabolic	O
diseases	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

Results	O
:	O
Anaemic	O
women	O
(	O
haemoglobin	O
concentration	O
<	O
12g	O
/	O
dL	O
)	O
were	O
more	O
likely	O
to	O
be	O
older	O
and	O
in	O
economic	O
deficit	O
at	O
baseline	O
.	O

The	O
field	O
supervision	O
team	O
will	O
comprise	O
of	O
five	O
Field	O
Research	O
Officers	O
and	O
five	O
District	O
Managers	O
.	O

Note	O
that	O
confidence	O
intervals	O
for	O
beta	O
coefficients	O
from	O
LASSO	O
and	O
Elastic	O
Net	O
are	O
not	O
available	O
using	O
standard	O
software	O
,	O
and	O
calculating	O
standard	O
errors	O
for	O
parameter	O
estimates	O
is	O
challenging	O
because	B
the	O
shrinkage	O
estimation	O
produces	O
biased	B
estimates	O
for	O
large	O
coefficients	O
.	O

Differential	O
expression	O
of	O
genes	O
related	O
to	O
lipid	O
,	O
ketone	O
body	O
,	O
and	O
amino	O
acid	O
metabolism	O
indicate	O
that	O
the	O
offspring	O
of	O
both	O
groups	O
uses	O
different	O
metabolic	O
directions	O
in	O
response	O
to	O
identical	O
nutritional	O
condition	O
during	O
postnatal	O
life	O
.	O

In	O
clinical	O
studies	O
,	O
researchers	O
from	O
Kaiser	O
Permanente	O
Northern	O
California	O
Hospitals	O
examined	O
291	O
children	O
born	O
from	O
1995	O
to	O
1999	O
,	O
compared	O
to	O
284	O
controls	O
.	O

However	O
,	O
we	O
chose	O
these	O
for	O
multiple	O
reasons	O
;	O
the	O
HAPO	O
study	O
used	O
similar	O
divisions	O
in	O
countries	O
with	O
a	O
latitude	O
of	O
41	O
.	O
9	O
–	O
43	O
.	O
7	O
°	O
North	O
[	O
7	O
],	O
mean	O
daily	O
temperatures	O
in	O
Ireland	O
are	O
highest	O
during	O
the	O
months	O
May	O
to	O
October	O
[	O
47	O
],	O
and	O
we	O
based	O
these	O
seasons	O
on	O
25OHD	O
concentrations	O
for	O
the	O
month	O
of	O
the	O
first	O
antenatal	O
visit	O
(	O
Additional	O
file1	O
:	O
Fig	O
.	O

Fetal	O
nutritional	O
programming	O
Fetal	O
programming	O
or	O
prenatal	O
programing	O
is	O
the	O
concept	O
that	O
mammalian	O
embryonic	O
and	O
fetal	O
development	O
are	O
linked	O
to	O
environmental	O
changes	O
,	O
thus	O
affecting	O
the	O
entire	O
life	O
[	O
152	O
].	O

The	O
prior	O
distribution	O
depends	O
on	O
hyperparameters	O
,	O
including	O
a	O
mean	O
μβand	O
standard	O
deviation	O
σβ	O
,	O
which	O
are	O
informed	O
by	O
the	O
data	O
and	O
can	O
be	O
quantified	O
when	O
fitted	O
to	O
the	O
data	O
.	O

Direct	O
iron	O
supplementation	O
has	O
been	O
extensively	O
used	O
in	O
most	O
developing	O
countries	O
as	O
an	O
intervention	O
to	O
prevent	O
iron	O
deficiency	O
and	O
consequently	O
anaemia	O
during	O
pregnancy	O
[	O
7	O
].	O

Recent	O
animal	O
studies	O
proved	O
that	O
sperm	O
count	O
,	O
motility	O
,	O
histological	O
structure	O
of	O
testis	O
,	O
and	O
spermatogenesis	O
are	O
more	O
dependent	O
on	O
proper	O
serum	O
calcium	O
and	O
phosphorus	O
levels	O
rather	O
than	O
VD	O
status	O
[	O
47	O
].	O

The	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O
Visfatin	O
has	O
extensive	O
effects	O
on	O
pregnancy	O
physiology	O
and	O
pathology	O
,	O
maternal	O
and	O
especially	O
neonatal	O
outcomes	O
,	O
and	O
its	O
effect	O
is	O
different	O
in	O
normal	O
weight	O
and	O
overweight	O
women	O
.	O

Evidence	O
for	O
genetic	O
influence	O
on	O
intake	O
regulation	O
is	O
also	O
reflected	O
in	O
the	O
relative	O
stability	O
of	O
behaviors	O
like	O
EAH	O
within	O
people	O
during	O
2	O
-	O
to	O
6	O
-	O
year	O
periods	O
in	O
childhood	O
(	O
47	O
,	O
67	O
).	O

Despite	O
this	O
,	O
it	O
remains	O
important	O
to	O
continue	O
to	O
follow	O
-	O
up	O
the	O
children	O
whose	O
mothers	O
participated	O
in	O
this	O
intervention	O
trial	O
,	O
particularly	O
in	O
view	O
of	O
the	O
well	O
recognised	O
association	O
between	O
high	O
-	O
infant	O
birth	O
weight	O
and	O
subsequent	O
childhood	O
obesity	O
[	O
48	O
],	O
and	O
the	O
emerging	O
associations	O
between	O
maternal	O
obesity	O
and	O
impaired	O
childhood	O
neurodevelopmental	O
function	O
[	O
46	O
].	O

Methods	O
:	O
We	O
conducted	O
a	O
retrospective	O
cohort	O
study	O
to	O
evaluate	O
associations	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
.	O

The	O
DHCR7	O
gene	O
encodes	O
7	O
-	O
DHC	O
reductase	O
,	O
which	O
converts	O
7	O
-	O
DHC	O
back	O
to	O
cholesterol	O
,	O
thereby	O
reducing	O
the	O
availability	O
of	O
7	O
-	O
DHC	O
for	O
conversion	O
to	O
previtamin	O
D	O
.	O
The	O
association	O
of	O
this	O
SNP	O
with	O
only	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
is	O
biologically	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
relative	O
proportion	O
of	O
25	O
(	O
OH	O
)	O
D	O
obtained	O
from	O
vitamin	O
D	O
biosynthesis	O
in	O
the	O
skin	O
as	O
opposed	O
to	O
dietary	O
intake	O
is	O
lower	O
following	O
supplementation	O
.	O

Briefly	O
,	O
normal	O
beat	O
to	O
beat	O
intervals	O
(	O
RR	O
)	O
were	O
transferred	O
from	O
Polar	O
S810i	O
to	O
Precision	O
Performance	O
Software	O
by	O
an	O
infrared	O
interface	O
device	O
.	O

Thus	O
,	O
miRNAs	O
are	O
involved	O
in	O
fine	O
tuning	O
gene	O
expression	O
,	O
whilst	O
piRNAs	O
and	O
esiRNAs	O
play	O
a	O
primary	O
role	O
in	O
maintaining	O
genome	O
stability	O
.	O

Upon	O
arrival	O
at	O
RMMCH	O
on	O
the	O
booked	O
date	O
,	O
the	O
trained	O
fieldworkers	O
explain	O
the	O
informed	O
consent	O
form	O
in	O
local	O
languages	O
and	O
all	O
are	O
given	O
the	O
opportunity	O
to	O
ask	O
questions	O
.	O

To	O
accelerate	O
change	O
,	O
we	O
provide	O
an	O
overview	O
of	O
the	O
comprehensive	O
strategy	O
required	O
,	O
the	O
tools	O
available	O
for	O
context	O
-	O
specific	O
health	O
system	O
implementation	O
now	O
,	O
and	O
the	O
priorities	O
for	O
research	O
and	O
innovation	O
.	O

Bos	O
taurus	O
cattle	O
generally	O
have	O
higher	O
marbling	O
and	O
better	O
tenderness	O
than	O
do	O
Bos	O
indicus	O
animals	O
[	O
1	O
,	O
37	O
].	O

A	O
rumen	O
-	O
protected	O
form	O
of	O
vitamin	O
C	O
is	O
preferred	O
as	O
a	O
dietary	O
supplement	O
because	O
vitamin	O
C	O
is	O
most	O
likely	O
degraded	O
in	O
the	O
rumen	O
[	O
146	O
].	O

Thus	O
,	O
significant	O
correlation	O
between	O
lower	O
HRV	O
parameters	O
and	O
low	O
birth	O
weight	O
found	O
in	O
healthy	O
children	O
may	O
have	O
adverse	O
prognostic	O
effects	O
and	O
serve	O
as	O
an	O
early	O
sign	O
of	O
cardiometabolic	O
diseases	O
.	O

To	O
our	O
knowledge	O
,	O
no	O
previous	O
study	O
has	O
related	O
25OHD	O
concentration	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
to	O
neonatal	O
outcomes	O
related	O
to	O
placental	O
dysfunction	O
.	O

The	O
data	O
included	O
partially	O
missing	B
information	O
.	O

Offspring	O
then	O
were	O
fed	O
either	O
a	O
control	O
or	O
a	O
high	O
fat	O
diet	O
from	O
the	O
time	O
of	O
weaning	O
to	O
adulthood	O
.	O

#	O
Beta	O
(	O
s	O
.	O
e	O
.	O

PFAS	O
were	O
expressed	O
in	O
units	O
of	O
μg	O
/	O
L	O
serum	O
.	O

There	O
are	O
two	O
major	O
forms	O
of	O
active	O
Vitamin	O
D	O
,	O
Vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
Vitamin	O
D3	O
(	O
cholecalciferol	O
).	O

Cancer	O
Causes	O
Control	O
15	O
(	O
6	O
):	O
559	O
–	O
570	O
.	O

However	O
,	O
thyroid	O
cancer	O
detected	O
during	O
pregnancy	O
may	O
cause	O
anxiety	O
about	O
the	O
optimal	O
timing	O
of	O
recommended	O
treatments	O
and	O
about	O
both	O
maternal	O
and	O
neonatal	O
morbidity	O
,	O
as	O
weel	O
as	O
pregnancy	O
following	O
a	O
diagnosis	O
of	O
thyroid	O
cancer	O
obviously	O
needs	O
both	O
maternal	O
and	O
foetal	O
management	O
.	O

For	O
plasma	O
separation	O
,	O
samples	O
were	O
centrifuged	O
at	O
3000	O
rpm	O
and	O
4	O
°	O
C	O
for	O
10	O
minutes	O
.	O

GDM	O
cases	O
were	O
older	O
,	O
and	O
heavier	O
than	O
women	O
who	O
did	O
not	O
develop	O
the	O
disorder	O
.	O

Participants	O
were	O
also	O
required	O
to	O
have	O
a	O
working	O
cell	O
phone	O
,	O
and	O
speak	O
and	O
read	O
English	O
.	O

2	O
.	O
9	O
.	O

The	O
smoking	O
evidence	O
is	O
particularly	O
compelling	O
as	O
it	O
has	O
been	O
established	O
by	O
multiple	O
independent	O
groups	O
investigating	O
different	O
epigenetic	O
mechanisms	O
.	O

Rats	O
receiving	O
daily	O
doses	O
of	O
arsenic	O
equivalent	O
to	O
the	O
levels	O
in	O
groundwater	O
from	O
heavily	O
arsenic	O
-	O
contaminated	O
areas	O
of	O
the	O
Bengal	O
Basin	O
retained	O
significantly	O
less	O
of	O
the	O
element	O
in	O
blood	O
and	O
liver	O
and	O
excreted	O
significantly	O
more	O
in	O
urine	O
when	O
fed	O
2	O
mg	O
/	O
mL	O
AGE	O
.	O

Implement	O
•	O
Adapt	O
integrated	O
packages	O
of	O
care	O
,	O
considering	O
contexts	O
,	O
and	O
tailored	O
to	O
local	O
health	O
service	O
delivery	O
channels	O
.	O

Although	O
not	O
significant	O
,	O
a	O
negative	O
trend	O
was	O
seen	O
between	O
the	O
number	O
of	O
infections	O
a	O
child	O
experienced	O
and	O
cathelicidin	O
concentration	O
.	O

In	O
the	O
United	O
States	O
,	O
about	O
18	O
%	O
to	O
30	O
%	O
of	O
women	O
in	O
the	O
childbearing	O
age	O
have	O
allergic	O
diseases	O
,	O
especially	O
rhinitis	O
[	O
8	O
]	O
and	O
asthma	O
[	O
9	O
].	O

Another	O
possible	O
explanation	O
may	O
be	O
that	O
the	O
frequent	O
intake	O
of	O
fish	O
and	O
PUFA	O
may	O
be	O
advantageous	O
in	O
lower	O
doses	O
but	O
disadvantageous	O
in	O
higher	O
doses	O
.	O

For	O
instance	O
,	O
interferon	O
-	O
γ	O
(	O
IFN	O
-	O
γ	O
)	O
and	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
were	O
detected	O
in	O
the	O
colostrums	O
of	O
healthy	O
women	O
[	O
64	O
].	O

LOD	O
scores	O
above	O
the	O
threshold	O
line	O
were	O
considered	O
significant	O
.	O

Cont	O
–	O
control	O
pregnancies	O
;	O
UN	O
P	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
only	O
;	O
UN	O
L	O
–	O
dams	O
undernourished	O
during	O
lactation	O
only	O
;	O
UN	O
PL	O
–	O
dams	O
undernourished	O
during	O
pregnancy	O
and	O
lactation	O
.	O

In	O
other	O
words	O
,	O
this	O
system	O
might	O
not	O
be	O
effective	O
unless	O
there	O
is	O
existing	O
infection	O
with	O
pathogens	O
when	O
vitamin	O
D	O
supplementation	O
is	O
given	O
.	O

A	O
basal	O
-	O
bolus	O
regimen	O
of	O
insulin	O
gives	O
the	O
most	O
effective	O
glucose	O
control	O
,	O
and	O
produces	O
better	O
fetal	O
outcomes	O
than	O
a	O
twice	O
daily	O
regime	O
.	O
34Prandial	O
fast	O
-	O
acting	O
insulin	O
is	O
administered	O
to	O
control	O
post	O
-	O
prandial	O
hyperglycemia	O
,	O
and	O
bedtime	O
basal	O
insulin	O
is	O
given	O
if	O
there	O
is	O
fasting	O
hyperglycemia	O
.	O

At	O
the	O
time	O
of	O
the	O
lung	O
function	O
testing	O
,	O
the	O
mean	O
body	O
weight	O
was	O
8	O
.	O
3	O
±	O
1	O
.	O
0	O
kg	O
,	O
and	O
the	O
mean	O
body	O
length	O
was	O
68	O
.	O
6	O
±	O
3	O
.	O
0	O
cm	O
.	O

However	O
,	O
the	O
present	O
study	O
is	O
the	O
first	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
in	O
Belgium	O
.	O

Our	O
study	O
was	O
approved	O
by	O
the	O
ethics	O
and	O
review	O
board	O
of	O
the	O
Ministry	O
of	O
Public	O
Health	O
of	O
Afghanistan	O
(	O
reference	O
422328	O
;	O
issued	O
May	O
12	O
,	O
2007	O
)	O
and	O
the	O
ethics	O
committee	O
of	O
the	O
London	O
School	O
of	O
Hygiene	O
and	O
Tropical	O
Medicine	O
(	O
application	O
number	O
5117	O
;	O
issued	O
May	O
29	O
,	O
2008	O
).	O

2	O
Number	O
of	O
surveyed	O
women	O
at	O
delivery	O
,	O
number	O
of	O
pregnant	O
women	O
vaccinated	O
for	O
month	O
stratified	O
by	O
trimester	O
of	O
vaccination	O
,	O
and	O
proportion	O
of	O
influenza	O
positive	O
samples	O
from	O
routine	O
surveillance	O
*,	O
Nicaragua	O
2014	O
*	O
Proportions	O
of	O
influenza	O
positive	O
samples	O
from	O
routine	O
surveillance	O
correspond	O
to	O
year	O
2014	O
.	O

We	O
identified	O
147	O
rodent	O
studies	O
within	O
PubMed	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
demonstrating	O
both	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
reduced	O
fertility	O
,	O
reproductive	O
,	O
developmental	O
or	O
other	O
organ	O
-	O
specific	O
abnormalities	O
,	O
or	O
adult	O
onset	O
diseases	O
(	O
cancer	O
,	O
diabetes	O
,	O
obesity	O
or	O
immune	O
disorders	O
))	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
histone	O
modification	O
,	O
DNA	O
methylation	O
,	O
epigenetic	O
machinery	O
or	O
miRNAs	O
)	O
following	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
chemicals	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
,	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
lactation	O
,	O
childhood	O
,	O
adolescence	O
and	O
adulthood	O
).	O

We	O
found	O
that	O
pregnancy	O
loss	O
was	O
associated	O
with	O
lower	O
25OHD	O
when	O
expressed	O
on	O
a	O
continuous	O
but	O
not	O
categorical	O
scale	O
.	O

Today	O
,	O
we	O
know	O
it	O
is	O
directly	O
associated	O
with	O
rs6058017	O
gene	O
polymorphism	O
[	O
35	O
].	O

Specifically	O
,	O
recommending	O
vitamin	O
D	O
supplementation	O
for	O
children	O
at	O
risk	O
of	O
dental	O
caries	O
may	O
result	O
in	O
a	O
decrease	O
in	O
the	O
overall	O
prevalence	O
of	O
S	O
-	O
ECC	O
and	O
,	O
ultimately	O
,	O
reduce	O
the	O
burden	O
on	O
pediatric	O
day	O
surgery	O
centres	O
.	O

proposed	O
that	O
permanent	O
changes	O
in	O
autonomic	O
tone	O
could	O
result	O
in	O
neurological	O
changes	O
in	O
the	O
fetus	O
,	O
especially	O
after	O
two	O
or	O
more	O
weeks	O
of	O
high	O
dose	O
β	O
2	O
adrenergic	O
receptor	O
agonist	O
exposure	O
.	O

The	O
infants	O
were	O
born	O
between	O
37	O
+	O
0	O
and	O
42	O
+	O
0	O
weeks	O
of	O
gestation	O
,	O
and	O
newborn	O
’	O
s	O
birth	O
weight	O
was	O
appropriate	O
for	O
gestational	O
age	O
(	O
SD	O
-	O
score	O
[	O
SDS	O
]	O
between	O
−	O
2	O
.	O
0	O
and	O
+	O
2	O
.	O
0	O
).	O

Personnel	O
costs	O
were	O
imputed	O
based	O
on	O
information	O
obtained	O
from	O
interviews	O
with	O
district	O
,	O
commune	O
and	O
village	O
health	O
workers	O
about	O
their	O
total	O
salary	O
and	O
the	O
proportion	O
of	O
time	O
they	O
spent	O
on	O
this	O
intervention	O
.	O

An	O
active	O
form	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
in	O
sperm	O
proves	O
the	O
existence	O
of	O
local	O
synthesis	O
of	O
cholecalciferol	O
and	O
strongly	O
suggests	O
its	O
paracrine	O
effect	O
on	O
spermatogenesis	O
as	O
described	O
inFigure	O
1	O
[	O
19	O
,	O
20	O
].	O

Lower	O
25OHD	O
in	O
early	O
pregnancy	O
was	O
only	O
associated	O
with	O
pregnancy	O
loss	O
.	O

Individuals	O
with	O
a	O
BMI	O
above	O
30	O
kg	O
/	O
m2are	O
classified	O
as	O
obese	O
;	O
those	O
with	O
a	O
BMI	O
between	O
25	O
and	O
30	O
kg	O
/	O
m2are	O
considered	O
to	O
be	O
overweight	O
.	O

In	O
2000	O
she	O
received	O
an	O
environmental	O
justice	O
grant	O
from	O
the	O
National	O
Institute	O
of	O
Environmental	O
Health	O
Sciences	O
to	O
collect	O
clinical	O
and	O
survey	O
data	O
from	O
people	O
living	O
on	O
the	O
Eastern	O
Navajo	O
Nation	O
.	O

PubMed	O
Central	O
:	O

On	O
initial	O
presentation	O
,	O
her	O
BP	O
was	O
94	O
/	O
30	O
mmHg	O
,	O
heart	O
rate	O
71	O
beats	O
/	O
min	O
,	O
respiratory	O
rate	O
16	O
breaths	O
/	O
min	O
,	O
oxygen	O
saturation	O
99	O
%	O
on	O
room	O
air	O
,	O
and	O
temperature	O
of	O
95	O
.	O
3	O
°	O
F	O
(	O
35	O
.	O
1	O
°	O
C	O
).	O

Mother	O
’	O
s	O
Milk	O
and	O
the	O
Environment	O
:	O
Might	O
Chemical	O
Exposures	O
Impair	O
Lactation	O
?	O

Height	O
is	O
also	O
examined	O
for	O
comparative	O
purposes	O
.	O

It	O
could	O
be	O
hypothesised	O
that	O
increased	O
insulin	O
resistance	O
during	O
winter	O
pregnancies	O
is	O
an	O
evolutionary	O
protective	O
mechanism	O
for	O
the	O
mother	O
and	O
fetus	O
,	O
of	O
laying	O
down	O
additional	O
fat	O
stores	O
to	O
ensure	O
survival	O
through	O
winter	O
.	O

Primiparous	O
women	O
were	O
eligible	O
if	O
the	O
following	O
criteria	O
were	O
met	O
:	O
Woman	O
planned	O
to	O
remain	O
in	O
the	O
study	O
area	O
for	O
at	O
least	O
one	O
month	O
before	O
and	O
one	O
month	O
after	O
delivery	O
.	O

It	O
is	O
the	O
precursor	O
to	O
form	O
25	O
-	O
hydroxyvitamin	O
D3	O
[	O
25	O
(	O
OH	O
)	O
D3	O
],	O
a	O
prehormone	O
,	O
which	O
is	O
ultimately	O
converted	O
to	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
],	O
one	O
of	O
the	O
most	O
potent	O
steroid	O
hormones	O
known	O
.	O

MicroRNA	O
RT	O
-	O
PCR	O
quantification	O
Total	O
RNA	O
was	O
extracted	O
from	O
liver	O
samples	O
using	O
the	O
TRIzol	O
reagent	O
(	O
Invitrogen	O
)	O
and	O
subsequently	O
purified	O
with	O
the	O
RNase	O
-	O
Free	O
DNase	O
Kit	O
(	O
Promega	O
)	O
according	O
to	O
the	O
manufacturer	O
׳	O
s	O
instructions	O
.	O

Results	O
Population	O
characteristics	O
.	O

This	O
relationship	O
was	O
also	O
present	O
when	O
the	O
IOM	O
threshold	O
for	O
adequacy	O
(	O
50	O
nmol	O
/	O
L	O
)	O
was	O
applied	O
(	O
p	O
=	O
0	O
.	O
05	O
,	O
OR	O
=	O
0	O
.	O
5	O
).	O

China	O
Begins	O
National	O
Survey	O
of	O
Pollution	O
Sources	O
Although	O
China	O
has	O
set	O
goals	O
to	O
cut	O
emissions	O
of	O
major	O
pollutants	O
,	O
emissions	O
of	O
sulfur	O
dioxide	O
and	O
some	O
indicators	O
of	O
poor	O
water	O
quality	O
increased	O
in	O
2006	O
.	O

Interestingly	O
,	O
caloric	O
restriction	O
induced	O
a	O
higher	O
reduction	O
in	O
total	O
intake	O
in	O
the	O
female	O
offspring	O
treated	O
with	O
AM251	O
.	O

Methods	O
The	O
study	O
was	O
a	O
randomized	O
trial	O
of	O
text4baby	O
at	O
Madigan	O
Army	O
Medical	O
Center	O
.	O

The	O
current	O
recommendation	O
of	O
health	O
care	O
professionals	O
is	O
to	O
avoid	O
anticonvulsant	O
drug	O
use	O
such	O
as	O
valproate	O
during	O
pregnancy	O
.	O

The	O
serum	O
and	O
follicular	O
fluid	O
VD	O
levels	O
were	O
in	O
significant	O
correlation	O
,	O
with	O
p	O
<	O
0	O
.	O
0000	O
,	O
but	O
fertilization	O
(	O
43	O
.	O
17	O
%,	O
53	O
.	O
37	O
%,	O
58	O
.	O
77	O
%,	O
respectively	O
)	O
and	O
implantation	O
percentages	O
(	O
17	O
.	O
33	O
,	O
15	O
.	O
26	O
,	O
18	O
.	O
75	O
%,	O
respectively	O
)	O
did	O
not	O
present	O
any	O
significant	O
correlation	O
(	O
p	O
>	O
0	O
.	O
5	O
)	O
[	O
60	O
].	O

Urine	O
samples	O
are	O
transferred	O
into	O
labelled	O
microtubes	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
within	O
4	O
h	O
.	O
Breast	O
milk	O
samples	O
(	O
fore	O
-	O
milk	O
)	O
are	O
collected	O
from	O
lactating	O
mothers	O
at	O
phases	O
5	O
and	O
6	O
as	O
described	O
previously	O
[	O
68	O
].	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
calorict	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
and	O
Ppar	O
γ	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
transcription	O
factors	O
(	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
)	O
regulating	O
the	O
expression	O
of	O
genes	O
implicated	O
in	O
lipid	O
and	O
carbohydrate	O
metabolism	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure6	O
).	O

We	O
suggest	O
further	O
clinical	O
trial	O
in	O
pregnant	O
mothers	O
who	O
are	O
at	O
risk	O
for	O
postnatal	O
depression	O
.	O

NICU	O
,	O
neonatal	O
intensive	O
care	O
unit	O
;	O
PNA	O
,	O
poor	O
neonatal	O
adaptation	O
.	O

Bodnar	O
et	O
al	O
.	O
8conducted	O
a	O
case	O
–	O
control	O
study	O
to	O
examine	O
the	O
association	O
between	O
vitamin	O
D	O
levels	O
,	O
race	O
and	O
SGA	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
with	O
an	O
online	O
miRNA	O
prediction	O
tool	O
[	O
4	O
].	O

The	O
erythrocyte	O
sedimentation	O
rate	O
(	O
ESR	O
)	O
(	O
Sarstedt	O
,	O
UK	O
)	O
and	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
(	O
Vitros	O
system	O
250	O
,	O
Johnson	O
&	O
Johnson	O
,	O
USA	O
)	O
were	O
measured	O
.	O

Body	O
fat	O
(%	O
BF	O
)	O
was	O
calculated	O
from	O
BIA	O
data	O
with	O
prediction	O
equations	O
[	O
25	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Skeletal	O
abnormalities	O
in	O
skeletal	O
morphology	O
mutant	O
(	O
Skm	O
)	O
mice	O
.	O

Background	O
With	O
an	O
increasing	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
and	O
insufficiency	O
reported	O
both	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
as	O
well	O
as	O
worldwide	O
[	O
1	O
],	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
deficiency	O
may	O
influence	O
health	O
in	O
pregnancy	O
.	O

It	O
does	O
not	O
include	O
substantial	O
participant	O
investment	O
of	O
time	O
and	O
effort	O
,	O
or	O
interactivity	O
.	O

The	O
second	O
re	O
-	O
programing	O
and	O
programing	O
event	O
involves	O
PGCs	O
only	O
.	O

Other	O
small	O
-	O
scale	O
studies	O
in	O
Belgium	O
showed	O
a	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
among	O
Belgian	O
postmenopausal	O
osteoporotic	O
women	O
[	O
33	O
]	O
and	O
elderly	O
[	O
34	O
].	O

A	O
proxy	O
variable	O
was	O
calculated	O
for	O
cumulative	O
influenza	O
exposure	O
using	O
influenza	O
surveillance	O
data	O
from	O
Nicaragua	O
[	O
38	O
].	O

Exposure	O
to	O
advertisements	O
would	O
decrease	O
by	O
restricting	O
food	O
advertisements	O
that	O
target	O
children	O
,	O
especially	O
during	O
times	O
,	O
such	O
as	O
Saturday	O
mornings	O
,	O
when	O
many	O
children	O
are	O
watching	O
television	O
(	O
87	O
).	O

The	O
involvement	O
of	O
a	O
dietician	O
and	O
diabetes	O
educator	O
experienced	O
in	O
the	O
care	O
of	O
women	O
with	O
GDM	O
will	O
facilitate	O
these	O
areas	O
of	O
management	O
.	O

The	O
LOESS	O
curve	O
for	O
the	O
MUSC	O
cohort	O
closely	O
tracks	O
the	O
LOESS	O
curve	O
for	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
,	O
as	O
well	O
as	O
maternal	O
age	O
,	O
socioeconomic	O
status	O
and	O
maternal	O
smoking	O
.	O

Results	O
Subjects	O
and	O
demographic	O
data	O
From	O
the	O
original	O
201	O
neonates	O
enrolled	O
in	O
the	O
study	O
,	O
122	O
pairs	O
of	O
maternal	O
-	O
cord	O
serum	O
were	O
collected	O
(	O
Fig	O
1	O
).	O

The	O
heritability	O
marbling	O
phenotype	O
in	O
Japanese	O
Wagyu	O
is	O
0	O
.	O
40	O
to	O
0	O
.	O
55	O
[	O
44	O
–	O
46	O
],	O
and	O
MS	O
heritabilities	O
in	O
Angus	O
and	O
Brahman	O
are	O
0	O
.	O
48	O
[	O
47	O
]	O
and	O
0	O
.	O
37	O
to	O
0	O
.	O
44	O
[	O
48	O
,	O
49	O
],	O
respectively	O
.	O

Consequences	O
in	O
newborns	O
are	O
low	O
birth	O
weight	O
,	O
neonatal	O
rickets	O
,	O
a	O
risk	O
of	O
neonatal	O
hypocalcaemia	O
,	O
asthma	O
and	O
/	O
or	O
type	O
1	O
diabetes	O
.	O

Furthermore	O
,	O
the	O
offspring	O
of	O
sensitized	O
mothers	O
are	O
prone	O
to	O
experience	O
suppression	O
and	O
a	O
later	O
onset	O
of	O
normal	O
levels	O
of	O
the	O
Th1	O
cytokine	O
IFN	O
-	O
γ	O
because	O
of	O
a	O
lower	O
frequency	O
of	O
IFN	O
-	O
γ	O
-	O
producing	O
cells	O
,	O
and	O
therefore	O
a	O
further	O
bias	O
toward	O
a	O
Th2	O
immune	O
response	O
.	O

Due	B
to	I
the	O
lack	O
of	O
conclusive	O
evidence	O
,	O
we	O
cannot	O
recommend	O
the	O
ubiquitous	O
use	O
of	O
prenatal	O
vitamins	O
,	O
in	O
particular	O
folate	O
,	O
in	O
men	O
attempting	O
to	O
plan	O
a	O
pregnancy	O
with	O
their	O
female	O
partner	O
at	O
this	O
time	O
.	O

Fifth	O
,	O
we	O
adjusted	O
for	O
gestational	O
age	O
non	O
-	O
parametrically	O
.	O

Scanning	O
densitometry	O
of	O
the	O
bands	O
corresponding	O
to	O
GR	O
α	O
/	O
β	O
normalized	O
over	O
GAPDH	O
revealed	O
no	O
apparent	O
differences	O
in	O
the	O
expression	O
of	O
these	O
variants	O
between	O
the	O
term	O
and	O
the	O
preterm	O
groups	O
(	O
Figure	O
1	O
(	O
b	O
)).	O

Previous	O
studies	O
demonstrated	O
short	O
-	O
term	O
effects	O
on	O
KAB	O
among	O
participants	O
,	O
including	O
the	O
initial	O
outcomes	O
of	O
the	O
Madigan	O
study	O
[	O
23	O
,	O
26	O
].	O

These	O
cells	O
can	O
also	O
produce	O
prostaglandins	O
and	O
other	O
neuroendocrine	O
markers	O
such	O
as	O
chromogranin	O
A	O
,	O
sometimes	O
used	O
together	O
with	O
calcitonin	O
and	O
CEA	O
in	O
MTC	O
patients	O
during	O
follow	O
-	O
up	O
.	O

Investigation	O
of	O
the	O
vitamin	O
D	O
nutritional	O
status	O
in	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
in	O
Beijing	O
Abstract	O
Background	O
Vitamin	O
D	O
deficiency	O
is	O
a	O
common	O
issue	O
,	O
which	O
has	O
relation	O
with	O
GDM	O
,	O
during	O
the	O
pregnant	O
period	O
.	O

From	O
October	O
2009	O
to	O
August	O
2011	O
,	O
otherwise	O
-	O
healthy	O
children	O
with	O
S	O
-	O
ECC	O
were	O
recruited	O
from	O
the	O
MHC	O
in	O
Winnipeg	O
,	O
Canada	O
(	O
49	O
°	O
53	O
′	O
North	O
)	O
on	O
the	O
day	O
of	O
their	O
dental	O
surgery	O
.	O

There	O
was	O
no	O
significant	O
effect	O
of	O
birth	O
hospital	O
on	O
the	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
when	O
ethnicity	O
was	O
accounted	O
for	O
by	O
covariate	O
analysis	O
(	O
p	O
=	O
0	O
.	O
37	O
).	O

The	O
delivery	O
mode	O
was	O
drawn	O
from	O
maternal	O
delivery	O
records	O
,	O
and	O
maternal	O
pre	O
-	O
pregnancy	O
height	O
,	O
weight	O
,	O
and	O
parity	O
were	O
determined	O
via	O
a	O
self	O
-	O
administered	O
questionnaire	O
upon	O
study	O
entry	O
and	O
used	O
to	O
compute	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
Melbourne	O
/	O
NIMPE	O
.	O

PubMed	O
Central	O
:	O

(	O
2011	O
)*	O
UrethaneMouseInjection	O
(	O
ip	O
)	O
(	O
1	O
mg	O
/	O
g	O
/	O
wk	O
)	O
Late	O
childhood	O
/	O
adolescence	O
+	O
early	O
adulthoodAdulthoodHepatic	O
tumorsHistone	O
modification	O
DNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsPandey	O
et	O
al	O
.	O

Nonetheless	O
,	O
analyses	O
using	O
the	O
2009	O
criteria	O
confirmed	O
the	O
current	O
study	O
'	O
s	O
findings	O
(	O
data	O
not	O
shown	O
).	O

Out	O
of	O
all	O
participants	O
randomly	O
selected	O
for	O
this	O
assessment	O
who	O
self	O
-	O
reported	O
receiving	O
influenza	O
vaccination	O
(	O
n	O
=	O
123	O
),	O
61	O
%	O
(	O
75	O
)	O
had	O
evidence	O
of	O
vaccination	O
.	O

Those	O
having	O
a	O
dmft	O
score	O
of	O
0	O
were	O
considered	O
caries	O
-	O
free	O
.	O

We	O
analysed	O
associations	O
between	O
maternal	O
intake	O
of	O
free	O
sugar	O
in	O
pregnancy	O
(	O
estimated	O
by	O
a	O
food	O
frequency	O
questionnaire	O
),	O
and	O
current	O
doctor	O
-	O
diagnosed	O
asthma	O
,	O
wheezing	O
,	O
hay	O
fever	O
,	O
eczema	O
,	O
atopy	O
,	O
serum	O
total	O
IgE	O
and	O
lung	O
function	O
in	O
children	O
aged	O
7	O
–	O
9	O
years	O
(	O
n	O
=	O
8956	O
with	O
information	O
on	O
maternal	O
diet	O
in	O
pregnancy	O
and	O
at	O
least	O
one	O
outcome	O
of	O
interest	O
).	O

The	O
average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

It	O
is	O
possible	O
that	O
the	O
increased	O
energy	O
,	O
protein	O
and	O
fat	O
observed	O
in	O
our	O
study	O
during	O
extended	O
summer	O
could	O
be	O
due	O
to	O
changes	O
in	O
dietary	O
habits	O
during	O
the	O
summer	O
holidays	O
.	O

Therefore	O
,	O
the	O
current	O
study	O
includes	O
133	O
women	O
who	O
received	O
SGA	O
medications	O
during	O
pregnancy	O
and	O
133	O
matched	O
healthy	O
women	O
(	O
N	O
=	O
266	O
).	O

Among	O
the	O
four	O
seasons	O
,	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
is	O
highest	O
in	O
Summer	O
,	O
lowest	O
in	O
the	O
Winter	O
,	O
which	O
is	O
significantly	O
lower	O
than	O
summer	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
spring	O
(	O
p	O
=	O
0	O
.	O
003	O
).	O

In	O
Bangladesh	O
,	O
Parveen	O
and	O
colleagues	O
found	O
that	O
mothers	O
perceived	O
handwashing	O
is	O
an	O
important	O
approach	O
to	O
nurturing	O
their	O
newborns	O
and	O
young	O
children	O
and	O
that	O
they	O
were	O
more	O
likely	O
to	O
practice	O
the	O
behavior	O
when	O
supported	O
to	O
do	O
so	O
by	O
their	O
families	O
.	O

The	O
only	O
study	O
satisfying	O
this	O
condition	O
used	O
a	O
nested	O
case	O
-	O
control	O
design	O
to	O
sample	O
an	O
underlying	O
prospective	O
cohort	O
comprising	O
over	O
7	O
million	O
individuals	O
who	O
served	O
in	O
the	O
US	O
military	O
and	O
had	O
at	O
least	O
two	O
serum	O
samples	O
stored	O
in	O
the	O
US	O
Department	O
of	O
Defense	O
Serum	O
Repository	O
.	O
18The	O
study	O
concluded	O
that	O
serum	O
concentration	O
of	O
25	O
hydroxyvitamin	O
D	O
in	O
healthy	O
young	O
white	O
adults	O
is	O
an	O
important	O
predictor	O
of	O
their	O
risk	O
of	O
developing	O
MS	O
,	O
independently	O
from	O
their	O
place	O
of	O
birth	O
and	O
latitude	O
of	O
residence	O
during	O
childhood	O
.	O
18In	O
a	O
prospective	O
investigation	O
comprising	O
approximately	O
200	O
,	O
000	O
women	O
in	O
the	O
USA	O
,	O
vitamin	O
D	O
intake	O
was	O
measured	O
every	O
4	O
years	O
by	O
a	O
comprehensive	O
semi	O
-	O
quantitative	O
food	O
frequency	O
questionnaire	O
.	O
37The	O
incidence	O
of	O
MS	O
during	O
the	O
30	O
-	O
year	O
follow	O
-	O
up	O
decreased	O
with	O
increasing	O
vitamin	O
D	O
intake	O
(	O
P	O
=	O
0	O
.	O
03	O
for	O
trend	O
)	O
and	O
was	O
33	O
%	O
lower	O
among	O
women	O
in	O
the	O
highest	O
quintile	O
of	O
vitamin	O
D	O
intake	O
versus	O
those	O
in	O
the	O
lowest	O
quintile	O
.	O
17Furthermore	O
,	O
MS	O
incidence	O
was	O
41	O
%	O
lower	O
among	O
women	O
taking	O
400	O
IU	O
per	O
day	O
or	O
more	O
from	O
supplements	O
compared	O
with	O
non	O
-	O
users	O
.	O
17Attempts	O
to	O
relate	O
vitamin	O
D	O
intake	O
to	O
MS	O
risk	O
have	O
also	O
been	O
made	O
in	O
casecontrol	O
studies	O
.	O

Interpretation	O
of	O
the	O
current	O
study	O
is	O
also	O
limited	O
because	O
of	O
the	O
lack	O
of	O
immunoblot	O
confirmation	O
of	O
the	O
differentially	O
expressed	O
spots	O
.	O

Legends	O
:	O
BM	O
,	O
body	O
mass	O
;	O
FI	O
,	O
food	O
intake	O
;	O
WI	O
,	O
water	O
intake	O
.	O

Previous	O
studies	O
in	O
Mexico	O
and	O
Bangladesh	O
have	O
shown	O
no	O
additional	O
benefit	O
on	O
haematological	O
parameters	O
when	O
women	O
of	O
reproductive	O
age	O
and	O
adolescents	O
were	O
given	O
MMN	O
compared	O
to	O
iron	O
-	O
folate	O
supplements	O
(	O
Ahmed	O
et	O
al	O
2005	O
,	O
Moriarty	O
-	O
Craige	O
et	O
al	O
2004	O
).	O

The	O
SDQ	O
was	O
used	O
to	O
measure	O
maladaptive	O
behaviour	O
.	O
Intervention	O
/	O
comparatorFish	O
intake	O
:	O
rarely	O
/	O
never	O
,	O
once	O
a	O
fortnight	O
,	O
1	O
–	O
3	O
times	O
per	O
week	O
,	O
4	O
or	O
more	O
times	O
per	O
week	O
.	O
Assumed	O
each	O
fish	O
serve	O
was	O
4	O
.	O
5	O
ounces	O
(~	O
0	O
g	O
,	O
64	O
g	O
,	O
255	O
g	O
and	O
510	O
g	O
per	O
week	O
).	O
Second	O
trimester	O
fish	O
servings	O
:	O
more	O
than	O
2	O
weekly	O
fish	O
servings	O
compared	O
to	O
2	O
or	O
less	O
.	O
Did	O
not	O
convert	O
servings	O
to	O
grams	O
.	O
Comparing	O
no	O
seafood	O
intake	O
and	O
1	O
–	O
340	O
g	O
per	O
week	O
with	O
more	O
than	O
340	O
g	O
per	O
week	O
(	O
3	O
servings	O
is	O
estimated	O
as	O
340	O
g	O
).	O
Fish	O
servings	O
per	O
week	O
in	O
early	O
and	O
late	O
pregnancy	O
:	O
never	O
,	O
less	O
than	O
1	O
,	O
1	O
–	O
2	O
times	O
,	O
3	O
or	O
more	O
times	O
.	O
Oily	O
fish	O
servings	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
:	O
never	O
,	O
less	O
than	O
1	O
,	O
1	O
or	O
more	O
.	O
Amount	O
not	O
specified	O
in	O
gramsOutcomeFish	O
consumption	O
during	O
pregnancy	O
resulted	O
in	O
modest	O
but	O
significant	O
improvement	O
in	O
developmental	O
scores	O
for	O
language	O
&	O
social	O
activity	O
at	O
15	O
–	O
18	O
months	O
age	O
.	O
Odds	O
ratio	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
for	O
high	O
test	O
score	O
for	O
MCDI	O
:	O
Vocabulary	O
comprehension	O
=	O
1	O
.	O
5	O
(	O
1	O
.	O
1	O
–	O
2	O
.	O
0	O
)	O
for	O
one	O
or	O
more	O
serves	O
compared	O
to	O
no	O
serves	O
.	O
Social	O
activity	O
=	O
1	O
.	O
6	O
(	O
1	O
.	O
2	O
–	O
2	O
.	O
2	O
)	O
for	O
1	O
/	O
fortnight	O
,	O
1	O
.	O
7	O
(	O
1	O
.	O
3	O
–	O
2	O
.	O
2	O
)	O
for	O
1	O
–	O
3	O
/	O
week	O
and	O
1	O
.	O
8	O
(	O
1	O
.	O
4	O
–	O
2	O
.	O
4	O
)	O
for	O
4	O
+	O
serves	O
/	O
week	O
compared	O
to	O
no	O
serves	O
.	O
Non	O
-	O
significant	O
increase	O
in	O
VRM	O
of	O
2	O
.	O
8	O
points	O
for	O
each	O
additional	O
weekly	O
fish	O
serving	O
(	O
95	O
%	O
CI	O
=	O
0	O
.	O
2	O
to	O
5	O
.	O
4	O
).	O

There	O
are	O
some	O
potential	O
limitations	O
to	O
our	O
findings	O
.	O

Given	O
that	O
the	O
month	O
in	O
which	O
the	O
serum	O
was	O
sampled	O
heavily	O
influences	O
vitamin	O
D	O
status	O
,	O
“	O
standardised	O
”	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
calculated	O
as	O
previously	O
described	O
[	O
34	O
]	O
in	O
order	O
to	O
normalise	O
against	O
seasonal	O
variation	O
.	O

The	O
existence	O
of	O
receptors	O
for	O
the	O
active	O
form	O
of	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
)	O
in	O
the	O
brain	O
induces	O
a	O
direct	O
effect	O
.	O

With	O
this	O
,	O
there	O
was	O
a	O
1	O
%	O
incidence	O
of	O
serious	O
perinatal	O
outcomes	O
(	O
death	O
,	O
shoulder	O
dystocia	O
,	O
fracture	O
,	O
and	O
nerve	O
palsy	O
)	O
compared	O
to	O
4	O
%	O
amongst	O
women	O
provided	O
with	O
standard	O
pregnancy	O
care	O
only	O
(	O
adjusted	O
risk	O
reduction	O
0	O
.	O
33	O
,	O
p	O
=	O
0	O
.	O
01	O
).	O

Reproducibility	O
of	O
DXA	O
Infant	O
Scans	O
;	O
BMC	O
=	O
3	O
.	O
8	O
%	O
and	O
BMD	O
=	O
4	O
.	O
1	O
%.	O

Vitamin	O
D	O
status	O
is	O
determined	O
by	O
measuring	O
circulating	O
serum	O
levels	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D2	O
+	O
3	O
(	O
25	O
(	O
OH	O
)	O
D	O
).	O

BMI	O
—	O
child	O
age	O
0	O
In	O
the	O
nuclear	O
family	O
,	O
the	O
correlation	O
between	O
the	O
child	O
and	O
the	O
mother	O
was	O
highly	O
significant	O
(	O
table	O
4	O
).	O

However	O
,	O
among	O
Gardener	O
et	O
al	O
.	O

This	O
resulted	O
in	O
41	O
distinct	O
bioinformatically	O
derived	O
classes	O
,	O
containing	O
at	O
least	O
one	O
CpG	O
,	O
based	O
on	O
bioinformatic	O
attributes	O
[	O
for	O
the	O
distribution	O
of	O
CpG	O
loci	O
by	O
bioinformatically	O
derived	O
class	O
,	O
see	O
Supplemental	O
Material	O
,	O
Table	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

Furthermore	O
,	O
the	O
divergence	O
of	O
results	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
reported	O
throughout	O
this	O
work	O
suggests	O
that	O
these	O
repetitive	O
element	O
methylation	O
markers	O
are	O
distinct	O
measures	O
and	O
may	O
not	O
represent	O
true	O
,	O
and	O
potentially	O
interchangeable	O
,	O
surrogates	O
of	O
“	O
global	O
”	O
methylation	O
.	O

Tyagi	O
et	O
al	O
.	O

Vitamin	O
D	O
deficiency	O
was	O
found	O
in	O
at	O
least	O
one	O
fourth	O
of	O
children	O
living	O
in	O
rural	O
areas	O
.	O

In	O
the	O
first	O
dimension	O
,	O
rehydrated	O
strips	O
were	O
focused	O
using	O
an	O
ElectrophoretIQ3	O
isoelectric	O
focusing	O
system	O
(	O
Proteome	O
Systems	O
)	O
for	O
a	O
total	O
of	O
120	O
kVh	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Arachnodactyly	O
and	O
kinked	O
tail	O
in	O
skeletal	O
morphology	O
mutant	O
1	O
(	O
Skm1	O
).	O

The	O
early	O
zygote	O
has	O
low	O
levels	O
of	O
miRNAs	O
,	O
but	O
high	O
expression	O
of	O
piRNAs	O
and	O
esiRNAs	O
,	O
with	O
esiRNAs	O
being	O
the	O
predominate	O
species	O
(	O
Garcia	O
-	O
Lopez	O
et	O
al	O
.	O
2015	O
).	O

Low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
correlated	O
with	O
increased	O
bacterial	O
vaginosis	O
in	O
the	O
first	O
trimester	O
.	O

Class	O
9	O
,	O
which	O
was	O
associated	O
with	O
AluYb8	O
methylation	O
extent	O
,	O
contained	O
a	O
high	O
proportion	O
of	O
CpG	O
loci	O
located	O
within	O
CGIs	O
(	O
81	O
%)	O
and	O
whose	O
genes	O
are	O
considered	O
PcG	O
target	O
genes	O
(	O
32	O
%).	O

Further	O
,	O
the	O
various	O
chapters	O
in	O
the	O
book	O
explain	O
the	O
basic	O
principles	O
in	O
nutrition	O
coupled	O
with	O
applications	O
in	O
different	O
clinical	O
conditions	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
General	O
characteristics	O
of	O
study	O
subjectsGroupsNAge	O
(	O
Year	O
)	O
Gestational	O
weeks	O
(	O
Week	O
)	O
Pre	O
-	O
pregnancy	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
Control1434	O
.	O
3	O
±	O
4	O
.	O
928	O
.	O
9	O
±	O
4	O
.	O
124	O
.	O
7	O
±	O
4	O
.	O
5Intervention8433	O
.	O
3	O
±	O
3	O
.	O
828	O
.	O
9	O
±	O
3	O
.	O
322	O
.	O
8	O
±	O
3	O
.	O
5	O
Comparison	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
women	O
of	O
the	O
two	O
groups	O
As	O
shown	O
in	O
Table	O
2	O
,	O
the	O
serum	O
levels	O
of	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
in	O
the	O
intervention	O
and	O
control	O
group	O
were	O
74	O
.	O

Introduction	O
In	O
2009	O
,	O
the	O
Institute	O
of	O
Medicine	O
(	O
IOM	O
)	O
revised	O
its	O
guidelines	O
for	O
appropriate	O
weight	O
gain	O
during	O
pregnancy	O
,	O
taking	O
into	O
account	O
the	O
growing	O
prevalence	O
of	O
obesity	O
in	O
women	O
of	O
childbearing	O
age	O
[	O
1	O
].	O

It	O
is	O
the	O
single	O
proportion	O
formula	O
(	O
n	O
=	O
[	O
Z	O
α	O
/	O
2	O
]	O
2	O
P	O
(	O
1	O
-	O
p	O
]	O
/	O
d2	O
)	O
at	O
95	O
%	O
confidence	O
interval	O
,	O
where	O
Z	O
α	O
/	O
2	O
=	O
1	O
.	O
96	O
,	O
P	O
=	O
prevalence	O
of	O
50	O
%,	O
and	O
d	O
=	O
5	O
%	O
of	O
marginal	O
error	O
[	O
22	O
].	O

This	O
has	O
been	O
elegantly	O
demonstrated	O
by	O
the	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
offspring	O
of	O
Pima	O
Indian	O
mothers	O
.	O
16	O
,	O
17Offspring	O
who	O
were	O
born	O
to	O
mothers	O
who	O
were	O
already	O
diabetic	O
when	O
pregnant	O
had	O
a	O
45	O
%	O
likelihood	O
of	O
type	O
2	O
diabetes	O
by	O
the	O
age	O
of	O
20	O
–	O
24	O
,	O
whereas	O
it	O
was	O
8	O
.	O
6	O
%	O
amongst	O
those	O
with	O
mothers	O
who	O
only	O
developed	O
diabetes	O
after	O
pregnancy	O
(	O
ie	O
,	O
were	O
prediabetic	O
).	O

Preeclampsia	O
rates	O
are	O
elevated	O
during	O
winter	O
months	O
,	O
when	O
sunlight	O
-	O
dependent	O
25	O
(	O
OH	O
)	O
D	O
productions	O
are	O
reduced	O
.	O

If	O
these	O
findings	O
are	O
replicated	O
we	O
would	O
design	O
an	O
appropriate	O
intervention	O
study	O
in	O
pregnancy	O
to	O
establish	O
or	O
refute	O
causality	O
.	O

The	O
problem	O
of	O
pregnancy	O
-	O
associated	O
thyroid	O
cancer	O
can	O
affect	O
three	O
groups	O
of	O
patients	O
:	O
New	O
diagnosis	O
Patients	O
with	O
no	O
prior	O
history	O
of	O
cancer	O
,	O
in	O
whom	O
a	O
malignant	O
thyroid	O
nodule	O
is	O
suspected	O
or	O
diagnosed	O
during	O
pregnancy	O
.	O

The	O
objective	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
haematological	O
outcomes	O
in	O
non	O
-	O
pregnant	O
,	O
rural	O
Gambian	O
women	O
of	O
reproductive	O
age	O
,	O
receiving	O
daily	O
MMN	O
supplements	O
for	O
one	O
-	O
year	O
.	O

There	O
have	O
been	O
experiments	O
with	O
fortification	O
of	O
fish	O
sauce	O
however	O
this	O
is	O
not	O
yet	O
on	O
a	O
commercial	O
scale	O
.	O

This	O
measure	O
is	O
widely	O
used	O
in	O
South	O
Africa	O
to	O
describe	O
the	O
socio	O
-	O
economic	O
status	O
of	O
the	O
population	O
[	O
33	O
].	O

Discussion	O
This	O
systematic	O
review	O
of	O
observational	O
cohort	O
studies	O
demonstrates	O
an	O
association	O
between	O
consumption	O
of	O
one	O
or	O
more	O
servings	O
of	O
fish	O
per	O
week	O
during	O
pregnancy	O
and	O
better	O
offspring	O
neurodevelopment	O
outcomes	O
.	O

Introduction	O
WHO	O
estimates	O
suggest	O
that	O
globally	O
up	O
to	O
500	O
million	O
women	O
of	O
reproductive	O
age	O
suffer	O
from	O
anaemia	O
.	O

Not	O
only	O
do	O
such	O
advertisements	O
promote	O
eating	O
,	O
but	O
eating	O
while	O
watching	O
television	O
also	O
often	O
leads	O
to	O
overeating	O
because	O
children	O
do	O
not	O
notice	O
how	O
much	O
they	O
are	O
eating	O
(	O
88	O
).	O

In	O
utero	O
exposure	O
to	O
SGA	O
monotherapy	O
appears	O
to	O
be	O
associated	O
with	O
less	O
risk	O
to	O
the	O
fetus	O
.	O

Atopy	O
For	O
newborns	O
at	O
suspected	O
risk	O
for	O
atopy	O
,	O
that	O
is	O
,	O
with	O
a	O
history	O
of	O
atopy	O
/	O
allergy	O
in	O
a	O
first	O
-	O
degree	O
relative	O
(	O
parents	O
,	O
siblings	O
),	O
exposure	O
to	O
irritating	O
air	O
pollutants	O
and	O
airborne	O
allergens	O
such	O
as	O
molds	O
should	O
be	O
minimized	O
.	O

Furthermore	O
,	O
a	O
higher	O
proportion	O
of	O
the	O
women	O
in	O
the	O
middle	O
and	O
high	O
level	O
symptoms	O
groups	O
had	O
grown	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
than	O
women	O
in	O
the	O
low	O
level	O
symptoms	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

At	O
baseline	O
,	O
anaemia	O
prevalence	O
was	O
50	O
.	O
7	O
%	O
(	O
MMN	O
group	O
)	O
and	O
54	O
.	O
1	O
%	O
(	O
placebo	O
group	O
).	O

The	O
most	O
common	O
causes	O
of	O
nasal	O
symptoms	O
necessitating	O
treatment	O
during	O
pregnancy	O
are	O
AR	O
,	O
rhinitis	O
medicamentosa	O
,	O
sinusitis	O
,	O
and	O
(	O
non	O
-	O
AR	O
)	O
vasomotor	O
[	O
24	O
].	O

The	O
direct	O
transfer	O
of	O
food	O
or	O
inhalant	O
allergens	O
via	O
the	O
placenta	O
or	O
breast	O
milk	O
has	O
long	O
been	O
recognized	O
[	O
58	O
-	O
60	O
].	O

In	O
western	O
studies	O
,	O
this	O
questionnaire	O
has	O
had	O
high	O
reliability	O
and	O
validity	O
[	O
40	O
,	O
41	O
].	O

investigated	O
the	O
role	O
of	O
supplemental	O
folate	O
,	O
zinc	O
and	O
antioxidants	O
(	O
vitamins	O
C	O
,	O
E	O
,	O
and	O
β	O
-	O
carotene	O
)	O
on	O
spermatocyte	O
aneuploidy	O
.	O

Therefore	O
,	O
a	O
cell	O
cycle	O
control	O
system	O
can	O
arrest	O
the	O
cycle	O
at	O
certain	O
checkpoints	O
.	O

When	O
the	O
“	O
deficient	O
”	O
threshold	O
(<	O
35	O
nmol	O
/	O
L	O
)	O
was	O
applied	O
,	O
this	O
relationship	O
failed	O
to	O
reach	O
significance	O
(	O
p	O
=	O
0	O
.	O
12	O
(	O
Fisher	O
’	O
s	O
Exact	O
Test	O
),	O
OR	O
=	O
2	O
.	O
7	O
).	O

In	O
the	O
study	O
,	O
steers	O
from	O
dams	O
fed	O
a	O
corn	O
-	O
based	O
diet	O
during	O
late	O
gestation	O
had	O
a	O
lower	O
MS	O
compared	O
with	O
progeny	O
from	O
dams	O
fed	O
diets	O
low	O
in	O
starch	O
(	O
grass	O
hay	O
or	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
).	O

Another	O
study	O
randomized	O
29	O
women	O
with	O
GDM	O
to	O
30	O
minutes	O
of	O
exercise	O
at	O
70	O
%	O
estimated	O
maximal	O
heart	O
rate	O
,	O
3	O
–	O
4	O
times	O
per	O
week	O
,	O
or	O
control	O
.	O
32There	O
was	O
a	O
trend	O
to	O
improved	O
glucose	O
levels	O
in	O
those	O
who	O
exercised	O
,	O
which	O
did	O
not	O
reach	O
significance	O
.	O

Experimental	O
Section	O
2	O
.	O
1	O
.	O

Hip	O
circumference	O
(	O
HP	O
)	O
was	O
measured	O
at	O
the	O
maximum	O
circumference	O
of	O
the	O
buttocks	O
.	O

The	O
results	O
of	O
this	O
study	O
to	O
address	O
these	O
hypotheses	O
are	O
presented	O
here	O
.	O

High	O
birth	O
weight	O
is	O
an	O
important	O
predictor	O
of	O
adult	O
obesity	O
[	O
171	O
],	O
and	O
a	O
higher	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
has	O
been	O
linked	O
to	O
greater	O
risk	O
for	O
adult	O
-	O
onset	O
glioma	O
[	O
172	O
].	O

Points	O
are	O
colored	O
by	O
taxonomy	O
represented	O
heavily	O
in	O
top	O
results	O
,	O
for	O
p	O
<	O
0	O
.	O
10	O
.	O

The	O
oxygen	O
saturation	O
and	O
heart	O
rate	O
of	O
participants	O
were	O
monitored	O
with	O
pulse	O
oximeter	O
during	O
the	O
procedure	O
and	O
until	O
they	O
became	O
fully	O
awake	O
.	O

studied	O
the	O
relationship	O
between	O
the	O
maternal	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
measured	O
in	O
the	O
18thweek	O
of	O
gestation	O
and	O
postnatal	O
depression	O
in	O
796	O
people	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Distribution	O
of	O
birth	O
weight	O
in	O
relation	O
to	O
participant	O
characteristics	O
among	O
women	O
in	O
the	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
Cincinnati	O
,	O
OHn	O
(%)	O
Birth	O
weight	O
(	O
g	O
)	O
mean	O
(	O
SD	O
)	O
All	O
participants384	O
(	O
100	O
%)	O
3371	O
(	O
618	O
)	O
Age	O
at	O
delivery	O
<	O
2593	O
(	O
24	O
.	O
2	O
%)	O
3079	O
(	O
597	O
)	O
25	O
-<	O
30107	O
(	O
27	O
.	O
8	O
%)	O
3489	O
(	O
876	O
)	O
30	O
-<	O
35121	O
(	O
31	O
.	O
5	O
%)	O
3469	O
(	O
906	O
)	O
>	O
3563	O
(	O
16	O
.	O
5	O
%)	O
3409	O
(	O
773	O
)	O
Race	O
White273	O
(	O
61	O
.	O
7	O
%)	O
3514	O
(	O
592	O
)	O
Black	O
or	O
Other147	O
(	O
38	O
.	O
3	O
%)	O
3141	O
(	O
753	O
)	O
Marital	O
Status	O
Living	O
with	O
spouse	O
/	O
partner248	O
(	O
64	O
.	O
5	O
%)	O
3484	O
(	O
600	O
)	O
Not	O
living	O
with	O
spouse	O
/	O
partner136	O
(	O
35	O
.	O
5	O
%)	O
3165	O
(	O
746	O
)	O
Employment	O
Status	O
Unemployed74	O
(	O
19	O
.	O
3	O
%)	O
3278	O
(	O
617	O
)	O
Employed310	O
(	O
80	O
.	O
7	O
%)	O
3392	O
(	O
1263	O
)	O
Income	O
<	O
25	O
,	O
000124	O
(	O
32	O
.	O
3	O
%)	O
3154	O
(	O
729	O
)	O
≥	O
25	O
,	O
000260	O
(	O
67	O
.	O
7	O
%)	O
3475	O
(	O
600	O
)	O
Insurance	O
Private272	O
(	O
70	O
.	O
8	O
%)	O
3466	O
(	O
601	O
)	O
Public	O
/	O
None112	O
(	O
29	O
.	O
2	O
%)	O
3141	O
(	O
714	O
)	O
Education	O
Level	O
≥	O
High	O
school343	O
(	O
89	O
.	O
3	O
%)	O
3409	O
(	O
608	O
)	O
<	O
High	O
school41	O
(	O
10	O
.	O
7	O
%)	O
3050	O
(	O
644	O
)	O
Tobacco	O
Use	O
(	O
Mean	O
Cotinine	O
Levels	O
)	O
Non	O
smoker	O
(≤	O
3	O
ng	O
/	O
ml	O
)	O
341	O
(	O
88	O
.	O
8	O
%)	O
3387	O
(	O
617	O
)	O
Active	O
Smoker	O
(>	O
3	O
ng	O
/	O
ml	O
)	O
43	O
(	O
12	O
.	O
1	O
%)	O
3241	O
(	O
655	O
)	O
Gender	O
of	O
Baby	O
Male178	O
(	O
46	O
.	O
3	O
%)	O
3477	O
(	O
610	O
)	O
Female206	O
(	O
53	O
.	O
7	O
%)	O
3279	O
(	O
897	O
)	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
Underweight4	O
(	O
0	O
.	O
1	O
%)	O
2940	O
(	O
625	O
)	O
Normal159	O
(	O
41	O
.	O
4	O
%)	O
3328	O
(	O
618	O
)	O
Overweight127	O
(	O
33	O
.	O
1	O
%)	O
3412	O
(	O
828	O
)	O
Obese94	O
(	O
24	O
.	O
4	O
%)	O
3406	O
(	O
779	O
)	O
Abbreviations	O
:	O
SD	O
standard	O
deviation	O
,	O
BMI	O
body	O
mass	O
index	O
Outcome	O
variables	O
The	O
outcome	O
variable	O
was	O
birth	O
weight	O
,	O
measured	O
in	O
grams	O
(	O
g	O
).	O

Samples	O
were	O
GC	O
-	O
RMA	O
normalised	O
(	O
Log2	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multiple	O
regression	O
for	O
mean	O
vitamin	O
D	O
levelVariableUnstandardized	O
regression	O
coefficient	O
(	O
b	O
)±	O
95	O
%	O
confidence	O
intervalP	O
value	O
Intercept71	O
.	O
01	O
//	O
S	O
-	O
ECC	O
(	O
Reference	O
=	O
Yes	O
)	O
5	O
.	O
331	O
.	O
24	O
,	O
9	O
.	O
420	O
.	O
01Regular	O
milk	O
drinker	O
(	O
Reference	O
=	O
Yes	O
)-	O
6	O
.	O
60	O
-	O
13	O
.	O
16	O
,	O
-	O
0	O
.	O
030	O
.	O
05Season	O
(	O
Reference	O
=	O
Winter	O
)	O
5	O
.	O
221	O
.	O
37	O
,	O
9	O
.	O
060	O
.	O
008Vitamin	O
D	O
drop	O
user	O
(	O
Reference	O
=	O
Yes	O
)-	O
2	O
.	O
172	O
.	O
01	O
,	O
-	O
6	O
.	O
130	O
.	O
28Yearly	O
income	O
(	O
Reference	O
=	O
<	O
28	O
k	O
)	O
2	O
.	O
732	O
.	O
06	O
,	O
-	O
1	O
.	O
320	O
.	O
19	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

In	O
those	O
studies	O
,	O
vitamin	O
D	O
supplementations	O
started	O
at	O
the	O
end	O
of	O
the	O
first	O
trimester	O
or	O
at	O
the	O
beginning	O
of	O
the	O
second	O
trimester	O
and	O
their	O
participants	O
had	O
higher	O
initial	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
compared	O
to	O
the	O
participants	O
in	O
our	O
study	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Maternal	O
mean	O
1	O
-	O
hour	O
plasma	O
glucose	O
concentrations	O
after	O
a	O
50	O
-	O
g	O
oral	O
glucose	O
challenge	O
.	O

The	O
U	O
.	O
S	O
.	O

Improving	O
the	O
nutritional	O
condition	O
of	O
cows	O
during	O
pregnancy	O
affects	O
growth	O
,	O
fat	O
deposition	O
,	O
and	O
beef	O
quality	O
in	O
steers	O
;	O
steers	O
from	O
cows	O
grazing	O
with	O
better	O
pasture	O
(	O
Thinopyrum	O
–	O
Elymus	O
–	O
Psathrystachus	O
,	O
CP	O
11	O
.	O
1	O
%	O
to	O
6	O
.	O
0	O
%)	O
during	O
mid	O
-	O
to	O
late	O
gestation	O
had	O
greater	O
live	O
body	O
weight	O
at	O
slaughter	O
,	O
HCW	O
,	O
and	O
tenderness	O
,	O
and	O
had	O
an	O
increased	O
tendency	O
for	O
IMF	O
deposition	O
compared	O
with	O
offspring	O
of	O
cows	O
grazing	O
on	O
native	O
range	O
(	O
Bouteloua	O
–	O
Hesperostipa	O
–	O
Pascopyron	O
,	O
CP	O
6	O
.	O
5	O
%	O
to	O
5	O
.	O
4	O
%)	O
[	O
155	O
].	O

Pregnancy	O
does	O
not	O
seem	O
to	O
be	O
compromised	O
by	O
thyroid	O
cancer	O
.	O

Animals	O
were	O
shown	O
to	O
exhibit	O
enhanced	O
insulin	O
sensitivity	O
,	O
while	O
they	O
become	O
obese	O
and	O
to	O
develop	O
insulin	O
resistance	O
a	O
few	O
weeks	O
later	O
,	O
during	O
hibernation	O
,	O
to	O
finally	O
recover	O
their	O
insulin	O
sensitivity	O
upon	O
awakening	O
.	O

Upon	O
further	O
exploration	O
through	O
GSEA	O
,	O
we	O
observed	O
an	O
overrepresentation	O
of	O
several	O
TFBSs	O
for	O
transcription	O
factors	O
critical	O
in	O
development	O
,	O
cellular	O
processes	O
,	O
immune	O
modulation	O
,	O
lipid	O
or	O
sterol	O
homeostasis	O
,	O
and	O
gene	O
expression	O
near	O
loci	O
associated	O
with	O
AluYb8	O
,	O
as	O
well	O
as	O
a	O
few	O
developmental	O
and	O
cellular	O
proliferation	O
pathways	O
for	O
LINE	O
-	O
1	O
.	O

A	O
report	O
from	O
the	O
Avon	O
Longitudinal	O
Study	O
of	O
Parents	O
and	O
Children	O
(	O
ALSPAC	O
)	O
found	O
that	O
fish	O
consumption	O
during	O
pregnancy	O
of	O
one	O
to	O
three	O
servings	O
per	O
week	O
was	O
shown	O
to	O
provide	O
a	O
modest	O
but	O
significant	O
improvement	O
in	O
developmental	O
scores	O
of	O
the	O
offspring	O
for	O
language	O
and	O
social	O
activity	O
at	O
fifteen	O
to	O
eighteen	O
months	O
of	O
age	O
[	O
18	O
].	O

Results	O
Demographic	O
and	O
underlying	O
variables	O
from	O
the	O
two	O
groups	O
are	O
presented	O
inTable	O
1	O
.	O

One	O
study	O
reported	O
that	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3inhibited	O
lipid	O
accumulation	O
by	O
inhibiting	O
key	O
adipogenic	O
factors	O
such	O
as	O
PPARG	O
[	O
143	O
].	O

Mothers	O
also	O
reported	O
duration	O
of	O
breastfeeding	O
on	O
postpartum	O
questionnaires	O
.	O

One	O
way	O
to	O
model	O
multi	O
-	O
exposure	O
mixtures	O
is	O
to	O
collapse	O
the	O
exposures	O
into	O
a	O
summary	O
term	O
that	O
is	O
included	O
in	O
regression	O
models	O
for	O
the	O
outcome	O
[	O
28	O
]	O
or	O
use	O
proxy	O
variables	O
[	O
29	O
].	O

Despite	O
this	O
fact	O
,	O
the	O
overall	O
direction	O
of	O
results	O
was	O
consistent	O
with	O
previous	O
text4baby	O
studies	O
and	O
additionally	O
we	O
found	O
a	O
behavioral	O
effect	O
.	O

However	O
,	O
there	O
is	O
a	O
limitation	O
to	O
the	O
use	O
of	O
some	O
of	O
these	O
biochemical	O
indicators	O
of	O
iron	O
status	O
in	O
certain	O
settings	O
and	O
conditions	O
;	O
thus	O
,	O
necessitating	O
caution	O
in	O
their	O
interpretations	O
.	O

50	O
.	O
9	O
±	O
29	O
nmol	O
/	O
L	O
,	O
p	O
=	O
0	O
.	O
05	O
).	O

3	O
.	O
2	O
.	O

As	O
with	O
asthma	O
,	O
preexisting	O
AR	O
can	O
worsen	O
,	O
improve	O
,	O
or	O
remain	O
unchanged	O
during	O
pregnancy	O
[	O
27	O
].	O

Additionally	O
,	O
there	O
is	O
a	O
high	O
correlation	O
between	O
vitamin	O
D	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
(	O
correlation	O
=	O
0	O
.	O
77	O
).	O

Results	O
Most	O
women	O
reported	O
multivitamin	O
763	O
/	O
1019	O
(	O
74	O
.	O
9	O
%)	O
use	O
before	O
and	O
/	O
or	O
early	O
in	O
pregnancy	O
.	O

All	O
participants	O
have	O
normal	O
liver	O
and	O
kidney	O
function	O
.	O

The	O
main	O
groups	O
of	O
PUFA	O
are	O
omega	O
-	O
6	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
,	O
of	O
which	O
some	O
need	O
to	O
be	O
supplied	O
through	O
the	O
diet	O
.	O

Background	O
Pregnancy	O
and	O
fetal	O
development	O
are	O
periods	O
of	O
rapid	O
growth	O
and	O
cell	O
differentiation	O
when	O
mother	O
and	O
offspring	O
are	O
vulnerable	O
to	O
changes	O
in	O
dietary	O
supply	O
.	O

Yet	O
she	O
was	O
surprised	O
by	O
the	O
high	O
prevalence	O
of	O
delayed	O
lactogenesis	O
—	O
meaning	O
no	O
signs	O
of	O
copious	O
milk	O
production	O
within	O
the	O
first	O
72	O
hours	O
of	O
giving	O
birth	O
—	O
in	O
mothers	O
who	O
were	O
striving	O
to	O
breastfeed	O
exclusively	O
.	O
31	O
“	O
I	O
kept	O
thinking	O
,	O
how	O
did	O
our	O
species	O
survive	O
?”	O
she	O
says	O
.	O

FGF21	O
deficiency	O
in	O
mice	O
was	O
shown	O
to	O
result	O
in	O
impaired	O
ability	O
to	O
adapt	O
to	O
long	O
-	O
term	O
cold	O
exposure	O
with	O
diminished	O
“	O
browning	O
”	O
of	O
WAT	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

Although	O
the	O
incidence	O
of	O
infant	O
wheeze	O
was	O
similar	O
between	O
the	O
groups	O
,	O
the	O
percentage	O
of	O
respiratory	O
tract	O
infection	O
was	O
significantly	O
higher	O
in	O
infants	O
with	O
a	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
(	O
Table	O
1	O
).	O

There	O
are	O
concerns	B
about	O
possible	O
detrimental	O
interactions	O
between	O
micronutrients	O
combined	O
within	O
a	O
single	O
supplement	O
but	O
experimental	O
data	O
are	O
sparse	O
and	O
the	O
potential	O
synergistic	O
and	O
positive	O
effects	O
of	O
particular	O
combinations	O
should	O
not	O
be	O
ignored	O
(	O
Sandstrom	O
2001	O
).	O

But	O
she	O
will	O
need	O
to	O
consume	O
much	O
more	O
to	O
obtain	O
this	O
daily	O
requirement	O
(	O
i	O
.	O
e	O
.,	O
between	O
20	O
and	O
48	O
mg	O
of	O
dietary	O
iron	O
)	O
[	O
18	O
].	O

increase	O
in	O
corticosterone	O
levels	O
,	O
suppression	O
of	O
physical	O
activity	O
,	O
alteration	O
in	O
circadian	O
behavior	O
)	O
(	O
Bookout	O
et	O
al	O
.,	O
2013	O
).	O

It	O
is	O
crucial	O
to	O
ensure	O
that	O
at	O
-	O
risk	O
women	O
are	O
aware	O
of	O
this	O
need	O
.	O

There	O
is	O
a	O
similar	O
gap	O
in	O
the	O
knowledge	O
base	O
for	O
optimal	O
dosing	O
,	O
as	O
there	O
is	O
little	O
empirical	O
robust	O
evidence	O
to	O
support	O
600	O
IU	O
/	O
day	O
.	O

At	O
baseline	O
,	O
no	O
correlation	O
was	O
observed	O
between	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
depression	O
score	O
(	O
r	O
=	O
0	O
.	O
13	O
,	O
p	O
=	O
0	O
.	O
09	O
).	O

[	O
57	O
].	O

Characteristics	O
of	O
the	O
women	O
in	O
the	O
two	O
treatment	O
arms	O
were	O
compared	O
using	O
the	O
t	O
test	O
,	O
Mann	O
-	O
Whitney	O
U	O
test	O
,	O
and	O
χ2test	O
for	O
normally	O
distributed	O
,	O
nonnormally	O
distributed	O
,	O
and	O
categorical	O
variables	O
,	O
respectively	O
.	O

Morton	O
et	O
al	O
16indicate	O
that	O
population	O
strategies	O
aimed	O
at	O
optimising	O
size	O
at	O
birth	O
require	O
intergenerational	O
considerations	O
for	O
social	O
as	O
well	O
as	O
biological	O
reasons	O
.	O

Therefore	O
,	O
we	O
hypothesized	O
that	O
the	O
effects	O
of	O
HV	O
gestational	O
diets	O
on	O
obesogenic	O
phenotype	O
in	O
the	O
offspring	O
arise	O
as	O
a	O
consequence	O
of	O
altered	O
hypothalamic	O
control	O
of	O
feeding	O
behavior	O
and	O
these	O
effects	O
could	O
be	O
prevented	O
by	O
feeding	O
them	O
HV	O
or	O
HFol	O
diets	O
.	O

Two	O
key	O
global	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
events	O
occur	O
,	O
one	O
after	O
fertilization	O
in	O
the	O
early	O
embryo	O
in	O
all	O
cells	O
,	O
and	O
the	O
second	O
in	O
germ	O
cells	O
only	O
during	O
primordial	O
germ	O
cell	O
(	O
PGC	O
)	O
development	O
(	O
Figure	O
1	O
).	O

The	O
persistence	O
of	O
the	O
relationship	O
between	O
postpartum	O
maternal	O
serum	O
visfatin	O
levels	O
and	O
anthropometric	O
indicators	O
can	O
be	O
attributed	O
to	O
excretion	O
of	O
visfatin	O
in	O
mother	O
’	O
s	O
milk	O
,	O
which	O
was	O
confirmed	O
by	O
Bienertová	O
-	O
Vašků	O
et	O
al	O
.(	O
25	O
).	O

The	O
current	O
vitamin	O
D	O
recommendations	O
for	O
pregnant	O
women	O
are	O
clearly	O
insufficient	B
to	O
prevent	O
and	O
even	O
more	O
to	O
treat	O
vitamin	O
D	O
deficient	O
pregnant	O
women	O
.	O

There	O
were	O
no	O
correlations	O
between	O
BMI	O
of	O
the	O
child	O
of	O
either	O
sex	O
at	O
ages	O
0	O
and	O
5	O
with	O
maternal	O
or	O
PGFs	O
,	O
so	O
this	O
evidence	O
suggests	O
that	O
transmission	O
of	O
BMI	O
is	O
not	O
primarily	O
genetic	O
.	O

Infants	O
of	O
overweight	O
/	O
obese	O
mothers	O
had	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
than	O
nonexposed	O
counterparts	O
,	O
but	O
the	O
postnatal	O
weight	O
trajectories	O
were	O
different	O
.	O

Chailurkit	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
asthma	O
,	O
wheeze	O
,	O
eczema	O
,	O
hay	O
fever	O
and	O
atopy	O
in	O
the	O
offspringMaternal	O
free	O
sugar	O
intake	O
during	O
pregnancyp	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAsthma	O
n	O
=	O
7677	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
14	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
41	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
77	O
–	O
1	O
.	O
23	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
56	O
)	O
1	O
.	O
37	O
(	O
1	O
.	O
04	O
–	O
1	O
.	O
81	O
)	O
1	O
.	O
07	O
(	O
1	O
.	O
00	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
04	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
18	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
29	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
31	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Wheeze	O
n	O
=	O
7762	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
21	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
52	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
54	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
85	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
09	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
25	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
58	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
59	O
)	O
1	O
.	O
42	O
(	O
1	O
.	O
05	O
–	O
1	O
.	O
92	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
08	O
Eczema	O
n	O
=	O
7748	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
19	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
44	O
)	O
1	O
.	O
13	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
30	O
)	O
0	O
.	O
91	O
(	O
0	O
.	O
70	O
–	O
1	O
.	O
17	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
92	O
–	O
1	O
.	O
03	O
)	O
0	O
.	O
33	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
17	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
42	O
)	O
1	O
.	O
15	O
(	O
0	O
.	O
94	O
–	O
1	O
.	O
41	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
86	O
–	O
1	O
.	O
33	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
74	O
–	O
1	O
.	O
26	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
05	O
)	O
0	O
.	O
70	O
Hay	O
fever	O
n	O
=	O
7728	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
07	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
38	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
93	O
–	O
1	O
.	O
63	O
)	O
1	O
.	O
22	O
(	O
0	O
.	O
88	O
–	O
1	O
.	O
69	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
14	O
)	O
0	O
.	O
13	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
03	O
(	O
0	O
.	O
79	O
–	O
1	O
.	O
33	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
95	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
21	O
(	O
0	O
.	O
91	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
75	O
)	O
1	O
.	O
07	O
(	O
0	O
.	O
99	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
10	O
Atopy	O
n	O
=	O
6117	O
Adjusted	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
99	O
(	O
0	O
.	O
81	O
–	O
1	O
.	O
21	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
34	O
)	O
1	O
.	O
19	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
47	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
60	O
)	O
1	O
.	O
06	O
(	O
1	O
.	O
01	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
03	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
98	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
20	O
)	O
1	O
.	O
10	O
(	O
0	O
.	O
89	O
–	O
1	O
.	O
35	O
)	O
1	O
.	O
20	O
(	O
0	O
.	O
96	O
–	O
1	O
.	O
49	O
)	O
1	O
.	O
38	O
(	O
1	O
.	O
06	O
–	O
1	O
.	O
78	O
)	O
1	O
.	O
09	O
(	O
1	O
.	O
02	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
006	O
#:	O
controlling	O
for	O
energy	O
intake	O
;¶:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

More	O
recently	O
,	O
the	O
effects	O
of	O
relative	O
‘	O
overnutrition	O
’	O
have	O
come	O
into	O
question	O
.	O

Asthma	O
and	O
Allergic	O
Diseases	O
in	O
Pregnancy	O
:	O
A	O
Review	O
Abstract	O
Asthma	O
and	O
allergic	O
disorders	O
can	O
affect	O
the	O
course	O
and	O
outcome	O
of	O
pregnancy	O
.	O

Furthermore	O
,	O
it	O
is	O
worth	O
noticing	O
that	O
the	O
increased	O
airway	O
resistance	O
may	O
result	O
in	O
a	O
higher	O
risk	O
of	O
wheezing	O
in	O
early	O
childhood	O
.	O

2010	O
).	O

Pepsin	O
(	O
0	O
.	O
01	O
%	O
in	O
0	O
.	O
01	O
M	O
HCl	O
)	O
was	O
used	O
to	O
treat	O
the	O
tissue	O
for	O
5	O
minutes	O
at	O
37	O
°	O
C	O
,	O
and	O
a	O
brief	O
rinse	O
in	O
DEPC	O
treated	O
H2O	O
followed	O
.	O

Similar	O
studies	O
using	O
a	O
Swedish	O
medical	O
birth	O
registry	O
observed	O
different	O
factors	O
that	O
affected	O
autism	O
spectrum	O
disorders	O
.	O

2010	O
;	O
Poage	O
et	O
al	O
.	O

When	O
evidence	O
for	O
associations	O
persisted	O
,	O
we	O
considered	O
other	O
factors	O
which	O
can	O
be	O
considered	O
either	O
as	O
potential	O
confounders	B
or	O
potential	O
mediators	O
of	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
childhood	O
outcomes	O
,	O
i	O
.	O
e	O
.	O

A	O
smaller	O
(	O
n	O
=	O
498	O
)	O
Japanese	O
study	O
did	O
not	O
demonstrate	O
a	O
positive	O
or	O
negative	O
association	O
between	O
maternal	O
fish	O
intake	O
during	O
pregnancy	O
and	O
neurodevelopment	O
as	O
measured	O
by	O
the	O
Neonatal	O
Behavioural	O
Assessment	O
tool	O
in	O
infants	O
at	O
three	O
days	O
of	O
age	O
[	O
25	O
].	O

Many	O
farm	O
chemicals	O
are	O
classified	O
as	O
probable	O
or	O
likely	O
human	O
carcinogens	O
by	O
the	O
US	O
Environmental	O
Protection	O
Agency	O
(	O
EPA	O
),	O
most	O
notably	O
acephate	O
,	O
dichlorvos	O
,	O
dimethoate	O
,	O
lindane	O
,	O
parathion	O
,	O
phosmet	O
,	O
and	O
tetrachlorvinphos	O
[	O
28	O
].	O

Discussion	O
Using	O
a	O
large	O
-	O
scale	O
ENU	O
mutagenesis	O
screen	O
,	O
we	O
have	O
identified	O
two	O
novel	O
mutations	O
,	O
Skm1	O
and	O
Skm2	O
,	O
that	O
result	O
in	O
congenital	O
spinal	O
deformities	O
in	O
mice	O
.	O

To	O
more	O
precisely	O
identify	O
which	O
microbial	O
taxa	O
contribute	O
to	O
the	O
observed	O
differences	O
in	O
infant	O
stool	O
microbial	O
community	O
composition	O
by	O
maternal	O
dietary	O
factors	O
,	O
we	O
used	O
a	O
series	O
of	O
linear	O
models	O
to	O
test	O
the	O
relationships	O
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
each	O
OTU	O
.	O

The	O
MAS5	O
algorithm	O
was	O
used	O
to	O
skip	O
those	O
transcripts	O
which	O
were	O
expressed	O
in	O
less	O
than	O
50	O
%	O
of	O
the	O
animals	O
within	O
one	O
dietary	O
group	O
per	O
stage	O
.	O

Persons	O
being	O
observed	O
by	O
a	O
stranger	O
,	O
such	O
as	O
a	O
study	O
data	O
collector	O
,	O
may	O
alter	O
their	O
behavior	O
compared	O
to	O
usual	O
practice	O
,	O
potentially	O
increasing	O
their	O
handwashing	O
in	O
the	O
presence	O
of	O
the	O
observer	O
[	O
29	O
,	O
30	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Flow	O
diagram	O
for	O
inclusion	O
of	O
journal	O
articles	O
[	O
17	O
].	O

We	O
recorded	O
GWG	O
at	O
first	O
measurement	O
,	O
at	O
approximately	O
the	O
12th	O
,	O
20th	O
and	O
30th	O
gestational	O
weeks	O
,	O
and	O
at	O
last	O
measurement	O
.	O

IPG	O
strips	O
were	O
reduced	O
,	O
alkylated	O
and	O
detergent	O
exchanged	O
using	O
SDS	O
equilibration	O
buffer	O
(	O
Proteome	O
Systems	O
,	O
20	O
min	O
)	O
and	O
loaded	O
onto	O
pre	O
-	O
cast	O
SDS	O
-	O
PAGE	O
gels	O
(	O
GelChip	O
™	O
2D	O
,	O
6	O
–	O
15	O
%,	O
10	O
×	O
15	O
cm	O
;	O
Proteome	O
Systems	O
)	O
for	O
second	O
dimension	O
molecular	O
mass	O
separation	O
using	O
the	O
ElectrophoreticIQ3	O
system	O
(	O
50mA	O
/	O
gel	O
,	O
15	O
°	O
C	O
for	O
90	O
min	O
).	O

A	O
number	O
of	O
reporter	O
mouse	O
models	O
,	O
including	O
the	O
Agouti	O
Avy	O
,	O
CabpIAP	O
and	O
AuxinFu	O
,	O
have	O
also	O
been	O
used	O
to	O
investigate	O
environmentally	O
induced	O
epigenetic	O
changes	O
in	O
in	O
vivo	O
exploratory	O
research	O
(	O
Dolinoy	O
et	O
al	O
.	O
2007	O
;	O
Waterland	O
et	O
al	O
.	O
2006	O
;	O
Rosenfeld2010	O
).	O

However	O
,	O
it	O
is	O
likely	O
that	O
by	O
three	O
months	O
of	O
age	O
,	O
vitamin	O
D	O
has	O
a	O
key	O
role	O
in	O
calcium	O
absorption	O
,	O
especially	O
in	O
breast	O
-	O
fed	O
infants	O
with	O
a	O
relatively	O
low	O
calcium	O
intake	O
compared	O
to	O
formula	O
-	O
fed	O
infants	O
.	O

To	O
some	O
degree	O
,	O
effect	O
modification	O
or	O
publication	B
bias	I
may	O
explain	O
the	O
inconsistencies	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	O
effects	O
of	O
diet	O
and	O
sex	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
in	O
liver	O
and	O
PAT	O
(	O
see	O
TableS4for	O
statistical	O
values	O
).	O

As	O
in	O
vaginally	O
delivered	O
infants	O
,	O
maternal	O
fish	O
and	O
seafood	O
intake	O
was	O
positively	O
associated	O
with	O
OTUs	O
in	O
the	O
genus	O
Streptococcus	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5c	O
).	O

Findings	O
suggest	O
the	O
need	O
for	O
prenatal	O
providers	O
of	O
low	O
-	O
income	O
,	O
minority	O
women	O
to	O
engage	O
patients	O
in	O
shaping	O
healthy	O
weight	O
gain	O
targets	O
as	O
a	O
precursor	O
to	O
preventing	O
excessive	O
GWG	O
and	O
its	O
complications	O
.	O

There	O
are	O
numerous	O
studies	O
which	O
have	O
shown	O
that	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
(	O
Most	O
recent	O
:	O
[	O
14	O
–	O
17	O
]),	O
particularly	O
in	O
populations	O
that	O
reside	O
at	O
higher	O
latitudes	O
.	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
30	O
ng	O
/	O
ml	O
)	O
and	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
of	O
the	O
pregnant	O
women	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
of	O
the	O
women	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
10	O
ng	O
/	O
ml	O
).	O

Whilst	O
the	O
latter	O
studies	O
were	O
not	O
specifically	O
performed	O
in	O
women	O
with	O
GDM	O
,	O
they	O
suggest	O
that	O
the	O
concept	O
of	O
GI	O
is	O
valid	O
in	O
pregnancy	O
,	O
and	O
it	O
would	O
be	O
appropriate	O
to	O
recommend	O
low	O
GI	O
carbohydrate	O
to	O
women	O
with	O
GDM	O
.	O

With	O
regards	O
to	O
waiting	O
time	O
at	O
the	O
clinic	O
,	O
the	O
women	O
recognized	O
that	O
most	O
of	O
the	O
time	O
wasting	O
was	O
due	B
to	I
late	O
coming	O
of	O
their	O
fellow	O
pregnant	O
women	O
.	O

All	O
cost	O
data	O
were	O
collected	O
in	O
Viet	O
Nam	O
dong	O
and	O
converted	O
to	O
US	O
dollars	O
using	O
the	O
exchange	O
rate	O
on	O
March	O
10	O
2010	O
(	O
USD1	O
.	O
00	O
=	O
VND18	O
,	O
685	O
).	O

In	O
the	O
mission	O
to	O
enhance	O
and	O
compound	O
the	O
benefit	O
of	O
services	O
delivered	O
under	O
ICDS	O
,	O
Government	O
of	O
India	O
has	O
developed	O
partnerships	O
with	O
the	O
international	O
agencies	O
like	O
United	O
Nations	O
International	O
Children	O
’	O
Emergency	O
Fund	O
(	O
for	O
providing	O
technical	O
guidance	O
in	O
developing	O
need	O
-	O
based	O
training	O
plans	O
;	O
assist	O
in	O
organizing	O
scientific	O
workshops	O
;	O
and	O
in	O
impact	O
assessment	O
on	O
early	O
childhood	O
nutrition	O
and	O
development	O
),	O
Cooperative	O
for	O
Assistance	O
and	O
Relief	O
Everywhere	O
(	O
contribution	O
in	O
the	O
areas	O
of	O
maternal	O
and	O
child	O
health	O
,	O
girl	O
primary	O
education	O
,	O
etc	O
.	O

BPA	O
is	O
added	O
to	O
many	O
plastics	O
and	O
consumer	O
products	O
[	O
9	O
,	O
10	O
].	O

Historic	O
influenza	O
surveillance	O
data	O
from	O
Nicaragua	O
shows	O
that	O
influenza	O
circulates	O
between	O
June	O
and	O
November	O
[	O
32	O
].	O

PubMed	O
Central	O
:	O

Results	O
Identification	O
of	O
the	O
Skm	O
mutants	O
During	O
our	O
ENU	O
mutagenesis	O
screen	O
for	O
infectious	O
disease	O
susceptibility	O
,	O
we	O
identified	O
two	O
mutations	O
that	O
contribute	O
to	O
skeletal	O
malformations	O
in	O
mice	O
.	O

Of	O
note	O
,	O
one	O
of	O
these	O
children	O
was	O
obese	O
,	O
one	O
had	O
seasonal	O
allergies	O
treated	O
with	O
a	O
long	O
-	O
term	O
steroid	O
nasal	O
spray	O
,	O
and	O
the	O
third	O
had	O
a	O
history	O
of	O
febrile	O
seizures	O
.	O

It	O
also	O
sought	O
to	O
establish	O
reasons	O
that	O
determined	O
these	O
women	O
'	O
s	O
choice	O
of	O
ANC	O
site	O
as	O
well	O
as	O
explore	O
the	O
geographic	O
distribution	O
of	O
the	O
women	O
with	O
respect	O
to	O
their	O
residence	O
and	O
their	O
attending	O
health	O
centre	O
.	O

The	O
gestation	O
period	O
is	O
very	O
important	O
because	O
it	O
determines	O
the	O
fate	O
of	O
progenitor	O
cells	O
that	O
will	O
become	O
muscle	O
cells	O
,	O
fibroblasts	O
,	O
or	O
adipocytes	O
[	O
16	O
].	O

She	O
described	O
the	O
pain	O
as	O
continuous	O
,	O
10	O
/	O
10	O
in	O
severity	O
,	O
worsened	O
with	O
movement	O
and	O
breathing	O
,	O
and	O
relieved	O
by	O
nothing	O
.	O

At	O
65	O
.	O
4	O
%,	O
the	O
prevalence	O
for	O
overweight	O
and	O
obesity	O
in	O
Latinas	O
aged	O
20	O
–	O
39	O
years	O
is	O
higher	O
than	O
the	O
national	O
prevalence	O
for	O
all	O
women	O
in	O
that	O
age	O
group	O
[	O
8	O
].	O

We	O
computed	O
generalized	O
UniFrac	O
distances	O
between	O
pairs	O
of	O
samples	O
using	O
OTU	O
tables	O
and	O
the	O
midpoint	O
rooted	O
phylogenetic	O
tree	O
.	O

The	O
Cronbach	O
’	O
s	O
α	O
coefficient	O
was	O
acceptable	O
for	O
all	O
sections	O
(	O
general	O
recommendations	O
,	O
0	O
.	O
66	O
;	O
sources	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
;	O
the	O
role	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
),	O
except	O
for	O
breastfeeding	O
(	O
0	O
.	O
60	O
),	O
which	O
was	O
therefore	O
eliminated	O
.	O

From	O
the	O
final	O
analysis	O
ten	O
questionnaires	O
were	O
excluded	O
representing	O
drop	O
-	O
outs	O
(	O
refusals	O
after	O
the	O
initial	O
moment	O
of	O
the	O
study	O
or	O
incomplete	O
questionnaires	O
).	O

However	O
,	O
at	O
childbirth	O
,	O
the	O
vitamin	O
D	O
group	O
had	O
significantly	O
higher	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
in	O
comparison	O
to	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

All	O
analyses	O
were	O
performed	O
in	O
R	O
software	O
(	O
R	O
version	O
3	O
.	O
2	O
.	O
2	O
).	O

Maternal	O
high	O
fat	O
exposure	O
We	O
found	O
that	O
exposure	O
to	O
a	O
high	O
fat	O
diet	O
either	O
throughout	O
the	O
lifetime	O
of	O
the	O
mother	O
or	O
restricted	O
to	O
pregnancy	O
and	O
/	O
or	O
lactation	O
led	O
to	O
early	O
pubertal	O
onset	O
.	O

A	O
meta	O
-	O
analysis	O
of	O
starch	O
digestion	O
in	O
dairy	O
cows	O
revealed	O
that	O
the	O
ruminal	O
digestibility	O
of	O
corn	O
was	O
57	O
.	O
4	O
%	O
[	O
112	O
],	O
demonstrating	O
that	O
a	O
substantial	O
portion	O
of	O
corn	O
can	O
be	O
digested	O
in	O
the	O
small	O
intestine	O
.	O

Prepregnancy	O
weight	O
and	O
weight	O
recorded	O
in	O
prenatal	O
clinics	O
were	O
utilised	O
to	O
calculate	O
gestational	O
weight	O
gain	O
(	O
GWG	O
)	O
(	O
kg	O
).	O

The	O
P8	O
rump	O
fat	O
depth	O
was	O
generally	O
greater	O
in	O
Hereford	O
than	O
Angus	O
,	O
and	O
Meat	O
Standard	O
Australia	O
(	O
MSA	O
)	O
MS	O
was	O
generally	O
lower	O
in	O
Hereford	O
than	O
in	O
Angus	O
and	O
Wagyu	O
×	O
Angus	O
.	O

Gene	O
specific	O
DNA	O
methylation	O
will	O
be	O
assessed	O
using	O
the	O
Qiagen	O
EpiTech	O
system	O
.	O

c	O
Linear	O
model	O
associations	O
between	O
maternal	O
aMED	O
score	O
and	O
relative	O
abundance	O
of	O
infant	O
stool	O
OTUs	O
.	O

These	O
values	O
were	O
changed	O
by	O
intervention	O
to	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%,	O
respectively	O
.	O

Data	O
will	O
also	O
be	O
analysed	O
retrospectively	O
in	O
matched	O
-	O
control	O
sub	O
-	O
studies	O
by	O
determining	O
associations	O
between	O
observed	O
outcomes	O
and	O
variables	O
collected	O
at	O
previous	O
time	O
points	O
.	O

Alcohol	O
Alcohol	O
intake	O
should	O
be	O
avoided	O
by	O
the	O
pregnant	O
mother	O
because	B
of	O
well	O
-	O
known	O
toxic	O
effects	O
on	O
both	O
mother	O
and	O
fetus	O
.	O

4	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
N	O
-	O
ethyl	O
-	O
N	O
-	O
nitrosourea	O
(	O
ENU	O
)	O
breeding	O
scheme	O
and	O
visible	O
morphology	O
of	O
skeletal	O
morphology	O
mutants	O
(	O
Skm	O
).	O

Several	O
countries	O
,	O
including	O
Korea	O
,	O
Japan	O
,	O
Australia	O
and	O
the	O
USA	O
,	O
have	O
considered	O
IMF	O
content	O
as	O
important	O
to	O
beef	O
quality	O
grade	O
(	O
QG	O
),	O
whereas	O
European	O
countries	O
,	O
including	O
France	O
and	O
Germany	O
,	O
prefer	O
leaner	O
meat	O
(	O
less	O
IMF	O
content	O
).	O

A	O
mound	O
of	O
uranium	O
-	O
laden	O
waste	O
the	O
size	O
of	O
several	O
football	O
fields	O
,	O
covered	O
with	O
a	O
thin	O
veneer	O
of	O
gravel	O
,	O
dominates	O
the	O
view	O
from	O
her	O
front	O
door	O
.	O

We	O
identified	O
76	O
human	O
cohort	O
studies	O
within	O
PubMed	O
that	O
associated	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
birth	O
outcomes	O
,	O
organ	O
-	O
specific	O
abnormalities	O
/	O
disorders	O
,	O
cancer	O
or	O
mortality	O
)	O
with	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
mainly	O
DNA	O
methylation	O
to	O
-	O
date	O
,	O
but	O
also	O
histone	O
modification	O
,	O
epigenetic	O
machinery	O
and	O
miRNAs	O
)	O
and	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
air	O
pollution	O
,	O
chemicals	O
,	O
fibers	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
childhood	O
,	O
adolescence	O
,	O
adulthood	O
and	O
lifetime	O
).	O

Metabolism	O
is	O
another	O
major	O
factor	O
that	O
can	O
determine	O
the	O
overall	O
effect	O
of	O
an	O
environmental	O
exposure	O
.	O

Recently	O
,	O
however	O
,	O
labor	O
induction	O
was	O
positively	O
correlated	O
with	O
autism	O
in	O
a	O
large	O
population	O
study	O
comparing	O
birth	O
records	O
in	O
North	O
Carolina	O
(	O
1990	O
–	O
1998	O
)	O
and	O
corresponding	O
school	O
records	O
of	O
autistic	O
children	O
(	O
1997	O
–	O
2007	O
).	O

The	O
research	O
done	O
by	O
Glasson	O
et	O
al	O
.	O

The	O
text4baby	O
program	O
is	O
an	O
example	O
of	O
scaled	O
mHealth	O
for	O
behavior	O
change	O
[	O
24	O
](	O
seeFigure	O
1	O
).	O

This	O
results	O
in	O
possible	O
aMED	O
score	O
values	O
from	O
0	O
to	O
7	O
,	O
with	O
a	O
higher	O
score	O
indicating	O
greater	O
adherence	O
to	O
a	O
Mediterranean	O
dietary	O
pattern	O
.	O

DNMT1	O
,	O
the	O
maintenance	O
DNMT	O
,	O
preferentially	O
methylates	O
hemimethylated	O
DNA	O
and	O
thus	O
maintains	O
DNA	O
methylation	O
following	O
DNA	O
replication	O
.	O

There	O
were	O
no	O
associations	O
between	O
the	O
predictor	O
T1	O
25OHD	O
and	O
the	O
outcomes	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
(	O
Table	O
3	O
).	O

This	O
committee	O
will	O
assist	O
in	O
translating	O
the	O
Shonjibon	O
study	O
findings	O
into	O
policy	O
.	O

PubMed	O
Central	O
:	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
study	O
groups	O
in	O
relation	O
to	O
the	O
baseline	O
depression	O
score	O
.	O

Although	O
the	O
importance	O
of	O
IFA	O
supplements	O
to	O
prevent	O
maternal	O
anaemia	O
and	O
mortality	O
is	O
widely	O
accepted	O
,	O
most	O
antenatal	O
IFA	O
supplements	O
distribution	O
programs	O
are	O
of	O
low	O
priority	O
.	O

For	O
example	O
,	O
chemicals	O
can	O
have	O
far	O
-	O
reaching	O
benefits	O
to	O
society	O
,	O
from	O
agriculture	O
to	O
medicine	O
and	O
food	O
/	O
product	O
safety	O
to	O
the	O
development	O
of	O
new	O
technologies	O
.	O

Vitamin	O
A	O
(	O
also	O
known	O
as	O
retinol	O
)	O
inhibits	O
adipocyte	O
differentiation	O
[	O
128	O
].	O

However	O
,	O
they	O
were	O
different	O
regarding	O
to	O
using	O
other	O
supplements	O
outside	O
the	O
study	O
’	O
s	O
protocol	O
and	O
planned	O
pregnancy	O
(	O
Table	O
1	O
).	O

The	O
epidemiologic	O
association	O
of	O
obesity	O
,	O
particularly	O
of	O
the	O
visceral	O
type	O
,	O
with	O
type	O
2	O
diabetes	O
has	O
been	O
recognized	O
for	O
decades	O
.	O

Competing	O
interets	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
conflict	O
of	O
interest	O
Authors	O
'	O
contribution	O
The	O
chapter	O
was	O
coordinated	O
by	O
JEL	O
with	O
MVK	O
;	O
drafted	O
by	O
JEL	O
,	O
MVK	O
,	O
CPH	O
,	O
EL	O
and	O
all	O
other	O
authors	O
reviewed	O
and	O
contributed	O
.	O

It	O
is	O
related	O
to	O
excess	O
vasopressinase	O
enzyme	O
activity	O
which	O
is	O
metabolized	O
in	O
the	O
liver	O
.	O

Measuring	O
dietary	O
intake	O
in	O
cohort	O
studies	O
is	O
problematic	B
due	B
to	I
the	O
difficulty	O
in	O
obtaining	O
detailed	O
information	O
without	O
causing	O
significant	O
subject	O
burden	B
.	O

The	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
20	O
ng	O
/	O
ml	O
(	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
following	O
variables	O
as	O
predictors	O
in	O
the	O
model	O
:	O
season	O
,	O
age	O
,	O
trimester	O
of	O
pregnancy	O
,	O
region	O
,	O
BMI	O
,	O
smoking	O
behaviour	O
,	O
alcohol	O
consumption	O
,	O
use	O
of	O
vitamin	O
D	O
-	O
containing	O
food	O
supplements	O
,	O
fish	O
consumption	O
,	O
milk	O
and	O
dairy	O
product	O
consumption	O
,	O
education	O
level	O
,	O
ethnicity	O
,	O
parity	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekdays	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekend	O
days	O
,	O
use	O
of	O
sunscreen	O
lotion	O
,	O
use	O
of	O
solarium	O
,	O
shadow	O
or	O
sun	O
preference	O
and	O
sometimes	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
(	O
yes	O
/	O
no	O
question	O
).	O

(	O
Table	O
1	O
)	O
Over	O
40	O
%	O
of	O
pregnant	O
women	O
exceed	O
the	O
IOM	O
recommendations	O
for	O
gestational	O
weight	O
gain	O
(	O
GWG	O
),	O
with	O
overweight	O
and	O
obese	O
women	O
at	O
increased	O
risk	O
[	O
2	O
].	O

Born	O
Too	O
Soon	O
:	O
Accelerating	O
actions	O
for	O
prevention	O
and	O
care	O
of	O
15	O
million	O
newborns	O
born	O
too	O
soon	O
Abstract	O
Preterm	O
birth	O
complication	O
is	O
the	O
leading	O
cause	O
of	O
neonatal	O
death	O
resulting	O
in	O
over	O
one	O
million	O
deaths	O
each	O
year	O
of	O
the	O
15	O
million	O
babies	O
born	O
preterm	O
.	O

Further	O
evidence	O
for	O
the	O
hypothesis	O
that	O
PUFA	O
is	O
involved	O
in	O
the	O
etiology	O
of	O
psychiatric	O
disease	O
has	O
been	O
put	O
forward	O
through	O
the	O
study	O
by	O
Stokes	O
et	O
al	O
.	O

Although	O
the	O
VitD	O
-	O
offspring	O
in	O
the	O
present	O
study	O
did	O
not	O
show	O
a	O
reduction	O
in	O
WT1	O
expression	O
,	O
maternal	O
vitamin	O
D	O
deficiency	O
did	O
alter	O
the	O
ratio	O
of	O
immature	O
-	O
to	O
-	O
mature	O
glomeruli	O
at	O
birth	O
by	O
extending	O
the	O
period	O
of	O
glomerular	O
maturation	O
.	O

There	O
were	O
very	O
few	O
protocol	O
violations	O
and	O
the	O
results	O
of	O
our	O
per	O
-	O
protocol	O
and	O
post	O
-	O
hoc	O
analyses	O
for	O
children	O
getting	O
four	O
and	O
five	O
consecutive	O
doses	O
were	O
not	O
different	O
from	O
that	O
of	O
our	O
intention	O
-	O
to	O
-	O
treat	O
analysis	O
(	O
table	O
2	O
,	O
3	O
;	O
appendix	O
)	O
A	O
further	O
post	O
-	O
hoc	O
analysis	O
of	O
the	O
pneumonia	O
rates	O
by	O
season	O
also	O
did	O
not	O
reveal	O
any	O
difference	O
between	O
the	O
groups	O
in	O
our	O
intention	O
-	O
to	O
-	O
treat	O
or	O
per	O
-	O
protocol	O
analyses	O
(	O
data	O
not	O
shown	O
).	O

However	O
,	O
feed	O
efficiency	O
decreases	O
as	O
animals	O
age	O
due	O
to	O
a	O
decrease	O
in	O
the	O
rate	O
of	O
muscle	O
growth	O
[	O
70	O
].	O

Excessive	O
rebound	O
and	O
early	O
rebound	O
(	O
before	O
age	O
5	O
)	O
are	O
related	O
to	O
higher	O
BMI	O
in	O
adulthood	O
(	O
83	O
).	O

The	O
final	O
adjusted	O
model	O
was	O
:	O
Y	O
=	O
β0	O
+	O
βx1X1	O
....	O
βxpXp	O
+	O
βc1C1	O
+....+	O
βckCk	O
+	O
spline	O
(	O
GA	O
)+	O
error	O
,	O
where	O
Y	O
is	O
the	O
outcome	O
birth	O
weight	O
,	O
β0is	O
the	O
y	O
-	O
intercept	O
,	O
βx1	O
...	O
βxpare	O
the	O
exposure	O
variable	O
regression	O
coefficients	O
,	O
X1	O
...	O
Xpare	O
the	O
exposure	O
variables	O
,	O
spline	O
(	O
GA	O
)	O
is	O
the	O
non	O
-	O
parametric	O
spline	O
for	O
GA	O
,	O
and	O
C1	O
…	O
Ckare	O
the	O
9	O
covariates	O
.	O

The	O
COPSAC2000study	O
have	O
failed	O
to	O
show	O
an	O
association	O
between	O
cord	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
lung	O
function	O
at	O
7	O
years	O
of	O
age	O
[	O
33	O
].	O

Diet	O
and	O
lifestyle	O
exposure	O
assessment	O
The	O
self	O
-	O
administered	O
questionnaire	O
in	O
the	O
parent	O
study	O
assessed	O
lifestyle	O
variables	O
(	O
smoking	O
history	O
,	O
alcoholic	O
drinking	O
),	O
anthropometry	O
(	O
height	O
,	O
weight	O
,	O
body	O
mass	O
index	O
,	O
BMI	O
),	O
medical	O
history	O
(	O
previous	O
diagnosis	O
of	O
major	O
diseases	O
)	O
and	O
average	O
intake	O
of	O
foods	O
and	O
beverages	O
[	O
19	O
].	O

A	O
P	O
-	O
value	O
≤	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Oral	O
consent	O
for	O
participation	O
was	O
provided	O
by	O
all	O
women	O
over	O
the	O
phone	O
.	O

Both	O
,	O
the	O
EpiTect	O
Methyl	O
II	O
Signature	O
and	O
EpiTect	O
Methyl	O
II	O
Complete	O
PCR	O
Arrays	O
(	O
Qiagen	O
)	O
will	O
be	O
considered	O
.	O

None	O
of	O
the	O
women	O
were	O
anemic	O
at	O
that	O
point	O
,	O
but	O
66	O
%	O
had	O
low	O
levels	O
of	O
ferritin	O
(	O
the	O
principal	O
form	O
of	O
stored	O
iron	O
),	O
suggesting	O
low	O
iron	O
nutritional	O
status	O
.	O

They	O
collected	O
milk	O
samples	O
at	O
multiple	O
points	O
throughout	O
lactation	O
and	O
estimated	O
concentrations	O
of	O
PCBs	O
and	O
DDE	O
(	O
a	O
breakdown	O
product	O
of	O
DDT	O
)	O
in	O
milk	O
at	O
birth	O
.	O

The	O
UPBEAT	O
trial	O
evaluated	O
the	O
effect	O
of	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
among	O
obese	O
women	O
,	O
with	O
no	O
impact	O
on	O
infant	O
birth	O
weight	O
demonstrated	O
[	O
17	O
].	O

PubMed	O
Central	O
:	O

This	O
sample	O
would	O
allow	O
detection	O
of	O
a	O
22	O
%	O
relative	O
difference	O
between	O
treatment	O
groups	O
with	O
80	O
%	O
power	O
.	O

)—	O
Low	O
Frequency	O
in	O
Normalized	O
Units	O
;	O
HF	O
(	O
n	O
.	O
u	O
.	O

Hence	O
there	O
is	O
a	O
need	O
to	O
mobilize	O
efforts	O
for	O
a	O
better	O
quality	O
assessment	O
in	O
our	O
health	O
care	O
provision	O
with	O
the	O
aim	O
of	O
improving	O
quality	O
in	O
terms	O
of	O
provision	O
of	O
health	O
care	O
services	O
.	O

However	O
,	O
1	O
study	O
showed	O
that	O
adolescents	O
who	O
had	O
been	O
born	O
prematurely	O
had	O
a	O
substantially	O
decreased	O
expiratory	O
volume	O
and	O
increased	O
bronchial	O
hyperresponsiveness	O
,	O
making	O
them	O
potential	O
candidates	O
for	O
developing	O
asthma	O
[	O
91	O
].	O

Moreover	O
,	O
males	O
were	O
housed	O
in	O
a	O
separate	O
room	O
.	O

Methods	O
We	O
interviewed	O
women	O
from	O
the	O
inpatient	O
post	O
-	O
natal	O
unit	O
at	O
BMC	O
about	O
what	O
herbs	O
they	O
used	O
during	O
pregnancy	O
,	O
socioeconomic	O
factors	O
,	O
changes	O
to	O
diet	O
,	O
and	O
use	O
of	O
prenatal	O
vitamins	O
.	O

Overdose	O
Hypervitaminosis	O
D	O
is	O
a	O
serious	O
,	O
albeit	O
very	O
rare	O
,	O
condition	O
.	O

Independent	O
t	O
-	O
tests	O
were	O
used	O
to	O
examine	O
the	O
relationship	O
between	O
continuous	O
variables	O
and	O
each	O
outcome	O
.	O

Additionally	O
,	O
more	O
women	O
using	O
metformin	O
indicated	O
that	O
their	O
treatment	O
was	O
acceptable	O
compared	O
to	O
those	O
on	O
insulin	O
.	O

Further	O
,	O
the	O
conversion	O
of	O
25	O
(	O
OH	O
)	O
D	O
to	O
the	O
active	O
form	O
of	O
the	O
hormone	O
,	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
,	O
was	O
optimized	O
at	O
40	O
ng	O
/	O
mL	O
among	O
pregnant	O
women	O
[	O
13	O
].	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
no	O
one	O
has	O
evaluated	O
the	O
impact	O
of	O
sleep	O
duration	O
and	O
snoring	O
on	O
maternal	O
glucose	O
metabolism	O
in	O
pregnancy	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
determinants	O
of	O
season	O
-	O
corrected	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
include	O
origin	O
,	O
sun	O
-	O
exposure	O
and	O
dietary	O
as	O
well	O
as	O
supplementary	O
vitamin	O
D	O
intake	O
[	O
18	O
].	O

Since	O
the	O
maternal	O
attitude	O
towards	O
the	O
pregnancy	O
was	O
a	O
significant	O
predictor	O
of	O
fetal	O
birth	O
weight	O
,	O
we	O
reexamined	O
this	O
association	O
as	O
a	O
function	O
of	O
the	O
GR	O
genepolymorphisms	O
,	O
resembling	O
a	O
gene	O
-	O
environment	O
interaction	O
and	O
statistically	O
controlling	O
for	O
mothers	O
'	O
age	O
,	O
BMI	O
,	O
pregnancy	O
planning	O
,	O
and	O
pregnancy	O
nutritional	O
habits	O
,	O
to	O
remove	O
any	O
potential	O
sources	O
of	O
statistical	O
bias	B
that	O
could	O
skew	O
our	O
data	O
.	O

The	O
phenomenon	O
of	O
circannual	O
rhythms	O
has	O
also	O
been	O
explored	O
in	O
relation	O
to	O
gestational	O
diabetes	O
[	O
24	O
–	O
26	O
,	O
28	O
].	O

However	O
,	O
more	O
GDM	O
mothers	O
were	O
vitamin	O
D	O
deficient	O
at	O
the	O
delivery	O
compared	O
with	O
non	O
-	O
GDM	O
mothers	O
[	O
7	O
.	O
4	O
%	O
(	O
6	O
/	O
81	O
)	O
vs	O
2	O
.	O
8	O
%	O
(	O
18	O
/	O
642	O
)	O
(	O
P	O
=	O
0	O
.	O
042	O
)].	O

Mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
was	O
not	O
significantly	O
associated	O
with	O
the	O
birth	O
weight	O
groups	O
(	O
see	O
Supplemental	O
Material	O
,	O
Table	O
1	O
).	O

Nevertheless	O
,	O
there	O
was	O
a	O
higher	O
(	O
adequate	O
level	O
)	O
mean	O
serum	O
concentration	O
of	O
calcifediol	O
at	O
the	O
end	O
of	O
first	O
supplementation	O
period	O
in	O
the	O
intervention	O
group	O
compared	O
with	O
the	O
lower	O
(	O
not	O
adequate	O
)	O
mean	O
concentrations	O
in	O
the	O
placebo	O
group	O
(	O
data	O
not	O
shown	O
).	O

Repeated	O
episodes	O
of	O
GDM	O
are	O
associated	O
with	O
the	O
earlier	O
development	O
of	O
diabetes	O
,	O
and	O
this	O
has	O
been	O
postulated	O
to	O
be	O
due	B
to	I
the	O
increased	O
stress	O
that	O
the	O
β	O
-	O
cells	O
are	O
exposed	O
to	O
with	O
each	O
pregnancy	O
.	O
75By	O
treating	O
the	O
mother	O
with	O
glyburide	O
,	O
it	O
is	O
possible	O
that	O
this	O
accentuates	O
β	O
-	O
cell	O
stress	O
and	O
accelerates	O
their	O
decline	O
,	O
whereas	O
insulin	O
therapy	O
would	O
conversely	O
provide	O
a	O
degree	O
of	O
relief	O
to	O
the	O
β	O
-	O
cells	O
.	O

None	O
of	O
the	O
mothers	O
reported	O
taking	O
additional	O
vitamin	O
D	O
supplements	O
separate	O
from	O
their	O
prenatal	O
vitamins	O
.	O

First	O
,	O
due	B
to	I
stipulations	O
made	O
during	O
the	O
ethics	O
approval	O
process	O
,	O
we	O
were	O
unable	B
to	I
include	O
participants	O
with	O
a	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
less	O
than	O
25	O
nmol	O
/	O
L	O
or	O
greater	O
than	O
100	O
nmol	O
/	O
L	O
.	O

Dietary	O
sources	O
of	O
vitamin	O
D	O
include	O
:	O
Fatty	O
fish	O
species	O
,	O
such	O
as	O
Catfish	O
,	O
Salmon	O
,	O
Mackerel	O
,	O
Tuna	O
etc	O
.,	O
egg	O
,	O
beef	O
and	O
fish	O
liver	O
oils	O
.	O

Women	O
with	O
a	O
higher	O
education	O
(	O
aOR	O
,	O
2	O
.	O
3	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
4	O
.	O
9	O
),	O
more	O
than	O
10	O
prenatal	O
visits	O
(	O
aOR	O
,	O
7	O
.	O
2	O
;	O
95	O
%	O
CI	O
,	O
3	O
.	O
4	O
-	O
15	O
.	O
0	O
)	O
and	O
those	O
who	O
received	O
advice	O
on	O
breastfeeding	O
(	O
aOR	O
,	O
2	O
.	O
0	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
3	O
.	O
5	O
)	O
were	O
more	O
likely	O
to	O
use	O
iron	O
during	O
pregnancy	O
.	O

PubMed	O
Central	O
:	O

Thus	O
,	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
conduct	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
children	O
stratified	O
by	O
birth	O
weight	O
quartiles	O
to	O
identify	O
alterations	O
in	O
autonomic	O
function	O
through	O
the	O
analysis	O
of	O
heart	O
rate	O
variability	O
(	O
HRV	O
).	O

Adjusted	O
analyses	O
included	O
both	O
variables	O
known	O
to	O
be	O
related	O
to	O
the	O
infant	O
gut	O
microbiome	O
by	O
previous	O
studies	O
and	O
variables	O
significantly	O
related	O
to	O
infant	O
gut	O
microbiota	O
in	O
our	O
population	O
to	O
control	O
confounding	O
.	O

However	O
,	O
this	O
information	O
is	O
limited	O
to	O
a	O
single	O
study	O
,	O
which	O
was	O
conducted	O
in	O
a	O
relatively	O
small	O
sample	O
(	O
n	O
=	O
217	O
).	O

Expression	O
of	O
other	O
genes	O
was	O
unaffected	O
.	O

Thus	O
,	O
there	O
exists	O
a	O
near	O
-	O
global	O
public	O
health	O
policy	O
of	O
maternal	O
iron	O
supplementation	O
during	O
pregnancy	O
.	O

A	O
recent	O
27	O
-	O
year	O
study	O
of	O
children	O
whose	O
mothers	O
smoked	O
during	O
pregnancy	O
found	O
larger	O
annual	O
changes	O
in	O
cholesterol	O
levels	O
;	O
high	O
-	O
density	O
lipoprotein	O
cholesterol	O
levels	O
decreased	O
and	O
low	O
-	O
density	O
lipoprotein	O
cholesterol	O
levels	O
increased	O
more	O
than	O
in	O
children	O
not	O
exposed	O
to	O
tobacco	O
in	O
utero	O
.	O

We	O
speculate	O
that	O
our	O
findings	O
may	O
imply	O
adaptive	O
responses	O
to	O
early	O
life	O
cues	O
predicted	O
by	O
a	O
life	O
-	O
history	O
approach	O
,	O
although	O
confirmation	O
of	O
these	O
predictions	O
requires	O
further	O
studies	O
to	O
assess	O
reproductive	O
fitness	O
.	O

The	O
means	O
for	O
serum	O
25	O
(	O
OH	O
)	O
D	O
by	O
month	O
of	O
sampling	O
were	O
also	O
separated	O
for	O
women	O
recruited	O
in	O
Adelaide	O
and	O
women	O
recruited	O
in	O
Auckland	O
(	O
Fig	O
.	O
1b	O
).	O

In	O
addition	O
,	O
high	O
IMF	O
deposition	O
may	O
negatively	O
affect	O
YG	O
(	O
or	O
retail	O
beef	O
yield	O
).	O

This	O
usually	O
means	O
the	O
commencement	O
of	O
insulin	O
.	O

Patients	O
must	O
be	O
monitored	O
closely	O
for	O
potential	O
adverse	O
effects	O
of	O
corticosteroids	O
,	O
especially	O
gestational	O
diabetes	O
,	O
preeclampsia	O
,	O
and	O
intrauterine	O
growth	O
retardation	O
.	O

The	O
differences	O
in	O
gene	O
regulation	O
dependent	O
on	O
diet	O
and	O
ontogenetic	O
stage	O
indicate	O
fetal	O
programming	O
in	O
terms	O
of	O
developmental	O
and	O
metabolic	O
disorders	O
(	O
arrows	O
between	O
boxes	O
show	O
direction	O
of	O
the	O
comparison	O
;	O
small	O
arrows	O
indicate	O
up	O
and	O
down	O
regulation	O
,	O
respectively	O
;	O
PLK	O
,	O
Polo	O
-	O
like	O
kinase	O
;	O
VEGF	O
,	O
Vascular	O
endothelial	O
growth	O
factor	O
,	O
mTOR	O
,	O
mammalian	O
target	O
of	O
rapamycin	O
;	O
AMPK	O
,	O
AMP	O
-	O
activated	O
protein	O
kinase	O
;	O
RhoA	O
,	O
Ras	O
homolog	O
gene	O
family	O
,	O
member	O
A	O
;	O
Rac	O
,	O
Ras	O
-	O
related	O
C3	O
botulinum	O
toxin	O
substrate	O
;	O
FA	O
,	O
Fatty	O
acid	O
)	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Comparison	O
of	O
microarray	O
data	O
and	O
qRT	O
-	O
PCR	O
of	O
selected	O
transcriptsGene	O
nameMicroarrayqRT	O
-	O
PCR	O
#	O
Correlation	O
##	O
p	O
-	O
valueFCRegulationp	O
-	O
valueFCRegulationExpr	O
.	O

Early	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
and	O
extended	O
winter	O
were	O
independently	O
associated	O
with	O
significantly	O
higher	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
(	O
B	O
=	O
0	O
.	O
15	O
and	O
0	O
.	O
13	O
,	O
respectively	O
).	O

Fenton	O
and	O
colleagues	O
have	O
shown	O
that	O
gestational	O
exposure	O
to	O
PFOA	O
altered	O
the	O
normal	O
formation	O
of	O
the	O
milk	O
duct	O
system	O
in	O
mice	O
.	O
26In	O
a	O
multigenerational	O
mouse	O
follow	O
-	O
up	O
study	O
,	O
they	O
showed	O
that	O
PFOA	O
exposure	O
not	O
only	O
impaired	O
the	O
mouse	O
mothers	O
’	O
ability	O
to	O
lactate	O
,	O
but	O
also	O
adversely	O
affected	O
prenatal	O
development	O
of	O
the	O
mammary	O
gland	O
in	O
their	O
female	O
offspring	O
.	O

They	O
were	O
suffering	O
from	O
vitamin	O
D	O
deficiency	O
based	O
on	O
new	O
perspective	O
towards	O
normal	O
serum	O
vitamin	O
D	O
concentration	O
[	O
46	O
].	O

A	O
significant	O
interaction	O
was	O
detected	O
between	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
genotype	O
and	O
vitamin	O
A	O
supplementation	O
for	O
IMF	O
content	O
in	O
the	O
LM	O
.	O

Furthermore	O
,	O
the	O
common	O
practice	O
of	O
swaddling	O
infants	O
might	O
reduce	O
exposure	O
to	O
sunlight	O
.	O
2Thus	O
young	O
children	O
are	O
at	O
a	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

The	O
frequency	O
-	O
domain	O
components	O
were	O
also	O
evaluated	O
by	O
a	O
2	O
power	O
spectrum	O
.	O

“	O
We	O
started	O
to	O
look	O
at	O
breastfeeding	O
as	O
a	O
confounding	B
factor	O
in	O
our	O
studies	O
primarily	O
because	O
it	O
is	O
known	O
to	O
be	O
beneficial	O
to	O
child	O
health	O
,”	O
he	O
says	O
.	O

Diagnostic	O
Tests	O
and	O
Clinical	O
Course	O
EKG	O
showed	O
a	O
sinus	O
rhythm	O
with	O
a	O
rate	O
of	O
75	O
and	O
no	O
signs	O
of	O
ischemic	O
changes	O
.	O

More	O
detailed	O
questions	O
were	O
asked	O
about	O
daily	O
consumption	O
of	O
a	O
further	O
eight	O
basic	O
foods	O
(	O
including	O
sugar	O
,	O
coffee	O
and	O
tea	O
).	O

In	O
addition	O
to	O
the	O
previously	O
mentioned	O
soluble	O
factors	O
,	O
also	O
cells	O
are	O
transferred	O
in	O
utero	O
,	O
for	O
instance	O
,	O
leukocytes	O
pass	O
from	O
mother	O
to	O
fetus	O
.	O

Clinically	O
-	O
relevant	O
trends	O
were	O
seen	O
in	O
changes	O
in	O
medication	O
requirements	O
;	O
the	O
percentage	O
of	O
women	O
requiring	O
pharmacologic	O
treatment	O
decreased	O
from	O
31	O
.	O
1	O
%	O
to	O
26	O
.	O
9	O
%.	O

Mild	O
laxatives	O
and	O
basti	O
,	O
which	O
will	O
smoothen	O
genital	O
tract	O
.	O

Among	O
women	O
with	O
initial	O
25	O
(	O
OH	O
)	O
D	O
<	O
40	O
ng	O
/	O
mL	O
,	O
PTB	O
rates	O
were	O
60	O
%	O
lower	O
for	O
those	O
with	O
≥	O
40	O
vs	O
.	O
<	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
(	O
p	O
=	O
0	O
.	O
006	O
);	O
38	O
%	O
for	O
whites	O
(	O
p	O
=	O
0	O
.	O
33	O
)	O
and	O
78	O
%	O
for	O
non	O
-	O
whites	O
(	O
p	O
=	O
0	O
.	O
01	O
).	O

Bioinformatics	O
was	O
employed	O
as	O
secondary	O
analyses	O
.	O

(	O
A	O
)	O
Genomic	O
DNA	O
sequence	O
chromatograms	O
from	O
normal	O
(	O
upper	O
)	O
and	O
mutant	O
(	O
lower	O
)	O
Skm1	O
and	O
Skm2	O
mice	O
(	O
left	O
panel	O
and	O
right	O
panel	O
,	O
respectively	O
).	O

Some	O
studies	O
have	O
attributed	O
seasonal	O
differences	O
in	O
gestational	O
diabetes	O
to	O
temperature	O
changes	O
.	O

However	O
,	O
a	O
multi	O
-	O
centre	O
study	O
might	O
have	O
resulted	O
in	O
a	O
wider	O
variety	O
of	O
socio	O
-	O
economic	O
backgrounds	O
.	O

However	O
,	O
folate	O
had	O
fewer	O
effects	O
on	O
the	O
hypothalamus	O
of	O
offspring	O
born	O
to	O
HV	O
dams	O
.	O

The	O
offspring	O
are	O
hypertensive	O
,	O
show	O
vascular	O
changes	O
,	O
and	O
have	O
high	O
blood	O
insulin	O
levels	O
.	O

Vitamin	O
A	O
Restricting	O
vitamin	O
A	O
intake	O
increases	O
IMF	O
deposition	O
.	O

Summary	O
Based	O
on	O
currently	O
available	O
evidence	O
,	O
guidelines	O
for	O
primary	O
and	O
secondary	O
prevention	O
of	O
allergic	O
disease	O
can	O
be	O
summarized	O
as	O
follows	O
(	O
Table3	O
).	O

In	O
this	O
context	O
,	O
the	O
sheep	O
appears	O
to	O
be	O
a	O
very	O
good	O
model	O
,	O
because	O
as	O
for	O
humans	O
,	O
the	O
major	O
source	O
of	O
BAT	O
in	O
the	O
fetus	O
is	O
around	O
central	O
organs	O
and	O
is	O
replaced	O
by	O
WAT	O
after	O
birth	O
,	O
whereas	O
in	O
rodents	O
,	O
the	O
primary	O
BAT	O
depot	O
is	O
interscapular	O
and	O
it	O
remains	O
throughout	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

The	O
researchers	O
checked	O
the	O
women	O
’	O
s	O
levels	O
of	O
hemoglobin	O
(	O
which	O
transports	O
oxygen	O
)	O
and	O
ferritin	O
every	O
four	O
weeks	O
through	O
the	O
end	O
of	O
pregnancy	O
.	O

Of	O
these	O
,	O
49	O
.	O
6	O
%	O
recommendations	O
were	O
made	O
by	O
friends	O
and	O
neighbors	O
(	O
12	O
.	O
4	O
%)	O
mother	O
or	O
sister	O
(	O
12	O
.	O
4	O
%)	O
and	O
husband	O
(	O
10	O
%).	O

Long	O
-	O
acting	O
insulin	O
analogs	O
,	O
particularly	O
glargine	O
,	O
are	O
increasingly	O
being	O
used	O
in	O
women	O
with	O
type	O
1	O
diabetes	O
,	O
and	O
they	O
are	O
often	O
continued	O
through	O
the	O
pregnancy	O
.	O

One	O
possible	O
interpretation	O
for	O
our	O
present	O
data	O
is	O
that	O
a	O
vagal	O
withdrawal	O
,	O
rather	O
than	O
a	O
sympathetic	O
overactivity	O
,	O
could	O
precede	O
the	O
development	O
of	O
hypertension	O
and	O
other	O
cardiometabolic	O
diseases	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

Adipogenesis	O
in	O
beef	O
cattle	O
is	O
first	O
initiated	O
in	O
abdominal	O
(	O
visceral	O
)	O
adipocytes	O
around	O
mid	O
-	O
gestation	O
[	O
16	O
].	O

They	O
sought	O
to	O
have	O
the	O
mother	O
and	O
family	O
members	O
identify	O
perceived	O
barriers	O
to	O
their	O
own	O
handwashing	O
,	O
to	O
address	O
those	O
barriers	O
through	O
behavioral	O
solutions	O
,	O
and	O
to	O
enhance	O
maternal	O
self	O
-	O
efficacy	O
for	O
handwashing	O
in	O
the	O
neonatal	O
period	O
.	O

As	O
this	O
is	O
an	O
observational	O
study	O
,	O
we	O
cannot	O
conclude	O
that	O
the	O
information	O
about	O
the	O
roles	O
or	O
sources	O
of	O
nutrients	O
or	O
general	O
recommendations	O
about	O
diet	O
during	O
pregnancy	O
directly	O
influence	O
the	O
frequency	O
with	O
which	O
supplements	O
are	O
used	O
,	O
despite	O
the	O
fact	O
that	O
nutritional	O
knowledge	O
appears	O
to	O
be	O
an	O
important	O
determinant	O
.	O

Re	O
-	O
establishment	O
of	O
new	O
epigenetic	O
marks	O
then	O
redirects	O
and	O
drives	O
development	O
of	O
the	O
zygote	O
through	O
embryogenesis	O
and	O
ultimately	O
into	O
a	O
mature	O
adult	O
.	O

All	O
rats	O
were	O
kept	O
in	O
the	O
same	O
room	O
with	O
a	O
constant	O
temperature	O
maintained	O
at	O
25	O
°	O
C	O
and	O
a	O
12	O
-	O
h	O
light	O
,	O
12	O
-	O
h	O
dark	O
cycle	O
.	O

found	O
that	O
vitamin	O
D	O
insufficiency	O
is	O
common	O
in	O
the	O
sunny	O
climate	O
in	O
Saudi	O
Arabia	O
[	O
3	O
].	O

Further	O
,	O
other	O
studies	O
using	O
animal	O
models	O
show	O
that	O
preclinical	O
findings	O
in	O
rodents	O
exposed	O
to	O
SSRIs	O
during	O
development	O
point	O
to	O
an	O
increase	O
in	O
depression	O
and	O
anxiety	O
,	O
exhibiting	O
alteration	O
in	O
social	O
behaviors	O
in	O
the	O
offspring	O
.	O

Effect	O
on	O
the	O
incidence	O
of	O
pneumonia	O
of	O
vitamin	O
D	O
supplementation	O
by	O
quarterly	O
bolus	O
dose	O
to	O
infants	O
in	O
Kabul	O
:	O
a	O
randomised	O
controlled	O
superiority	O
trial	O
AbstractSummary	O
Background	O
Vitamin	O
D	O
has	O
a	O
role	O
in	O
regulating	O
immune	O
function	O
,	O
and	O
its	O
deficiency	O
is	O
a	O
suggested	O
risk	O
factor	O
for	O
childhood	O
pneumonia	O
.	O

We	O
also	O
report	O
unadjusted	O
estimates	O
for	O
analyses	O
and	O
analyses	O
further	O
adjusted	O
for	O
infant	O
age	O
at	O
sample	O
collection	O
in	O
the	O
supplemental	O
information	O
.	O

75	O
%	O
of	O
black	O
and	O
19	O
%	O
of	O
white	O
women	O
were	O
vitamin	O
D	O
deficient	O
in	O
the	O
first	O
trimester	O
.	O

Values	O
are	O
plotted	O
for	O
the	O
entire	O
cohort	O
(	O
black	O
),	O
lean	O
(	O
body	O
mass	O
index	O
<	O
25	O
kg	O
/	O
m2	O
,	O
blue	O
)	O
and	O
overweight	O
(	O
body	O
mass	O
index	O
≥	O
25	O
kg	O
/	O
m2	O
,	O
red	O
)	O
women	O
,	O
respectively	O
.	O

In	O
animals	O
,	O
D3is	O
synthesized	O
in	O
the	O
skin	O
from	O
its	O
derivate	O
(	O
7	O
-	O
dehydrocholesterol	O
)	O
in	O
the	O
presence	O
of	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
),	O
while	O
D2is	O
made	O
in	O
fungi	O
and	O
yeast	O
.	O

For	O
example	O
,	O
a	O
meta	O
-	O
analysis	O
by	O
Govarts	O
et	O
al	O
.	O

Skin	O
prick	O
tests	O
to	O
determine	O
sensitisation	O
to	O
common	O
allergens	O
are	O
common	O
medical	O
practice	O
in	O
infants	O
older	O
than	O
4	O
months	O
[	O
59	O
,	O
60	O
].	O

